Note: Descriptions are shown in the official language in which they were submitted.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
NOVEL PESTICIDAL PROTEINS AND STRAINS
The present invention is drawn to methods and compositions for controlling
plant
and non-plant pests. Particularly, new pesticidal proteins are disclosed which
are
isolatable from the vegetative growth stage of Bacillus. Bacillus strains,
proteins, and
genes encoding the proteins are provided. The methods and compositions of the
invention may be used in a variety of systems for controlling plant and non-
plant
pests.
Insect pests are a major factor in the loss of the world's commercially
important
agricultural crops. Broad spectrum chemical pesticides have been used
extensively to
control or eradicate pests of agricultural importance. There is, however,
substantial
interest in developing effective alternative pesticides.
Microbial pesticides have played an important role as alternatives to chemical
pest
control. The most extensively used microbial product is based on the bacterium
Bacillus thuringiensis (Bt). Bt is a gram-positive spore forming Bacillus
which
produces an insecticidal crystal protein (ICP) during sporulation.
Numerous varieties of Bt are known that produce more than 25 different but
related
ICP's. The majority of ICP's made by Bt are toxic to larvae of certain insects
in the
orders Lepidoptera, Diptera and Coleoptera. In general, when an ICP is
ingested by a
susceptible insect the crystal is solubilized and transformed into a toxic
moiety by the
insect gut proteases. None of the ICP's active against coleopteran larvae such
as
Colorado potato beetle (Leptinotarsa decemlineata) or Yellow mealworm
(Tenebrio
molitor) have demonstrated significant effects on members of the genus
Diabrotica
particularly Diabrotica virgifera virgiferal the western corn rootworm (WCRW)
or
Diabrotica longicornis barberi, the northern corn rootworm.
Bacillus cereus (Bc) is closely related to Bt. A major distinguishing
characteristic is
the absence of a parasporal crystal in Bc. Bc is a widely distributed
bacterium that is
commonly found in soil and has been isolated from a variety of foods and
drugs. The
organism has been implicated in the spoilage of food.
Although Bt has been very useful in controlling insect pests, there is a need
to
expand the number of potential biological control agents.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-2-
Within the present invention compositions and methods for controlling plant
pests
are provided. In particular, novel pesticidal proteins are provided which are
produced
during vegetative growth of Bacillus strains. The proteins are useful as
pesticidal
agents.
More specifically, the present invention relates to a substantially purified
Bacillus
strain which produces a pesticidal protein during vegetative growth wherein
said
Bacillus is not B. sphaericus SSII-1. Preferred are a Bacillus cereus strain
having
Accession No. NRRL B-21058 and Bacillus thuringiensis strain having Accession
No.
NRRL B-21060. Also preferred is a Bacillus strain selected from Accession
Numbers
NRRL B-21224, NRRL B-21225, NRRL B-21226, NRRL B-21227, NRRL B-21228,
NRRL B-21229, NRRL B-21230, and NRRL B-21439.
The invention further relates to an insect-specific protein isolatable during
the
vegetative growth phase of Bacillus spp, but preferably of a Bacillus
thuringiensis and
B. cereus strain, and components thereof, wherein said protein is not the
mosquitocidal toxin from B. sphaericus SSII-1. The insect-specific protein of
the
invention is preferably toxic to Coleoptera or Lepidoptera insects and has a
molecular
weight of about 30 kDa or greater, preferably of about 60 to about 100 kDa,
and more
preferably of about 80 kDa.
More particularly, the insect-specific protein of the invention has a spectrum
of
insecticidal activity that includes an activity against Agrotis and/or
Spodoptera
species, but preferably a black cutworm [Agrotis ipsilon ; BCW] and/or fall
armyworm
[Spodoptera frugiperda] and/or beet armyworm [Spodoptera exigua ] and/or
tobacco
budworm and/or corn earworm [Helicoverpa zea] activity.
The insect-specific protein of the invention can preferably be isolated, for
example,
from Bacillus cereus having Accession No. NRRL B-21058, or from Bacillus
thuringiensis having Accession No. NRRL B-21060.
The insect-specific protein of the invention can also preferably be isolated
from a
Bacillus spp strain selected from Accession Numbers NRRL B-21224, NRRL 8-
21225, NRRL B-21226, NRRL B-21227, NRRL B-21228, NRRL B-21229, NRRL B-
21230, and NRRL B-21439.
The present invention especially encompasses an insect-specific protein that
has
the amino acid sequence selected from the group consisting of SEQ ID NO:5 and
CA 02199049 2011-06-06
30506-101
-3-
SEQ ID NO: 7, including any proteins that are structurally and/or functionally
homologous
thereto.
Further preferred is an insect-specific protein, wherein said protein has the
sequence selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 21,
SEQ ID NO: 29, SEQ ID NO: 32 and SEQ ID NO: 2, including any proteins that are
structurally and/or functionally homologous thereto.
Especially preferred is an insect-specific protein, wherein said protein has
the sequence selected from the group consisting of SEQ ID NO: 29 and SEQ ID
NO: 32,
including any proteins that are structurally and/or functionally homologous
thereto.
In a specific embodiment, the invention relates to a vegetative insecticidal
protein secreted during the vegetative growth phase of Bacillus spp., wherein
said
vegetative insecticidal protein has at least 80% identity to SEQ ID NO: 29 or
SEQ ID NO: 32.
A further preferred embodiment of the invention comprises an
insect-specific protein of the invention, wherein the sequences representing
the secretion
signal have been removed or inactivated.
The present invention further encompasses auxiliary proteins which
enhance the insect-specific activity of an insect-specific protein. The said
auxiliary
proteins preferably have a molecular weight of about 50 kDa and can be
isolated, for
example, from the vegetative growth phase of a Bacillus cereus strain, but
especially of
Bacillus cereus strain AB78.
A preferred embodiment of the invention relates to an auxiliary protein,
wherein the sequences representing the secretion signal have been removed or
inactivated.
The present invention further relates to multimeric pesticidal proteins,
which comprise more than one polypeptide chain and wherein at least one of the
said
polypeptide chains represents an insect-specific protein of the invention and
at least one
of the said polypeptide chains represents an auxiliary
CA 02199049 2010-11-22
30506-101
-3a-
protein of the invention, which activates or enhances the pesticidal activity
of the
said insect-specific protein.
The multimeric pesticidal proteins according to the invention
preferably have a molecular weight of about 50 kDa to about 200 kDa.
The invention especially encompasses a multimeric pesticidal
protein, which comprises an insect-specific protein of the invention and an
auxiliary protein according to the invention, which activates or enhances the
pesticidal activity of the said insect-specific protein.
The present invention further relates to fusion proteins comprising
several protein domains including at least an insect-specific protein of the
invention and/or an auxiliary protein according to the invention produced by
in
frame genetic fusions,
2 199049
WO 96/10083 PCT/EP95/03826
-4-
which, when translated by ribosomes, produce a fusion protein with at least
the
combined attributes of the insect-specific protein of the invention and/or an
auxiliary
protein according to the invention and, optionally, of the other components
used in the
fusion.
A specific embodiment of the invention relates to a fusion protein comprising
a ribo-
nuclease S-protein, an insect-specific protein of the invention and an
auxiliary protein
according to the invention.
A further specific embodiment of the invention relates to a fusion protein
comprising an insect-specific protein according to the invention and an
auxiliary
protein according to the invention having either the insect-specific protein
or the
auxiliary protein at the N-terminal end of the said fusion protein.
Preferred is a fusion protein, which comprises an insect-specific protein as
given in
SEQ ID NO:5 and an auxiliary protein as given in SEQ ID NO: 2 resulting in the
protein given in SEQ ID NO: 23, including any proteins that are structurally
and/or
functionally homologous thereto.
Also preferred is a fusion protein, which comprises an insect-specific protein
as
given in SEQ ID NO:35 and an auxiliary protein as given in SEQ ID NO: 27
resulting in
the protein given in SEQ ID NO: 50, including any proteins that are
structurally and/or
functionally homologous thereto.
The invention further relates to a fusion protein comprising an insect-
specific
protein of the invention and/or an auxiliary protein according to the
invention fused to
a signal sequence, preferably a secretion signal sequence or a targeting
sequence
that directs the transgene product to a specific organelle or cell
compartment, which
signal sequence is of herterologous origin with respect to the recipient
protein.
Especially preferred within this invention is a fusion protein wherein the
said protein
has a sequence as given in SEQ ID NO: 43, or in SEQ ID NO: 46, including any
proteins that are structurally and/or functionally homologous thereto.
As used in the present application, substantial sequence homology means close
structural relationship between sequences of amino acids. For example,
substantially
homologous proteins may be 40% homologous, preferably 50% and most preferably
60% or 80% homologous, or more. Homology also includes a relationship wherein
one or several subsequences of amino acids are missing, or subsequences with
additional amino acids are interdispersed.
CA 02199049 2011-06-06
30506-101
-5-
A further aspect of the invention relates to a DNA molecule comprising
a nucleotide sequence which encodes an insect-specific protein isolatable
during the
vegetative growth phase of Bacillus spp. and components thereof, wherein said
protein is not the mosquitocidal toxin from B. sphaericus SSII-1. In
particular, the
present invention relates to a DNA molecule comprising a nucleotide sequence
which
encodes an insect-specific protein wherein the spectrum of insecticidal
activity
includes an activity against Agrotis and/or Spodoptera species, but preferably
a black
cutworm [Agrotis ipsilon; BCW] and/or fall armyworm [Spodoptera frugiperda]
and/or
beet armyworm [Spodoptera exigua] and/or tobacco budworm and/or corn earworm
[Helicoverpa zea] activity.
Preferred is a DNA molecule, wherein the said molecule comprises a
nucleotide sequence as given in SEQ ID NO: 4, or SEQ ID NO: 6, including any
DNA
molecules that are structurally and/or functionally homologous thereto.
Also preferred is a DNA molecule, wherein the said molecule comprises
a nucleotide sequence as given SEQ ID NO: 19, SEQ ID NO: 28, SEQ ID NO: 31, or
SEQ ID NO: 1, including any DNA molecules that are structurally and/or
functionally
homologous thereto.
In a specific embodiment, the invention relates to a DNA molecule
comprising a nucleotide sequence which encodes a vegetative insecticidal
protein
secreted during the vegetative growth phase of Bacillus spp., wherein a
complement
of said nucleotide sequence hybridizes to SEQ ID NO: 28 or SEQ ID NO: 31 at 65
C
in a buffer comprising 7% SDS and 0.5 M sodium phosphate.
In another specific embodiment, the invention relates to a DNA
molecule comprising a nucleotide sequence which encodes a vegetative
insecticidal
protein secreted during the vegetative growth phase, wherein said nucleotide
sequence has at least 80% identity to SEQ ID NO: 28 or SEQ ID NO: 31.
CA 02199049 2010-11-22
30506-101
-5a-
The invention further relates to a DNA molecule comprising a
nucleotide sequence which encodes an auxiliary protein according to the
invention
which enhances the insect-specific activity of an insect-specific protein.
Preferred is a DNA molecule, wherein the said molecule comprises a
nucleotide sequence as given SEQ ID NO: 19, including any DNA molecules that
are structurally and/or functionally homologous thereto.
A further embodiment of the invention relates to a DNA molecule
comprising a nucleotide sequence which encodes an insect-specific protein
isolatable during the vegetative growth phase of Bacillus spp. and components
thereof, wherein said protein is not the mosquitocidal toxin from B.
sphaericus
SSII-1, which nucleotide sequence has been optimized for expression in a
microorganism or a plant.
Preferred is a DNA molecule, wherein the said molecule comprises a
nucleotide sequence as given in SEQ ID NO: 17 or SEQ ID NO: 18, including any
DNA molecules that are structurally and/or functionally homologous thereto.
Also preferred is a DNA molecule, wherein the said molecule
comprises a nucleotide sequence as given in SEQ ID NO: 24, SEQ ID NO: 26,
SEQ ID NO: 27, or
2199049
WO 96/10083 PCT/EP95/03826
-6-
SEQ ID NO:30, including any DNA molecules that are structurally and/or
functionally
homologous thereto.
The invention further relates to a DNA molecule which comprises a nucleotide
sequence encoding a multimeric pesticidal protein, which comprises more than
one
polypeptide chains and wherein at least one of the said polypeptide chains
represents
an insect-specific protein of the invention and at least one of the said
polypeptide
chains represents an auxiliary protein according to the invention, which
activates or
enhances the pesticidal activity of the said insect-specific protein.
Preferred is a DNA molecule comprising a nucleotide sequence encoding an
insect-specific protein of the invention and an auxiliary protein according to
the
invention, which activates or enhances the pesticidal activity of the said
insect-specific
protein.
Especially preferred is a DNA molecule, wherein said molecule comprises a
nucleotide sequence as given in SEQ ID NO:1 or SEQ ID NO:19, including any
nucleotide sequences that are structurally and/or functionally homologous
thereto.
A further embodiment of the invention relates to a DNA molecule which
comprises a
nucleotide sequence encoding a fusion protein comprising several protein
domains
including at least an insect-specific protein of the invention and/or an
auxiliary protein
according to the invention produced by in frame genetic fusions, which, when
translated by ribosomes, produce a fusion protein with at least the combined
attributes
of the insect-specific protein of the invention and/or an auxiliary protein
according to
the invention and, optionally, of the other components used in the fusion.
Preferred within the invention is a DNA molecule which comprises a nucleotide
sequence encoding a fusion protein comprising an insect-specific protein
according to
the invention and an auxiliary protein according to the invention having
either the
insect-specific protein or the auxiliary protein at the N-terminal end of the
said fusion
protein. Especially preferred is a DNA molecule, wherein the said molecule
comprises
a nucleotide sequence as given in SEQ ID NO:22, including any DNA molecules
that
are structurally and/or functionally homologous thereto.
The invention further relates to a DNA molecule which comprises a nucleotide
sequence encoding a fusion protein comprising an insect-specific protein of
the
invention and/or an auxiliary protein of the invention fused to a signal
sequence,
preferably a secretion signal sequence or a targeting sequence that directs
the
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95103826
-7-
transgene product to a specific organelle or cell compartment, which signal
sequence
is of herterologous origin with respect to the recipient DNA.
The present invention further encompasses a DNA molecule comprising a
nucleotide sequence encoding a fusion protein or a mulitmeric protein
according to
the invention that has been optimized for expression in a microorganism or
plant.
Preferred is an optimized DNA molecule, wherein the said molecule comprises a
nucleotide sequence as given in SEQ ID NO:42, SEQ ID NO:45, or SEQ ID NO:49,
including any DNA molecules that are structurally and/or functionally
homologous
thereto.
The invention further relates to an optimized DNA molecule, wherein the
sequences encoding the secretion signal have been removed from its 5' end, but
especially to an optimized DNA molecule, wherein the said molecule comprises a
nucleotide sequence as given in SEQ ID NO: 35 or SEQ ID NO:39, including any
DNA
molecules that are structurally and/or functionally homologous thereto.
As used in the present application, substantial sequence homology means close
structural relationship between sequences of nucleotides. For example,
substantially
homologous DNA molecules may be 60% homologous, preferably 80% and most
preferably 90% or 95% homologous, or more. Homology also includes a
relationship
wherein one or several subsequences of nucleotides or amino acids are missing,
or
subsequences with additional nucleotides or amino acids are interdispersed.
Also comprised by the present invention are DNA molecules which hybridizes to
a
DNA molecule according to the invention as defined hereinbefore, but
preferably to an
oligonucleotide probe obtainable from said DNA molecule comprising a
contiguous
portion of the coding sequence for the said insect-specific protein at least
10
nucleotides in length, under moderately stringent conditions and which
molecules
have insect-specific activity and also the insect-specific proteins being
encoded by the
said DNA molecules.
Preferred are DNA molecules, wherein hybridization occurs at 65 C in a buffer
comprising 7% SDS and 0.5 M sodium phosphate.
Especially preferred is a DNA molecule comprising a nucleotide sequence which
encodes an insect-specific protein according to the invention obtainable by a
process
comprising
CA 02199049 2010-11-22
30506-101
-8-
(a) obtaining a DNA molecule comprising a nucleotide sequence encoding an
insect-specific protein; and
(b) hybridizing said DNA molecule with an oligonucleotide probe as described
herein obtained from a DNA molecule comprising a nucleotide sequence as given
in SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 31; and
(c) isolating said hybridized DNA.
In a specific embodiment, the invention relates to a DNA molecule
comprising a nucleotide sequence which encodes the vegetative insecticidal
protein as described herein obtained by a process comprising: (a) obtaining a
DNA molecule comprising a nucleotide sequence encoding a vegetative
insecticidal protein; and (b) hybridizing said DNA molecule to the complement
of
SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 31 at 65 C in a buffer comprising
7% SDS and 0.5 M sodium phosphate; and (c) isolating said hybridized DNA.
The invention further relates to an insect-specific protein, wherein
the said protein is encoded by a DNA molecule according to the invention.
Also encompassed by the invention is an expression cassette
comprising a DNA molecule according to the invention operably linked to
expression sequences including the transcriptional and translational
regulatory
signals necessary for expression of the associated DNA constructs in a host
organism, preferably a microorganism or a plant, and optionally further
regulatory
sequences.
The invention further relates to a vector molecule comprising an
expression cassette according to the invention.
The expression cassette and/or the vector molecule according to the
invention are preferably part of the plant genome.
CA 02199049 2010-11-22
30506-101
-8a-
A further embodiment of the invention relates to a host organism,
preferably a host organism selected from the group consisting of plant and
insect
cells, bacteria, yeast, baculoviruses, protozoa, nematodes and algae,
comprising
a DNA molecule according to the invention, an expression cassette comprising
the
said DNA molecule or a vector molecule comprising the said expression
cassette,
preferably stably incorporated into the genome of the host organism.
The invention further relates to a transgenic plant, but preferably a
maize plant, including parts as well as progeny and seed thereof comprising a
DNA molecule according to the invention, an expression cassette comprising the
said DNA molecule or a vector molecule comprising the said expression
cassette,
preferably stably incorporated into the plant genome.
Preferred is a transgenic plant including parts as well as progeny
and seed thereof which has been stably transformed with a DNA molecule
according to the invention, an expression cassette comprising the said DNA
molecule or a vector molecule comprising the said expression cassette.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-9-
Also preferred is a transgenic plant including parts as well as progeny and
seed
thereof which expresses an insect-specific protein according to the invention.
The invention further relates to a transgenic plant, preferably a maize plant,
according to the invention as defined hereinbefore, which further expresses a
second
distinct insect control principle, but preferably a Bt S-endotoxin. The said
plant is
preferably a hybrid plant.
Parts of transgenic plants are to be understood within the scope of the
invention to
comprise, for example, plant cells, protoplasts, tissues, callus, embryos as
well as
flowers, stems, fruits, leaves, roots originating in transgenic plants or
their progeny
previously transformed with a DNA molecule according to the invention and
therefore
consisting at least in part of transgenic cells, are also an object of the
present
invention.
The invention further relates to plant propagating material of a plant
according to
the invention, which is treated with a seed protectant coating.
The invention further encompasses a microorganism transformed with a DNA
molecule according to the invention, an expression cassette comprising the
said DNA
molecule or a vector molecule comprising the said expression cassette, wherein
the
said microorganism is preferably a microorganism that multiply on plants and
more
preferably a root colonizing bacterium.
A further embodiment of the invention relates to an encapsulated insect-
specific
protein which comprises a microorganism comprising an insect specific protein
according to the invention.
The invention also relates to an entomocidal composition comprising a host
organism of the invention, but preferably a purified Bacillus strain, in an
insecticidally-
effective amount together with a suitable carrier.
Further comprised by the invention is an entomocidal composition comprising an
isolated protein molecule according to the invention, alone or in combination
with a
host organism of the invention and/or an encapsulated insect-specific protein
according to the invention, in an insecticidally-effective amount, together
with a
suitable carrier.
A further embodiment of the invention relates to a method of obtaining a
purified
insect-specific protein according to the invention, said method comprising
applying a
CA 02199049 2011-06-06
30506-101
-10-
solution comprising said insect-specific protein to a NAD column and eluting
bound
protein.
Also comprised is a method for identifying insect activity of an
insect-specific protein according to the invention, said method comprising:
growing a Bacillus strain in a culture;
obtaining supernatant from said culture;
allowing insect larvae to feed on diet with said supernatant; and,
determining mortality.
Another aspect of the invention relates to a method for isolating an
insect-specific protein according to the invention, said method comprising:
growing a Bacillus strain in a culture;
obtaining supernatant from said culture; and,
isolating said insect-specific protein from said supernatant.
In a particular embodiment, the invention relates to a method for
isolating a vegetative insecticidal protein as described herein, said method
comprising: (a) growing a Bacillus strain in a liquid culture; (b) obtaining
supernatant
from said culture; (c) precipitating secreted proteins from the supernatant of
step (b);
and (d) isolating said vegetative insecticidal protein from said supernatant.
The invention also encompasses a method for isolating a DNA
molecule comprising a nucleotide sequence encoding an insect-specific protein
exhibiting the insecticidal activity of the proteins according to the
invention, said
method comprising:
CA 02199049 2011-06-06
30506-101
- 10a -
obtaining a DNA molecule comprising a nucleotide sequence encoding
an insect-specific protein; and
hybridizing said DNA molecule with DNA obtained from a Bacillus
species; and
isolating said hybridized DNA.
In a particular embodiment, the invention relates to a method for
isolating a DNA molecule comprising a nucleotide sequence encoding a
vegetative
insecticidal protein as described herein, said method comprising: (a)
obtaining a
DNA molecule comprising a nucleotide sequence encoding a vegetative
insecticidal
protein; and (b) hybridizing said DNA molecule with SEQ ID NO: 28, SEQ ID NO:
30,
SEQ ID NO: 31 or SEQ ID NO: 51; and (c) isolating said hybridized DNA.
The invention further relates to a method of increasing insect target
range by using an insect specific protein according to the invention in
combination
with at least one second insecticidal protein that is different from the
insect specific
protein according to the invention, but preferably with an insecticidal
protein selected
from the group consisting of Bt b-endotoxins, protease inhibitors, lectins, a-
amylases
and peroxidases.
Preferred is a method for increasing insect target range within a plant
by expressing within the said plant a insect specific protein according to the
invention
in combination with at least one second insecticidal protein that is different
from the
insect specific protein according to the invention, but preferably with an
insecticidal
protein selected from the group consisting of Bt 6-endotoxins, protease
inhibitors,
lectins, a-amylases and peroxidases.
WO 96/10083 y PCT/EP95/03826
-11-
Also comprised is a method of protecting plants against damage caused by an
insect pest, but preferably by Spodoptera and/or Agrotis species, and more
preferably
by an insect pest selected from the group consisting of black cutworm [Agrotis
ipsilon ;
BCW], fall armyworm [Spodoptera frugiperda], beet armyworm [Spodoptera exigua
],
tobacco budworm and corn earworm [Helicoverpa zea] comprising applying to the
plant or the growing area of the said plant an entomocidal composition or a
toxin
protein according to the invention.
The invention further relates to method of protecting plants against damage
caused by an insect pest, but preferably by Spodoptera and/or Agrotis species,
and
more preferably by an insect pest selected from the group consisting of black
cutworm
[Agrotis ipsilon ; BCW], fall armyworm [Spodoptera frugiperda], beet armyworm
[Spodoptera exigua ], tobacco budworm and corn earworm [Helicoverpa zea]
comprising planting a transgenic plant expressing a insect-specific protein
according
to the invention within an area where the said insect pest may occur.
The invention also encompasses a method of producing a host organism which
comprises stably integrated into its genome a DNA molecule according to the
invention and preferably expresses an insect-specific protein according to the
invention comprising transforming the said host organism with a DNA molecule
according to the invention, an expression cassette comprising the said DNA
molecule
or a vector molecule comprising the said expression cassette.
A further embodiment of the invention relates to a method of producing a
transgenic plant or plant cell which comprises stably integrated into the
plant genome
a DNA molecule according to the invention and preferably expresses an insect-
specific protein according to the invention comprising transforming the said
plant and
plant cell, respectively, with a DNA molecule according to the invention, an
expression
cassette comprising the said DNA molecule or a vector molecule comprising the
said
expression cassette.
The invention also relates to a method of producing an entomocidal composition
comprising mixing an isolated Bacillus strain and/or a host organism and/or an
isolated protein molecule, and/or an encapsulated protein according to the
invention
in an insecticidally-effective amount with a suitable carrier.
The invention also encompasses a method of producing transgenic progeny of a
transgenic parent plant comprising stably incorporated into the plant genome a
DNA
CA 02199049 2011-06-06
30506-101
-12-
molecule comprising a nucleotide sequence encoding an insect-specific protein
according to the invention comprising transforming the said parent plant with
a DNA
molecule according to the invention, an expression cassette comprising the
said DNA
molecule or a vector molecule comprising the said expression cassette and
transferring the pesticidal trait to the progeny of the said transgenic parent
plant
involving known plant breeding techniques.
Also encompassed by the invention is an oligonucleotide probe capable
of specifically hybridizing to a nucleotide sequence encoding an insect-
specific
protein isolatable during the vegetative growth phase of Bacillus spp. and
components thereof, wherein said protein is not the mosquitocidal toxin from
B. sphaericus SSII-1, wherein said probe comprises a contiguous portion of the
coding sequence for the said insect-specific protein at least 10 nucleotides
in length
and the use of the said oligonucleotide probe for screening of any Bacillus
strain or
other organisms to determine whether the insect-specific protein is naturally
present
or whether a particular transformed organism includes the said gene.
In a specific embodiment, the invention relates to an oligonucleotide
probe for identifying a vegetative insecticidal protein coding sequence,
wherein said
probe is capable of specifically hybridizing at 65 C in a buffer comprising 7%
SDS
and 0.5 M sodium phosphate to a nucleotide sequence encoding a vegetative
insecticidal protein secreted during the vegetative growth phase of Bacillus
spp.,
wherein said probe comprises at least a 10 contiguous nucleotide portion of
SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO: 51.
The present invention recognizes that pesticidal proteins are produced
during vegetative growth of Bacillus strains. Having recognized that such a
class
exists, the present invention embraces all vegetative insecticidal proteins,
hereinafter
referred to as VIPs, except for the mosquitocidal toxin from B. sphaericus.
CA 02199049 2010-11-22
30506-101
-12a-
The present VIPs are not abundant after sporulation and are
particularly expressed during log phase growth before stationary phase. For
the
purpose of the present invention vegetative growth is defined as that period
of
time before the onset of sporulation. Genes encoding such VIPs can be
isolated,
cloned and transformed into various delivery vehicles for use in pest
management
programs.
For purposes of the present invention, pests include but are not
limited to insects, fungi, bacteria, nematodes, mites, ticks, protozoan
pathogens,
animal-parasitic liver flukes, and the like. Insect pests include insects
selected
from the orders Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga,
Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera,
Anoplura, Siphonaptera, Trichoptera, etc., particularly Coleoptera and
Lepidoptera.
Tables 1 - 10 gives a list of pests associated with major crop plants
and pests of human and veterinary importance. Such pests are included within
the scope of the present invention.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-13-
TABLE 1
Lepidoptera (Butterflies and Moth)
Maize
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
Helicoverpa zea, corn earworm
Spodoptera frugiperda, fall armyworm
Diatraea grandiosella, southwestern corn borer
Elasmopalpus lignosellus, lesser cornstalk borer
Diatraea saccharalis, sugarcane borer
Sorghum
Chilo partellus, sorghum borer
Spodoptera frugiperda, fall armyworm
Helicoverpa zea, corn earworm
Elasmopalpus lignosellus, lesser cornstalk borer
Feltia subterranea, granulate cutworm
Wheat
Pseudaletia unipunctata, army worm
Spodoptera frugiperda, fall armyworm
Elasmopalpus lignosellus, lesser cornstalk borer
Agrotis orthogonia, pale western cutworm
Elasmopalpus lignosellus, lesser cornstalk borer
Sunflower
Suleima helianthana, sunflower bud moth
Homoeosoma electellum, sunflower moth
Cotton
Heliothis virescens, cotton boll worm
Helicoverpa zea, cotton bollworm
Spodoptera exigua, beet armyworm
Pectinophora gossypiella, pink bollworm
Rice
Diatraea saccharalis, sugarcane borer
Spodoptera frugiperda, fall armyworm
Helicoverpa zea, corn earworm
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-14-
Soybean
Pseudoplusia includens, soybean looper
Anticarsia gemmatalis, velvetbean caterpillar
Plathypena scabra, green cloverworm
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
Spodoptera exigua, beet armyworm
Heliothis virescens, cotton boll worm
Helicoverpa zea, cotton bollworm
Barley
Ostrinia nubilalis, European corn borer
Agrotis ipsilon, black cutworm
TABLE 2
Coleoptera (Beetles)
Maize
Diabrotica virgifera virgifera, western corn rootworm
Diabrotica longicornis barberi, northern corn rootworm
Diabrotica undecimpunctata howardi, southern corn rootworm
Melanotus spp., wireworms
Cyclocephala borealis, northern masked chafer (white grub)
Cyclocephala immaculata, southern masked chafer (white grub)
Popilliajaponica, Japanese beetle
Chaetocnema pulicaria, corn flea beetle
Sphenophorus maidis, maize billbug
Sorghum
Phyllophaga crinita, white grub
Eleodes, Conoderus, and Aeolus spp., wireworms
Oulema melanopus, cereal leaf beetle
Chaetocnema pulicaria, corn flea beetle
Sphenophorus maidis, maize billbug
Wheat
Oulema melanopus, cereal leaf beetle
Hypera punctata, clover leaf weevil
Diabrotica undecimpunctata howardi, southern corn rootworm
Sunflower
WO 96/10083 2 1 9.9 0 4 9 PCT/EP95/03826
-15-
Zygogramma exclamationis, sunflower beetle
Bothyrus gibbosus, carrot beetle
Cotton
Anthonomus grandis, boll weevil
Rice
Colaspis brunnea, grape colaspis
Lissorhoptrus oryzophilus, rice water weevil
Sitophilus oryzae, rice weevil
Soybean
Epilachna varivestis, Mexican bean beetle
TABLE 3
Homoptera (Whiteflies, Aphids etc..)
Maize
Rhopalosiphum maidis, corn leaf aphid
Anuraphis maidiradicis, corn root aphid
Sorghum
Rhopalosiphum maidis, corn leaf aphid
Sipha flava, yellow sugarcane aphid
Wheat
Russian wheat aphid
Schizaphis graminum, greenbug
Macrosiphum avenae, English grain aphid
Cotton
Aphis gossypii, cotton aphid
Pseudatomoscelis seriatus, cotton fleahopper
Trialeurodes abutilonea, bandedwinged whitefly
Rice
Nephotettix nigropictus, rice leafhopper
---2199049
WO 96/10083 PCT/EP95/03826
-16-
Soybean
Myzus persicae, green peach aphid
Empoasca fabae, potato leafhopper
Barley
Schizaphis graminum, greenbug
Oil Seed Rape
Brevicoryne brassicae, cabbage aphid
TABLE 4
Hemiptera (Bugs)
Maize
Blissus leucopterus leucopterus, chinch bug
Sorghum
Blissus leucopterus leucopterus, chinch bug
Cotton
Lygus lineolaris, tarnished plant bug
Rice
Blissus leucopterus leucopterus, chinch bug
Acrosternum hilare, green stink bug
Soybean
Acrosternum hilare, green stink bug
Barley
Blissus leucopterus leucopterus, chinch bug
Acrosternum hilare, green stink bug
Euschistus servus, brown stink bug
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-17-
TABLE 5
Orthoptera (Grasshoppers, Crickets, and Cockroaches)
Maize
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus sanguinipes, migratory grasshopper
Wheat
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Melanoplus sanguinipes, migratory grasshopper
Cotton
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Soybean
Melanoplus femurrubrum, redlegged grasshopper
Melanoplus differentialis, differential grasshopper
Structural/Household
Periplaneta americana, American cockroach
Blattella germanica, German cockroach
Blatta orientalis, oriental cockroach
TABLE 6
Diptera (Flies and Mosquitoes)
Maize
Hylemya platura, seedcorn maggot
Agromyza parvicornis, corn blotch leafminer
Sorghum
Contarinia sorghicola, sorghum midge
2 199049
WO 96/10083 PCT/EP95/03826
-18-
Wheat
Mayetiola destructor, Hessian fly
Sitodiplosis mosellana, wheat midge
Meromyza americana, wheat stem maggot
Hylemya coarctata, wheat bulb fly
Sunflower
Neolasioptera murtfeldtiana, sunflower seed midge
Soybean
Hylemya platura, seedcorn maggot
Barley
Hylemya platura, seedcorn maggot
Mayetiola destructor, Hessian fly
Insects attacking humans and animals and disease carriers
Aedes aegypti, yellowfever mosquito
Aedes albopictus, forest day mosquito
Phiebotomus papatasii, sand fly
Musca domestica, house fly
Tabanus atratus, black horse fly
Cochliomyia hominivorax, screwworm fly
TABLE 7
Thysanoptera (Thrips)
Maize
Anaphothrips obscurus, grass thrips
Wheat
Frankliniella fusca, tobacco thrips
Cotton
Thrips tabaci, onion thrips
Frankliniella fusca, tobacco thrips
WO 96/10083 2 1 S 9 4 9 1 PCT/EP95/03826
-19-
Soybean
Sericothrips variabilis, soybean thrips
Thrips tabaci, onion thrips
TABLE 8
Hymenoptera (Sawflies, Ants, Wasps, etc.)
Maize
Solenopsis milesta, thief ant
Wheat
Cephus cinctus, wheat stem sawfly
TABLE 9
Other Orders and Representative Species
Dermaptera (Earwigs)
Forficula auricularia, European earwig
Isoptera (Termites)
Reticulitermes flavipes, eastern subterranean termite
Mallophaga (Chewing Lice)
Cuclotogaster heterographa, chicken head louse
Bovicola bovis, cattle biting louse
Anoplura (Sucking Lice)
Pediculus humanus, head and body louse
Siphonaptera (Fleas)
Ctenocephalides felis, cat flea
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-20-
TABLE 10
Acari (Mites and Ticks)
Maize
Tetranychus urticae, twospotted spider mite
Sorghum
Tetranychus cinnabarinus, carmine spider mite
Tetranychus urticae, twospotted spider mite
Wheat
Aceria tulipae, wheat curl mite
Cotton
Tetranychus cinnabarinus, carmine spider mite
Tetranychus urticae, twospotted spider mite
Soybean
Tetranychus turkestani, strawberry spider mite
Tetranychus urticae, twospotted spider mite
Barley
Petrobia latens, brown wheat mite
Important human and animal Acari
Demacentor variabilis, American dog tick
Argas persicus, fowl tick
Dermatophagoides farinae, American house dust mite
Dermatophagoides pteronyssinus, European house dust mite
Now that it has been recognized that pesticidal proteins can be isolated from
the
vegetative growth phase of Bacillus, other strains can be isolated by standard
techniques and tested for activity against particular plant and non-plant
pests.
Generally Bacillus strains can be isolated from any environmental sample,
including
soil, plant, insect, grain elevator dust, and other sample material, etc., by
methods
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-21-
known in the art. See, for example, Travers et a!. (1987) Appl. Environ.
Microbiol.
53:1263-1266; Saleh et al. (1969) Can J. Microbiol. 15:1101-1104; DeLucca et
al.
(1981) Can. J. Microbiol. 27:865-870; and Norris, et al. (1981) "The genera
Bacillus
and Sporolactobacillus," In Starr et al. (eds.), The Prokaryotes: A Handbook
on
Habitats, Isolation, and Identification of Bacteria, Vol. II, Springer-Verlog
Berlin
Heidelberg. After isolation, strains can be tested for pesticidal activity
during
vegetative growth. In this manner, new pesticidal proteins and strains can be
identified.
Such Bacillus microorganisms which find use in the invention include Bacillus
cereus and Bacillus thuringiensis, as well as those Bacillus species listed in
Table 11.
TABLE 11
List of Bacillus species
Morphological Group 1
B. megaterium
B. cereus*
B. cereus var. mycoides
B. thuringiensis*
B. licheniformis
B. subtilis*
B. pumilus
B. firmus*
B. coagulans
Morphological Group 2
B. polymyxa
B. macerans
B. circulans
B. stearothermophilus
B. alvei*
B. laterosporus*
B. brevis
B. pulvifaciens
B. popilliae*
B. lentimorbus *
B. larvae*
2199049
WO 96/10083 PCT/EP95/03826
-22-
Morphological Group 3
B. sphaericus*
B. pasteurii
Unassigned Strains
Subgroup A
B. apiarus*
B. filicolonicus
B. thiaminolyticus
B. alcalophilus
Subgroup B
B. cirroflagellosus
B. chitinosporus
B. lentus
Subgroup C
B. badius
B. aneurinolyticus
B. macroides
B. freundenreichii
Subgroup D
B. pantothenticus
B. epiphytus
Subgroup El
B. aminovorans
B. globisporus
B. insolitus
B. psychrophilus
Subgroup E2
B. psychrosaccharolyticus
B. macquariensis
*=Those Bacillus strains that have been previously found associated with
insects
Grouping according to Parry, J.M. et al. (1983) Color Atlas of Bacillus
species, Wolfe
Medical Publications, London.
WO 96/10083 9 0J PCT/EP95/03826
-23-
In accordance with the present invention, the pesticidal proteins produced
during
vegetative growth can be isolated from Bacillus. In one embodiment,
insecticidal
proteins produced during vegetative growth, can be isolated. Methods for
protein
isolation are known in the art. Generally, proteins can be purified by
conventional
chromatography, including gel-filtration, ion-exchange, and immunoaffinity
chromatography, by high-performance liquid chromatography, such as
reversed-phase high-performance liquid chromatography, ion-exchange
high-performance liquid chromatography, size-exclusion high-performance liquid
chromatography, high-performance chromatofocusing and hydrophobic interaction
chromatography, etc., by electrophoretic separation, such as one-dimensional
gel
electrophoresis, two-dimensional gel electrophoresis, etc. Such methods are
known
in the art. See for example Current Protocols in Molecular Biology, Vols. 1
and 2,
Ausubel et al. (eds.), John Wiley & Sons, NY (1988). Additionally, antibodies
can be
prepared against substantially pure preparations of the protein. See, for
example,
Radka et al. (1983) J. Immunol. 128:2804; and Radka et al. (1984)
Immunogenetics
19:63. Any combination of methods may be utilized to purify protein having
pesticidal
properties. As the protocol is being formulated, pesticidal activity is
determined after
each purification step.
Such purification steps will result in a substantially purified protein
fraction. By
"substantially purified" or "substantially pure" is intended protein which is
substantially
free of any compound normally associated with the protein in its natural
state.
"Substantially pure" preparations of protein can be assessed by the absence of
other
detectable protein bands following SDS-PAGE as determined visually or by
densitometry scanning. Alternatively, the absence of other amino-terminal
sequences
or N-terminal residues in a purified preparation can indicate the level of
purity. Purity
can be verified by rechromatography of "pure" preparations showing the absence
of
other peaks by ion exchange, reverse phase or capillary electrophoresis. The
terms
"substantially pure" or "substantially purified" are not meant to exclude
artificial or
synthetic mixtures of the proteins with other compounds. The terms are also
not
meant to exclude the presence of minor impurities which do not interfere with
the
biological activity of the protein, and which may be present, for example, due
to
incomplete purification.
r 2199049
WO 96/10083 PCT/EP95/03826
-24-
Once purified protein is isolated, the protein, or the polypeptides of which
it is
comprised, can be characterized and sequenced by standard methods known in the
art. For example, the purified protein, or the polypeptides of which it is
comprised,
may be fragmented as with cyanogen bromide, or with proteases such as papain,
chymotrypsin, trypsin, lysyl-C endopeptidase, etc. (Oike et al. (1982) J.
Biol. Chem.
257:9751-9758; Liu eta!. (1983) Int. J. Pept. Protein Res. 21:209-215). The
resulting
peptides are separated, preferably by HPLC, or by resolution of gels and
electroblotting onto PVDF membranes, and subjected to amino acid sequencing.
To
accomplish this task, the peptides are preferably analyzed by automated
sequenators.
It is recognized that N-terminal, C-terminal, or internal amino acid sequences
can be
determined. From the amino acid sequence of the purified protein, a nucleotide
sequence can be synthesized which can be used as a probe to aid in the
isolation of
the gene encoding the pesticidal protein.
It is recognized that the pesticidal proteins may be oligomeric and will vary
in
molecular weight, number of protomers, component peptides, activity against
particular pests, and in other characteristics. However, by the methods set
forth
herein, proteins active against a variety of pests may be isolated and
characterized.
Once the purified protein has been isolated and characterized it is recognized
that
it may be altered in various ways including amino acid substitutions,
deletions,
truncations, and insertions. Methods for such manipulations are generally
known in
the art. For example, amino acid sequence variants of the pesticidal proteins
can be
prepared by mutations in the DNA. Such variants will possess the desired
pesticidal
activity. Obviously, the mutations that will be made in the DNA encoding the
variant
must not place the sequence out of reading frame and preferably will not
create
complementary regions that could produce secondary mRNA structure. See, EP
Patent Application Publication No. 75,444.
In this manner, the present invention encompasses the pesticidal proteins as
well
as components and fragments thereof. That is, it is recognized that component
protomers, polypeptides or fragments of the proteins may be produced which
retain
pesticidal activity. These fragments include truncated sequences, as well as
N-terminal, C-terminal, internal and internally deleted amino acid sequences
of the
proteins.
WO 96/10083 - PCT/EP95/03826
2199049
-25-
Most deletions, insertions, and substitutions of the protein sequence are not
expected to produce radical changes in the characteristics of the pesticidal
protein.
However, when it is difficult to predict the exact effect of the substitution,
deletion, or
insertion in advance of doing so, one skilled in the art will appreciate that
the effect
will be evaluated by routine screening assays.
The proteins or other component polypeptides described herein may be used
alone
or in combination. That is, several proteins may be used to control different
insect
pests.
Some proteins are single polypeptide chains while many proteins consist of
more
than one polypeptide chain, i.e., they are oligomeric. Additionally, some VIPs
are
pesticidally active as oligomers. In these instances, additional protomers are
utilized
to enhance the pesticidal activity or to activate pesticidal proteins. Those
protomers
which enhance or activate are referred to as auxiliary proteins. Auxiliary
proteins
activate or enhance a pesticidal protein by interacting with the pesticidal
protein to
form an oligomeric protein having increased pesticidal activity compared to
that
observed in the absence of the auxiliary protein.
Auxiliary proteins activate or increase the activity of pesticidal proteins
such as the
VIP1 protein from AB78. Such auxiliary proteins are exemplified by, but not
limited to,
the VIP2 protein from AB78. As demonstrated in the Experimental section of the
application, auxiliary proteins can activate a number of pesticidal proteins.
Thus, in
one embodiment of the invention, a plant, Parent 1, can be transformed with an
auxiliary protein. This Parent 1 can be crossed with a number of Parent 2
plants
transformed with one or more pesticidal proteins whose pesticidal activities
are
activated by the auxiliary protein.
Amongst the pesticidal proteins of the invention a new class of insect-
specific
proteins could be surprisingly identified within the scope of the present
invention. The
said proteins, which are designated throughout this application as VIP3, can
be
obtained from Bacillus spp strains, but preferably from Bacillus thuringiensis
strains
and most preferably from Bacillus thuringiensis strains AB88 and AB424. The
said
VIPs are present mostly in the supernatants of Bacillus cultures amounting to
at least
75% of the total in strain AB88. The VIP3 proteins are further characterized
by their
unique spectrum of insectical acitivity, which includes an activity against
Agrotis
and/or Spodoptera species, but especially a black cutworm [BCW] and/or fall
WO 96/10083 e 2 1 9 9 0 4 9 PCT/EP95/03826
-26-
armyworm and/or beet armyworm and/or tobacco budworm and/or corn earworm
activity.
Black cutworm is an agronomically important insect quite resistant to S-
endotoxins.
Macintosh et al (1990) J Invertebr Pathol 56, 258-266 report that the
&endotoxins
CryIA(b) and CryIA(c) possesses insecticidal properties against BCW with LCso
of
more than 80 g and 18 gg/ml of diet respectively. The vip3A insecticidal
proteins
according to the invenition provide >50% mortality when added in an amount of
protein at least 10 to 500, preferably 50 to 350, and more preferably 200 to
300 fold
lower than the amount of CrylA proteins needed to achieve just 50% mortality.
Especially preferred within the invention are vip3A insecticidal proteins
which provide
100% mortality when added in an amount of protein at least 260 fold lower than
the
amount of CrylA proteins needed to achieve just 50% mortality.
The vip3 insecticidal proteins according to the invention are present mostly
in the
supernatants of the cultures and are therefore are to be classified as
secreted
proteins. They preferably contain in the N-terminal sequence a number of
positively
charged residues followed by a hydrophobic core region and are not N-
terminally
processed during export.
As the other pesticidal proteins reported hereto within the scope of the
invention,
the VIP3 proteins can be detected in growth stages prior to sporulation
establishing a
further clear distinction from other proteins that belong to the S-endotoxin
family.
Preferably, expression of the insect-specific protein starts during mid-log
phase and
continues during sporulation. Owing to the specific expression pattern in
combination
with the high stability of the VIP3 proteins, large amounts of the VIP3
proteins can be
found in supernatants of sporulating cultures. Especially preferred are the
VIP3
proteins identified in SEQ ID NO:29 and SEQ ID NO:32 and the corresponding DNA
molecules comprising nucleotide sequences encoding the said proteins, but
especially
those DNA molecules comprising the nucleotide sequences given in SEQ ID NO:28,
SEQ ID NO:30 and SEQ ID NO:31.
The pesticidal proteins of the invention can be used in combination with Bt
endotoxins or other insecticidal proteins to increase insect target range.
Furthermore,
the use of the VIPs of the present invention in combination with Bt S-
endotoxins or
other insecticidal principles of a distinct nature has particular utility for
the prevention
and/or management of insect resistance. Other insecticidal principles include
CA 02199049 2008-07-07
30041-89
-27-
protease inhibitors (both serine and cysteine types), lectins, a-amylase and
peroxidase. In one preferred embodiment, expression of VIPs in a transgenic
plant is
accompanied by the expression of one or more Bt S-endotoxins. This co-
expression
of more than one insecticidal principle in the same transgenic plant can be
achieved
by genetically engineering a plant to contain and express all the genes
necessary.
Alternatively, a plant, Parent 1, can be genetically engineered for the
expression of
VIPs. A second plant, Parent 2, can be genetically engineered for the
expression of
Bt S-endotoxin. By crossing Parent 1 with Parent 2, progeny plants are
obtained
which express all the genes introduced into Parents 1 and 2. Particularly
preferred Bt
S-endotoxins are those disclosed in EP-A 0618976.
A substantial number of cytotoxic proteins, though not all, are binary in
action.
Binary toxins typically consist of two protein domains, one called the A
domain and
the other called the B domain (see Sourcebook of Bacterial Protein Toxins, J.
E.
About and J. H. Freer eds.(1991) Academic Press). The A domain possesses a
potent
cytotoxic activity. The B domain binds an external cell surface receptor
before being
internalized. Typically, the cytotoxic A domain must be escorted to the
cytoplasm by a
transbocation domain. Often the A and B domains are separate polypeptides or
protomers, which are associated by a protein-protein interaction or a di-
sulfide bond.
However, the toxin can be a single polypeptide which is proteolytically
processed
within the cell into two domains as in the case for Pseudomonas exotoxin A. In
summary binary toxins typically have three important domains, a cytotoxic A
domain, a
receptor binding B domain and a translocation domain. The A and B domain are
often
associated by protein-protein interacting domains.
The receptor binding domains of the present invention are useful for
delivering any
protein, toxin, enzyme, transcription factor, nucleic acid, chemical or any
other factor
into target insects having a receptor recognized by the receptor binding
domain of the
binary toxins described in this patent. Similarly, since binary toxins have
transbocation
domains which penetrate phosopholipid bilayer membranes and escort cytotoxins
across those membranes, such transbocation domains may be useful in escorting
any
protein, toxin, enzyme, transcription factor, nucleic acid, chemical or any
other factor
across a phospholipid bibayer such as the plasma membrane or a vesicle
membrane.
The translocation domain may itself perforate membranes, thus having toxic or
insecticidal properties. Further, all binary toxins have cytotoxic domains;
such a
199049 WO 96/10083 PCT/EP95/03826
-28-
cytotoxic domain may be useful as a lethal protein, either alone or when
delivered into
any target cell(s) by any means.
Finally, since binary toxins comprised of two polypeptides often form a
complex, it
is likely that there are protein-protein interacting regions within the
components of the
binary toxins of the invention. These protein-protein interacting domains may
be
useful in forming associations between any combination of toxins, enzymes,
transcription factors, nucleic acids, antibodies, cell binding moieties, or
any other
chemicals, factors, proteins or protein domains.
Toxins, enzymes, transcription factors, antibodies, cell binding moieties or
other
protein domains can be fused to pesticidal or auxiliary proteins by producing
in frame
genetic fusions which, when translated by ribosomes, would produce a fusion
protein
with the combined attributes of the VIP and the other component used in the
fusion.
Furthermore, if the protein domain fused to the VIP has an affinity for
another protein,
nucleic acid, carbohydrate, lipid, or other chemical or factor, then a three-
component
complex can be formed. This complex will have the attributes of all of its
components.
A similar rationale can be used for producing four or more component
complexes.
These complexes are useful as insecticidal toxins, pharmaceuticals, laboratory
reagents, and diagnostic reagents, etc. Examples where such complexes are
currently used are fusion toxins for potential cancer therapies, reagents in
ELISA
assays and immunoblot analysis.
One strategy of altering pesticidal or auxiliary proteins is to fuse a 15-
amino-acid
"S-tag" to the protein without destroying the insect cell binding domain(s),
translocation domains or protein-protein interacting domains of the proteins.
The S-
tag has a high affinity (Kd = 10-9 M) for a ribonuclease S-protein, which,
when bound
to the S-tag, forms an active ribonuclease (See F. M. Richards and H. W.
Wyckoff
(1971) in "The Enzymes", Vol. IV (Boyer, P.D. ed.). pp. 647-806. Academic
Press,
New York). The fusion can be made in such a way as to destroy or remove the
cytotoxic activity of the pesticidal or auxiliary protein, thereby replacing
the VIP
cytotoxic activity with a new cytotoxic ribonuclease activity. The final toxin
would be
comprised of the S-protein, a pesticidal protein and an auxiliary protein,
where either
the pesticidal protein or the auxiliary protein is produced as translational
fusions with
the S-tag. Similar strategies can be used to fuse other potential cytotoxins
to
pesticidal or auxiliary proteins including (but not limited to) ribosome
inactivating
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-29-
proteins, insect hormones, hormone receptors, transcription factors,
proteases,
phosphatases, Pseudomonas exotoxin A, or any other protein or chemical factor
that
is lethal when delivered into cells. Similarly, proteins can be delivered into
cells which
are not lethal, but might alter cellular biochemistry or physiology.
The spectrum of toxicity toward different species can be altered by fusing
domains
to pesticidal or auxiliary proteins which recognize cell surface receptors
from other
species. Such domains might include (but are not limited to) antibodies,
transferrin,
hormones, or peptide sequences isolated from phage displayed affinity
selectable
libraries. Also, peptide sequences which are bound to nutrients, vitamins,
hormones,
or other chemicals that are transported into cells could be used to alter the
spectrum
of toxicity. Similarly, any other protein or chemical which binds a cell
surface receptor
or the membrane and could be internalized might be used to alter the spectrum
of
activity of VIP1 and VIP2.
The pesticidal proteins of the present invention are those proteins which
confer a
specific pesticidal property. Such proteins may vary in molecular weight,
having
component polypeptides at least a molecular weight of 30 kDa or greater,
preferably
about 50 kDa or greater.
The auxiliary proteins of the invention may vary in molecular weight, having
at least
a molecular weight of about 15 kDa or greater, preferably about 20 kDa or
greater;
more preferably, about 30 kDa or greater. The auxiliary proteins themselves
may
have component polypeptides.
It is possible that the pesticidal protein and the auxiliary protein may be
components of a multimeric, pesticidal protein. Such a pesticidal protein
which
includes the auxiliary proteins as one or more of its component polypeptides
may vary
in molecular weight, having at least a molecular weight of 50 kDa up to at
least 200
kDa, preferably about 100 kDa to 150 kDa.
An auxiliary protein may be used in combination with the pesticidal proteins
of the
invention to enhance activity or to activate the pesticidal protein. To
determine
whether the auxiliary protein will affect activity, the pesticidal protein can
be expressed
alone and in combination with the auxiliary protein and the respective
activities
compared in feeding assays for pesticidal activity.
It may be beneficial to screen strains for potential pesticidal activity by
testing
activity of the strain alone and in combination with the auxiliary protein. In
some
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-30-
instances an auxiliary protein in combination with the native proteins of the
strains
yields pesticidal activity where none is seen in the absence of an auxiliary
protein.
The auxiliary protein can be modified, as described above, by various methods
known in the art. Therefore, for purposes of the invention, the term
"Vegetative
Insecticidal Protein" (VIP) encompasses those proteins produced during
vegetative
growth which alone or in combination can be used for pesticidal activity. This
includes
pesticidal proteins, auxiliary proteins and those proteins which demonstrate
activity
only in the presence of the auxiliary protein or the polypeptide components of
these
proteins.
It is recognized that there are alternative methods available to obtain the
nucleotide
and amino acid sequences of the present proteins. For example, to obtain the
nucleotide sequence encoding the pesticidal protein, cosmid clones, which
express
the pesticidal protein, can be isolated from a genomic library. From larger
active
cosmid clones, smaller subclones can be made and tested for activity. In this
manner,
clones which express an active pesticidal protein can be sequenced to
determine the
nucleotide sequence of the gene. Then, an amino acid sequence can be deduced
for
the protein. For general molecular methods, see, for example, Molecular
Cloning, A
Laboratory Manual, Second Edition, Vols. 1-3, Sambrook et al. (eds.) Cold
Spring
Harbor Laboratory Press, Cold Spring Harbor, NY (1989), and the references
cited
therein.
The present invention also encompasses nucleotide sequences from organisms
other than Bacillus, where the nucleotide sequences are isolatable by
hybridization
with the Bacillus nucleotide sequences of the invention. Proteins encoded by
such
nucleotide sequences can be tested for pesticidal activity. The invention also
encompasses the proteins encoded by the nucleotide sequences. Furthermore, the
invention encompasses proteins obtained from organisms other than Bacillus
wherein
the protein cross-reacts with antibodies raised against the proteins of the
invention.
Again the isolated proteins can be assayed for pesticidal activity by the
methods
disclosed herein or others well-known in the art.
Once the nucleotide sequences encoding the pesticidal proteins of the
invention
have been isolated, they can be manipulated and used to express the protein in
a
variety of hosts including other organisms, including microorganisms and
plants.
CA 02199049 2008-07-07
30041-89
-31 -
The pesticidal genes of the invention can be optimized for enhanced expression
in
plants. See, for example EP-A 0618976; EP-A 0359472; EP-A 0385962; WO
91/16432; Perlak et al. (1991) Proc. Natl. Acad. Sci. USA 88:3324-3328; and
Murray
et al. (1989) Nucleic Acids Research 17: 477-498. In this manner, the genes
can be
synthesized utilizing plant preferred codons. That is the preferred codon for
a
particular host is the single codon which most frequently encodes that amino
acid in
that host. The maize preferred codon, for example, for a particular amino acid
may be
derived from known gene sequences from maize. Maize codon usage for 28 genes
from maize plants is found in Murray et al. (1989), Nucleic Acids Research
17:477-
498 , Synthetic genes can
also be made based on the distribution of codons a particular host uses for a
particular amino acid.
In this manner, the nucleotide sequences can be optimized for expression in
any
plant. It is recognized that all or any part of the gene sequence may be
optimized or
synthetic. That is, synthetic or partially optimized sequences may also be
used.
In like manner, the nucleotide sequences can be optimized for expression in
any
microorganism. For Bacillus preferred codon usage, see, for example US Patent
No.
5,024,837 and Johansen et al. (1988) Gene 65:293-304.
Methodologies for the construction of plant expression cassettes as well as
the
introduction of foreign DNA into plants are described in the art. Such
expression
cassettes may include promoters, terminators, enhancers, leader sequences,
introns
and other regulatory sequences operably linked to the pesticidal protein
coding
sequence. It is further recognized that promoters or terminators of the VIP
genes can
be used in expression cassettes.
Generally, for the introduction of foreign DNA into plants Ti plasmid vectors
have
been utilized for the delivery of foreign DNA as well as direct DNA uptake,
liposomes,
electroporation. micro-injection, and the use of microprojectiles. Such
methods had
been published in the art. See, for example, Guerche et aL, (1987) Plant
Science
52:111-116; Neuhause et aL, (1987) Theor. Appi. Genet. 75:30-36; Klein et al.,
(1987)
Nature 327: 70-73; Howell et al., (1980) Science 208:1265; Horsch et al.,
(1985)
Science 227: 1229-1231; DeBlock et al., (1989) Plant Physiology 91:694-701;
Methods for Plant Molecular Biology (Weissbach and Weissbach, eds.) Academic
Press, Inc. (1988); and Methods in Plant Molecular Biology (Schuler and
Zielinski,
CA 02199049 2008-07-07
30041-89
-32-
eds.) Academic Press, Inc. (1989). See also, EP-A 0193259 and EP-A
0451878. It is understood that the method of transformation will depend upon
the
plant cell to be transformed.
It is further recognized that the components of the expression cassette may be
modified to increase expression. For example, truncated sequences, nucleotide
substitutions or other modifications may be employed. See, for example Perlak
et al.
(1991) Proc. Natl. Acad. Sci. USA 88:3324-3328; Murray et al., (1989) Nucleic
Acids
Research 17:477-498; and WO 91/16432.
The construct may also include any other necessary regulators such as
terminators, (Guerineau et aL, (1991), Mol. Gen. Genet., 226:141-144;
Proudfoot,
(1991), Cell, 64:671-674; Sanfacon et al., (1991), Genes Dev., 5:141-149;
Mogen of
al., (1990), Plant Cell, 2:1261-1272; Munroe et al., (1990), Gene, 91:151-158;
Ballas
el al el al., (1989), Nucleic Acids Res., 1 /:/891-/903; Joshi el al., (198/),
Nucleic
Acid Res., 15:9627-9639); plant translational consensus sequences (Joshi,
C.P.,
(1987), Nucleic Acids Research, 15:6643-6653), introns (Luehrsen and Walbot,
(1991), Mol. Gen. Genet., 225:81-93) and the like, operably linked to the
nucleotide
sequence. It may be beneficial to include 5' leader sequences in the
expression
cassette construct. Such leader sequences can act to enhance translation.
Translational leaders are known in the art and include:
Picornavirus leaders, for example, EMCV leader (encephalomyocarditis 5'
noncoding region) (Elroy-Stein, 0., Fuerst, T.R., and Moss, B. (1989) PNAS USA
86:6126-6130);
Potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison of
aL,
(1986); MDMV leader (Maize Dwarf Mosaic Virus); Virolog , 154:9-20), and
Human immunoglobulin heavy-chain binding protein (BiP), (Macejak, D.G., and
Sarnow, P., (1991), Nature, 353:90-94;
Untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV
RNA
4), (Jobling, S.A., and Gehrke, L., (1987), Nature, 325:622-625;
Tobacco mosaic virus leader (TMV), (Gallie, D.R. et al., (1989), Molecular
Biology
of RNA, pages 237-256; and
Maize Chiorotic Mottle Virus leader (MCMV) (Lommel, S.A. of al., (1991),
Virology,
81:382-385. See also, Della-Cioppa of al., (1987), Plant Physiolog, 84:965-
968.
CA 02199049 2008-07-07
30041-89
- 33 -
A plant terminator may be utilized in the expression cassette. See, Rosenberg
et
a1., (1987), Gene, 56:125; Guerineau etal., (1991), Mol. Gen. Genet., 226:141-
144;
Proudfoot, (1991), Cell, 64:671-674; Sanfacon et al., (1991), Genes Dev.,
5:141-149;
Mogen et al, (1990), Plant Cell, 2:1261-1272; Munroe et aL, (1990), Gene,
91:151-158; Ballas et aL, (1989), Nucleic Acids Res., 17:7891-7903; Joshi et
a1.,
(1987), Nucleic Acid Res., 15:9627-9639.
For tissue specific expression, the nucleotide sequences of the invention can
be
operably linked to tissue specific promoters. See, for example, EP-A 0618976,
Further comprised within the scope of the present invention are transgenic
plants, in
particular transgenic fertile plants transformed by means of the
aforedescribed
processes and their asexual and/or sexual progeny, which comprise and
preferably
also express the pesticidal protein according to the invention. Especially
preferred are
hybrid plants.
The transgenic plant according to the invention may be a dicotyledonous or a
monocotyledonous plant. Preferred are monocotyledonous plants of the
Graminaceae
family involving Lolium, Zea, Triticum, Triticale, Sorghum, Saccharum, Bromus,
O zae Avena, Hordeum, Secale and Setaria plants.
Especially preferred are transgenic maize, wheat, barley, sorghum, rye, oats,
turf
grasses and rice.
.Among the dicotyledonous plants soybean, cotton, tobacco, sugar beet, oilseed
rape, and sunflower are especially preferred herein.
The expression 'progeny' is understood to embrace both, "asexually" and
"sexually"
generated progeny of transgenic plants. This definition is also meant to
include all
mutants and variants obtainable by means of known processes, such as for
example
cell fusion or mutant selection and which still exhibit the characteristic
properties of
the initially transformed parent plant, together with all crossing and fusion
products of
the transformed plant material.
Another object of the invention concerns the proliferation material of
transgenic
plants.
The proliferation material of transgenic plants is defined relative to the
invention as
any plant material that may be propagated sexually or asexually in vivo or in
vitro.
Particularly preferred within the scope of the present invention are
protoplasts, cells,
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 34 -
calli, tissues, organs, seeds, embryos, pollen, egg cells, zygotes, together
with any
other propagating material obtained from transgenic plants.
Parts of plants, such as for example flowers, stems, fruits, leaves, roots
originating in
transgenic plants or their progeny previously transformed by means of the
process of
the invention and therefore consisting at least in part of transgenic cells,
are also an
object of the present invention.
Before the plant propagation material [fruit, tuber, grains, seed], but
expecially
seed is sold as a commerical product, it is customarily treated with a
protectant
coating comprising herbicides, insecticides, fungicides, bactericides,
nematicides,
molluscicides or mixtures of several of these preparations, if desired
together with
further carriers, surfactants or application-promoting adjuvants customarily
employed
in the art of formulation to provide protection against damage caused by
bacterial,
fungal or animal pests.
In order to treat the seed, the protectant coating may be applied to the seeds
either
by impregnating the tubers or grains with a liquid formulation or by coating
them with a
combined wet or dry formulation. In addition, in special cases, other methods
of
application to plants are possible, eg treatment directed at the buds or the
fruit.
The plant seed according to the invention comprising a DNA molecule comprising
a
nucleotide sequence encoding a pesticidal protein according to the invention
may be
treated with a seed protectant coating comprising a seed treatment compound,
such
as, for example, captan, carboxin, thiram (TMTD ), methalaxyl (Apron ) and
pirimiphos-methyl (Actellic ) and others that are commonly used in seed
treatment.
Preferred within the scope of the invention are seed protectant coatings
comprising an
entomocidal composition according to the invention alone or in combination
with one
of the a seed protectant coating customarily used in seed treatment.
It is thus a further object of the present invention to provide plant
propagation
material for cultivated plants, but especially plant seed that is treated with
a seed
protectant coating as defined hereinbefore.
It is recognized that the genes encoding the pesticidal proteins can be used
to
transform insect pathogenic organisms. Such organisms include Baculoviruses,
fungi,
protozoa, bacteria and nematodes.
The Bacillus strains of the invention may be used for protecting agricultural
crops
and products from pests. Alternatively, a gene encoding the pesticide may be
WO 96/10083 2 1 9 9 0 4-'9j PCT/EP95/03826
-35-
introduced via a suitable vector into a microbial host, and said host applied
to the
environment or plants or animals. Microorganism hosts may be selected which
are
known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere,
and/or
rhizoplana) of one or more crops of interest. These microorganisms are
selected so
as to be capable of successfully competing in the particular environment with
the wild-
type microorganisms, provide for stable maintenance and expression of the gene
expressing the polypeptide pesticide, and, desirably, provide for improved
protection
of the pesticide from environmental degradation and inactivation.
Such microorganisms include bacteria, algae, and fungi. Of particular interest
are
microorganisms, such as bacteria, e.g., Pseudomonas, Erwinia, Serratia,
Klebsiella,
Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylius,
Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter,
Leuconostoc,
and Alcaligenes; fungi, particularly yeast, e.g., Saccharomyces, Cryptococcus,
Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular
interest are such phytosphere bacterial species as Pseudomonas syringae,
Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum,
Agrobacteria,
Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti,
Alcaligenes entrophus, C/avibacterxyli and Azotobacter vinlandii; and
phytosphere
yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R.
aurantiaca,
Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S.
pretoriensis,
S. cerevisiae, Sporobolomyces rosues, S. odorus, Kluyveromyces veronae, and
Aureobasidium pollulans. Of particular interest are the pigmented
microorganisms.
A number of ways are available for introducing a gene expressing the
pesticidal
protein into the microorganism host under conditions which allow for stable
maintenance and expression of the gene. For example, expression cassettes can
be
constructed which include the DNA constructs of, interest operably linked with
the
transcriptional and translational regulatory signals for expression of the DNA
constructs, and a DNA sequence homologous with a sequence in the host
organism,
whereby integration will occur, and/or a replication system which is
functional in the
host, whereby integration or stable maintenance will occur.
Transcriptional and translational regulatory signals include but are not
limited to
promoter, transcriptional initiation start site, operators, activators,
enhancers, other
regulatory elements, ribosomal binding sites, an initiation codon, termination
signals,
WO 96/10083 2 19904 9 PCT/EP95/03826
-36-
and the like. See, for example, US Patent 5,039,523; US Patent No. 4,853,331;
EPO
0480762A2; Sambrook et al. supra; Molecular Cloning, a Laboratory Manual,
Maniatis
et a!. (eds) Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1982);
Advanced
Bacterial Genetics, Davis et al. (eds.) Cold Spring Harbor Laboratory, Cold
Spring
Harbor, NY (1980); and the references cited therein.
Suitable host cells, where the pesticide-containing cells will be treated to
prolong
the activity of the toxin in the cell when the then treated cell is applied to
the
environment of the target pest(s), may include either prokaryotes or
eukaryotes,
normally being limited to those cells which do not produce substances toxic to
higher
organisms, such as mammals. However, organisms which produce substances toxic
to higher organisms could be used, where the toxin is unstable or the level of
application sufficiently low as to avoid any possibility of toxicity to a
mammalian host.
As hosts, of particular interest will be the prokaryotes and the lower
eukaryotes, such
as fungi. Illustrative prokaryotes, both Gram-negative and -positive, include
Enterobacteriaceae, such as Escherichia, Erwinia, Shigella, Salmonella, and
Proteus;
Bacillaceae; Rhizobiceae, such as Rhizobium; Spirillaceae, such as
photobacterium,
Zymomonas, Serratia, Aeromonas, Vibrio, Desulfovibrio, Spirillum;
Lactobacillaceae;
Pseudomonadaceae, such as Pseudomonas and Acetobacter, Azotobacteraceae and
Nitrobacteraceae. Among eukaryotes are fungi, such as Phycomycetes and
Ascomycetes, which includes yeast, such a Saccharomyces and
Schizosaccharromyces; and Basidiomycetes yeast, such as Rhodotorula,
Aureobasidium, Sporobolomyces, and the like.
Characteristics of particular interest in selecting a host cell for purposes
of
production include ease of introducing the protein gene into the host,
availability of
expression systems, efficiency of expression, stability of the protein in the
host, and
the presence of auxiliary genetic capabilities. Characteristics of interest
for use as a
pesticide microcapsule include protective qualities for the pesticide, such as
thick cell
walls, pigmentation, and intracellular packaging or formation of inclusion
bodies; leaf
affinity; lack of mammalian toxicity; attractiveness to pests for ingestion;
ease of killing
and fixing without damage to the toxin; and the like. Other considerations
include
ease of formulation and handling, economics, storage stability, and the like.
Host organisms of particular interest include yeast, such as Rhodotorula sp.,
Aureobasidium sp., Saccharomyces sp., and Sporobolomyces sp.; phylloplane
PCT/EP95/03826
WO 96/10083 2 1 9 9 /- 4 9
-37-
organisms such as Pseudomonas sp., Erwinia sp. and Flavobacterium sp.; or such
other organisms as Escherichia, LactoBacillus sp., Bacillus sp., and the like.
Specific
organisms include Pseudomonas aeurginosa, Pseudomonas fluorescens,
Saccharomyces cerevisiae, Bacillus thuringiensis, Escherichia coli, Bacillus
subtilis,
and the like.
VIP genes can be introduced into micro-organisms that multiply on plants
(epiphytes) to deliver VIP proteins to potential target pests. Epiphytes can
be gram-
positive or gram-negative bacteria for example.
Root colonizing bacteria, for example, can be isolated from the plant of
interest by
methods known in the art. Specifically, a Bacillus cereus strain which
colonizes roots
could be isolated from roots of a plant ( for example see J. Handelsman, S.
Raffel, E.
Mester, L. Wunderlich and C. Grau, Appl. Environ. Microbiol. 56:713-718,
(1990)).
VIP1 and/or VIP2 and/or VIP3 could be introduced into a root colonizing
Bacillus
cereus by standard methods known in the art.
Specifically, VIP1 and/or VIP2 derived from Bacillus cereus strain AB78 can be
introduced into a root colonizing Bacillus cereus by means of conjugation
using
standard methods (J. Gonzalez, B. Brown and B. Carlton, Proc. Natl. Acad. Sci.
79:6951-6955, (1982)).
Also, VIP1 and/or VIP2 and/or VIP3 or other VIPs of the invention can be
introduced into the root colonizing Bacillus by means of electro-
transformation.
Specifically, VIPs can be cloned into a shuttle vector, for example, pHT3101
(D.
Lereclus et al., FEMS Microbiol. Letts., 60:211-218 (1989)) as described in
Example
10. The shuttle vector pHT3101 containing the coding sequence for the
particular VIP
can then be transformed into the root colonizing Bacillus by means of
electroporation
(D. Lereclus et al. 1989, FEMS Microbiol. Letts. 60:211-218).
Expression systems can be designed so that VIP proteins are secreted outside
the
cytoplasm of gram negative bacteria, E. coli, for example. Advantages of
having VIP
proteins secreted are (1) it avoids potential toxic effects of VIP proteins
expressed
within the cytoplasm and (2) it can increase the level of VIP protein
expressed and (3)
can aid in efficient purification of VIP protein.
VIP proteins can be made to be secreted in E. coli, for example, by fusing an
appropriate E. coli signal peptide to the amino-terminal end of the VIP signal
peptide
or replacing the VIP signal peptide with the E. coil signal peptide. Signal
peptides
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-38-
recognized by E. coli can be found in proteins already known to be secreted in
E. coli,
for example the OmpA protein (J. Ghrayeb, H. Kimura, M. Takahara, Y. Masui and
M.
Inouye, EMBO J., 3:2437-2442 (1984)). OmpA is a major protein of the E.
co/iouter
membrane and thus its signal peptide is thought to be efficient in the
translocation
process. Also, the OmpA signal peptide does not need to be modified before
processing as may be the case for other signal peptides, for example
lipoprotein
signal peptide
(G. Duffaud, P. March and M. Inouye, Methods in Enzymology, 153:492 (1987)).
Specifically, unique BamHI restriction sites can be introduced at the amino-
terminal and carboxy-terminal ends of the VIP coding sequences using standard
methods known in the art. These BamHI fragments can be cloned, in frame, into
the
vector pIN-III-ompA1, A2 or A3 (J. Ghrayeb, H. Kimura, M. Takahara, H. Hsiung,
Y.
Masui and M. Inouye, EMBO J., 3:2437-2442 (1984)) thereby creating ompA:VIP
fusion gene which is secreted into the periplasmic space. The other
restriction sites in
the polylinker of pIN-III-ompA can be eliminated by standard methods known in
the art
so that the VIP amino-terminal amino acid coding sequence is directly after
the ompA
signal peptide cleavage site. Thus, the secreted VIP sequence in E. coliwould
then
be identical to the native VIP sequence.
When the VIP native signal peptide is not needed for proper folding of the
mature
protein, such signal sequences can be removed and replaced with the ompA
signal
sequence. Unique BamH I restriction sites can be introduced at the amino-
termini of
the proprotein coding sequences directly after the signal peptide coding
sequences of
VIP and at the carboxy-termini of VIP coding sequence. These BamHl fragments
can
then be cloned into the pIN-III-ompA vectors as described above.
General methods for employing the strains of the invention in pesticide
control or in
engineering other organisms as pesticidal agents are known in the art. See,
for
example US Patent No. 5,039,523 and EP 0480762A2.
VIPs can be fermented in a bacterial host and the resulting bacteria processed
and
used as a microbial spray in the same manner that Bacillus thuringiensis
strains have
been used as insecticidal sprays. In the case of a VIP(s) which is secreted
from
Bacillus, the secretion signal is removed or mutated using procedures known in
the
art. Such mutations and/or deletions prevent secretion of the VIP protein(s)
into the
growth medium during the fermentation process. The VIPs are retained within
the cell
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-39-
and the cells are then processed to yield the encapsulated VIPs. Any suitable
microorganism can be used for this purpose. Psuedomonas has been used to
express
Bacillus thuringiensis endotoxins as encapsulated proteins and the resulting
cells
processed and sprayed as an insecticide. (H. Gaertner et al. 1993, In Advanced
Engineered Pesticides, L. Kim ed.)
Various strains of Bacillus thuringiensis are used in this manner. Such Bt
strains
produce endotoxin protein(s) as well as VIPs. Alternatively, such strains can
produce
only VIPs. A sporulation deficient strain of Bacillus subtilis has been shown
to produce
high levels of the CryIIIA endotoxin from Bacillus thuringiensis (Agaisse, H.
and
Lereclus, D., "Expression in Bacillus subtilis of the Bacillus thuringiensis
CryllIA toxin
gene is not dependent on a sporulation-specific sigma factor and is increased
in a
spoOA mutant", J. Bacteriol., 176:4734-4741 (1994)). A similar spoOA mutant
can be
prepared in Bacillus thuringiensis and used to produce encapsulated VIPs which
are
not secreted into the medium but are retained within the cell.
To have VIPs maintained within the Bacillus cell the signal peptide can be
disarmed so that it no longer functions as a secretion signal. Specifically,
the
putative signal peptide for VIP1 encompasses the first 31 amino acids of the
protein
with the putative consensus cleavage site, Ala-X-Ala, at the C-terminal
portion of this
sequence (G. von Heijne , J. Mol. Biol. 184:99-105 (1989)) and the putative
signal
peptide for VIP2 encompasses the first 40 amino acids of the protein with the
putative
cleavage site after Ala40. The cleavage sites in either VIP1 or VIP2 can be
mutated
with methods known in the art to replace the cleavage site consensus sequence
with
alternative amino acids that are not recognized by the signal peptidases.
Alternatively, the signal peptides of VIP1, VIP2 and/or other VIPs of the
invention
can be eliminated from the sequence thereby making them unrecognizable as
secretion proteins in Bacillus. Specifically, a methionine start site can be
engineered
in front of the proprotein sequence in VIP1, starting at Asp32, or the
proprotein
sequence in VIP2, starting at Glu41 using methods known in the art.
VIP genes can be introduced into micro-organisms that mutiply on plants
(epiphytes) to deliver VIP proteins to potential target pests. Epiphytes can
be gram-
positive or gram-negative bacteria for example.
The Bacillus strains of the invention or the microorganisms which have been
genetically altered to contain the pesticidal gene and protein may be used for
WO 96/10083 9 9 0 9 PCT/EP95/03826
_40-
protecting agricultural crops and products from pests. In one aspect of the
invention,
whole, i.e., unlysed, cells of a toxin (pesticide)-producing organism are
treated with
reagents that prolong the activity of the toxin produced in the cell when the
cell is
applied to the environment of target pest(s).
Alternatively, the pesticides are produced by introducing a heterologous gene
into
a cellular host. Expression of the heterologous gene results, directly or
indirectly, in
the intracellular production and maintenance of the pesticide. These cells are
then
treated under conditions that prolong the activity of the toxin produced in
the cell when
the cell is applied to the environment of target pest(s). The resulting
product retains
the toxicity of the toxin. These naturally encapsulated pesticides may then be
formulated in accordance with conventional techniques for application to the
environment hosting a target pest, e.g., soil, water, and foliage of plants.
See, for
example EPA 0192319, and the references cited therein.
The active ingredients of the present invention are normally applied in the
form of
compositions and can be applied to the crop area or plant to be treated,
simultaneously or in succession, with other compounds. These compounds can be
both fertilizers or micronutrient donors or other preparations that influence
plant
growth. They can also be selective herbicides, insecticides, fungicides,
bactericides,
nematicides, mollusicides or mixtures of several of these preparations, if
desired,
together with further agriculturally acceptable carriers, surfactants or
application-promoting adjuvants customarily employed in the art of
formulation.
Suitable carriers and adjuvants can be solid or liquid and correspond to the
substances ordinarily employed in formulation technology, e.g. natural or
regenerated
mineral substances, solvents, dispersants, wetting agents, tackifiers, binders
or
fertilizers.
Preferred methods of applying an active ingredient of the present invention or
an
agrochemical composition of the present invention which contains at least one
of the
insect-specific proteins produced by the bacterial strains of the present
invention are
leaf application, seed coating and soil application. The number of
applications and
the rate of application depend on the intensity of infestation by the
corresponding
pest.
The present invention thus further provides an entomocidal composition
comprising as an active ingrdient at least one of the novel insect-specific
proteins
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-41 -
according to the invention and/or a recombinant microorganism containing at
least
one DNA molecule comprising a nucleotide sequence encoding the novel insect-
specific proteins in recombinant form, but especially a recombinant Bacillus
spp strain,
such as Bacillus cereus or Bacillus thuringiensis, containing at least one one
DNA
molecule comprising a nucleotide sequence encoding the novel insect-specific
proteins in recombinant form, or a derivative or mutant thereof, together with
an
agricultural adjuvant such as a carrier, diluent, surfactant or application-
promoting
adjuvant. The composition may also contain a further biologically active
compound.
The said compound can be both a fertilizer or micronutrient donor or other
preparations that influence plant growth. It can also be a selective
herbicide,
insecticide, fungicide, bactericide, nematicide, molluscide or mixtures of
several of
these preparations, if desired, together with further agriculturally
acceptable carriers,
surfactants or application-promoting adjuvants customarily employed in the art
of
formulation. Suitable carriers and adjuvants can be solid or liquid and
correspond to
the substances ordinarily employed in formulation technology, e.g. natural or
regenerated mineral substances, solvents, dispersants, wetting agents,
tackifiers,
binders or fertilizers
The composition may comprise from 0.1 to 99% by weight of the active
ingredient,
from 1 to 99.9% by weight of a solid or liquid adjuvant, and from 0 to 25% by
weight of
a surfactant. The acitve ingredient comprising at least one of the novel
insect-specific
proteins according to the invention or a recombinant microorganism containing
at least
one DNA molecule comprising a nucleotide sequence encoding the novel insect-
specific proteins in recombinant form, but especially a recombinant Bacillus
spp strain,
such as Bacillus cereus or Bacillus thuringiensis strain containing at least
one DNA
molecule comprising a nucleotide sequence encoding the novel insect-specific
proteins in recombinant form, or a derivative or mutant thereof, or the
composition
containing the said acitve ingredient, may be administered to the plants or
crops to be
protected together with certain other insecticides or chemicals (1993 Crop
Protection
Chemicals Reference, Chemical and Pharmaceutical Press, Canada) without loss
of
potency. It is compatible with most other commonly used agricultural spray
materials
but should not be used in extremely alkaline spray solutions. It may be
administered
as a dust, a suspension, a wettable powder or in any other material form
suitable for
agricultural application.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-42-
The invention further provides methods for for controlling or inhibiting of
insect
pests by applying an active ingredient comprising at least one of the novel
insect-
specific proteins according to the invention or a recombinant microorganism
containing at least one DNA molecule comprising a nucleotide sequence encoding
the novel insect-specific proteins in recombinant form or a composition
comprising the
said active ingredient to (a) an environment in which the insect pest may
occur, (b) a
plant or plant part in order to protect said plant or plant part from damage
caused by
an insect pest, or (c) seed in order to protect a plant which develops from
said seed
from damage caused by an insect pest.
A preferred method of application in the area of plant protection is
application to
the foliage of the plants (foliar application), with the number of
applications and the
rate of application depending on the plant to be protected and the risk of
infestation
by the pest in question. However, the active ingredient may also penetrate the
plants
through the roots (systemic action) if the locus of the plants is impregnated
with a
liquid formulation or if the active ingredient is incorporated in solid form
into the locus
of the plants, for example into the soil, e.g. in granular form (soil
application). In paddy
rice crops, such granules may be applied in metered amounts to the flooded
rice field.
The compositions according to the invention are also suitable for protecting
plant
propagating material, e.g. seed, such as fruit, tubers or grains, or plant
cuttings, from
insect pests. The propagation material can be treated with the formulation
before
planting: seed, for example, can be dressed before being sown. The acitve
ingredient
of the invention can also be applied to grains (coating), either by
impregnating the
grains with a liquid formulation or by coating them with a solid formulation.
The
formulation can also be applied to the planting site when the propagating
material is
being planted, for example to the seed furrow during sowing. The invention
relates
also to those methods of treating plant propagation material and to the plant
propagation material thus treated.
The compositions according to the invention comprising as an active ingredient
a
recombinant microorganism containing at least one of the novel toxin genes in
recombinant form, but especially a recombinant Bacillus spp strain, such as
Bacillus
cereus or Bacillus thuringiensis strain containing at least one DNA molecule
comprising a nucleotide sequence encoding the novel insect-specific proteins
in
recombinant form, or a derivative or mutant thereof may be applied in any
method
WO 96/10083 r 2 1 9 9 0 4 9 PCT/EP95/03826
-43-
known for treatment of seed or soil with bacterial strains. For example, see
US Patent
No.4,863,866. The strains are effective for biocontrol even if the
microorganism is not
living. Preferred is, however, the application of the living microorganism.
Target crops to be protected within the scope of the present invention
comprise,
e.g., the following species of plants:
cereals (wheat, barley, rye, oats, rice, sorghum and related crops), beet
(sugar beet
and fodder beet), forage grasses (orchardgrass, fescue, and the like), drupes,
pomes
and soft fruit (apples, pears, plums, peaches, almonds, cherries,
strawberries,
raspberries and blackberries), leguminous plants (beans, lentils, peas,
soybeans), oil
plants (rape, mustard, poppy, olives, sunflowers, coconuts, castor oil plants,
cocoa
beans, groundnuts), cucumber plants (cucumber, marrows, melons) fiber plants
(cotton, flax, hemp, jute), citrus fruit (oranges, lemons, grapefruit,
mandarins),
vegetables (spinach, lettuce, asparagus, cabbages and other Brassicae, onions,
tomatoes, potatoes, paprika), lauraceae (avocados, carrots, cinnamon,
camphor),
deciduous trees and conifers (e.g. linden-trees, yew-trees, oak-trees, alders,
poplars,
birch-trees, firs, larches, pines), or plants such as maize, tobacco, nuts,
coffee, sugar
cane, tea, vines, hops, bananas and natural rubber plants, as well as
ornamentals
(including composites).
A recombinant Bacillus spp strain, such as Bacillus cereus or Bacillus
thuringiensis strain, containing at least one DNA molecule comprising a
nucleotide
sequence encoding the novel insect-specific proteins in recombinant form is
normally
applied in the form of entomocidal compositions and can be applied to the crop
area
or plant to be treated, simultaneously or in succession, with further
biologically active
compounds. These compounds may be both fertilizers or micronutrient donors or
other preparations that influence plant growth. They may also be selective
herbicides,
insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures
of
several of these preparations, if desired together with further carriers,
surfactants or
application-promoting adjuvants customarily employed in the art of
formulation.
The active ingredient according to the invention may be used in unmodified
form or
together with any suitable agriculturally acceptable carrier. Such carriers
are adjuvants
conventionally employed in the art of agricultural formulation, and are
therefore
formulated in known manner to emulsifiable concentrates, coatable pastes,
directly
sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble
powders,
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-44-
dusts, granulates, and also encapsulations, for example, in polymer
substances. Like
the nature of the compositions, the methods of application, such as spraying,
atomizing, dusting, scattering or pouring, are chosen in accordance with the
intended
objective and the prevailing circumstances. Advantageous rates of application
are
normally from about 50 g to about 5 kg of active ingredient (a.i.) per hectare
("ha",
approximately 2.471 acres), preferably from about 100 g to about 2kg a.i./ha.
Important rates of application are about 200 g to about 1 kg a.i./ha and 200g
to 500g
a.i./ha.
For seed dressing advantageous application rates are 0.5 g to 1000 g a.i.per
100 kg
seed, preferably 3 g to 100 g a.i. per 100 kg seed or 10 g to 50 g a.i.per 100
kg seed.
Suitable carriers and adjuvants can be solid or liquid and correspond to the
substances ordinarily employed in formulation technology, e.g. natural or
regenerated
mineral substances, solvents, dispersants, wetting agents, tackifiers, binders
or
fertilizers. The formulations, i.e. the entomocidal compositions, preparations
or
mixtures containing the recombinant Bacillus spp strain, such as Bacillus
cereus or
Bacillus thuringiensis strain containing at least one DNA molecule comprising
a
nucleotide sequence encoding the novel insect-specific proteins in recombinant
form
as an active ingredient or combinations thereof with other active ingredients,
and,
where appropriate, a solid or liquid adjuvant, are prepared in known manner,
e.g., by
homogeneously mixing and/or grinding the active ingredients with extenders,
e.g.,
solvents, solid carriers, and in some cases surface-active compounds
(surfactants).
Suitable solvents are: aromatic hydrocarbons, preferably the fractions
containing
8 to 12 carbon atoms, e.g. xylene mixtures or substituted naphthalenes,
phthalates
such as dibutyl phthalate or dioctyl phthalate, aliphatic hydrocarbons such as
cyclohexane or paraffins, alcohols and glycols and their ethers and esters,
such as
ethanol, ethylene glycol monomethyl or monoethyl ether, ketones such as
cyclohexanone, strongly polar solvents such as N-methyl-2-pyrrolidone,
dimethylsulfoxide or dimethylformamide, as well as vegetable oils or
epoxidised
vegetable oils such as epoxidised coconut oil or soybean oil; or water.
The solid carriers used, e.g., for dusts and dispersible powders, are normally
natural mineral fillers such as calcite, talcum, kaolin, montmorillonite or
attapulgite. In
order to improve the physical properties it is also possible to add highly
dispersed
silicic acid or highly dispersed absorbent polymers. Suitable granulated
adsorptive
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-45-
carriers are porous types, for example pumice, broken brick, sepiolite or
bentonite;
and suitable nonsorbent carriers are materials such as calcite or sand. In
addition, a
great number of pregranulated materials of inorganic or organic nature can be
used,
e.g. especially dolomite or pulverized plant residues.
Depending on the nature of the active ingredients to be formulated, suitable
surface-active compounds are non-ionic, cationic and/or anionic surfactants
having
good emulsifying, dispersing and wetting properties. The term "surfactants"
will also
be understood as comprising mixtures of surfactants. Suitable anionic
surfactants
can be both water-soluble soaps and
water-soluble synthetic surface-active compounds. Suitable soaps are the
alkali metal
salts, alkaline earth metal salts or unsubstituted or substituted ammonium
salts of
higher fatty acids (C,o -Ca), e.g. the sodium or potassium salts of oleic or
stearic acid,
or of natural fatty acid mixtures which can be obtained, e.g. from coconut oil
or tallow
oil. Further suitable surfactants are also the fatty acid methyltaurin salts
as well as
modified and unmodified phospholipids.
More frequently, however, so-called synthetic surfactants are used, especially
fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or
alkylarylsulfonates. The fatty sulfonates or sulfates are usually in the forms
of alkali
metal salts, alkaline earth metal salts or unsubstituted or substituted
ammonium salts
and generally contain a C8 -C22 alkyl radical which also includes the alkyl
moiety of
acyl radicals, e.g. the sodium or calcium salt of lignosulfonic acid, of
dodecylsulfate,
or of a mixture of fatty alcohol sulfates obtained from natural fatty acids.
These
compounds also comprise the salts of sulfuric acid esters and sulfonic acids
of fatty
alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives
preferably
contain 2 sulfonic acid groups and one fatty acid radical containing about 8
to 22
carbon atoms. Examples of alkylarylsulfonates are the sodium, calcium or
triethanolamine salts of dodecylbenzenesulfonic acid,
dibutylnaphthalenesulfonic acid,
or of a naphthalenesulfonic acid/formaldehyde condensation product. Also
suitable
are corresponding phosphates, e.g. salts of the phosphoric acid ester of an
adduct of
p-nonylphenol with 4 to 14 moles of ethylene oxide.
Non-ionic surfactant are preferably polyglycol ether derivatives of aliphatic
or
cycloaliphatic alcohols, or saturated or unsaturated fatty acids and
alkylphenols, said
derivatives containing 3 to 30 glycol ether groups and 8 to 20 carbon atoms in
the
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-46-
(aliphatic) hydrocarbon moiety and.6 to 18 carbon atoms in the alkyl moiety of
the
alkylphenols.
Further suitable non-ionic surfactants are the water-soluble adducts of
polyethylene oxide with polypropylene glycol, ethylenediaminopolypropylene
glycol
and alkylpolypropylene glycol containing 1 to 10 carbon atoms in the alkyl
chain,
which adducts contain 20 to 250 ethylene glycol ether groups and 10 to 100
propylene glycol ether groups. These compounds usually contain 1 to 5 ethylene
glycol units per propylene glycol unit. Representative examples of non-ionic
surfactants are nonylphenolpolyethoxyethanols, castor oil polyglycol ethers,
polypropylene/polyethylene oxide adducts, tributylphenoxypolyethoxyethanol,
polyethylene glycol and octylphenoxypolyethoxyethanol. Fatty acid esters of
polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate, are also
suitable
non-ionic surfactants.
Cationic surfactants are preferably quaternary ammonium salts which contain,
as
N-substituent, at least one C8 -C22 alkyl radical and, as further
substituents, lower
unsubstituted or halogenated alkyl, benzyl or hydroxyl-lower alkyl radicals.
The salts
are preferably in the form of halides, methylsulfates or ethylsulfates, e.g.,
stearyltrimethylammonium chloride or benzyldi-(2-chloroethyl)ethylammonium
bromide.
The surfactants customarily employed in the art of formulation are described,
e.g., in "McCutcheon's Detergents and Emulsifiers Annual", MC Publishing Corp.
Ridgewood, N.J., 1979; Dr. Helmut Stache, "Tensid Taschenbuch" (Handbook of
Surfactants), Carl Hanser Verlag, MunichNienna.
Another particularly preferred characteristic of an entomocidal composition of
the
present invention is the persistence of the active ingredient when applied to
plants
and soil. Possible causes for loss of activity include inactivation by ultra-
violet light,
heat, leaf exudates and pH. For example, at high pH, particularly in the
presence of
reductant, S-endotoxin crystals are solubilized and thus become more
accessible to
proteolytic inactivation. High leaf pH might also be important, particularly
where the
leaf surface can be in the range of pH 8-10. Formulation of an entomocidal
composition of the present invention can address these problems by either
including
additives to help prevent loss of the active ingredient or encapsulating the
material in
such a way that the active ingredient is protected from inactivation.
Encapsulation
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-47-
can be accomplished chemically (McGuire and Shasha, J Econ Entomol 85: 1425-
1433, 1992) or biologically (Barnes and Cummings, 1986; EP-A 0 192 319).
Chemical
encapsulation involves a process in which the active ingredient is coated with
a
polymer while biological encapsulation involves the expression of the S-
endotoxin
genes in a microbe. For biological encapsulation, the intact microbe
containing at
least one DNA molecule comprising a nucleotide sequence encoding the novel
insect-specific proteins in recombinant form is used as the active ingredient
in the
formulation. The addition of UV protectants might effectively reduce
irradiation
damage. Inactivation due to heat could also be controlled by including an
appropriate
additive.
Preferred within the present application are formulations comprising living
microorganisms as active ingredient either in form of the vegetative cell or
more
preferable in form of spores, if available. Suitable formulations may consist,
for
example, of polymer gels which are crosslinked with polyvalent cations and
comprise
these microorganisms. This is described, for example, by D.R. Fravel et al. in
Phytopathology, Vol. 75, No. 7, 774-777, 1985 for alginate as the polymer
material. It
is also known from this publication that carrier materials can be co-used.
These
formulations are as a rule prepared by mixing solutions of naturally occurring
or
synthetic gel-forming polymers, for example alginates, and aqueous salt
solutions of
polyvalent metal ions such that individual droplets form, it being possible
for the
microorganisms to be suspended in one of the two or in both reaction
solutions. Gel
formation starts with the mixing in drop form. Subsequent drying of these gel
particles
is possible. This process is called ionotropic gelling. Depending on the
degree of
drying, compact and hard particles of polymers which are structurally
crosslinked via
polyvalent cations and comprise the microorganisms and a carrier present
predominantly uniformly distributed are formed. The size of the particles can
be up to
mm.
Compositions based on partly crosslinked polysaccharides which, in addition to
a
microorganism, for example, can also comprise finely divided silicic acid as
the carrier
material, crosslinking taking place, for example, via Ca++ ions, are described
in
EP-A1-0 097 571. The compositions have a water activity of not more than 0.3.
W.J.
Cornick et al. describe in a review article [New Directions in Biological
Control:
Alternatives for Suppressing Agricultural Pests and Diseases, pages 345-372,
Alan R.
2199049
WO 96/10083 PCT/EP95/03826
-48-
Liss, Inc. (1990)] various formulation systems, granules with vermiculite as
the carrier
and compact alginate beads prepared by the ionotropic gelling process being
mentioned. Such compositions are also disclosed by D.R.Fravel in Pesticide
Formulations and Application Systems: 11th Volume, ASTM STP 1112 American
Society for Testing and Materials, Philadelphia, 1992, pages 173 to 179 and
can be
used to formulate the recombinant microorganisms according to the invention.
The entomocidal compositions of the invention usually contain from about 0.1
to
about 99%, preferably about 0.1 to about 95%, and most preferably from about 3
to
about 90% of the active ingredient, from about 1 to about 99.9%, preferably
from
about 1 to about 99%, and most preferably from about 5 to about 95% of a solid
or
liquid adjuvant, and from about 0 to about 25%, preferably about 0.1 to about
25%,
and most preferably from about 0.1 to about 20% of a surfactant.
In a preferred embodiment of the invention the entomocidal compositions
usually
contain 0.1 to 99%, preferably 0.1 to 95%, of a recombinant Bacillus spp
strain, such
as Bacillus cereus or Bacillus thuringiensis strain containing at least one
DNA
molecule comprising a nucleotide sequence encoding the novel insect-specific
proteins in recombinant form, or combination thereof with other active
ingredients, 1 to
99.9% of a solid or liquid adjuvant, and 0 to 25%, preferably 0.1 to 20%, of a
surfactant.
Whereas commercial products are preferably formulated as concentrates, the
end user will normally employ dilute formulations of substantially lower
concentration.
The entomocidal compositions may also contain further ingredients, such as
stabilizers, antifoams, viscosity regulators, binders, tackifiers as well as
fertilizers or
other active ingredients in order to obtain special effects.
In one embodiment of the invention a Bacillus cereus microorganism has been
isolated which is capable of killing Diabrotica virgifera virgifera, and
Diabrotica
longicornis barbed The novel B. cereus strain AB78 has been deposited in the
Agricultural Research Service, Patent Culture Collection (NRRL), Northern
Regional
Research Center, 1815 North University Street, Peoria, IL 61604, USA and given
Accession No. NRRL B-21058.
A fraction protein has been substantially purified from the B. cereus strain.
This
purification of the protein has been verified by SDS-PAGE and biological
activity. The
CA 02199049 2008-07-07
30041-89
-49-
protein has a molecular weight of about 60 to about 100 kDa, particularly
about 70 to
about 90 kDa, more particularly about 80 kDa, hereinafter VIP.
Amino-terminal sequencing has revealed the N-terminal amino-acid sequence to
be:
NH2-Lys-Arg-Glu-ile-Asp-Glu-Asp-Thr-Asp-Thr-Asx-Gly-Asp-Ser-Ile-Pro-
(SEQ ID NO:8) where Asx represents either Asp or Asn. The entire amino acid
sequence is given in SEQ ID NO:7. The DNA sequence which encodes the amino
acid sequence of SEQ ID NO:7 is disclosed in SEQ ID NO:6.
An oligonuleotide probe for the region of the gene encoding amino acids 3-9 of
the
NH2-terminus has been generated. The probe was synthesized based on the codon
usage of a Bacillus thuringiensis (Bt) 8-endotoxin gene. The nucleotide
sequence of
the oligonucleotide probe used for Southern hybridizations was as follows:
5'- GAA ATT GAT CAA GAT ACN GAT -3' (SEQ ID NO:9)
where N represents any base.
In addition, the DNA probe for the Bc AB78 VIP1 gene described herein, permits
the screening of any Bacillus strain or other organisms to determine whether
the VIP1
gene (or related gene) is naturally present or whether a particular
transformed
organism includes the VIP1 gene.
The invention now being generally described, the same will be better
understood
by reference to the following detailed examples that are provided for the
purpose of
illustration and are not to be considered limiting of the invention unless so
specified.
A standard nomenclature has been developed based on the sequence identity of
the proteins encompassed by the present invention. The gene and protein names
for
the detailed examples which follow and their relationship to the names used in
the
parent application [Canadian Patent Application
No. 2,157,297] are shown below.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-50-
Gene / Protein Gene / Description of Protein
Name under Protein
Standard Name in
Nomenclature Parent
VIP1A(a) VIP1 VIP1 from strain AB78 as disclosed in
SEQ ID NO:5.
VIP2A(a) VIP2 VIP2 from strain AB78 as disclosed in
SEQ ID NO:2.
VIP1 A(b) VIP1 VIP1 from Bacillus thuringiensis var.
homolog tenebrionis as disclosed in SEQ ID
NO:21.
VIP2A(b) VIP2 VIP2 from Bacillus thuringiensis var.
homolog tenebrionis as disclosed in SEQ ID
NO:20.
VIP3A(a) -- VIP from strain AB88 as disclosed in
SEQ ID NO:28 of the present application
VIP3A(b) -- VIP from strain AB424 as disclosed in
SEQ ID NO:31 of the present application
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-51 -
EXPERIMENTAL
Formulation Examples
The active ingredient used in the following formulation examples are Bacillus
cereus
strain AB78 having Accession No. NRRL B-21058; Bacillus thuringiensis strains
having Accession Nos. NRRL B-21060, NRRL B-21224, NRRL B-21225, NRRL 8-
21226, NRRL B-21227, and NRRL B-21439; and Bacillus spp strains having
Accession Nos NRRL B-21228, NRRL B-21229, and NRRL B-21230. All the
mentioned strains are natural isolates comprising the insect-specific proteins
according to the invention.
Alternatively, the isolated insect-specific proteins are used as the active
ingredient
alone or in combination with the above-mentioned Bacillus strains.
Al. Wettable powders
a) b) c)
Bacillus thuringiensis spores 25% 50% 75%
sodium lignosufonate 5% 5% --
sodium laurylsulfate 3% -- 5%
sodium diisobutylnaphthalenesulfonate -- 6% 10%
octylphenol polyethylene glycol ether -- 2% --
(7-8 moles of ethylene oxid)
highly dispersed silicid acid 5% 10% 10%
kaolin 62% 27% --
The spores are thoroughly mixed with the adjuvants and the mixture is
thoroughly
ground in a suitable mill, affording wettable powders which can be diluted
with water
to give suspensions of the desired concentrations.
A2. Emulsifiable concentrate
Bacillus thuringiensis spores 10%
octylphenol polyethylene glycol ether (4-5 moles ethylene oxide) 3%
clacium dodecylbenzensulfonate 3%
_2199049
WO 96/10083 PCT/EP95/03826
-52-
castor oil polyglycol ether (36 moles of ethylene oxide) 4%
cyclohexanone 30%
xylene mixture 50%
Emulsions of any required concentration can be obtained from this concentrate
by
dilution with water.
A3. Dusts
a) b)
Bacillus thuringiensis spores 5% 8%
talcum 95% --
kaolin -- 92%
Ready for use dusts are obtained by mixing the active ingredient with the
carriers and
grinding the mixture in a suitable mill.
A4. Extruder Granulate
Bacillus thuringiensis spores 10%
sodium lignosulfonate 2%
carboxymethylcellulose 1%
kaolin 87%
The active ingredient or combination is mixed and ground with the adjuvants
and the
mixture is subsequently moistened with water. The mixture is extruded,
granulated
and the dried in a stream of air.
A5. Coated Granule
Bacillus thuringiensis spores 3%
polyethylene glycol (mol wt 200) 3%
kaolin 94%
-2 1 '9 I'D WO 96/10083 4 PCT/EP95/03826
-53-
The active ingredient or combination is uniformly applied in a mixer to the
kaolin
moistened with polyethylene glycol. Non-dusty coated granulates are obtained
in this
manner.
A6. Suspension Concentrate
Bacillus thuringiensis spores 40%
ethylene glycol 10%
nonylphenol polyethylene glycol ether (15 moles of ethylene oxide) 6%
sodium lignosulfonate 10%
carboxymethylcelIulose 1 %
37% aqueous formaldehyde solution 0.2%
silicone oil in the form of a 75% aqueous solution 0.8%
water 32%
The active ingredient or combination is intimately mixed with the adjuvants
giving a
suspension concentrate from which suspensions of any desired concentration can
be
obtained by dilution with water.
EXAMPLE 1. AB78 ISOLATION AND CHARACTERIZATION
Bacillus cereus strain AB78 was isolated as a plate contaminant in the
laboratory
on T3 media (per liter: 3 g tryptone, 2 g tryptose, 1.5 g yeast extract, 0.05
M sodium
phosphate (pH 6.8), and 0.005 g MnCl2i Travers, R.S. 1983). During log phase
growth, AB78 gave significant activity against western corn rootworm.
Antibiotic
activity against gram-positive Bacillus spp. was also demonstrated (Table 12).
WO 96/10083 2 19904 9 PCT/EP95/03826
-54-
TABLE 12
Antibiotic activity of AB78 culture supernatant
Zone of inhibition(cm)
Bacteria tested AB78 Streptomycin
E. coli 0.0 3.0
B. megaterium 1.1 2.2
B. mycoides 1.3 2.1
B. cereus CB 1.0 2.0
B. cereus 11950 1.3 2.1
B. cereus 14579 1.0 2.4
B. cereus AB78 0.0 2.2
Bt var. israelensis 1.1 2.2
Bt var. tenebrionis 0.9 2.3
Morphological characteristics of AB78 are as follows:
Vegetative rods straight, 3.1-5.0 mm long and 0.5-2.0 mm wide. Cells with
rounded
ends, single in short chains. Single subterminal, cylindrical-oval, endospore
formed
per cell. No parasporal crystal formed. Colonies opaque, erose, lobate and
flat. No
pigments produced. Cells motile. Flagella present.
Growth characteristics of AB78 are as follows:
Facultative anaerobe with optimum growth temperature of 21-30 C. Will grow at
15, 20, 25, 30 and 37 C. Will not grow above 40 C. Grows in 5-7% NaCl.
Table 13 provides the biochemical profile of AB78.
WO 96/10083 2 9 9 0 4 9 PCT/EP95/03826
-55-
TABLE 13
Biochemical characteristics of B. cereus strain AB78.
Acid from L-arabinose - Methylene blue reoxidized +
Gas from L-arabinose - Nitrate reduced +
Acid from D-xylose - NO3 reduced to NO2 +
Gas from D-xylose - - VP +
Acid from D-glucose + H202 decomposed +
Gas from D-glucose - Indole -
Acid from lactose - Tyrosine decomposed +
Gas from lactose - Dihydroxiacetone -
Acid from sucrose - Litmus milk acid -
Gas from sucrose - Litmus milk coagulated -
Acid from D-mannitol - Litmus milk alkaline -
Gas from D-mannitol - Litmus milk peptonized -
Proprionate utilization + Litmus milk reduced -
Citrate utilization + Casein hydrolyzed +
Hippurate hydrolysis w Starch hydrolyzed +
Methylene blue reduced + Gelatin liquidified +
Lecithinase produced w
w= weak reaction
EXAMPLE 2. BACTERIAL CULTURE
A subculture of Bc strain AB78 was used to inoculate the following medium,
known
as TB broth:
Tryptone 12 g/l
Yeast Extract 24 g/l
Glycerol 4 ml/I
KH2PO4 2.1 g/l
K2HPO4 14.7 g/l
pH 7.4
CA 02199049 2008-07-07
30041-89
-56-
The potassium phosphate was added to the autoclaved broth after cooling.
Flasks were incubated at 30 C on a rotary shaker at 250 rpm for 24 h-36 h,
which
represents an early to mid-log growth phase.
The above procedure can be readily scaled up to large fermentors by procedures
well known in the art.
During vegetative growth, usually 24-36 h. after starting the culture, which
represents an early to mid-log growth phase, AB78 bacteria were centrifuged
from the
culture supernatant. The culture supernatant containing the active protein was
used
in bioassays.
EXAMPLE 3. INSECT BIOASSAYS
B. cereus strain AB78 was tested against various insects as described below.
Western, Northern and Southern corn rootworm, Diabrotica virgifera virgifera,
D.
longcornis barberi and D. undecempunctata howardi, respectively: dilutions
were
made of AB78 culture supernatant grown 24-36 h., mixed with molten artificial
diet
(Marrone et at (1985) J. of Economic Entomology 78:290-293) and allowed to
solidify.
Solidified diet was cut and placed in dishes. Neonate larvae were placed on
the diet
and held at 30 C. Mortality was recorded after 6 days.
E. coli clone bioassay: E. coli cells were grown overnight in broth containing
100
pg/ml ampicillin at 37 C. Ten ml culture was sonicated 3X for 20 sec each. 500
l of
sonicated culture was added to molten western corn rootworm diet.
Colorado potato beetle, Leptinotarsa decemlineata: dilutions in Tritori`X-100
(to
give final concentration of 0.1% TX-100) were made of AB78 culture supernatant
grown 24-36 h. Five cm2 potato leaf pieces were dipped into these dilutions,
air dried,
and placed on moistened filter paper in plastic dishes. Neonate larvae were
placed
on the leaf pieces and held at 30 C. Mortality was recorded after 3-5 days.
Yellow meaiworm, Tenebrio molitor dilutions were made of AB78 culture
supernatant grown 24-36 h., mixed with molten artificial diet (Bioserv #F9240)
and
allowed to solidify. Solidified diet was cut and placed in plastic dishes.
Neonate
larvae were placed on the diet and held at 30 C. Mortality was recorded after
6-8
days.
*Trade-mark
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-57-
European corn borer, black cutworm, tobacco budworm, tobacco hornworm and
beet armyworm; Ostrinia nubilalis, Agrotis ipsilon, Heliothis virescens,
Manduca sexta
and Spodoptera exigua, respectively: dilutions, in TX-100 (to give final
concentration
of 0.1% TX-100), were made of AB78 culture supernatant grown 24-36 hrs. 100 I
was pipetted onto the surface of 18 cm of solidified artificial diet (Bioserv
#F9240)
and allowed to air dry. Neonate larvae were then placed onto the surface of
the diet
and held at 30 C. Mortality was recorded after 3-6 days.
Northern house mosquito, Culexpipiens:-dilutions were made of AB78 culture
supernatant grown 24-36 h. 100 l was pipetted into 10 ml water in a 30 ml
plastic
cup. Third instar larvae were added to the water and held at room temperature.
Mortality was recorded after 24-48 hours. The spectrum of entomocidal activity
of
AB78 is given in Table 14.
TABLE 14
Activity of AB78 culture supernatant against various insect species
Insect species
tested to date Order Activity
Western corn rootworm
(Diabrotica virgifera
virgifera) Col +++
Northern corn rootworm
(Diabrotica longicornis
barbers) Col +++
Southern corn rootworm
(Diabrotica undecimpunctata
howardi) Col -
Colorado potato beetle
(Leptinotarsa decemlineata) Col -
Yellow mealworm
(Tenebrio molito,) Col -
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-58-
European corn borer
(Ostrinia nubilalis) Lep -
Tobacco budworm
(Heliothis virescens) Lep -
Tobacco hornworm
(Manduca sexta) Lep -
Beet armyworm
(Spodoptera exigua) Lep -
Black cutworm
(Agrotis ipsilon) Lep -
Northern house mosquito
(Culex pipiens) Dip -
The newly discovered B. cereus strain AB78 showed a significantly different
spectrum of insecticidal activity as compared to known coleopteran active
S-endotoxins from Bt. In particular, AB78 showed more selective activity
against
beetles than known coleopteran-active Bt strains in that it was specifically
active
against Diabrotica spp. More specifically, it was most active against D.
virgifera
virgifera and D. longicornis barberi but not D. undecimpunctata howardi.
A number of Bacillus strains were bioassayed for activity during vegetative
growth
(Table 15) against western corn rootworm. The results demonstrate that AB78 is
unique in that activity against western corn rootworm is not a general
phenomenon.
WO 96/10083 a.2 1 9 9 0 4 9 PCT/EP95/03826
-59-
TABLE 15
Activity of culture supernatants from various Bacillus spp. against western
corn
rootworm
Percent
Bacillus strain WCRW mortality
B. cereus AB78 (Bat.1) 100
B. cereus AB78 (Bat.2) 100
B. cereus (Carolina Bio.) 12
B. cereus ATCC 11950 12
B. cereus ATCC 14579 8
B. mycoides (Carolina Bio.) 30
B. popilliae 28
B. thuringiensis HD135 41
B. thuringiensis HD191 9
B. thuringiensis GC91 4
B. thuringiensis isrealensis 24
Water Control 4
Specific activity of AB78 against western corn rootworm is provided in Table
16.
WO 96/10083 -2_ 1 9 9 0 4 9 PCT/EP95/03826
-60-
TABLE 16
Activity of AB78 culture supernatant against neonate western corn rootworm
Culture supernatant Percent
concentration (u.l/mi) WCRW mortality
100 100
25 87
80
5 40
2.5 20
1 6
0 0
The LC50 was calculated to be 6.2 l of culture supernatant per ml of western
corn
rootworm diet.
The cell pellet was also bioassayed and had no activity against WCRW. Thus,
the
presence of activity only in the supernatant indicates that this VIP is an
exotoxin.
EXAMPLE 4. ISOLATION AND PURIFICATION OF CORN ROOTWORM
ACTIVE PROTEINS FROM AB78.
Culture media free of cells and debris was made to 70% saturation by the
addition
of solid ammonium sulfate (472 g/L). Dissolution was at room temperature
followed
by cooling in an ice bath and centrifugation at 10,000 X g for thirty minutes
to pellet
the precipitated proteins. The supernatant was discarded and the pellet was
dissolved
in 1/10 the original volume of 20 mM TRIS-HCI at pH 7.5. The dissolved pellet
was
desalted either by dialysis in 20 mM TRIS-HCI pH 7.5, or passing through a
desalting
column.
The desalted material was titrated to pH 3.5 using 20 mM sodium citrate pH
2.5.
Following a thirty minute room temperature incubation the solution was
centrifuged at
WO 96/10083 2 'M *" 9 0 4 9 PCT/EP95/03826
-61 -
3000 X g for ten minutes. The supernatant at this stage contained the greatest
amount of active protein.
Following neutralization of the pH to 7.0 the supernatant was applied to a
Mono-Q,
anion exchange, column equilibrated with 20 mM TRIS pH 7.5 at a flow rate of
300
mL/min. The column was developed with a stepwise and linear gradient employing
400 mM NaCl in 20 mM TRIS pH 7.5.
Bioassay of the column fractions and SDS-PAGE analysis were used to confirm
the active fractions. SDS-PAGE analysis identified the biologically active
protein as
having components of a molecular weight in the range of about 80 kDa and 50
kDa.
EXAMPLE 5. SEQUENCE ANALYSIS OF THE CORN ROOTWORM ACTIVE
PROTEIN
The 80 kDa component isolated by SDS-PAGE was transferred to PVDF
membrane and was subjected to amino-terminal sequencing as performed by
repetitive Edman cycles on an ABI 470 pulsed-liquid sequencer. Transfer was
carried
out in 10 mM CAPS buffer with 10% methanol pH 11.0 as follows:
Incubation of the gel following electrophoresis was done in transfer buffer
for five
minutes. ProBlott PVDF membrane was wetted with 100% MeOH briefly then
equilibrated in transfer buffer. The sandwich was arranged between foam
sponges
and filter paper squares with the configuration of cathode-gel-membrane-anode.
Transfer was performed at 70 V constant voltage for 1 hour.
Following transfer, the membrane was rinsed with water and stained for two
minutes with 0.25% Coomassie Blue R-250 in 50% MeOH.
Destaining was done with several rinses with 50% MeOH 40% water 10% acetic
acid.
Following destaining the membrane was air dried prior to excision of the bands
for
sequence analysis. A BlottCartridge and appropriate cycles were utilized to
achieve
maximum efficiency and yield. Data analysis was performed using model 610
Sequence Analysis software for identifying and quantifying the PTH-amino acid
derivatives for each sequential cycle.
The N-terminal sequence was determined to be:
NH2-Lys-Arg-Glu-Ile-Asp-Glu-Asp-Thr-Asp-Thr-Asx-Gly-Asp-Ser-Ile- Pro-
WO 96/10083 r 2 1 9 9 Q 41 9 PCT/EP95/03826
2 9
-62-
(SEQ ID NO:8) where Asx represents Asp or Asn. The complete amino acid
sequence for the 80 kDa component is disclosed in SEQ ID NO:7. The DNA
sequence which encodes SEQ ID NO:7 is disclosed in SEQ ID NO:6.
EXAMPLE 6. CONSTRUCTION OF DNA PROBE
An oligonucleotide probe for the region of the gene encoding amino acids 3-9
of
the N-terminal sequence (Example 5) was generated. The probe was synthesized
based on the codon usage of a Bacillus thuringiensis (Bt) S-endotoxin gene.
The
nucleotide sequence
5'- GAA ATT GAT CAA GAT ACN GAT -3' (SEQ ID NO:9)
was used as a probe in Southern hybridizations. The oligonucleotide was
synthesized
using standard procedures and equipment.
= EXAMPLE 7. ISOELECTRIC POINT DETERMINATION OF THE CORN
ROOTWORM ACTIVE PROTEIN
Purified protein from step 5 of the purification process was analyzed on a 3-9
pl
isoelectric focusing gel using the Phastgel electrophoresis system
(Pharmacia).
Standard operating procedures for the unit were followed for both the
separation and
silver staining development procedures. The pl was approximated at about 4.9.
EXAMPLE 8. PCR DATA ON AB78
PCR analysis (See, for example US patent application serial no. 08/008,006;
and,
Carozzi et al. (1991) Appl. Environ. Microbiol. 57(11):3057-3061, herein
incorporated
by reference.) was used to verify that the B. cereus strain AB78 did not
contain any
insecticidal crystal protein genes of B. thuringiensis or B. sphaericus (Table
17).
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-63-
TABLE 17
Bacillus insecticidal crystal protein gene primers tested by PCR against AB78
DNA.
Primers Tested Product Produced
2 sets specific for CryllIA Negative
CrylliB Negative
2 sets specific for CrylA Negative
CrylA(a) Negative
CrylA(b) specific Negative
CryiB Negative
CryIC specific Negative
CrylE specific Negative
2 sets specific for B. sphaericus Negative
2 sets specific for CryIV Negative
Bacillus control (PI-PLC) Positive
EXAMPLE 9. COSMID CLONING OF TOTAL DNA FROM B. CEREUS STRAIN
AB78
The VIP1A(a) gene was cloned from total DNA prepared from strain AB78 as
follows:
Isolation of AB78 DNA was as follows:
1. Grow bacteria in 10 ml L-broth overnight. (Use 50 ml sterile centrifuge
tube)
2. Add 25 ml of fresh L-broth and ampicillin (30 gg/ml).
3. Grow cells 2-6 h. at 30 C with shaking.
4. Spin cells in a 50 ml polypropylene orange cap tube in IEC benchtop
clinical
centrifuge at 3/4 speed.
5. Resuspend cell pellet in 10 ml TES (TES = 50 mM TRIS pH 8.0, 100 mM EDTA,
15
mM NaCl).
6. Add 30 mg lysozyme and incubate 2 hrs at 37 C.
WO 96/10083 2 1 9 9 4 9 PCT/EP95/03826
- 64 -
7. Add 200 gl 20% SDS and 400 l Proteinase K stock (20 mg/ml). Incubate at 37
C.
8. Add 200 gl fresh Proteinase K. Incubate 1 hr. at 55 C. Add 5 ml TES to make
15
ml final volume.
9. Phenol extract twice (10 ml phenol, spin at room temperature at 3/4 speed
in an
IEC benchtop clinical centrifuge). Transfer supernatant (upper phase) to a
clean tube
using a wide bore pipette.
10. Extract once with 1:1 vol. phenol:chloroform/isoamyl alcohol (24:1 ratio).
11. Precipitate DNA with an equal volume of cold isopropanol; Centrifuge to
pellet DNA.
12. Resuspend pellet in 5 ml TE.
13. Precipitate DNA with 0.5 ml 3M NaOAc pH 5.2 and 11 ml 95% ethanol. Place
at -20 C for 2 h.
14. "Hook" DNA from tube with a plastic loop, transfer to a microfuge tube,
spin,
pipette off excess ethanol, dry in vacuo.
15. Resuspend in 0.5 ml TE. Incubate 90 min. at 65 C to help get DNA back into
solution.
16. Determine concentration using standard procedures.
Cosmid Cloning of AB78
All procedures, unless indicated otherwise, were performed according to
Stratagene Protocol, Supercos 1 Instruction Manual, Cat. No. 251301.
Generally, the steps were as follows:
A. Sau 3A partial digestion of the AB78 DNA.
B. Preparation of vector DNA
C. Ligation and packaging of DNA
D. Tittering the cosmid library
1. Start a culture of HB101 cells by placing 50 ml of an overnight culture in
mis of TB with 0.2% maltose. Incubate 3.5 hrs. at 37 C.
2. Spin out cells and resuspend in 0.5 ml 10 mM MgSO4.
3. Add together:
100 I cells
100 I diluted packaging mixture
100 110 mM MgSO4
WO 96/10083
2 19904 PCT/EP95/03826
-65-
30 1 TB
4. Adsorb at room temperature for 30 minutes with no shaking.
5. Add 1 ml TB and mix gently. Incubate 30 minutes at 37 C.
6. Plate 200 I onto L-amp plates. Incubate at 37 C overnight.
At least 400 cosmid clones were selected at random and screened for activity
against western corn rootworm as described in Example 3. DNA from 5 active
clones
and 5 non-active clones were used in Southern hybridizations. Results
demonstrated
that hybridization using the above described oligonucleotide probe correlated
with
western corn rootworm activity (Table 18).
Cosmid clones P3-12 and P5-4 have been deposited with the Agricultural
Research Service Patent Culture Collection (NRRL) and given Accession Nos.
NRRL
B-21061 and NRRL B-21059 respectively.
TABLE 18
Activity of AB78 cosmid clones against western corn rootworm.
Mean
Clone percent mortality (N=4)
Clones which hybridize with probe
P l-73 47
P1-83 64
P2-2 69
P3-12 85
P5-4 97
Clones which do not hybridize with probe
P1-2 5
P3-8 4
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-66-
P3-9 12
P3-18 0
P4-6 9
EXAMPLE 10. IDENTIFICATION OF A 6 KB REGION ACTIVE AGAINST
WESTERN CORN ROOTWORM.
DNA from P3-12 was partially digested with restriction enzyme Sau 3A, and
ligated into the E. coli vector pUC19 and transformed into E. coli. A DNA
probe
specific for the 80 kDa VIP1A(a) protein was synthesized by PCR amplification
of a
portion of P3-12 DNA. Oligonucleotides MK113 and MK117, which hybridize to
portions of VIP1A(a), were synthesized using the partial amino acid sequence
of the
80 kDa protein. Plasmid subclones were identified by colony hybridization to
the
PCR-generated probe, and tested for activity against western corn rootworm.
One
such clone, PL2, hybridized to the PCR-generated fragment, and was active
against
western corn rootworm in the assay previously described.
A 6 kb Cla I restriction fragment from p12 was cloned into the Sma I site of
the E.
coli-_Bacillus shuttle vector pHT 3101 (Lereclus, D. et al., FEMS Microbiology
Letters
60:211-218 (1989)) to yield pCIB6201. This construct confers anti-western corn
rootworm activity upon both Bacillus and E.colistrains, in either orientation.
pCIB6022
contains this same 6 kb Cla I fragment in pBluescript SK(+) (Stratagene),
produces
equivalent VIP1A(a) protein (by western blot), and is also active against
western corn
rootworm.
The nucleotide sequence of pCIB6022 was determined by the dideoxy
termination method of Sanger et al., Proc. Natl. Acad. Sci. USA, 74:5463-5467
(1977), using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits
and PRISM Sequenase Terminator Double-Stranded DNA Sequencing Kit and
analyzed on an ABI 373 automatic sequencer. The sequence is given in SEQ ID
NO:1. The 6 kb fragment encodes both VIP1A(a) and VIP2A(a), as indicated by
the
open reading frames described in SEQ ID NO:1. The sequence encoding VIP2A(a)
is
further disclosed in SEQ ID NO:4. The relationship between VIP1A(a) and
VIP2A(a)
within the 6 kb fragment found in pCIB6022 is depicted in Table 19. pCIB6022
was
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
-67-
deposited with the Agricultural Research Service, Patent Culture Collection,
(NRRL),
Northern Regional Research Center, 1815 North University Street, Peoria,
Illinois
61604, USA, and given the Accession No. NRRL B-21222.
EXAMPLE 11. FUNCTIONAL DISSECTION OF THE VIP1A(a) DNA REGION.
To confirm that the VIP1A(a) open reading frame (ORF) is necessary for
insecticidal activity a translational frameshift mutation was created in the
gene. The
restriction enzyme Bgl II recognizes a unique site located 857 bp into the
coding
region of VIP1A(a). pCIB6201 was digested with Bgl II, and the single-stranded
ends
filled-in with DNA polymerase (Klenow fragment) and dNTPS. The plasmid was re-
ligated and transformed into E. coli. The resulting plasmid, pCIB6203,
contains a four
nucleotide insertion in the coding region of VIP1A(a). pCIB6203 does not
confer
WCRW insecticidal activity, confirming that VIP1A(a) is an essential component
of
western corn rootworm activity.
To further define the region necessary to encode VIP1A(a), subclones of the
VIP1A(a) and VIP2A(a) (auxiliary protein) region were constructed and tested
for their
ability to complement the mutation in pCIB6203. pCIB6023 contains the 3.7kb
Xba I-
EcoRV fragment in pBluescript SK(+) (Stratagene). Western blot analysis
indicates
that pCIB6023 produces VIP1A(a) protein of equal size and quantity as clones
PL2
and pCIB6022. pCIB6023 contains the entire gene encoding the 80 kD protein.
pCIB6023 was deposited with the Agricultural Research Service, Patent Culture
Collection, (NRRL), Northern Regional Research Center, 1815 North University
Street,
Peoria, Illinois 61604, USA, and given the Accession No. NRRL B-21223N.
pCIB6206
contains the 4.3 kb Xba I-CIa I fragment from pCIB6022 in pBluescript SK(+)
(Stratagene). pCIB6206 was also deposited with the Agricultural Research
Service,
Patent Culture Collection, (NRRL), Northern Regional Research Center, 1815
North
University Street, Peoria, Illinois 61604, USA, and given the Accession No.
NRRL B-
21321.
pCIB6023, pCIB6206, and pCIB6203 do not produce detectable western corn
rootworm activity when tested individually. However, a mixture of cells
containing
pCIB6203 (VIP1A(a)-mutated, plus VIP2A(a)) and cells containing pCIB6023 (only
WO 96/10083 2 1 9 9 0 4 7 PCT/EP95/03826
-68-
VIP1 A(a)) shows high activity against western corn rootworm. Similarly, a
mixture of
cells containing pCIB6206 and cells containing pCIB6203 shows high activity
against
western corn rootworm.
To further define the limits of VIP2A(a), we constructed pCIB6024, which
contains
the entirety of VIP2A(a), but lacks most of the VIP1A(a) coding region.
pCIB6024 was
constructed by gel purifying the 2.2 kb CIa I-Sca I restriction fragment from
pCIB6022,
filling in the single-stranded ends with DNA polymerase (Klenow fragment) and
dNTPs, and ligating this fragment into pBluescript SK(+) vector (Stratagene)
digested
with the enzyme Eco RV. Cells containing pCIB6024 exhibit no activity against
western corn rootworm. However, a mixture of cells containing pCIB6024 and
cells
containing pCIB6023 shows high activity against western corn rootworm .(See
Table
19).
Thus, pCIB6023 and pCIB6206 must produce a functional VIP1A(a) gene
product, while pCIB6203 and pCIB6024 must produce a functional VIP2A(a) gene
product. These results suggest a requirement for a gene product(s) from the
VIP2A(a) region, in combination with VIP1A(a), to confer maximal western corn
rootworm activity. (See Table 19.)
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-69-
Table 19
Characterization of pCIB6022
Activity vs.
WCRW
C X S RIB RV C
I ~11.2A I I 111121 Alm
~_ rF fx,.>'.vr<r pCIB6203 -
-wpCIB6023 -
I pCIB6206 -
=tiFF.......::J=x= -
l :i:::=frim':~:.,v..:t.': pC 186024
{f;r
Functional Complementation of VIP
v-> f> I pCIB6203
+++
pCIB6023
pCIB6203
-o- 4 pCIB6206
- w I pCIB6023
'=N;:;.<:< ;':f: l pCIB6024
Boxed regions represent the extent of VIP1A(a) and VIP2A(a). White box
represents the
portion of VIP1 encoding the 80 kDa peptide observed in Bacillus. Dark box
represents the N-
terminal 'propeptide' of VIPI A(a) predicted by DNA sequence analysis.
Stippled box represents
the VIP2A(a) coding region. Large'X' represents the location of the frameshift
mutation
introduced into VIP1A(a). Arrows represent constructs transcribed by the beta-
galactosidase
WO 96/10083 Z 9 9 0 4 9 PCT/EP95/03826
-70-
EXAMPLE 12. AB78 ANTIBODY PRODUCTION
Antibody production was initiated in 2 Lewis rats to allow for both the
possibility of
moving to production of hybridoma cell lines and also to produce enough serum
for
limited screening of genomic DNA library. Another factor was the very limited
amount
of antigen available and the fact that it could only be produced to purity by
PAGE and
subsequent electrotransfer to nitrocellulose.
Due to the limited availability of antigen on nitrocellulose, the
nitrocellulose was
emulsified in DMSO and injected into the hind footpads of the animals to
elicit B-cell
production in the popliteal lymph nodes just upstream. A strong reacting serum
was
produced as judged by western blot analysis with the first production bleed.
Several
subsequent injections and bleeds produced enough serum to accomplish all of
the
screening required.
Hybridoma production with one of the rats was then initiated. The popliteal
lymph
node was excised, macerated, and the resulting cells fused with mouse myeloma
P3x63Ag8.653. Subsequent cell screening was accomplished as described below.
Four initial wells were selected which gave the highest emulsified antigen
reaction to
be moved to limited dilution cloning. An additional 10 wells were chosen for
expansion and cryoperservation.
Procedure to Emulsify AB78 on nitrocellulose in DMSO for ELISA screening:
After electrotransfer of AB78 samples run on PAGE to nitrocellulose, the
reversible
strain Ponceau S is used to visualize all protein transferred. The band
corresponding
to AB78 toxin, previously identified and N-terminal sequenced, was identified
and
excised from nitrocellulose. Each band is approximately 1 mm x 5 mm in size to
minimize the amount of nitrocellulose emulsified. A single band is placed in a
microfuge tube with 250 l of DMSO and macerated using a plastic pestle
(Kontes,
Vineland, NJ). To aid in emulsification, the DMSO mixture is heated for 2-3
minutes at
37 C-45 C. Some further maceration might be necessary following heating;
however,
all of the nitrocellulose should be emulsified. Once the AB78 sample is
emulsified, it
is placed on ice. In preparation for microtiter plate coating with the
emulsified antigen,
the sample must be diluted in borate buffered saline as follows: 1:5, 1:10,
1:15, 1:20,
1:30, 1:50, 1:100, and 0. The coating antigen must be prepared fresh
immediately
prior to use.
ELISA protocol:
WO 96/10083 - 2 9 9 0-4'9- PCT/EP95/03826
-71 -
1. Coat with AB78/DMSO in BBS. Incubate overnight at 4 C.
2. Wash plate 3X with 1 X ELISA wash buffer.
3. Block (1% BSA & 0.05% Tween 20 in PBS) for 30 minutes at Room
Temperature.
4. Wash plate 3X with 1 X ELISA wash buffer.
5. Add rat serum. Incubate 1.5 hours at 37 C.
6. Wash plate 3X with 1 X ELISA wash buffer.
7. Add goat anti-rat at a concentration of 2 gg/ml in ELISA diluent. Incubate
1
hr. at 37 C.
8. Wash plate 3X with 1X ELISA wash buffer.
9. Add rabbit anti-goat alkaline phosphatase at 2 g/ml in ELISA diluent.
Incubate 1 hr. at 37 C.
10. Wash 3X with 1 X ELISA wash buffer.
11. Add Substrate. Incubate 30 minutes at room temperature.
12. Stop with 3N NaOH after 30 minutes.
Preparation of VIP2A(a) Antisera
A partially purified AB78 culture supernatant was separated by discontinuous
SDS
PAGE (Novex) following manufacturer's instructions. Separated proteins were
electrophoresed to nitrocellulose (S&S #21640) as described by Towbin et al.,
(1979).
The nitrocellulose was stained with Ponceau S and the VIP2A(a) band
identified. The
VIP2A(a) band was excised and emulsified in DMSO immediately prior to
injection. A
rabbit was initially immunized with emulsified VIP2A(a) mixed approximately
1:1 with
Freund's Complete adjuvant by intramuscular injection at four different sites.
Subsequent immunizations occurred at four week intervals and were identical to
the
first, except for the use of Freund' Incomplete adjuvant. The first serum
harvested
following immunization reacted with VIP2A(a) protein. Western blot analysis of
AB78
culture supernatant using this antisera identifies predominately full length
VIP2A(a)
protein.
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
-72-
EXAMPLE 13. ACTIVATION OF INSECTICIDAL ACTIVITY OF NON-ACTIVE BT
STRAINS WITH AB78 VIP CLONES.
Adding pCIB6203 together with a 24 h culture (early to mid-log phase)
supernatant
from Bt strain GC91 produces 100% mortality in Diabrotica virgifera virgifera.
Neither
pCIB6203 nor GC91 is active on Diabrotica virgifera virgifera by itself. Data
are
shown below:
Test material Percent Diabrotica mortality
pCIB6203 0
GC91 16
pCIB6203 + GC91 100
Control 0
EXAMPLE 14. ISOLATION AND BIOLOGICAL ACTIVITY OF B. CEREUS AB81.
A second B. cereus strain, designated AB81, was isolated from grain bin dust
samples by standard methodologies. A subculture of AB81 was grown and prepared
for bioassay as described in Example 2. Biological activity was evaluated as
described in Example 3. The results are as follows:
Insect species Percent
tested Mortality
Ostrinia nubilalis 0
Agrotis ipsilon 0
Diabrotica virgifera virgifera 55
WO 96/10083 2 199-0,4-9 PCT/EP95/03826
-73-
EXAMPLE 15. ISOLATION AND BIOLOGICAL ACTIVITY OF
B. THURINGIENSIS AB6.
A B. thuringiensis strain, designated AB6, was isolated from grain bin dust
samples by standard methods known in the art. A subculture of AB6 was grown
and
prepared for bioassay as described in Example 2. Half of the sample was
autoclaved
15 minutes to test for the presence of 3-exotoxin.
Biological activity was evaluated as described in Example 3. The results are
as
follows:
Insect species Percent
tested Mortality
Ostrinia nubilalis 0
Agrotis ipsilon 100
Agrotis ipsilon (autoclaved sample) 0
Diabrotica virgifera virgifera 0
The reduction of insecticidal acitivity of the culture supernatant to
insignificant
levels by autoclaving indicates that the active principle is not (i-exotoxin.
Strain AB6 has been deposited in the Agricultural Research Service, Patent
Culture Collection (NRRL), Northern Regional Research Center, 1815 North
University
Street, Peoria, Illinois 61604, USA, and given Accession No. NRRL B-21060.
EXAMPLE 16. ISOLATION AND BIOLOGICAL CHARACTERIZATION OF
B. THURINGIENSIS AB88.
A Bt strain, designated AB88, was isolated from grain bin dust samples by
standard methodologies. A subculture of AB88 was grown and prepared for
bioassay
as described in Example 2. Half of the sample was autoclaved 15 minutes to
test for
the presence of R-exotoxin. Biological activity was evaluated against a number
of
insect species as described in Example 3. The results are as follows:
WO 96/10083 2 199049 PCT/EP95/03826
-74-
Percent mortality of culture
supernatant
Insect species Order Non-
tested autoclaved Autoclav
ed
Agrotis ipsilon Lepidoptera 100 5
Ostrinia Lepidoptera 100 0
nubilalis
Spodoptera
frugiperda Lepidoptera 100 4
Helicoverpa Lepidoptera 100 12
zea
Heliothis Lepidoptera 100 12
virescens
Leptinotarsa
decemlineata Coleoptera 0 0
Diabrotica
virgifera Coleoptera 0 5
virgifera
The reduction of insecticidal acitivity of the culture supernatant to
insignificant
levels by autoclaving indicates that the active principle is not R-exotoxin.
Delta-endotoxin crystals were purified from strain AB88 by standard
methodologies. No activity from pure crystals was observed when bioassayed
against
Agrotis ipsilon.
EXAMPLE 17. PURIFICATION OF VIPS FROM STRAIN AB88:
Bacterial liquid culture was grown overnight [for 12h] at 30 C in TB media.
Cells
were centrifuged at 5000 x g for 20 minutes and the supernatant retained.
Proteins
present in the supernatant were precipitated with ammonium sulfate (70%
saturation),
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-75-
centrifuged [at 5000 x g for 15 minutes] and the pellet retained. The pellet
was
resuspended in the original volume of 20 mM Tris pH 7.5 and dialyzed overnight
against the same buffer at 4 C. AB88 dialysate was more turbid than comparable
material from AB78. The dialysate was titrated to pH 4.5 using 20 mM sodium
citrate
(pH 2.5) and, after 30 min incubation at room temperature, the solution was
centrifuged at 3000 x g for 10 min. The protein pellet was redissolved in 20
mM Bis-
Tris-Propane pH 9Ø
AB88 proteins have been separated by several different methods following
clarification including isoelectric focusing (Rotofor, BioRad, Hercules, CA),
precipitation at pH 4.5, ion-exchange chromotography, size exclusion
chromatography
and ultrafiltration.
Proteins were separated on a Poros HQ/N anion exchange column (PerSeptive
Biosystems, Cambridge, MA) using a linear gradient from 0 to 500 mM NaCl in 20
mM
Bis-Tris-Propane pH 9.0 at a flow rate of 4 ml/min. The insecticidal protein
eluted at
250 mM NaCl.
European corn borer (ECB)-active protein remained in the pellet obtained by pH
4.5 precipitation of dialysate. When preparative IEF was done on the dialysate
using
pH 3-10 ampholytes, ECB insecticidal activity was found in all fractions with
pH of 7 or
greater. SDS-PAGE analysis of these fractions showed protein bands of MW -60
kDa and -80 kDa. The 60 kDa and 80 kDa bands were separated by anion exchange
HPLC on a Poros-Q column (PerSeptive Biosystems, Cambridge, MA). N-terminal
sequence was obtained from two fractions containing proteins of slightly
differing MW,
but both of approximately 60 kDa in size. The sequences obtained were similar
to
each other and to some 8-endotoxins.
anion exchange fraction 23 (smaller): xEPFVSAxxxQxxx (SEQ ID NO:10)
anion exchange fraction 28 (larger): xEYENVEPFVSAx (SEQ ID NO:11)
When the ECB-active pH 4.5 pellet was further separated by anion exchange on
a Poros-Q column, activity was found only in fractions containing a major band
of -60
kDa.
Black cutworm-active protein also remained in the pellet when AB88 dialysate
was brought down to pH 4.5. In preparative IEF using pH 3-10 ampholytes,
activity
was not found in the ECB-active IEF fractions; instead, it was highest in a
fraction of
pH 4.5-5Ø Its major components have molecular weights of -35 and -80 kDa.
WO 96/10083 r f9 " PCT/EP95/03826
-76-
The pH 4.5 pellet was separated by anion exchange HPLC to yield fractions
containing only the 35 kDa material and fractions containing both 35 kDa and
80 kDa
bands.
EXAMPLE 18. CHARACTERIZATION OF AB88 VIP.
Fractions containing the various lepidopteran active vegetative proteins were
generated as described in Example 17. Fractions with insecticidal acitivity
were
separated in 8 to 16% SIDS-pollyacrylamide gels and transferred to PVDF
membranes
[LeGendre et al, (1989) in: A Practical Guide to Protein and Peptide
Purification for
Microsequencing, ed Matsudaria PT (Academic Press Inc, New Yorkl]. Biological
analysis of fractions demonstrated that different VIPs were responsible for
the
different lepidopteran species activity.
The Agrotis ipsilon activity is due to an 80 kDa and/or a 35 kDa protein,
either
delivered singly or in combination. These proteins are not related to any &-
endotoxins
from Bt as evidenced by the lack of sequence homology of known Bt &-endotoxin
sequences. The vip3A(a) insecticidal protein from strain AB88 is present
mostly (at
least 75% of the total) in supernatants of AB88 cultures.
Also, these proteins are not found in the AB88 &-endotoxin crystal. N-terminal
sequences of the major &-endotoxin proteins were compared with the N-terminal
sequences of the 80 kDa and 35 kDa VIP and revealed no sequence homology. The
N-terminal sequence of the vip3A(a) insecticidal protein posses a number of
positively
charged residues (from Asn2 to Asn7) followed by a hydrophobic core region
(from
Thr8 to Ile34). Unlike most of the known secretion proteins, the vip3A(a)
insecticidal
protein from strain AB88 is not N-terminally processed during export.
A summary of the results follows:
WO 96/10083 2 1 9 9 0 4 PCT/EP95/03826
-77-
Agrotis VIP N-terminal sequences N-terminal sequence of
major 8-endotoxin proteins
130 kDa
MDNNPNINE (SEQ ID
NO:14)
80 kDa 80 kDa
MNKNNTKLPTRALP (SEQ ID MDNNPNINE (SEQ ID
NO:12) NO:15)
60 kDa
MNVLNSGRTTI (SEQ ID
NO:16)
35 kDa
ALSENTGKDGGYIVP (SEQ ID
NO:13)
The Ostrinia nubilalis activity is due to a 60 kDa VIP and the Spodoptera
frugiperda activity is due to a VIP of unknown size.
Bacillus thuringiensis strain AB88 has been deposited in the Agricultural
Research Service, Patent Culture Collection (NRRL), Northern Regional Research
Center, 1815 North University Street, Peoria, Illinois 61604, USA and given
the
Accession No. NRRL B-21225.
EXAMPLE 18A. ISOLATION AND BIOLOGICAL ACTIVITY OF B.
THURINGIENSIS AB424
A B. thuringiensis strain, designated AB424, was isolated from a moss covered
pine cone sample by standard methods known in the art. A subculture of AB424
was
grown and prepared for bioassay as described in Example 2.
Biological activity was evaluated as described in Example 3. The results are
as
follows:
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-78-
Insect species tested Percent
mortality
Ostrinia nubilalis 100
Agrotis ipsilon 100
Diabrotica virgifera 0
virgifera
Strain AB424 has been deposited in the Agricultural Research Service, Patent
Culture Collection (NRRL), Northern Regional Research Center, 1815 North
University
Street, Peoria, Illinois 61604, USA, and given Accession No. NRRL B-21439.
EXAMPLE 18B. CLONING OF THE VIP3A(a) and VIP3A(b) GENES WHICH
ENCODE PROTEINS ACTIVE AGAINST BLACK CUTWORM.
Total DNA from isolates AB88 and AB424 was isolated [Ausubel et al (1988), in:
Current Protocols in Molecular Biology (John Wiley & Sons, NY)] and digested
with
the restriction enzymes Xbal [library of 4.0 to 5.0 Kb size-fractionated Xbal
fragments
of B thuringiensis AB88 DNA] and EcoRl [library of 4.5 to 6.0 Kb size-
fractionated
EcoRl fragments B thuringiensis AB424 DNA] respectively, ligated into
pBluescript
vector previously linearized with the same enzymes and dephosphorylated, and
transformed into E. coli DH5a strain. Recombinant clones were blotted onto
nitrocellulose filters which were subsequently probed with a 32 P labeled 33-
bases long
oligonucleotide corresponding to the 11-N terminal amino acids of the 80 kDa
protein
active against Agrotis ipsilon (black cutworm). Hybridization was carried out
at 42 C in
2 x SSC/0.1% SDS (1 x SSC = 0.15 m NaCI/0.015 M sodium citrate, pH 7.4) for 5
min
and twice at 50 C in 1 x SSC/0.1 SDS for 10 min. Four out of 400 recombinant
clones
were positive. Insect bioassays of the positive recombinants exhibited
toxicity to black
cutworm larvae comparable to that of AB88 or AB424 supernantants.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-79-
Plasmid pCIB7104 contains a 4.5 Kb Xbal fragment of AB88 DNA. Subclones were
constructed to define the coding region of the insecticidal protein.
E coli pCIB7105 was constructed by cloning the 3.5 Kb Xbal-Accl fragment of
pCIB7104 into pBluescript.
Plasmid pCIB7106 contained a 5.0 Kb EcoRl fragment of AB424 DNA. This
fragment was further digested with Hincll to render a 2.8 kb EcoRl-Hincll
insert
(pCIB7107), which still encoded a functional insecticidal protein.
The nucleotide sequence of pCIB7104, a positive recombinant clone from AB88,
and of pCIB7107, a positive recombinant clone from AB424, was determined by
the
dideoxy termination method of Sanger et al., Proc. NatI. Acad. Sci. USA, 74:
5463-
5467 (1977), using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing
Kits and PRISM Sequenase Terminator Double-Stranded DNA Sequencing Kit and
analysed on an ABI 373 automatic sequencer.
The clone pCIB7104 contains the VIP3A(a) gene whose coding region is disclosed
in SEQ ID NO:28 and the encoded protein sequence is disclosed in SEQ ID NO:29.
A
synthetic version of the coding region designed to be highly expressed in
maize is
given in SEQ ID NO:30. Any number of synthetic genes can be designed based on
the amino acid sequence given in SEQ ID NO:29.
The clone pCIB7107 contains the VIP3A(b) gene whose coding region is disclosed
in SEQ ID NO:31 and the encoded protein is disclosed in SEQ ID NO:32. Both
pCIB7104 and pCIB7107 have been deposited with the Agricultural Research
Service
Patent Culture Collection (NRRL) and given Accession Nos. NRRL B-21422 and B-
21423, respectively.
The VIP3A(a) gene contains an open reading frame (ORF) that extends form
nucleotide 732 to 3105. This ORF encodes a peptide of 791 amino acids
corresponding to a molecular mass of 88,500 daltons. A Shine-Dalgarno (SD)
sequence is located 6 bases before the first methionine and its sequence
identifies a
strong SD for Bacillus.
The VIP3A(b) gene is 98% identical to VIP3A(a).
When blost of total DNA isolated from AB88 B thuringiensis cells were probed
with
a 33.base fragment that spans the N-terminal region of the VIP3A-insecticidal
protein,
single bands could be observed in different restriction digests. This result
was
WO 96/10083 2 199049 PCT/EP95/03826
-80-
confirmed by using larger probes spanning the coding region of the gene. A
search of
the GenBank data base revealed no homology to known proteins.
EXAMPLE 18C. EXPRESSION OF THE VIP3A INSECTICIDAL PROTEINS
The time course for expression of the VIP3A(a) insecticidal protein was
analyzed by
western blot. Samples from Bacillus thuringiensis Ab88 clutures were taken
throughout ist growth curve and sporulation. The VIP3A(a) insecticidal protein
can be
detected in the supernatants of AB88 cultures during logarithmic phase, as
early as
15 h after initiating the culture. It reached its maximum level during early
stages of
stationary phase and remained at high levels during and after sporulation.
Similar
results were obtained when supernatants of AB424 Bacillus cereus cultures were
used. The levels of VIP3A(a) insecticidal protein reflected the expression of
the
VIP3A(a) gene as determined by Northern blot. The initiation of the
sporulation was
determined by direct microscopic observations and by analyzing the presence of
5-
endotoxins in cell pellets. Cry-I type prtoeins could be detected late in the
stationary
phase , during and after sporulation.
EXAMPLE 18D. IDENTIFICATION OF NOVEL VIP3-LIKE GENES BY
HYBRIDIZATION
To identify Bacillus containing genes related to the VIP3A(a) from isolate
AB88, a
collection of Bacillus isolates was screened by hybridization. Cultures of 463
Bacillus
strains were grown in microtiter wells until sporulation. A 96-pin colony
stampel was
used to transfer the cultures to 150 mm plates containing L-agar. Inoculated
plates
were kept at 30 C for 10 hours, then at 4 C overnight. Colonies were blotted
onto
nylon filters and probed with a 1.2Kb Hindlll VIP3A(a) derived fragment.
Hybridization
was performed overnight at 62 C using hybridization conditions of Maniatis et
al.
Molecular Cloning: A Laboratory Manual (1982). Filters were washed with
2xSSC/0.1 % SDS at 62 C and exposed to X-ray film.
Of the 463 Bacillus strains screened, 60 contain VIP3-like genes that could
detected by hybridization. Further characterization of some of them (AB6 and
AB426)
WO 96/10083 2 1 9 9 04 PCT/EP95/03826
-81 -
showed that their supernatants contain a BCW insecticidal protein similar to
the Vip3
protein that are active against black cutworm.
EXAMPLE 18E. CHARACTERIZATION OF A B. thuringiensis STRAIN M2194
CONTAINING A CRYPTIC VIP3-LIKE GENE
A B. thuringiensis strain, designated M2194, was shown to contain VIP3-like
gene(s) by colony hybridization as described in Example 18C. The M2194 VIP3
like
gene is considered cryptic since no expression can be detected throughout the
bacterial growth phases either by immunoblot analysis using polyclonal
antibodies
raised against the VIP3A(a) protein isolated from AB88 or by bioassay as
described in
Example 3.
Antiserum against purified VIP3A(a) insecticidal protein was produced in
rabbits.
Nictrocellulose-bound protein (50 g) was dissolved in DMSO and emulsified
with
Freund's complete adjuvant (Difco). Two rabbits were given subcutaneous
injections
each month for three month. They were bled 10 days after the second and third
injection and the serum was recovered from the blood sample [Harlow et al
(1988) in
Antibodies: A Laboratory Manual (Cold Spring Harbor Lab Press, Plainview,
NY)].
The M2194 VIP3-like gene was cloned into pKS by following the protocol
described in Example 9, which created pCIB7108. E. coli containing pCIB7108
which
comprises the M2194 VIP3 gene were active against black cutworm demonstrating
that the gene encodes a functional protein with insecticidal activity. The
plasmid
pCIB7108 has been deposited with the Agricultural Research Service Patent
Culture
Collection (NRRL) and given Accession No. NRRL B-21438.
EXAMPLE 18F. INSECTICIDAL ACITIVITY OF VIP3A PROTEINS
The activity spectrum of VIP3A insecticidal proteins was qualitatively
determined in
insect bioassays in which recombinant E coli carrying the VIP*A genes were fed
to
larvae. In these assays, cells carrying the VIP3A(a) and VIP3A(b) genes were
insecticidal to Agrotis ipsilon, Spodoptera frugiperda, Spodoptera exigua,
Heliothis
virescens and Helicoverpa zea. Under the same expermimental conditions,
bacterial
extracts containing VIP3A proteins did not show any activity against Ostrinia
nubilalis.
WO 96/10083 2 199049 PCT/EP95/03826
-82-
Effect of VIP*A insecticidal proteins on Agrotis ipsilon larvae
Treatment (%) Mnrtality
TB medium 5
AB88 Supernatant 100
Ab424 Supernatant 100
Buffer 7
E coli pKS 10
E coli pCIB7104 (AB88) 100
E coli pCIB7105 (AB88) 100
E coli pCIB7106 (AB424) 100
E coli pCIB7107 (AB424) 100
Effect of VIP3A insecticidal proteins on lepidopteran insect larvae
Treatment Insect (%) Mortality
E coli pKS BCW 10
FAW 5
BAW 10
TBW 8
CEW 10
ECB 5
E coli pCIB7105
Ecoli pCIB7107 BCW 100
FAW 100
BAW 100
TBW 100
CEW 50
ECB 10
BCW = Black Cut Worm; FAW = Fall Army Worm; BAW = Beet Army Worm; TBW =
Tobacco Bud
Worm; CEW = Corn Ear Worm; ECB = European Corn Borer
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-83-
EXAMPLE 19. ISOLATION AND BIOLOGICAL ACTIVITY OF OTHER
BACILLUS SP.
Other Bacillus species have been isolated which produce proteins with
insecticidal activity during vegetative growth. These strains were isolated
from
environmental samples by standard methodologies. Isolates were prepared for
bioassay and assayed as described in Examples 2 and 3 respectively. Isolates
which
produced insecticidal proteins during vegetative growth with activity against
Agrotis
ipsilon in the bioassay are tabulated below. No correlation was observed
between the
presence of a S-endotoxin crystal and vegetative insecticidal protein
production.
Presence of &
Bacillus isolate endotoxin crystal Percent mortality
AB6 + 100
AB53 - 80
AB88 + 100
AB 195 - 60
AB211 - 70
AB217 - 83
AB272 - 80
AB279 - 70
AB289 + 100
AB292 + 80
AB294 - 100
AB300 - 80
AB359 - 100
Isolates AB289, AB294 and AB359 have been deposited in the Agricultural
Research Service, Patent Culture Collection (NRRL), Northern Regional Research
Center, 1815 North University Street, Peoria II 61604, USA and given the
Accession
Numbers NRRL B-21227, NRRL B-21229, and NRRL B-21226 respectively.
Bacillus isolates which produce insecticidal proteins during vegetative growth
with
activity against Diabrotica virgifera virgifera are tabulated below.
4 9
WO 96/10083 2 19 ,9 0 PCT/EP95/03826
-84-
Presence of 8-
Bacillus isolate endotoxin crystal Percent mortality
AB52 - 50
AB59 - 71
AB68 + 60
AB78 - 100
AB122 - 57
AB218 - 64
AB256 - 64
Isolates AB59 and AB256 have been deposited in the Agricultural Research
Service, Patent Culture Collection (NRRL), Northern Regional Research Center,
1815
North University Street, Peoria Illinois 61604, USA, and given the Accession
Numbers
NRRL B-21228 and NRRL B-21230, respectively.
EXAMPLE 20. IDENTIFICATION OF NOVEL VIPINIP2 LIKE GENES BY
HYBRIDIZATION
To identify strains containing genes related to those found in the
VIP1A(a)/VIP2A(a) region of AB78, a collection of Bacillus strains was
screened by
hybridization. Independent cultures of 463 Bacillus strains were grown in
wells of 96
well microtiter dishes (five plates total) until the cultures sporulated. Of
the strains
tested, 288 were categorized as Bacillus thuringiensis, and 175 were
categorized as
other Bacillus species based on the presence or absence of 8-endotoxin
crystals. For
each microtiter dish, a 96-pin colony stamper was used to transfer
approximately 10 l
of spore culture to two 150 mm plates containing L-agar. Inoculated plates
were
grown 4-8 hours at 30 C, then chilled to 4 C. Colonies were transferred to
nylon
filters, and the cells lysed by standard methods known in the art. The filters
were
hybridized to a DNA probe generated from DNA fragments containing both
VIP1A(a)
and VIP2A(a) DNA sequences. Hybridization was performed overnight at 65 C
using
the hybridization conditions of Church and Gilbert (Church, G.M., and W.
Gilbert,
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-85-
PNAS, 81:1991-1995 (1984)). Filters were washed with 2x SSC containing 0.1%
SDS
at 65 C and exposed to X-Ray film.
Of the 463 Bacillus strains screened, 55 strains were identified that
hybridized to
the VIP1A(a)/VIP2A(a) probe. DNA was isolated from 22 of these strains, and
analyzed using a Southern blot with VIP1A(a)/VIP2A(a) DNA as probes. These
strains were grouped into 8 classes based on their Southern blot pattern. Each
class
differed in Southern blot pattern from AB78. One class had a pattern identical
to that
of the VIP1A(a)NIP2A(a) homologs from Bacillus thuringiensis var tenebrionis
(see
below). Each of the 22 strains was tested for activity against western corn
rootworm
(WCRW). Three strains, AB433, AB434, and AB435 were found to be active on
WCRW. Western blot analysis using VIP2A(a) antisera revealed that strains AB6,
AB433, AB434, AB435, AB444, and AB445 produce a protein(s) of equivalent size
to
VIP2A(a).
Notable among the strains identified was Bacillus thuringiensis strain AB6,
(NRRL
B-21060) which produced a VIP active against black cutworm (Agrotis ipsilon)
as
described in Example 15. Western blot analysis with polyclonal antisera to
VIP2A(a)
and polyclonal antisera to VIP1A(a) suggests that AB6 produces proteins
similar to
VIP2A(a) and VIP1A(a). Thus, AB6 may contain VIPs similar to VIP1A(a) and
VIP2A(a), but with a different spectrum of insecticidal activity.
EXAMPLE 21. CLONING OF A VIP1 A(a)NIP2A(a) HOMOLOG FROM
BACILLUS THURINGIENSIS VAR. TENEBRIONIS.
Several previously characterized Bacillus strains were tested for presence of
DNA
similar to VIP1 A(a)NIP2A(a) by Southern blot analysis. DNA from Bacillus
strains
AB78, AB88, GC91, HD-1 and ATCC 10876 was analyzed for presence of
VIP1A(a)NIP2A(a) like sequences. DNA from Bt strains GC91 and HD-1, and the Bc
strain ATCC 10876 did not hybridize to VIP2A(a)NIP1A(a) DNA, indicating they
lack
DNA sequences similar to VIP1A(a)/VIP2A(a) genes. Similarly, DNA from the
insecticidal strain AB88 (Example 16) did not hybridize to VIP1A(a)NIP2A(a)
DNA
region, suggesting that the VIP activity produced by this strain does not
result from
VIP1A(a)NIP2A(a) homologs. In contrast, Bacillus thuringiensis var.
tenebrionis (Btt)
WO 96/10083 2 19904 9 PCT/EP95/03826
-86-
contained sequences that hybridized to the VIP1A(a)/VIP2A(a) region. Further
analysis confirmed that Btt contains VIP1A(a)/VIP2A(a) like sequences.
To characterize the Btt homologs of VIP2A(a) and VIP1A(a), the genes encoding
these proteins were cloned. Southern blot analysis identified a 9.5 kb Eco RI
restriction fragment likely to contain the coding regions for the homologs.
Genomic
DNA was digested with Eco RI, and DNA fragments of approximately 9.5 kb in
length
were gel-purified. This DNA was ligated into pBluescript SK(+) digested with
Eco RI,
and transformed into E. coli to generate a plasmid library. Approximately
10,000
colonies were screened by colony hybridization for the presence of VIP2A(a)
homologous sequences. Twenty eight positive colonies were identified. All
twenty
eight clones are identical, and contain VIP1A(a)NIP2A(a) homologs. Clone
pCIB7100
has been deposited in the Agricultural Research Service, Patent Culture
Collection
(NRRL), Northern Regional Research Center, 1815 North University Street,
Peoria
Illinois 61604, USA, and given the Accession Number B-21322. Several subclones
were constructed from pCIB7100. A 3.8 kb Xba I fragment from pCIB7100 was
cloned into pBluescript SK(+) to yield pCIB71 01. A 1.8 kb Hind III fragment
and a 1.4
kb Hind III fragment from pCIB7100 were cloned into pBluescript SK(+) to yield
pCIB7102 and pCIB7103, respectively. Subclones pCIB7101, pCIB7102 and
pCIB7103 have been deposited in the Agricultural Research Service, Patent
Culture
Collection (NRRL), Northern Regional Research Center, 1815 North University
Street,
Peoria Illinois 61604, USA, and given the Accession Numbers B-21323, B-21324
and
B-21325 respectively.
The DNA sequence of the region of pCIB7100 containing the VIP2A(a)NIP1A(a)
homologs was determined by the dideoxy chain termination method (Sanger et
al.,
1977, Proc. NatI. Acad. Sci. USA 74:5463-5467). Reactions were performed using
PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits and PRISM
Sequenase Terminator Double-Stranded DNA Sequencing Kits, and analyzed on
an ABI model 373 automated sequencer. Custom oligonucleotides were used as
primers to determine the DNA sequence in certain regions. The DNA sequence of
this
region is shown in SEQ ID NO:19.
The 4 kb region shown in SEQ ID NO:19 contains two open readings frames
(ORFs), which encode proteins with a high degree of similarity to VIP1A(a) and
VIP2A(a) proteins from strain AB78. The amino acid sequence of the VIP2A(a)
WO 96/10083 2 1 9 9 p 4 9 PCT/EP95/03826
-87-
homolog, designated as VIP2A(b) using the standardized nomenclature, is found
at
SEQ ID NO:20 and the amino acid sequence of the VIP1A(a) homolog, designated
as
VIP1A(b) using the standardized nomenclature, is disclosed at SEQ ID NO:21.
The
VIP2A(b) protein exhibits 91% amino acid identity to VIP2A(a) from AB78. An
alignment of the amino acid sequences of the two VIP2 proteins is provided in
Table
20. The VIP1A(b) protein exhibits 77 % amino acid identity to VIP1A(a) from
AB78.
An alignment of these two VIP1 proteins is provided in Table 21. The alignment
shown in Table 21 discloses the similarity between VIP1A(b) and VIP1A(a) from
AB78. This alignment reveals that the amino terminal regions of the two VIP1
proteins share higher amino acid identity in the amino-terminal region than in
the
carboxy terminal region. In fact, the amino terminal two thirds (up to as 618
of the
VIP1 A(b) sequence shown in Table 21) of the two proteins exhibit 91 %
identity, while
the carboxy-terminal third (from as 619-833 of VIP1A(b)) exhibit only 35%
identity.
Western blot analysis indicated that Bacillus thuringiensis var. tenebrionis
(Btt)
produces both VIP1A(a) like and VIP2A(a) like proteins. However, these
proteins do
not appear to have activity against western corn rootworm. Bioassay for
activity
against western corn rootworm was performed using either a 24 h culture
supernatant
from Btt or E. coli clone pCIB7100 (which contains the entire region of the
VIP1 A(a)NIP2A(a) homologs). No activity against western corn rootworm was
detected in either case.
Given the similarity between the VIP2 proteins from Btt and AB78, the ability
of
VIP2A(b) from Btt to substitute for VIP2A(a) from AB78 was tested. Cells
containing
pCIB6206 (which produces AB78 VIP1A(a) but not VIP2A(a) protein) were mixed
with
Btt culture supernatant, and tested for activity against western corn
rootworm. While
neither Btt culture supernatant nor cells containing pCIB6206 had activity on
WCRW,
the mixture of Btt and pCIB6206 gave high activity against WCRW. Furthermore,
additional bioassay showed that the Btt clone pCIB7100, which contains the Btt
VIP1A(b)/VIP2A(b) genes in E. coli, also confers activity against WCRW when
mixed
with pCIB6206. Thus, the VIP2A(b) protein produced by Btt is functionally
equivalent
to the VIP2A(a) protein produced by AB78.
Thus, the ability to identify new strains with insecticidal activity by using
VIP DNA
as hybridization probes has been demonstrated. Furthermore, Bacillus strains
that
contain VIP1A(a)NIP2A(a) like sequences, produce VI P1A(a)NIP2A(a) like
protein,
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-88-
yet demonstrate toxicity toward different insect pests. Similar methods can
identify
many more members of the VIP1/VIP2 family. Furthermore, use of similar methods
can identify homologs of other varieties of VIPs (for example, the VIPs from
AB88).
TABLE 20
Alignment of VIP2 Amino Acid Sequences from Bacillus thuringiensis var.
tenebrionis (VIP2A(b)) vs. AB78 (VIP2A(a))
Btt 1 MQRMEGKLFVVSKTLQVVTRTVLLSTVYSITLINNVVIKADQLNINSQSK 50 SEQ ID NO:20
1.1111111:111.1111 :1111III:11.1111 IIII:111111111
AB78 1 MKRMEGKLFMVSKKLQWTKTVLLSTVFSISLLNNEVIKAEQLNINSQSK 50 SEQ ID NO:2
51 YTNLQNLKIPDNAEDFKEDKRMKEWGKEKGEEWRPPATEKGEMNNFLDN 100
IIIIIIIII.I=.IIIIIII:IIIIIIIII:.II: =11111.1111111
51 YTNLQNLKITDKVEDFKEDKEKAKEWGKEKEKEWKLTATEKGKMNNELDN 100
101 KNDIKTNYKEITFSMAGSCEDEIKDLEEIDKIFDKANLSSSIITYKNVEP 150
IIII III1111111111 1111111.1111:111.111.1111111111
101 KNDIXTNYEEITFSMAGSFEDEIKDLKEIDKMFDKTNLSNSIITYKNVEP 150
151 ATIGFNKSLTEGNTINSDAMAQFKEQFLGKDMKFDSYLDTHLTAQQVSSK 200
.11111111111111I11111I111111::I:IIIIIIIIIIII111111
151 TTIGFNKSLTEGNTINSDAMAQFKEQFIDRDIKFDSYLDTHLTAQQVSSK 200
201 KRVILK TVPSGKGSTTPTKAGVILNNNEYKMLIDNGYVLHVDKVSKVVK 250
.1IIIII11111111IIIIIIII 111=1111111111::11111111II
201 ERVILKVTVPSGKGSTTPTKAGVILNNSEYKMLIDNGYMVHVDKVSKVVK 250
251 KG^ECLQVEGTLKKSLDFKNDINAEAHSWGMKIYEDWAKNLTASQREALD 300
11:1111:1111 III1111111111IIIIII II:111:11=11111II
251 KGVECIQIEGTLKKSLDFKNDINAEAHSWG4KNYEEWAKDLTDSQREALD 300
WO 96/10083 1-0 2 1 9 9 V 4-9 PCT/EP95/03826
- 89 -
301 GYARQDYKEINNYLRNQGGSGNEKLDAQLKNISDALGKKPIPENITVYRW 350
IIIIIIIIIIIIIIIillllltllllll:VIII I IIIIIIIIIIIII
301 GYARQDYKEINNYLRNQGGSGNEKLDAQIKNISDALGKKPIPENITVYRW 350
351 CG PEFGYQISDPLPSLKDFEEQFLNTIKEDKGYMSTSLSSERLAP1FGSR 400
IIIIIIIIIIII111111111 IIIII11111 IIIIIIIIIIIIIIII
351 CGMPEFGYQISDPLPSLKDFEEQFLNTIKEDKGYMSTSLSSERLAAFGSR 400
401 KIILRLQVPKGSTGAYLSAIGGFASEKEILLDKDSKYHIDKATEVIIKGV 450
11111III 11111111111111111111111111111111.11111111
401 KIILRLQVPKGSTGAYLSAIGGFASEKEILLDKDSKYHIDKVTEVIIKGV 450
451 KRYVVDATLLTN 462
111111IIIII
451 KRYVVDATLLTN 462
TABLE 21
Alignment of VIP1 Amino Acid Sequences from Bacillus thuringiensis var.
tenebrionis (VIP1 A(b)) vs. AB78 (VIP1 A(a))
Btt 1 NnWlEQ4<LA.SVVTCMLLAPMFLNGNVNAVNADSKINQISTTQENQQKEMD 50 SEQ ID NO:21
IIIIIIIIIIII IIIIIIIIIIIIII 1111.1 1111 1.111 III
Ab78 1 MKNNB44QLA.SVVTCTLLAPMFLNGNVNAVYADSKTNQISTTQKNQQKEMD 50 SEQ ID NO:5
51 RKGLLGYYFKGEOFNNLTMFAPTRDNTIMYDQQTANALLDKKQQEYQSIR 100
IIIIIIIIIIIIII.1111-IIIII.II:IIIIIII IIIIIIIIIIIII
51 RKGLLGYYFKGKDFSNLTMFAPTRDSTLIYDQQTANKLLDKKQQEYQSIR 100
101 WIGLIQRKETGDFTFNLSKDEQAIIEIDGKIISNKGKEKQVVHLEKEKLV 150
111111.11 III11111.IIIIIIII:11 IIIII1111111111:111
101 WIGLIQSKETGDFTFNLSEDEQAIIEINGKIISNKGKEKQVVHLEKGKLV 150
151 PIKIEYQSDTK NIDSKTFKELKLFKIDSQNQSQQVQ...LRNPEFNKKE 197
11111111111 IIIIIIIIIIII11111 II.1111 IIIIIIIIll
WO 96/10083 `2 1 9 9 0 4 9 PCT/EP95/03826
- 90 -
151 PIKIEYQSDTKFNIDSKTFKELKLFKIDSQNQPQQVQQDELRNPEFNKKE 200
198 SQEFLAKASKTNLFKQKMKRDIDEDTDTDGDSIPDLWEENGYTIQNKVAV 247
1111111:11.III.11111:11111111 IIIIIIIIIIIIIII11::1I
201 SQEFLAKPSKINIFT K-DMEIDEDTDTDGDSIPDLWEENGYTIQNRIAV 250
248 KWDDSLASKGYTKFVSNPLDSHTVGDPYTDYEKAARDLDLSNAKETFNPL 297
111111IIIIIIItIIIii:IIIIIIIIIIIIII11111IIII111111I
251 KWDDSLASKGYTKFVSNPLESHTVGDPYTDYEKAARDLDLSNAKETFNPL 300
298 VAAFPSVNVSMEKVILSPNENLSNSVESHSSTNWSYTNTEGASIEAGGGP 347
IIII11111 IIIIIII111111II111111111111111111:III II
301 VAAFPSVNVSMEKVILSPNENLSNSVESHSSTNWSYTNTEGASVEAGIGP 350
348 LGLSFGVSVrYQHSETVAQEWGTSTGNTSQFNTASAGYLNANVRYNNVGT 397
I:111111.111I lilt 111111 IIIIIIIIIIIIIIIillllllllll
351 KGISFGVSVNYQHSETVAQEWGTSTGNTSQFNTASAGYLNANVRYNNVGT 400
398 GAIYDVKPTTSFVLNNNTIATITAKSNSTALRISPGDSYPEIGENAIAIT 447
1111111111111111:11111111111111.1111:111. 1:1:1111
401 GAIYDVKPTTSFVLNNDTIATITAKSNSTALNISPGESYPKKGQNGIAIT 450
448 SMDDFNSHPITLNKQQVNQLINNKPIMLETDQTDGVYKIRDTHGNIVTGG 497
11111111111111.II:.I:IIII:IIII:IIIIIIII:IIIII11111
451 SMDDFNSHPITLNKKQVDNLLNNKPYI-ILETNQTDGVYKIKDTHGNIVPGG 500
498 EWNGVTQQIKAKTASIIVDDGKQVAEKRVAAKDYGHPEDKTPPLTLKDTL 547
IIIII.111111111111111..IIIIIIIIIII::111111.11111.1
501 EWNGVIQQIKAKTASIIVDDGERVAEKRVAAKDYENPEDKTPSLTLKDAL 550
548 KLSYPDEIKETNGLLYYDDKPIYESSVMTYLDENTAKEVKKQINDTTGKF 597
I1111111iI.:IIIII.: IllIIIIIIIIlIIIIIII1.11:1111111
551 KLSYPDEIKEIEGLLYYKNKPIYESSVMTYLDENTAKEVTKQLNDTTGKF 600
WO 96/10083 2 1 9 9 4 PCT/EP95/03826
-91 -
... 598 KDVNHLYDVKLTPKMNFTIKMASLYDGAENNHNSLGTWYLTYNVAGGNTG 647
III.IIIIIIIIIIII=III:. III=II=I=II:I=I I I=III=I
.... 601 KDVSHLYDVKLTPKI'4NVTIKLSILYDNAESNDNSIGKWTNTNIVSGGNNG 650
648 KRQYRSAHSCAHVALSSEAKKK NQ STTEPTIEVAGE 697
I:II.I=== I:==I.=:I..III=I :II:I:III....I:=.I=..II
651 KKQYSSNNPDANLTLNTDAQEKLNKNRDYYISLYMKSEKNTQCEITIDGE 700
698 KSAITSKKVKLNNQNYQRVDILVKNSERNPMDKIYIRGNGTTNVYGDDVT 747
:II=I=I=:I=:II=I:II:=.I ==II:====I:.I:=.... II:=
701 IYPITTKTVNVNKDNYKRLDIIAHNIKSNPISSLHIKTNDEITLFWDDIS 750
748 IPEVSAINPASLSDEEIQEIFKDSTIEYGNPSFVADAVTFK......... 788
751 ITDVASIKPENLTDSEIKQIYSRYGIKLEDGILIDKKGGIHYGEFINEAS 800
789 .NIKPLQNYVKEYEIYHK....... SHRYEKKI'VFDIMGVHYEYSIAREQ 830
II=IIIIII==I.= I. I...=.= ... ..
801 FNIEPLQNYVTKYKVTYSSELGQNVSDTLESDKIYKDGTIKFDFTKYSKN 850
831 KKA 833
851 EQG 853
EXAMPLE 22. FUSION OF VIP PROTEINS TO MAKE A SINGLE
POLYPEPTIDE
VIP proteins may occur in nature as single polypeptides, or as two or more
interacting polypeptides. When an active VIP is comprised of two or more
interacting
protein chains, these protein chains can be produced as a single polypeptide
chain
from a gene resulting from the fusion of the two (or more) VIP coding regions.
The
genes encoding the two chains are fused by merging the coding regions of the
genes
to produce a single open reading frame encoding both VIP polypeptides. The
composite polypeptides can be fused to produce the smaller polypeptide as the
NH2
terminus of the fusion protein, or they can be fused to produce the larger of
the
WO 96/10083 1990-4-9 PCT/EP95/03826
-92-
polypeptides as the NH2 terminus of the fusion protein. A linker region can
optionally
be used between the two polypeptide domains. Such linkers are known in the
art. This
linker can optionally be designed to contain protease cleavage sites such that
once
the single fused polypeptide is ingested by the target insect it is cleaved in
the linker
region to liberate the two polypeptide components of the active VIP molecule.
VIP1A(a) and VIP2A(a) from B. cereus strain AB78 are fused to make a single
polypeptide by fusing their coding regions. The resulting DNA comprises a
sequence
given in SEQ ID NO:22 with the encoded protein given in SEQ ID NO:23. In like
manner, other fusion proteins may be produced.
The fusion of the genes encoding VIP1A(a) and VIP2A(a) is accomplished using
standard techniques of molecular biology. The nucleotides deleted between the
VIP1A(a) and VIP2A(a) coding regions are deleted using known mutagenesis
techniques or, alternatively, the coding regions are fused using PCR
techniques.
The fused VIP polypeptides can be expressed in other organisms using a
synthetic
gene, or partially synthetic gene, optimized for expression in the alternative
host. For
instance, to express the fused VIP polypeptide from above in maize, one makes
a
synthetic gene using the maize preferred codons for each amino acid, see for
example EP-A 0618976, herein incorporated by reference. Synthetic DNA
sequences
created according to these methods are disclosed in SEQ ID NO:17 (maize
optimized
version of the 100 kDa VIP1A(a) coding sequence), SEQ ID NO:18 (maize
optimized
version of the 80 kDa VIP1A(a) coding sequence) and SEQ ID NO:24 (maize
optimized version of the VIP2A(a) coding sequence).
Synthetic VIP1 and VIP2 genes optimized for expression in maize can be fused
using PCR techniques, or the synthetic genes can be designed to be fused at a
common restriction site. Alternatively, the synthetic fusion gene can be
designed to
encode a single polypeptide comprised of both VIP1 and VIP2 domains.
Addition of a peptide linker between the VIP1 and VIP2 domains of the fusion
protein can be accomplished by PCR mutagenesis, use of a synthetic DNA linker
encoding the linker peptide, or other methods known in the art.
The fused VIP polypeptides can be comprised of one or more binding domains. If
more than one binding domain is used in the fusion, multiple target pests are
controlled using such a fusion. The other binding domains can be obtained by
using
all or part of other VIPs; Bacillus thuringiensis endotoxins, or parts
thereof; or other
WO 96/10083 F- 2 1 9 9 0 4 9 PCT/EP95/03826
-93-
proteins capable of binding to the target pest or appropriate biding domains
derived
from such binding proteins.
One example of a fusion construction comprising a maize optimized DNA
sequence encoding a single polypeptide chain fusion having VIP2A(a) at the N-
terminal end and VIP1A(a) at the C-terminal end is provided by pCIB5531. A DNA
sequence encoding a linker with the peptide sequence PSTPPTPSPSTPPTPS (SEQ
ID NO:47) has been inserted between the two coding regions. The sequence
encoding this linker and relevant cloning sites is 5'- CCC GGG CCT TCT ACT CCC
CCA ACT CCC TCT CCT AGC ACG CCT CCG ACA CCT AGC GAT ATC GGA TC C
-3' (SEQ ID NO:48). Oligonucleotides were synthesized to represent both the
upper
and lower strands and cloned into a pUC vector following hybridization and
phosphorylation using standard procedures. The stop codon in VIP2A(a) was
removed using PCR and replaced by the BglII restriction site with a Smal site.
A
translation fusion was made by ligating the Bam HI / Pstl fragment of the
VIP2A(a)
gene from pCIB5522 (see Example 24), a PCR fragment containing the Pstl-end
fragment of the VIP2A(a) gene (identical to that used to construct pCIB5522),
a
synthetic linker having ends that would ligate with a blunt site at the 5' end
and with
BamHl at the 3' end and the modified synthetic VIP1A(a) gene from pCIB5526
described below (See SEQ ID NO:35). The fusion was obtained by a four way
ligation
that resulted in a plasmid containing the VIP2A(a) gene without a translation
stop
codon, with a linker and the VIP1 A(a) coding region without the Bacillus
secretion
signal. The DNA sequence for this construction is disclosed in SEQ ID NO:49,
which
encodes the fusion protein disclosed in SEQ ID NO:50. A single polypeptide
fusion
where VIP1A(a) is at the N-terminal end and VIP2A(a) is at the C-terminal end
can be
made in a similar fashion. Furthermore, either one or both genes can be linked
in a
translation fusion with or without a linker at either the 5' or the 3' end to
other
molecules like toxin encoding genes or reporter genes.
EXAMPLE 23. TARGETING OF VIP2 TO PLANT ORGANELLES
Various mechanisms for targeting gene products are known to exist in plants
and
the sequences controlling the functioning of these mechanisms have been
characterized in some detail. For example, the targeting of gene products to
the
2199'n49
WO 96/10083 PCT/EP95/03826
-94-
chloroplast is controlled by a signal sequence found at the amino-terminal end
of
various proteins. This signal is cleaved during chloroplast import, yielding
the mature
protein (e.g. Comai et al. J. Biol. Chem. 263: 15104-15109 (1988)). These
signal
sequences can be fused to heterologous gene products such as VIP2 to effect
the
import of those products into the chloroplast (van den Broeck et al. Nature
313: 358-
363 (1985)). DNA encoding for appropriate signal sequences can be isolated
from
the 5' end of the cDNAs encoding the RUBISCO protein, the CAB protein, the
EPSP
synthase enzyme, the GS2 protein and many other proteins which are known to be
chloroplast localized.
Other gene products are localized to other organelles such as the
mitochondrion
and the peroxisome (e.g. Unger et al. Plant Molec. Biol. 13: 411-418 (1989)).
The
cDNAs encoding these products can also be manipulated to effect the targeting
of
heterologous gene products such as VIP2 to these organelles. Examples of such
sequences are the nuclear-encoded ATPases and specific aspartate amino
transferase isoforms for mitochondria. Similarly, targeting to cellular
protein bodies
has been described by Rogers et al. (Proc. Natl. Acad. Sci. USA 82: 6512-6516
(1985)).
By the fusion of the appropriate targeting sequences described above to coding
sequences of interest such as VIP2 it is possible to direct the transgene
product to
any organelle or cell compartment. For chloroplast targeting, for example, the
chloroplast signal sequence from the RUBISCO gene, the CAB gene, the EPSP
synthase gene, or the GS2 gene is fused in frame to the amino-terminal ATG of
the
transgene. The signal sequence selected should include the known cleavage site
and
the fusion constructed should take into account any amino acids after the
cleavage
site which are required for cleavage. In some cases this requirement may be
fulfilled
by the addition of a small number of amino acids between the cleavage site and
the
start codon ATG, or alternatively replacement of some amino acids within the
coding
sequence. Fusions constructed for chloroplast import can be tested for
efficacy of
chloroplast uptake by in vitro translation of in vitro transcribed
constructions followed
by in vitro chloroplast uptake using techniques described by (Bartlett et al.
In:
Edelmann et al. (Eds.) Methods in Chloroplast Molecular Biology, Elsevier. pp
1081-
1091 (1982); Wasmann et al. Mol. Gen. Genet. 205: 446-453 (1986)). These
WO 96/10083 2 1 9 9 0 4 PCT/EP95/03826
-95-
construction techniques are well known in the art and are equally applicable
to
mitochondria and peroxisomes.
The above described mechanisms for cellular targeting can be utilized not only
in
conjunction with their cognate promoters, but also in conjunction with
heterologous
promoters so as to effect a specific cell targeting goal under the
transcriptional
regulation of a promoter which has an expression pattern different to that of
the
promoter from which the targeting signal derives.
A DNA sequence encoding a secretion signal is present in the native Bacillus
VIP2
gene. This signal is not present in the mature protein which has the N-
terminal
sequence of LKITDKVEDF (amino acid residues 57 to 66 of SEQ ID NO:2). It is
possible to engineer VIP2 to be secreted out of the plant cell or to be
targeted to
subcellular organelles such as the endoplasmic reticulum, vacuole,
mitochondria or
plastids including chloroplasts. Hybrid proteins made by fusion of a secretion
signal
peptide to a marker gene have been successfully targeted into the secretion
pathway.
(Itirriaga G. et al., The Plant Cell, 1: 381-390 (1989) , Denecke et al., The
Plant Cell,
2:51-59 (1990). Amino-terminal sequences have been identified that are
responsible
for targeting to the ER, the apoplast, and extracellular secretion from
aleurone cells
(Koehler & Ho, Plant Cell 2: 769-783 (1990)).
The presence of additional signals are required for the protein to be retained
in the
endoplasmic reticulum or the vacuole. The peptide sequence KDEUHDEL at the
carboxy-terminal of a protein is required for its retention in the endoplasmic
reticulum
(reviewed by Pelham, Annual Review Cell Biol., 5:1-23 (1989). The signals for
retention of proteins in the vacuole have also been characterized. Vacuolar
targeting
signals may be present either at the amino-terminal portion, (Holwerda et al.,
The
Plant Cell, 4:307-318 (1992), Nakamura et al., Plant Physiol., 101:1-5
(1993)),
carboxy- terminal portion, or in the internal sequence of the targeted
protein. (Tague
et al., The Plant Cell, 4:307-318 (1992), Saalbach et al., The Plant Cell,
3:695-708
(1991)). Additionally, amino-terminal sequences in conjunction with carboxy-
terminal
sequences are responsible for vacuolar targeting of gene products (Shinshi et
al.
Plant Molec. Biol. 14: 357-368 (1990)). Similarly, proteins may be targeted to
the
mitochondria or plastids using specific carboxy terminal signal peptide
fusions (Heijne
et al., Eur. J. Biochem., 180:535-545 (1989), Archer and Keegstra, Plant
Molecular
Biology, 23:1105-1115 (1993)).
WO 96/10083 9 4 9 PCT/EP95/03826
-96-
In order to target VIP2, either for secretion or to the various subcellular
organelles,
a maize optimized DNA sequence encoding a known signal peptide(s) may be
designed to be at the 5' or the 3' end of the gene as required. To secrete
VIP2 out of
the cell, a DNA sequence encoding the eukaryotic secretion signal peptide
MGWSWIFLFLLSGAAGVHCL (SEQ ID NO:25) from PCT application No. IB95/00497
or any other described in the literature (Itirriaga et al., The Plant
Cell,_1:381-390
(1989) , Denecke, et al., The Plant Cell, 2:51-59 (1990)) may be added to the
5' end
of either the complete VIP2 gene sequence or to the sequence truncated to
encode
the mature protein or the gene truncated to nucleotide 286 or encoding a
protein to
start at amino acid residue 94 (methionine). To target VIP2 to be retained in
the
endoplasmic reticulum, a DNA sequence encoding the ER signal peptide KDEL
/HDEL, in addition to the secretion signal, can be added to the 3' end of the
gene. For
vacuolar targeting a DNA sequence encoding the signal peptide
SSSSFADSNPIRVTDRAAST (SEQ ID NO:3; Holwerda et a!., The Plant Cell, 4:307-
318 (1992)) can be designed to be adjacent to the secretion signal or a
sequence
encoding a carboxyl signal peptide as described by Dombrowski et al., The
Plant
Cell, 5:587-596 (1993) or a functional variation may be inserted at the 3' end
of the
gene. Similarly, VIP2 can be designed to be targeted to either the
mitochondria or the
plastids, including the chloroplasts, by inserting sequences in the VIP2
sequence
described that would encode the required targeting signals. The bacterial
secretion
signal present in VIP2 may be retained or removed from the final construction.
One example of a construction which incorporates a eukaryotic secretion signal
fused to a coding sequence for a VIP is provided by pCIB5528. Oligonucleotides
corresponding to both the upper and lower strand of sequences encoding the
secretion signal peptide of SEQ ID NO:25 was synthesized and has the sequence
5-
GGATCCACC ATG GGC TGG AGC TGG ATC TTC CTG TTC CTG CTG AGC GGC
GCC GCG GGC GTG CAC TGC CTGCAG-3' (SEQ ID NO:41). When hybridized, the
5' end of the secretion signal resembled "sticky-ends" corresponding to
restriction
sites BamHl and Pstl. The oligonucleotide was hybridized and phosphorylated
and
ligated into pCIB5527 (construction described in Example 23A) which had been
digested with BamHl/ Pstl using standard procedures. The resulting maize
optimized
coding sequence is disclosed in SEQ ID NO:42 which encodes the protein
disclosed
WO 96/10083 2 1 9 9 Q 4 9 PCT/EP95/03826
-97-
in SEQ ID NO:43. This encoded protein comprises the eukaryotic secretion
signal in
place of the Bacillus secretion signal.
One example of a construction which incorporates a vacuolar targetting signal
fused to a coding sequence for a VIP is provided by pCIB5533. Oligonucleotides
corresponding to both the upper and lower strand of sequences encoding the
vacuolar targetting peptide of SEQ ID NO:3 was synthesized and has the
sequence
5'-CCG CGG GCG TGC ACT GCC TCA GCA GCA GCA GCT TCG CCG ACA GCA
ACC CCA TCC GCG TGA CCG ACC GCG CCG CCA GCA CCC TGC AG-3' (SEQ ID
NO:44). When hybridized, the 5' end of the vacuolar targetting signal
resembled
"sticky-ends" corresponding to restriction sites SacII and Pstl. The
oligonucleotide
was hybridized and phosphorylated and ligated into pCIB5528 (construction
described
above) which had been digested with Sacll / Pstl using standard procedures.
The
resulting maize optimized coding sequence is disclosed in SEQ ID NO:45 which
encodes the protein disclosed in SEQ ID NO:46. This encoded protein comprises
the
vacuolar targetting peptide in addition to the eukaryotic secretion signal.
The VIP1 gene can also be designed to be secreted or targeted to subcellular
organelles by similar procedures.
EXAMPLE 23A. REMOVAL OF BACILLUS SECRETION SIGNAL FROM
VIP1 A(a) AND VIP2A(a)
VIP1A(a) and VIP2A(a) are secreted during the growth of strain AB78. The
nature
of peptide sequences that act as secretion signals has been described in the
literature
(Simonen and Palva, Microbiological reviews, pg. 109-137 (1993)). Following
the
information in the above publication, the putative secretion signal was
identified in
both genes. In VIP1 A(a) this signal is composed of amino acids 1-33 (See SEQ
ID
NO:5). Processing of the secretion signal probably occurs after the serine at
amino
acid 33. The secretion signal in VIP2A(a) was identified as amino acids 1-49
(See
SEQ ID NO:2). N-terminal peptide analysis of the secreted mature VIP2A(a)
protein
revealed the N-terminal sequence LKITDKVEDFKEDK. This sequence is found
beginning at amino acid 57 in SEQ ID NO:2. The genes encoding these proteins
have been modified by removal of the Bacillus secretion signals.
A maize optimized VIP1A(a) coding region was constructed which had the
sequences encoding the first 33 amino acids, i.e., the secretion signal,
removed from
its 5' end. This modification was obtained by PCR using an forward primer that
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-98-
contained the sequence 5'-GGA TCC ACC ATG AAG ACC AAC CAG ATC AGC-3'
(SEQ ID NO:33), which hybridizes with the maize optimized gene (SEQ ID NO:26)
at
nucleotide position 100, and added a BamHl restriction site and a eukaryotic
translation start site consensus including a start codon. The reverse primer
that
contained the sequence 5'-AAG CTT CAG CTC CTT G-3' (SEQ ID NO:34) hybridizes
on the complementary strand at nucelotide position 507. A 527 bp amplification
product was obtained containing the restriction sites BamHl at the 5' end and
Hindlll
site at the 3' end. The amplification product was cloned into a T- vector
(described in
Example 24, below) and sequenced to ensure the correct DNA sequence. The BamHl
/ Hind Ill fragment was then obtained by restriction digest and used to
replace the
BamHl/Hindlll fragment of the maize optimized VIP1A(a) gene cloned in the root-
preferred promoter cassette. The construct obtained was designated pCIB5526.
The
maize optimized coding region for VIP1A(a) with the Bacillus secretion signal
removed
is disclosed as SEQ ID NO:35 and the encoded protein is disclosed as SEQ ID
NO:36.
The gene encoding the processed form of VIP2A(a), i.e., a coding region with
the
secretion signal removed, was constructed by a procedure similar to that
described for
that used to construct the processed form of VIP1A(a), above. The modification
was
obtained by PCR using the forward primer 5'-GGA TCC ACC ATG CTG CAG AAC
CTG AAG ATC AC -3' (SEQ ID NO:37). This primer hybridizes at nucleotide
position
150 of the maize optimized VIP2A(a) gene (SEQ ID NO:27). A silent mutation has
been inserted at nucleotide position 15 of this primer to obtain a Pstl
restriction site.
The reverse primer has the sequence 5'-AAG CTT CCA CTC CTT CTC-3' (SEQ ID
NO:38). A 259 bp product was obtained with Hindlll restriction site at the 3'
end. The
amplification product was cloned into a T- vector, sequenced and ligated to a
BamHI
/Hindlll digested root-preferred promoter cassette containing the maize
optimized
VIP2A(a). The construct obtained was designated pCIB5527. The maize optimized
coding region for VIP2A(a) with the Bacillus secretion signal removed is
disclosed as
SEQ ID NO:39 and the encoded protein is disclosed as SEQ ID NO:40.
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-99-
EXAMPLE 24. CONSTRUCTION AND CLONING OF THE VIP1A(a) AND VIP2A(a)
MAIZE OPTIMIZED GENES
Desi n: The maize optimized genes were designed by reverse translation of the
native VIP1A(a) and VIP2A(a) protein sequences using codons that are used most
often in maize (Murray et al., Nucleic Acid Research, 17:477-498 (1989)). To
facilitate
cloning, the DNA sequence was further modified to incorporate unique
restriction sites
at intervals of every 200-360 nucleotides. VIP1A(a) was designed to be cloned
in 11
such fragments and VIP2A(a) was cloned in 5 fragments. Following cloning of
the
individual fragments, adjacent fragments were joined using the restriction
sites
common to both fragments, to obtain the complete gene. To clone each fragment,
oligonucleotides (50-85 nucleotides) were designed to represent both the upper
and
the lower strand of the DNA. The upper oligo of the first oligo pair was
designed to
have a 15 bp single stranded region at the 3' end which was homologous to a
similar
single stranded region of the lower strand of the next oligo pair to direct
the orientation
and sequence of the various oligo pairs within a given fragment. The oligos
are also
designed such that when the all the oligos representing a fragment are
hybridized, the
ends have single stranded regions corresponding to the particular restriction
site to be
formed. The structure of each oligomer was examined for stable secondary
structures
such as hairpin loops using the OLIGO program from NBI Inc. Whenever
neccesary,
nucleotides were changed to decrease the stability of the secondary structure
without
changing the amino acid sequence of the protein. A plant ribosomal binding
site
consensus sequence, TAAACAATG (Joshi et al., Nucleic Acid Res., 15:6643-6653
(1987)) or eukaryotic ribosomal binding site concensus sequence CCACCATG
(Kozak, Nucleic Acid Research, 12:857-872 (1984)) was inserted at the
translational
start codon of the gene.
Clonin : Oligos were synthesized by IDT Inc., and were supplied as lyophilized
powders. They were resuspended at a concentration of 200 M. To 30 gl of each
oligo formamide was added a final concentration of 25-50% and the sample was
boiled for two minutes before separation on a premade 10% polyacryamide / urea
gel
obtained from Novex. After electrophoresis, the oligo was detected by UV
shadowing
by placing the gel on a TLC plate containing a fluorescent indicator and
exposing it to
UV light. The region containing DNA of the correct size was excised and
extracted
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-100-
from the polyacryamide by an overnight incubation of the minced gel fragment
in a
buffer containing 0.4 M LiCI, 0.1 mM EDTA. The DNA was separated from the gel
residue by centrifugation through a Millipore UFMC filter. The extracted DNA
was
ethanol precipitated by the addition of 2 volumes of absolute alcohol. After
centrifugation, the precipitate was resuspended in dH2O at a concentration of
2.5 M.
Fragments were cloned either by hybridization of the oligos and ligation with
the
appropriate vector or by amplification of the hybridized fragment using a
equimolar
mixture of all the oligos for a particular fragment as a template and end-
specific PCR
primers.
Cloning by hybridization and ligation: Homologous double stranded oligo pairs
were obtained by mixing 5 d of the upper and of the lower oligo for each oligo
pair
with buffer containing 1 X polynucleotide kinase (PNK) buffer (70 mM Tris-HCI
(pH
7.6), 10 mM MgCl2.5 mM dithiothreitol (DTT)), 50 mM KCI, and 5 % formamide in
a
final volume of 50 l. The oligos were boiled for 10 minutes and slow cooled
to 37 C
or room temperature. 10 l was removed for analysis on a 4% agarose in a TAE
buffer system (Metaphore0; FMC). Each hybridized oligo pair was kinased by the
addition of ATP at a final concentration of 1 mM, BSA at a final concentration
of 100
gg per ml and 200 units of polynucleotide kinase and 1 RI of 1 OX PNK buffer
in a
volume of 10 l. Following hybridization and phosphorylation, the reaction was
incubated at 37 C for 2 hours to overnight. 10 Rl of each of the oligo pairs
for a
particular fragment, were mixed in a final volume of 50 W. The oligo pairs
were
hybridized by heating at 80 C for 10 minutes and slow cooling to 37 C. 2 I
of oligos
was mixed with about 100 ng of an appropriate vector and ligated using a
buffer
containing 50 mM Tris-HCI (pH 7.8), 10 mM MgCI2, 10 mM DTT, 1 mM ATP. The
reaction was incubated at room temp. for 2 hours to overnight and transformed
into
DH5a strain of E.coli , plated on L- plates containing ampicillin at a
concentration of
100 g/ml using standard procedures. Positive clones were further
characterized and
confirmed by PCR miniscreen described in detail in EP-A 0618976 using the
universal
primers "Reverse" and M13 "-20 " as primers. Positive clones were identified
by
digestion of DNA with appropriate enzymes followed by sequencing. Recombinants
that had the expected DNA sequence were then selected for further work.
WO 96/10083 - 2 1 9 9 0 4 9 PCT/EP95/03826
- 101 -
PCR Amplification and cloning into T- vector:
PCR amplification was carried out by using a mixture of all the oligomers that
represented the upper and the lower strand of a particular fragment ( final
concentration 5 mM each) as template, specific end primers for the particular
fragment
( final concentration 2 M) 200 gM of each dATP, dTTP, dCTP and dGTP, 10 mM
Tris-HCI (pH 8.3), 50 mM KCI, 1.5 mM MgC12,0.01% gelatin and 5 units of Taq
polymerase in a final reaction volume of 50 III. The amplification reaction
was carried
out in a Perkin Elmer thermocycler 9600 by incubation at 950 C for 1 min (1
cycle ),
followed by 20 cycles of 95 C for 45 sec., 50 C for 45 sec., 72 C for 30
sec. Finally
the reaction was incubated for 5 min at 72 C before analyzing the product. 10
0 of
the reaction was analyzed on a 2.5% Nusieve (FMC) agarose gel in a TAE buffer
system. The correct size fragment was gel purified and used for cloning into a
PCR
cloning vector or T-vector. T-vector construction was as described by Marchuk
et al.,
Nucleic Acid Research, 19:1154 (1991). pBluescriptsk+ (Stratagene , Ca.) was
used as the parent vector. Transformation and identification of the correct
clone was
carried out as described above.
Fragments 1, 3, 4, 5, 6, 8, and 9 of VIP1A(a) and fragments 2 and 4 of
VIP2A(a)
were obtained by cloning of PCR amplification products; whereas, fragments 2,
7, 10
and 11 of VIP1A(a) and fragments 1, 3, and 5 of VIP2A(a) were obtained by
hybridization/ ligation.
Once fragments with the desired sequence were obtained, the complete gene was
assembled by cloning together adjacent fragments. The complete gene was
resequenced and tested for activity against WCRW before moving it into plant
expression vectors containing the root preferred promoter (disclosed in U.S.
patent
application serial no. 08/017,209, herein incorporated by reference) and the
rice actin
promoter.
One such plant expression vector is pCIB5521. The maize optimized VIP1A(a)
coding region (SEQ ID NO:26) was cloned in a plant expression vector
containing the
root preferred promoter at the 5' of the gene with the PEP Carboxylase intron
#9
followed by the 35S terminator at the 3' end. The plasmid also contains
sequences
for ampicillin resistance from the plasmid pUC1 9. Another plant expression
vector is
pCIB5522, which contains the maize optimized VIP2A(a) coding region (SEQ ID
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-102-
NO:27) fused to the root preferred promoter at the 5' of the gene with the PEP
Carboxylase intron #9 followed by the 35S terminator at the 3' end.
EXAMPLE 25. NAD AFFINITY CHROMATOGRAPHY
A purification strategy was used based on the affinity of VIP2 for the
substrate
NAD. The supernatant from the pH 3.5 sodium citrate buffer treatment described
in
Example 4 was dialyzed in 20 mM TRIS pH 7.5 overnight. The neutralized
supernatant was added to an equal volume of washed NAD agarose and incubated
with gentle rocking at 40 C overnight. The resin and protein solution were
added to a
ml disposable polypropylene column and the protein solution allowed to flow
out.
The column was washed with 5 column volumes of 20 mM TRIS pH 7.5 then washed
with 2-5 column volumes of 20 mM TRIS pH 7.5, 100 mM NaCl, followed by 2-5
column volumes of 20 mM TRIS 7.5. The VIP proteins were eluted in 20 mM TRIS
pH
7.5 supplemented with 5 mM NAD. Approximately 3 column volumes of the effluent
were collected and concentrated in a Centricon -10. Yield is typically about 7-
15 Rg of
protein per ml of resin.
When the purified proteins were analyzed by SDS-PAGE followed by silver
staining, two polypeptides were visible, one with Mr of approximately 80,000
and one
with Mr of approximately 45,000. N-terminal sequencing revealed that the Mr
80,000
protein corresponded to a proteolytically processed form of VIP1A(A) and the
Mr
45,000 form corresponded to a proteolytically processed form of VIP2A(a). The
co-
purification of VIP1A(a) with VIP2A(a) indicates that the two proteins
probably form a
complex and have protein-protein interacting regions. VIP1A(a) and VIP2A(a)
proteins purified in this manner were biologically active against western com
rootworm.
EXAMPLE 26. EXPRESSION OF MAIZE OPTIMIZED VIP1A(a) AND VIP2A(a)
E. coli strains containing different plasmids comprising VIP genes were
assayed
for expression of VIPs. E. coil strains harboring the individual plasmids were
grown
overnight in L-broth and expressed protein was extracted from the culture as
described in Example 3, above. Protein expression was assayed by Western Blot
analysis using antibodies developed using standard methods known in the art,
similar
WO 96/10083 2 1 9 90 4 9 PCT/EP95/03826
-103-
to those described in Example 12, above. Also, insecticidal activity of the
expressed
proteins were tested against Western corn rootworm according to the method in
Example 3, above. The results of the E. coli expression assays are described
below.
Expression of VIPs in E. coli
Extract of E. coil Strain Assay Assay Protein
Harboring Indicated Plasmid No. 1 No. 2 Detected
% Mortality
Control 0 0 no
pCIB5521 (maize optimized 47 27 yes
VIP1A(a))
pCIB5522 (maize optimized 7 7 yes
VIP2A(a))
pCIB6024 (native VIP2A(a)) 13 13 yes
pCIB6206 (native VIP1A(a)) 27 40 yes
Extracts pCIB5521 + pCIB5522 87 47
combined
Extracts pCIB5521 + pCIB6024 93 100
combined
Extracts pCIB5522 + pCIB6206 100 100
combined
Extracts pCIB6024 + pCIB6206 100 100
combined
The DNA from these plasmids was used to transiently express the VIPs in a
maize protoplast expression system. Protoplasts were isolated from maize 2717
Line
6 suspension cultures by digestion of the cell walls using Cellulase RS and
Macerase
R10 in appropriate buffer. Protoplasts were recovered by sieving and
centrifugation.
Protoplasts were transformed by a standard direct gene transfer method using
approximately 75 g plasmid DNA and PEG-40. Treated protoplasts were incubated
overnight in the dark at room temperature. Analysis of VIP expression was
PCT/EP95/03826
WO 96/10083 2 1 9 9 0 4
9
-104-
accomplished on protoplast explants by Western blot analysis and insecticidal
activity
against Western corn rootworm as described above for the expression in E.
coli. The
results of the maize protoplast expression assays are described below.
Expression of VIPs in Plant Protoplasts
Extract Tested Assay No. 1 Assay No. 2 Protein
Detected
% Mortality
No DNA control 27 10 no
pCIB5521 (p) (maize 20 (0) 30 yes
optimized VIP1A(a))
pCIB5522 (p) (maize 20 (0) 20 yes
optmizied VIP2A(a))
Extracts pCIB5521 (p) + 87 (82) 90
pCIB5522 (p) combined
Extracts pCIB5521 (p) + 100 -
pCIB5522 (e) combined
Extracts pCIB5522 (p) + 53 (36) -
pCIB5521 (e) combined
Extracts pCIB5521 (p) + 100 -
pCIB6024 (e) combined
Extracts pCIB5522 (p) + 100 -
pCIB6206 (e) combined
pCIB6024(e) (native 0 - yes
VIP2A(a))
pCIB6206(e) (native 20 - yes
VIP1A(a))
pCIB5521 + pCIB 5522 100 100 yes
(plasmids delivered by
cotransformation)
(p) = extract of protoplast culture transformed with indicated plasmid
CA 02199049 2008-07-07
30041-89
-105-
(e) = extract of E. cols strain harboring indicated plasmid
The expression data obtained with both E. coli and maize protoplasts show that
the
maize optimized VIP1A(a) and VIP2A(a) genes make the same protein as the
native
VIP 1A(a) and VIP2A(a) genes, respectively, and that the proteins encoded by
the
maize optimized genes are functionally equivalent to the proteins encoded by
the
native genes.
All publications and patent applications mentioned in this specification are
indicative of the level of skill of those skilled in the art to which this
invention pertains.
The following deposits have been made at Agricultural Research Service, Patent
Culture Collection (NRRL), Northern Regional Research Center, 1815 North
University
Street, Peoria, Illinois 61604, USA:
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03816
-106-
Strain designation Deposition Number Deposition Date
1. E. coli PL2 NRRL B-21221 March 09, 1994
2. E. coli PL2 NRRL B-21221 N September 02, 1994
3. E. colipCIB6022 NRRL B-21222 March 09, 1994
4. E. coli pCIB6023 NRRL B-21223 March 09, 1994
5. E. co/ipCIB6023 NRRL B-21223N September 02, 1994
6. Bacillus thuringiensis
HD73-78VIP NRRL B-21224 March 09, 1994
7. Bacillus thuringiensis AB88 NRRL B-21225 March 09, 1994
8. Bacillus thuringiensis AB359 NRRL B-21226 March 09, 1994
9. Bacillus thuringiensis AB289 NRRL B-21227 March 09, 1994
10. Bacillus sp. AB59 NRRL B-21228 March 09, 1994
11. Bacillus sp. AB294 NRRL B-21229 March 09, 1994
12. Bacillus sp. AB256 NRRL B-21230 March 09, 1994
13. E. coli P5-4 NRRL B-21059 March 18, 1993
14. E. coli P3-12 NRRL B-21061 March 18, 1993
15. Bacillus cereus AB78 NRRL B-21058 March 18, 1993
16. Bacillus thuringiensis AB6 NRRL B-21060 March 18, 1993
17. E. co/ipCIB6202 NRRL B-21321 September 02, 1994
18. E. colipCIB7100 NRRL B-21322 September 02, 1994
19. E. colipCIB7101 NRRL B-21323 September 02, 1994
20. E. co/ipCIB7102 NRRL B-21324 September 02, 1994
21. E. co/ipCIB7103 NRRL B-21325 September 02, 1994
22. E. colipCIB7104 NRRL B-21422 March 24, 1995
23. E. co/ipCIB7107 NRRL B-21423 March 24, 1995
24. E. coli pCIB7108 NRRL B-21438 May 05, 1995
25. Bacillus thuringiensis AB424 NRRL B-21439 May 05, 1995
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
107-
Although the foregoing invention has been described in some detail by way of
illustration and example for purposes of clarity of understanding, it will be
obvious that
certain changes and modifications may be practiced within the scope of the
appended
claims.
WO 96/10083 2 1 9. 9 0 4 9 PCT/EP95/03826
-108-
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(A) NAME: CIBA-GEIGY AG
(B) STREET: Klybeckstr. 141
(C) CITY: Basel
(E) COUNTRY: Switzerland
(F) POSTAL CODE (ZIP): 4002
(G) TELEPHONE: +41 61 69 11 11
(H) TELEFAX: + 41 61 696 79 76
(I) TELEX: 962 991
(ii) TITLE OF INVENTION: Novel Pesticidal Proteins and Strains
(iii) NUMBER OF SEQUENCES: 52
(iv) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWAFE: Patentln Release #1.0, Version #1.30B
(2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 6049 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus cereus
(B) STRAIN: AB78
(C) INDIVIDUAL ISOLATE: NRRL B-21058
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1082..2467
(D) OTHER INFORMATION: /product= "VIP2A(a)"
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 2475..5126
(D) OTHER INFORMATION: /note= "Coding sequence for the 100
kd VIP1A(a) protein. This coding sequence is repeated in SEQ ID
NO:4 and translated separately."
2 199049
PCT/EP95/03826
WO 96/10083
-109-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:
ATCGATACAA TGTTGTTTTA CTTAGACCGG TAGTCTCTGT AATTTGTTTA ATGCTATATT 60
CTTTACTTTG ATACATTTTA ATAGCCATTT CAACCTTATC AGTATGTTTT TGTGGTCTTC 120
CTCCTTTTTT TCCACGAGCT CTAGCTGCGT TTAATCCTGT TTTGGTACGT TCGCTAATAA 180
TATCTCTTTC TAATTCTGCA ATACTTGCCA TCATTCGAAA GAAGAATTTC CCCATAGCAT 240
TAGAGGTATC AATGTTGTCA TGAATAGAAA TAAAATCTAC ACCTAGCTCT TTGAATTrTT 300
CACTTAACTC AATTAGGTGT TTTGTAGAGC GAGGAATTCG ATCAAGTTTG TAAACAACTA 360
TCTTATCGCC TTTACGTAAT ACTTTTAGCA ACTCTTCGAG TTGAGGGCGC TCTTTTTTTA 420
TTCCTGTTAT TTTCTCCTGA TATAGCCTTT CTACACCATA TTGTTGCAAA GCATCTATTT 480
GCATATCGAG ATTTTGTTCT TCTGTGCTGA CACGAGCATA ACCAAAAATC AAATTGGTTT 540
CACTTCCTAT CTAAATATAT CTATTAAAAT AGCACCAAAA ACCTTATTAA ATTAAAATAA 600
GGATCTTTGT TTTTGGATAT GGATTTTGGT ACTCAATATG GATGAGTTTT TAACGCTTTT 660
GTTAAAAAAC AAACAAGTGC CATAAACGGT CGTTTTTGGG ATGACATAAT AAATAATCTG 720
TTTGATTAAC CTAACCTTGT ATCCTTACAG CCCAGTTTTA TTTGTACTTC AACTGACTGA 780
ATATGAAAAC AACATGAAGG TTTCATAAAA TTTATATATT TTCCATAACG GATGCTCTAT 840
CTTTAGGTTA TAGTTAAATT ATAAGAAAAA AACAAACGGA GGGAGTGAAA AAAAGCATCT 900
TCTCTATAAT TTTACAGGCT CTTTCATAAG AAGGGGGGAG ATTAGATAAT AAATATGAAT 960
ATCTATCTAT AATTGTTTGC TTCTACAATA ACTTATCTAA CTTTCATATA CAACAACAAA 1020
ACAGACTAAA TCCAGATTGT ATATTCATTT TCAGTTGTTC CTTTATAAAA TAATTTCATA 1080
A ATG AAA AGA ATG GAG GGA AAG TTG TTT ATG GTG TCA AAA AAA TTA 1126
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys Leu
1 5 10 15
CAA GTA GTT ACT AAA ACT GTA TTG CTT AGT ACA GTT TTC TCT ATA TCT 1174
Gln Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile Ser
20 25 30
TTA TTA AAT AAT GAA GTG ATA AAA GCT GAA CAA TTA AAT ATA AAT TCT 1222
Leu Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu Asn Ile Asn Ser
35 40 45
CAA AGT AAA TAT ACT AAC TTG CAA AAT CTA AAA ATC ACT GAC AAG GTA 1270
Gln Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys Val
50 55 60
GAG GAT TTT AAA GAA GAT AAG GAA AAA GCG AAA GAA TGG GGG AAA GAA 1318
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 110 -
Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu
65 70 75
AAA GAA AAA GAG TGG AAA CTA ACT GCT ACT GAA AAA GGA AAA ATG AAT 1366
Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn
80 85 90 95
AAT TTT TTA GAT AAT AAA AAT GAT ATA AAG ACA AAT TAT AAA GAA ATT 1414
Asn Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile
100 105 110
ACT TTT TCT ATG GCA GGC TCA TTT GAA GAT GAA ATA AAA GAT TTA AAA 1462
Thr Phe Ser Met Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys
115 120 125
GAA ATT GAT AAG ATG TTT GAT AAA ACC AAT CTA TCA AAT TCT ATT ATC 1510
Glu Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile
130 135 140
ACC TAT AAA AAT GTG GAA CCG ACA ACA ATT GGA TTT AAT AAA TCT TTA 1558
Thr Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu
145 150 155
ACA GAA GGT AAT ACG ATT AAT TCT GAT GCA ATG GCA CAG TTT AAA GAA 1606
Thr Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu
160 165 170 175
CAA TTT TTA GAT AGG GAT ATT AAG TTT GAT AGT TAT CTA GAT ACG CAT 1654
Gln Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His
180 185 190
TTA ACT GCT CAA CAA GTT TCC AGT AAA GAA AGA GTT ATT TTG AAG GTT 1702
Leu Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val
195 200 205
ACG GTT CCG AGT GGG AAA GGT TCT ACT ACT CCA ACA AAA GCA GGT GTC 1750
Thr Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Giy Val
210 215 220
ATT TTA AAT AAT AGT GAA TAC AAA ATG CTC ATT GAT AAT GGG TAT ATG 1798
Ile Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met
225 230 235
GTC CAT GTA GAT AAG GTA TCA AAA GTG GTG AAA AAA GGG GTG GAG TGC 1846
Val His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys
240 245 250 255
TTA CAA ATT GAA GGG ACT TTA AAA AAG AGT CTT GAC TTT AAA AAT GAT 1894
Leu Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp
260 265 270
ATA AAT GCT GAA GCG CAT AGC TGG GGT ATG AAG AAT TAT GAA GAG TGG 1942
Ile Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Tip
275 280 285
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-111 -
GCT AAA GAT TTA ACC GAT TCG CAA AGG GAA GCT TTA GAT GGG TAT GCT 1990
Ala Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala
290 295 300
AGG CAA GAT TAT AAA GAA ATC AAT AAT TAT TTA AGA AAT CAA GGC GGA 2038
Arg Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly
305 310 315
AGT GGA AAT GAA AAA CTA GAT GCT CAA ATA AAA AAT ATT TCT GAT GCT 2086
Ser Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala
320 325 330 335
TTA GGG AAG AAA CCA ATA CCG GAA AAT ATT ACT GTG TAT AGA TGG TGT 2134
Leu Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys
340 345 350
GGC ATG CCG GAA TTT GGT TAT CAA ATT AGT GAT CCG TTA CCT TCT TTA 2182
Gly Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu
355 360 365
AAA GAT TTT GAA GAA CAA TTT TTA AAT ACA ATC AAA GAA GAC AAA GGA 2230
Lys Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly
370 375 380
TAT ATG AGT ACA AGC TTA TCG AGT GAA CGT CTT GCA GCT TTT GGA TCT 2278
Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser
385 390 395
AGA AAA ATT ATA TTA CGA TTA CAA GTT CCG AAA GGA AGT ACG GGT GCG 2326
Arg Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala
400 405 410 415
TAT TTA AGT GCC ATT GGT GGA TTT GCA AGT GAA AAA GAG ATC CTA CTT 2374
Tyr Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu
420 425 430
GAT AAA GAT AGT AAA TAT CAT ATT GAT AAA GTA ACA GAG GTA ATT ATT 2422
Asp Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile
435 440 445
AAA GGT GTT AAG CGA TAT GTA GTG GAT GCA ACA TTA TTA ACA AAT 2467
Lys Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
450 455 460
TAAGGAGATG AAAAATATGA AGAAAAAGTT AGCAAGTGTT GTAACGTGTA CGTTATTAGC 2527
TCCTATGTTT TTGAATGGAA ATGTGAATGC TGTTTACGCA GACAGAAAAA CAAATCAAAT 2587
TTCTACAACA CAGAAAAATC AACAGAAAGA GATGGACCGA AAAGGATTAC TTGGGTATTA 2647
TTTCAAAGGA AAAGATTTTA GTAATCTTAC TATGTTTGCA CCGACACGTG ATAGTACTCT 2707
TATTTATGAT CAACAAACAG CAAATAAACT ATTAGATAAA AAACAACAAG AATATCAGTC 2767
TATTCGTTGG ATTGGTTTGA TTCAGAGTAA AGAAACGGGA GATTTCACAT TTAACTTATC 2827
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 112 -
TGAGGATGAA CAGGCAATTA TAGAAATCAA TGGGAAAATT ATTTCTAATA AAGGGAAAGA 2887
AAAGCAAGTT GTCCATTTAG AAAAAGGAAA ATTAGTTCCA ATCAAAATAG AGTATCAATC 2947
AGATACAAAA TTTAATATTG ACAGTAAAAC ATTTAAAGAA CTTAAATTAT TTAAAATAGA 3007
TAGTCAAAAC CAACCCCAGC AAGTCCAGCA AGATGAACTG AGAAATCCTG AATTTAACAA 3067
GAAAGAATCA CAGGAATTCT TAGCGAAACC ATCGAAAATA AATCTTTTCA CTCAAAAAAT 3127
GAAAAGGGAA ATTGATGAAG ACACGGATAC GGATGGGGAC TCTATTCCTG ACCTTTGGGA 3187
AGAAAATGGG TATACGATTC ACAATAGAAT CGCTGTAAAG TGGGACGATT CTCTAGCAAG 3247
TAAAGGGTAT ACGAAATTTG TTTCAAATCC ACTAGAAAGT CACACAGTTG GTGATCCTTA 3307
TACAGATTAT GAAAAGGCAG CAAGAGATCT AGATTTGTCA AATGCAAAGG AAACGTTTAA 3367
CCCATTGGTA GCTGCTTTTC CAAGTGTGAA TGTTAGTATG GAAAAGGTGA TATTATCACC 3427
AAATGAAAAT TTATCCAATA GTGTAGAGTC TCATTCATCC ACGAATTGGT CTTATACAAA 3487
TACAGAAGGT GCTTCTGTTG AAGCGGGGAT TGGACCAAAA GGTATTTCGT TCGGAGTTAG 3547
CGTAAACTAT CAACACTCTG AAACAGTTGC ACAAGAATGG GGAACATCTA CAGGAAATAC 3607
TTCGCAATTC AATACGGCTT CAGCGGGATA TTTAAATGCA AATGTTCGAT ATAACAATGT 3667
AGGAACTGGT GCCATCTACG ATGTAAAACC TACAACAAGT TTTGTATTAA ATAACGATAC 3727
TATCGCAACT ATTACGGCGA AATCTATTTC TACAGCCTTA AATATATCTC CTGGAGAAAG 3787
TTACCCGAAA AAAGGACAAA ATGGAATCGC AATAACATCA ATGGATGATT TTAATTCCCA 3847
TCCGATTACA TTAAATAAAA AACAAGTAGA TAATCTGCTA AATAATAAAC CTATGATGTT 3907
GGAAACAAAC CAAACAGATG GTGTTTATAA GATAAAAGAT ACACATGGAA ATATAGTAAC 3967
TGGCGGAGAA TGGAATGGTG TCATACAACA AATCAAGGCT AAAACAGCGT CTATTATTGT 4027
GGATGATGGG GAACGTGTAG CAGAAAAACG TGTAGCGGCA AAAGATTATG AAAATCCAGA 4087
AGATAAAACA CCGTCTTTAA CTTTAAAAGA TGCCCTGAAG CTTTCATATC CAGATGAAAT 4147
AAAAGAAATA GAGGGATTAT TATATTATAA AAACAAACCG ATATACGAAT CGAGCGTTAT 4207
GACTTACTTA GATGAAAATA CAGCAAAAGA AGTGACCAAA CAATTAAATG ATACCACTGG 4267
GAAATTTAAA GATGTAAGTC ATTTATATGA TGTAAAACTG ACTCCAAAAA TGAATGTTAC 4327
AATCAAATTG TCTATACTTT ATGATAATGC TGAGTCTAAT GATAACTCAA TTGGTAAATG 4387
GACAAACACA AATATTGTTT CAGGTGGAAA TAACGAAAAA AAACAATATT CTTCTAATAA 4447
WO 96/10083
2 19904 PCT/EP95/03826
-113-
TCCGGATGCT AATTTGACAT TAAATACAGA TGCTCAAGAA ATATTAAATA AAAATCGTGA 4507
CTATTATATA AGTTTATATA TGAAGTCAGA AATAAACACA CAATGTGAGA TTACTATAGA 4567
TGGGGAGATT TATCCGATCA CTACAAAAAC AGTGAATGTG AATAAAGACA ATTACAAAAG 4627
ATTAGATATT ATAGCTCATA ATATAAAAAG TAATCCAATT TCTTCACTTC ATATTAAAAC 4687
GAATGATGAA ATAAATTTAT TTTGGGATGA TATTTCTATA ACAGATGTAG CATCAATAAA 4747
ACCGGAAAAT TAATCAGATT CAGAAATTAA ACAGATTTAT AGTAGGTATG GTATTAAGTT 4807
AGAAGATGGA ATCCTTATTG ATATAAAGGG TGGGATTCAT TATGGTGAAT TTATTAATGA 4867
AGCTAGTTTT AATATTGAAC CATTGCAAAA TTATGTGACC AAATATGAAG TTACTTATAG 4927
TAGTGAGTTA GGACCAAACG TGAGTGACAC ACTTGAAAGT GATAAAATTT ACAAGGATGG 4987
GACAATTAAA TTTGATTTTA CCAAATATAG TAAAAATGAA CAAGGATTAT TTTATGACAG 5047
TGGATTAAAT TGGGACTCTA AAATTAATGC TATTACTTAT GATGGTAAAG AGATGAATGT 5107
TTTTCATAGA TATAATAAAT AGTTATTATA TCTATGAAGC TGGTGCTAAA GATAGTGTAA 5167
AAGTTAATAT ACTGTAGGAT TGTAATAAAA GTATTGGAAT TGATATCGTA CTTTGGAGTG 5227
GGGGATACTT TGTAAATAGT TCTATCAGAA ACATTAGACT AAGAAAAGTT ACTACCCCCA 5287
CTTGAAAATG AAGATTCAAC TGATTACAAA CAACCTGTTA AATATTATAA GGTTTTAACA 5347
AAATATTAAA CTCTTTATGT TAATACTGTA ATATAAAGAG TTTAATTGTA TTCAAATGAA 5407
GCTTTCCCAC AAAATTAGAC TGATTATCTA ATGAAATAAT CAGTCTAATT TTGTAGAACA 5467
GGTCTGGTAT TATTGTACGT GGTCACTAAA AGATATCTAA TATTATTGGG CAAGGCGTTC 5527
CATGATTGAA TCCTCGAATG TCTTGCCCTT TTCATTTATT TAAGAAGGAT TGTGGAGAAA 5587
TTATGGGTTA GATAATGAAG AAAGACTTCA CTTCTAATTT TTGATGTTAA ATAAATCAAA 5647
ATTTGGCGAT TCACATTGTT TAATCCACTG ATAAAACATA CTGGAGTGTT CTTAAAAAAT 5707
CAGCTTTTTT CTTTATAAAA TTTTGCTTAG CGTACGAAAT TCGTGTTTTG TTGGTGGGAC 5767
CCCATGCCCA TCAACTTAAG AGTAAATTAG TAATGAACTT TCGTTCATCT GGATTAAAAT 5827
AACCTCAAAT TAGGACATGT TTTTAAAAAT AAGCAGACCA AATAAGCCTA GAATAGGTAT 5887
CATTTTTAAA AATTATGCTG CTTTCTTTTG TTTTCCAAAT CCATTATACT CATAAGCAAC 5947
ACCCATAATG TCAAAGACTG TTTTTGTCTC ATATCGATAA GCTTGATATC GAATTCCTGC 6007
AGCCCGGGGG ATCCACTAGT TCTAGAGCGG CCGCCACCGC GG 6049
WO 96/10083 2 1 9 90 4 9 PCT/EP95/03826
-114-
(2) INFORMATION FOR SEQ ID NO:2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 462 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys Leu Gln
1 5 10 15
Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile Ser Leu
20 25 30
Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu Asn Ile Asn Ser Gln
35 40 45
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu
50 55 60
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys
65 70 75 80
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn
85 90 95
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
100 105 110
Phe Ser Met Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu
115 120 125
Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr
130 135 140
Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr
145 150 155 160
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln
165 170 175
Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
180 185 190
Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr
195 200 205
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
210 215 220
Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val
225 230 235 240
2199049
WO 96/10083 PCT/EP95/03826
115-
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu
245 250 255
Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
260 265 270
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala
275 280 285
Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
290 295 300
Gin Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
305 310 315 320
Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu
325 330 335
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
340 345 350
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
355 360 365
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
370 375 380
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
385 390 395 400
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
405 410 415
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
420 425 430
Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys
435 440 445
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
450 455 460
(2) INFORMATION FOR SEQ ID NO:3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 20 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(ix) FEATURE:
WO 96/10083 2 1 9 n ~ ~ ~ PCT/EP95/03826
I -116-
(A) NAME/KEY: Peptide
(B) LOCATION: 1..20
(D) OTHER INFORMATION: /note= "Signal peptide for vacuolar
targetting"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:
Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro Ile Arg Val Thr Asp Arg
1 5 10 15
Ala Ala Ser Thr
(2) INFORMATION FOR SEQ ID NO:4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus cereus
(B) STRAIN: AB78
(C) INDIVIDUAL ISOLATE: NRRL B-21058
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1..2652
(D) OTHER INFORMATION: /product= "100 kDa protein VIP1A(a)"
/note= "This sequence is identical to the portion of SEQ ID NO:1
between and including nucleotide 2475 to 5126."
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:
ATG AAA AAT ATG AAG AAA AAG TTA GCA AGT GTT GTA ACG TGT ACG TTA 48
Met Lys Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Thr Leu
465 470 475
TTA GCT CCT ATG TTT TTG AAT GGA AAT GTG AAT GCT GTT TAC GCA GAC 96
Leu Ala Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Tyr Ala Asp
480 485 490
AGC AAA ACA AAT CAA ATT TCT ACA ACA CAG AAA AAT CAA CAG AAA GAG 144
Ser Lys Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu
495 500 505 510
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 117 -
ATG GAC CGA AAA GGA TTA CTT GGG TAT TAT TTC AAA GGA AAA GAT TTT 192
Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe
515 520 525
AGT AAT CTT ACT ATG TTT GCA CCG ACA CGT GAT AGT ACT CTT ATT TAT 240
Ser Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr
530 535 540
GAT CAA CAA ACA GCA AAT AAA CTA TTA GAT AAA AAA CAA CAA GAA TAT 288
Asp Gln Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr
545 550 555
CAG TCT ATT CGT TGG ATT GGT TTG ATT CAG AGT AAA GAA ACG GGA GAT 336
Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp
560 565 570
TTC ACA TTT AAC TTA TCT GAG GAT GAA CAG GCA ATT ATA GAA ATC AAT 384
Phe Thr Phe Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu Ile Asn
575 580 585 590
GGG AAA ATT ATT TCT AAT AAA GGG AAA GAA AAG CAA GTT GTC CAT TTA 432
Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gin Val Val His Leu
595 600 605
GAA AAA GGA AAA TTA GTT CCA ATC AAA ATA GAG TAT CAA TCA GAT ACA 480
Glu Lys Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr
610 615 620
AAA TTT AAT ATT GAC AGT AAA ACA TTT AAA GAA CTT AAA TTA TTT AAA 528
Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys
. 625 630 635
ATA GAT AGT CAA AAC CAA CCC CAG CAA GTC CAG CAA GAT GAA CTG AGA 576
Ile Asp Ser Gln Asn Gln Pro Gln Gln Val Gln Gln Asp Glu Leu Arg
640 645 650
AAT CCT GAA TTT AAC AAG AAA GAA TCA CAG GAA TTC TTA GCG AAA CCA 624
Asn Pro Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro
655 660 665 670
TCG AAA ATA AAT CTT TTC ACT CAA AAA ATG AAA AGG GAA ATT GAT GAA 672
Ser Lys Ile Asn Leu Phe Thr Gln Lys Met Lys Arg Glu Ile Asp Glu
675 680 685
GAC ACG GAT ACG GAT GGG GAC TCT ATT CCT GAC CTT TGG GAA GAA AAT 720
Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn
690 695 700
GGG TAT ACG ATT CAA AAT AGA ATC GCT GTA AAG TGG GAC GAT TCT CTA 768
Gly Tyr Thr Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp Ser Leu
705 710 715
GCA AGT AAA GGG TAT ACG AAA TTT GTT TCA AAT CCA CTA GAA AGT CAC 816
Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His
720 725 730
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-118-
ACA GTT GGT GAT CCT TAT ACA GAT TAT GAA AAG GCA GCA AGA GAT CTA 864
Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu
735 740 745 750
GAT TTG TCA AAT GCA AAG GAA ACG TTT AAC CCA TTG GTA GCT GCT TTT 912
Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe
755 760 765
CCA AGT GTG AAT GTT AGT ATG GAA AAG GTG ATA TTA TCA CCA AAT GAA 960
Pro Ser Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu
770 775 780
AAT TTA TCC AAT AGT GTA GAG TCT CAT TCA TCC ACG AAT TGG TCT TAT 1008
Asn Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr
785 790 795
ACA AAT ACA GAA GGT GCT TCT GTT GAA GCG GGG ATT GGA CCA AAA GGT 1056
Thr Asn Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly
800 805 810
ATT TCG TTC GGA GTT AGC GTA AAC TAT CAA CAC TCT GAA ACA GTT GCA 1104
Ile Ser Phe Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala
815 820 825 830
CAA GAA TGG GGA ACA TCT ACA GGA AAT ACT TCG CAA TTC AAT ACG GCT 1152
Gln Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala
835 840 845
TCA GCG GGA TAT TTA AAT GCA AAT GTT CGA TAT AAC AAT GTA GGA ACT 1200
Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr
850 855 860
GGT GCC ATC TAC GAT GTA AAA CCT ACA ACA AGT TTT GTA TTA AAT AAC 1248
Gly Ala Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn
865 870 875
GAT ACT ATC GCA ACT ATT ACG GCG AAA TCT AAT TCT ACA GCC TTA AAT 1296
Asp Thr Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn
880 885 890
ATA TCT CCT GGA GAA AGT TAC CCG AAA AAA GGA CAA AAT GGA ATC GCA 1344
Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala
895 900 905 910
ATA ACA TCA ATG GAT GAT TTT AAT TCC CAT CCG ATT ACA TTA AAT AAA 1392
Ile Thr Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys
915 920 925
AAA CAA GTA GAT AAT CTG CTA AAT AAT AAA CCT ATG ATG TTG GAA ACA 1440
Lys Gln Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr
930 935 940
AAC CAA ACA GAT GGT GTT TAT AAG ATA AAA GAT ACA CAT GGA AAT ATA 1488
Asn Gln Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile
WO 96/10083 r-2 1 9 9 0,4,.9j PCT/EP95/03826
- 119-
945 950 955
GTA ACT GGC GGA GAA TGG AAT GGT GTC ATA CAA CAA ATC AAG GCT AAA 1536
Val Thr Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys
960 965 970
ACA GCG TCT ATT ATT GTG GAT GAT GGG GAA CGT GTA GCA GAA AAA CGT 1584
Thr Ala Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg
975 980 985 990
GTA GCG GCA AAA GAT TAT GAA AAT CCA GAA GAT AAA ACA CCG TCT TTA 1632
Val Ala Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu
995 1000 1005
ACT TTA AAA GAT GCC CTG AAG CTT TCA TAT CCA GAT GAA ATA AAA GAA 1680
Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu
1010 1015 1020
ATA GAG GGA TTA TTA TAT TAT AAA AAC AAA CCG ATA TAC GAA TCG AGC 1728
Ile Glu Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser
1025 1030 1035
GTT ATG ACT TAC TTA GAT GAA AAT ACA GCA AAA GAA GTG ACC AAA CAA 1776
Val Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln
1040 1045 1050
TTA AAT GAT ACC ACT GGG AAA TTT AAA GAT GTA AGT CAT TTA TAT GAT 1824
Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp
1055 1060 1065 1070
GTA AAA CTG ACT CCA AAA ATG AAT GTT ACA ATC AAA TTG TCT ATA CTT 1872
Val Lys Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu
1075 1080 1085
TAT GAT AAT GCT GAG TCT AAT GAT AAC TCA ATT GGT AAA TGG ACA AAC 1920
Tyr Asp Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn
1090 1095 1100
ACA AAT ATT GTT TCA GGT GGA AAT AAC GGA AAA AAA CAA TAT TCT TCT 1968
Thr Asn Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr Ser Ser
1105 1110 1115
AAT AAT CCG GAT GCT AAT TTG ACA TTA AAT ACA GAT GCT CAA GAA AAA 2016
Asn Asn Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gln Glu Lys
1120 1125 1130
TTA AAT AAA AAT CGT GAC TAT TAT ATA AGT TTA TAT ATG AAG TCA GAA 2064
Leu Asn Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu
1135 1140 1145= 1150
AAA AAC ACA CAA TGT GAG ATT ACT ATA GAT GGG GAG ATT TAT CCG ATC 2112
Lys Asn Thr Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile
1155 1160 1165
ACT ACA AAA ACA GTG AAT GTG AAT AAA GAC AAT TAC AAA AGA TTA GAT 2160
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-120-
Thr Thr Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp
1170 1175 1180
ATT ATA GCT CAT AAT ATA AAA AGT AAT CCA ATT TCT TCA CTT CAT ATT 2208
Ile Ile Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu His Ile
1185 1190 1195
AAA ACG AAT GAT GAA ATA ACT TTA TTT TGG GAT GAT ATT TCT ATA ACA 2256
Lys Thr Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr
1200 1205 1210
GAT GTA GCA TCA ATA AAA CCG GAA AAT TTA ACA GAT TCA GAA ATT AAA 2304
Asp Val Ala Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu Ile Lys
1215 1220 1225 1230
CAG ATT TAT AGT AGG TAT GGT ATT AAG TTA GAA GAT GGA ATC CTT ATT 2352
Gln Ile Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile
1235 1240 1245
GAT AAA AAA GGT GGG ATT CAT TAT GGT GAA TTT ATT AAT GAA GCT AGT 2400
Asp Lys Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser
1250 1255 1260
TTT AAT ATT GAA CCA TTG CAA AAT TAT GTG ACC AAA TAT GAA GTT ACT 2448
Phe Asn Ile Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Glu Val Thr
1265 1270 1275
TAT AGT AGT GAG TTA GGA CCA AAC GTG AGT GAC ACA CTT GAA AGT GAT 2496
Tyr Ser Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu Ser Asp
1280 1285 1290
AAA ATT TAC AAG GAT GGG ACA ATT AAA TTT GAT TTT ACC AAA TAT AGT 2544
Lys Ile Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser
1295 1300 1305 1310
AAA AAT GAA CAA GGA TTA TTT TAT GAC AGT GGA TTA AAT TGG GAC TTT 2592
Lys Asn Glu Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe
1315 1320 1325
AAA ATT AAT GCT ATT ACT TAT GAT GGT AAA GAG ATG AAT GTT TTT CAT 2640
Lys Ile Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His
1330 1335 1340
AGA TAT AAT AAA TAG 2655
Arg Tyr Asn Lys
1345
(2) INFORMATION FOR SEQ ID NO:5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 884 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
WO 96/10083 2 9 0 4 9 PCf/EP95/03826
- 121 -
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:
Met Lys Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Thr Leu
1 5 10 15
Leu Ala Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Tyr Ala Asp
20 25 30
Ser Lys Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu
35 40 45
Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe
50 55 1 60
Ser Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr
65 70 75 80
Asp Gln Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr
85 90 95
Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp
100 105 110
Phe Thr Phe Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu Ile Asn
115 120 125
Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu
130 135 140
Glu Lys Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr G1n-Ser Asp Thr
145 150 155 160
Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys
165 170 175
Ile Asp Ser Gln Asn Gln Pro Gln Gin Val Gln Gln Asp Glu Leu Arg
180 185 190
Asn Pro Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro
195 200 205
Ser Lys Ile Asn Leu Phe Thr Gln Lys Met Lys Arg Glu Ile Asp Glu
210 215 220
Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn
225 230 235 240
Gly Tyr Thr Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp Ser Leu
245 250 255
Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His
260 265 270
WO 96/10083 r 2 1 9 9 U 4 9 PCT/EP95/03826
-122-
Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu
275 280 285
Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe
290 295 300
Pro Ser Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu
305 310 315 320
Asn Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr
325 330 335
Thr Asn Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly
340 345 350
Ile Ser Phe Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala
355 360 365
Gln Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala
370 375 380
Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr
385 390 395 400
Gly Ala Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn
405 410 415
Asp Thr Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn
420 425 430
Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala
435 440 445
Ile Thr Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys
450 455 460
Lys Gln Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr
465 470 475 480
Asn Gln Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile
485 490 495
Val Thr Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys
500 505 510
Thr Ala Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg
515 520 525
Val Ala Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu
530 535 540
Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu
545 550 555 560
Ile Glu Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser
WO 96/10083 2`1`9 9 PCT/EP95/03826
-123-
565 570 575
Val Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln
580 585 590
Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp
595 600 605
Val Lys Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu
610 615 620
Tyr Asp Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn
625 630 635 640
Thr Asn Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr Ser Ser
645 650 655
Asn Asn Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gln Glu Lys
660 665 670
Leu Asn Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu
675 680 685
Lys Asn Thr Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile
690 695 700
Thr Thr Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp
705 710 715 720
Ile Ile Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu His Ile
725 730 735
Lys Thr Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr
740 745 750
Asp Val Ala Ser Ile Lys Pro.Glu Asn Leu Thr Asp Ser Glu Ile Lys
755 760 765
Gln Ile Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile
770 775 780
Asp Lys Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser
785 790 795 800
Phe Asn Ile Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Glu Val Thr
805 810 815
Tyr Ser Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu Ser Asp
820 825 830
Lys Ile Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser
835 840 845
Lys Asn Glu Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe
850 855 860
WO 96/10083 2 1 9 9 0 4 9 PGT/EP95/03826
-124-
Lys Ile Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His
865 870 875 880
Arg Tyr Asn Lys
(2) INFORMATION FOR SEQ ID NO:6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2004 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus cereus
(B) STRAIN: AB78
(C) INDIVIDUAL ISOLATE: NRRL B-21058
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1..2001
(D) OTHER INFORMATION: /product= "80 kDa protein VIP1A(a)"
/note= "This sequence is identical to that found in SEQ ID NO:1
between and including nucleotide positions 3126 and 5126"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:
ATG AAA AGG GAA ATT GAT GAA GAC ACG GAT ACG GAT GGG GAC TCT ATT 48
Met Lys Arg Glu Ile Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser Ile
885 890 895 900
CCT GAC CTT TGG GAA GAA AAT GGG TAT ACG ATT CAA AAT AGA ATC GCT 96
Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr Ile Gln Asn Arg Ile Ala
905 910 915
GTA AAG TGG GAC GAT TCT CTA GCA AGT AAA GGG TAT ACG AAA TTT GTT 144
Val Lys Trp Asp Asp Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe Val
920 925 930
TCA AAT CCA CTA GAA AGT CAC ACA GTT GGT GAT CCT TAT ACA GAT TAT 192
Ser Asn Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr
935 940 945
GAA AAG GCA GCA AGA GAT CTA GAT TTG TCA AAT GCA AAG GAA ACG TTT 240
Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe
950 955 960
WO 96/10083 2 1 9 9 04 g PCT/EP95/03826
-125-
AAC CCA TTG GTA GCT GCT TTT CCA AGT GTG AAT GTT AGT ATG GAA AAG 288
Asn Pro Leu Val Ala Ala Phe Pro Ser Val Asn Val Ser Met Glu Lys
965 970 975 980
GTG ATA TTA TCA CCA AAT GAA AAT TTA TCC AAT AGT GTA GAG TCT CAT 336
Val Ile Leu Ser Pro Asn Glu Asn Leu Ser Asn Ser Val Glu Ser His
985 990 995
TCA TCC ACG AAT TGG TCT TAT ACA AAT ACA GAA GGT GCT TCT GTT GAA 384
Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu
1000 1005 1010
GCG GGG ATT GGA CCA AAA GGT ATT TCG TTC GGA GTT AGC GTA AAC TAT 432
Ala Gly Ile Gly Pro Lys Gly Ile Ser Phe Gly Val Ser Val Asn Tyr
1015 1020 1025
CAA CAC TCT GAA ACA GTT GCA CAA GAA TGG GGA ACA TCT ACA GGA AAT 480
Gln His Ser Glu Thr Val Ala Gln Glu Trp Gly Thr Ser Thr Gly Asn
1030 1035 1040
ACT TCG CAA TTC AAT ACG GCT TCA GCG GGA TAT TTA AAT GCA AAT GTT 528
Thr Ser Gln Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn Val
1045 1050 1055 1060
CGA TAT AAC AAT GTA GGA ACT GGT GCC ATC TAC GAT GTA AAA CCT ACA 576
Arg Tyr Asn Asn Val Gly Thr Giy Ala Ile Tyr Asp Val Lys Pro Thr
1065 1070 1075
ACA AGT TTT GTA TTA AAT AAC GAT ACT ATC GCA ACT ATT ACG GCG AAA 624
Thr Ser Phe Val Leu Asn Asn Asp Thr Ile Ala Thr Ile Thr Ala Lys
1080 1085 1090
TCT AAT TCT ACA GCC TTA AAT ATA TCT CCT GGA GAA AGT TAC CCG AAA 672
Ser Asn Ser Thr Ala Leu Asn Ile Ser Pro Gly Glu Ser Tyr Pro Lys
1095 1100 1105
AAA GGA CAA AAT GGA ATC GCA ATA ACA TCA ATG GAT GAT TTT AAT TCC 720
Lys Gly Gln Asn Gly Ile Ala Ile Thr Ser Met Asp Asp Phe Asn Ser
1110 1115 1120
CAT CCG ATT ACA TTA AAT AAA AAA CAA GTA GAT AAT CTG CTA AAT AAT 768
His Pro Ile Thr Leu Asn Lys Lys Gln Val Asp Asn Leu Leu Asn Asn
1125 1130 1135 1140
AAA CCT ATG ATG TTG GAA ACA AAC CAA ACA GAT GGT GTT TAT AAG ATA 816
Lys Pro Met Met Leu Glu Thr Asn Gln Thr Asp Gly Val Tyr Lys Ile
1145 1150 1155
AAA GAT ACA CAT GGA AAT ATA GTA ACT GGC GGA GAA TGG AAT GGT GTC 864
Lys Asp Thr His Gly Asn Ile Val Thr Gly Gly Glu Trp Asn Gly Val
1160 1165 1170
ATA CAA CAA ATC AAG GCT AAA ACA GCG TCT ATT ATT GTG GAT GAT GGG 912
Ile Gln Gln Ile Lys Ala Lys Thr Ala Ser Ile Ile Val Asp Asp Gly
WO 96/10083 2 19904 9 PCT/EP95/03826
-126-
1175 1180 1185
GAA CGT GTA GCA GAA AAA CGT GTA GCG GCA AAA GAT TAT GAA AAT CCA 960
Glu Arg Val Ala Glu Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn Pro
1190 1195 1200
GAA GAT AAA ACA CCG TCT TTA ACT TTA AAA GAT GCC CTG AAG CTT TCA 1008
Glu Asp Lys Thr Pro Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu Ser
1205 1210 1215 1220
TAT CCA GAT GAA ATA AAA GAA ATA GAG GGA TTA TTA TAT TAT AAA AAC 1056
Tyr Pro Asp Glu Ile Lys Glu Ile Glu Gly Leu Leu Tyr Tyr Lys Asn
1225 1230 1235
AAA CCG ATA TAC GAA TCG AGC GTT ATG ACT TAC TTA GAT GAA AAT ACA 1104
Lys Pro Ile Tyr Glu Ser Ser Val Met Thr Tyr Leu Asp Glu Asn Thr
1240 1245 1250
GCA AAA GAA GTG ACC AAA CAA TTA AAT GAT ACC ACT GGG AAA TTT AAA 1152
Ala Lys Glu Val Thr Lys Gln Leu Asn Asp Thr Thr Gly Lys Phe Lys
1255 1260 1265
GAT GTA AGT CAT TTA TAT GAT GTA AAA CTG ACT CCA AAA ATG AAT GTT 1200
Asp Val Ser His Leu Tyr Asp Val Lys Leu Thr Pro Lys Met Asn Val
1270 1275 1280
ACA ATC AAA TTG TCT ATA CTT TAT GAT AAT GCT GAG TCT AAT GAT AAC 1248
Thr Ile Lys Leu Ser Ile Leu Tyr Asp Asn Ala Glu Ser Asn Asp Asn
1285 1290 1295 1300
TCA ATT GGT AAA TGG ACA AAC ACA AAT ATT GTT TCA GGT GGA AAT AAC 1296
Ser Ile Gly Lys Trp Thr Asn Thr Asn Ile Val Ser Gly Gly Asn Asn
1305 1310 1315
GGA AAA AAA CAA TAT TCT TCT AAT AAT CCG GAT GCT AAT TTG ACA TTA 1344
Gly Lys Lys Gln Tyr Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr Leu
1320 1325 1330
AAT ACA GAT GCT CAA GAA AAA TTA AAT AAA AAT CGT GAC TAT TAT ATA 1392
Asn Thr Asp Ala Gln Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr Ile
1335 1340 1345
AGT TTA TAT ATG AAG TCA GAA AAA AAC ACA CAA TGT GAG ATT ACT ATA 1440
Ser Leu Tyr Met Lys Ser Glu Lys Asn Thr Gln Cys Glu Ile Thr Ile
1350 1355 1360
GAT GGG GAG ATT TAT CCG ATC ACT ACA AAA ACA GTG AAT GTG AAT AAA 1488
Asp Gly Glu Ile Tyr Pro Ile Thr Thr Lys Thr Val Asn Val Asn Lys
1365 1370 1375 1380
GAC AAT TAC AAA AGA TTA GAT ATT ATA GCT CAT AAT ATA AAA AGT AAT 1536
Asp Asn Tyr Lys Arg Leu Asp Ile Ile Ala His Asn Ile Lys Ser Asn
1385 1390 1395
CCA ATT TCT TCA CTT CAT ATT AAA ACG AAT GAT GAA ATA ACT TTA TTT 1584
WO 96/10083 2 1 9 9 0 4 9- PCT/EP95/03826
-127-
Pro Ile Ser Ser Leu His Ile Lys Thr Asn Asp Glu Ile Thr Leu Phe
1400 1405 1410
TGG GAT GAT ATT TCT ATA ACA GAT GTA GCA TCA ATA AAA CCG GAA AAT 1632
Trp Asp Asp Ile Ser Ile Thr Asp Val Ala Ser Ile Lys Pro Glu Asn
1415 1420 1425
TTA ACA GAT TCA GAA ATT AAA CAG ATT TAT AGT AGG TAT GGT ATT AAG 1680
Leu Thr Asp Ser Glu Ile Lys Gln Ile Tyr Ser Arg Tyr Gly Ile Lys
1430 1435 1440
TTA GAA GAT GGA ATC CTT ATT GAT AAA AAA GGT GGG ATT CAT TAT GGT 1728
Leu Glu Asp Gly Ile Leu Ile Asp Lys Lys Gly Gly Ile His Tyr Gly
1445 1450 1455 1460
GAA TTT ATT AAT GAA GCT AGT TTT AAT ATT GAA CCA TTG CCA AAT TAT 1776
Glu Phe Ile Asn Glu Ala Ser Phe Asn Ile Glu Pro Leu Pro Asn Tyr
1465 1470 1475
GTG ACC AAA TAT GAA GTT ACT TAT AGT AGT GAG TTA GGA CCA AAC GTG 1824
Val Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly Pro Asn Val
1480 1485 1490
AGT GAC ACA CTT GAA AGT GAT AAA ATT TAC AAG GAT GGG ACA ATT AAA 1872
Ser Asp Thr Leu Glu Ser Asp Lys Ile Tyr Lys Asp Gly Thr Ile Lys
1495 1500 1505
TTT GAT TTT ACC AAA TAT AGT AAA AAT GAA CAA GGA TTA TTT TAT GAC 1920
Phe Asp Phe Thr Lys Tyr Ser Lys Asn Glu Gln Gly Leu Phe Tyr Asp
1510 1515 1520
AGT GGA TTA AAT TGG GAC TTT AAA ATT AAT GCT ATT ACT TAT GAT GGT 1968
Ser Gly Leu Asn Trp Asp Phe Lys Ile Asn Ala Ile Thr Tyr Asp Gly
1525 1530 1535 1540
AAA GAG ATG AAT GTT TTT CAT AGA TAT AAT AAA TAG 2004
Lys Glu Met Asn Val Phe His Arg Tyr Asn Lys
1545 1550
(2) INFORMATION FOR SEQ ID NO:7:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 667 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:
Met Lys Arg Glu Ile Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser Ile
1 5 10 15
Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr Ile Gln Asn Arg Ile Ala
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
-128-
20 25 30
Val Lys Trp Asp Asp Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe Val
35 40 45
Ser Asn Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr
50 55 60
Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe
65 70 75 80
Asn Pro Leu Val Ala Ala Phe Pro Ser Val Asn Val Ser Met Glu Lys
85 90 95
Val Ile Leu Ser Pro Asn Glu Asn Leu Ser Asn Ser Val Glu Ser His
100 105 110
Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu
115 120 125
Ala Gly Ile Gly Pro Lys Gly Ile Ser Phe Gly Val Ser Val Asn Tyr
130 135 140
Gln His Ser Glu Thr Val Ala Gln Glu Trp Gly Thr Ser Thr Gly Asn
145 150 155 160
Thr Ser Gln Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn Val
165 170 175
Arg Tyr Asn Asn Val Gly Thr Gly Ala Ile Tyr Asp Val Lys Pro Thr
180 185 190
Thr Ser Phe Val Leu Asn Asn Asp Thr Ile Ala Thr Ile Thr Ala Lys
195 200 205
Ser Asn Ser Thr Ala Leu Asn Ile Ser Pro Gly Glu Ser Tyr Pro Lys
210 215 220
Lys Gly Gln Asn Gly Ile Ala Ile Thr Ser Met Asp Asp Phe Asn Ser
225 230 235 240
His Pro Ile Thr Leu Asn Lys Lys Gln Val Asp Asn Leu Leu Asn Asn
245 250 255
Lys Pro Met Met Leu Glu Thr Asn Gin Thr Asp Gly Val Tyr Lys Ile
260 265 270
Lys Asp Thr His Gly Asn Ile Val Thr Gly Gly Glu Trp Asn Gly Val
275 280 285
Ile Gln Gin Ile Lys Ala Lys Thr Ala Ser Ile Ile Val Asp Asp Gly
290 295 300
Glu Arg Val Ala Glu Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn Pro
305 310 315 320
WO 96/10083 -- 2 1 9 9 0 4 9 PCTIEP95/03826
-129-
Glu Asp Lys Thr Pro Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu Ser
325 330 335
Tyr Pro Asp Glu Ile Lys Glu Ile Glu Gly Leu Leu Tyr Tyr Lys Asn
340 345 350
Lys Pro Ile Tyr Glu Ser Ser Val Met Thr Tyr Leu Asp Glu Asn Thr
355 360 365
Ala Lys Glu Val Thr Lys Gln Leu Asn Asp Thr Thr Gly Lys Phe Lys
370 375 380
Asp Val Ser His Leu Tyr Asp Val Lys Leu Thr Pro Lys Met Asn Val
385 390 395 400
Thr Ile Lys Leu Ser Ile Leu Tyr Asp Asn Ala Glu Ser Asn Asp Asn
405 410 415
Ser Ile Gly Lys Trp Thr Asn Thr Asn Ile Val Ser Gly Gly Asn Asn
420 425 430
Gly Lys Lys Gln Tyr Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr Leu
435 440 445
Asn Thr Asp Ala Gln Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr Ile
450 455 460
Ser Leu Tyr Met Lys Ser Glu Lys Asn Thr Gln Cys Glu Ile Thr Ile
465 470 475 480
Asp Gly Glu Ile Tyr Pro Ile Thr Thr Lys Thr Val Asn Val Asn Lys
485 490 495
Asp Asn Tyr Lys Arg Leu Asp Ile Ile Ala His Asn Ile Lys Ser Asn
500 505 510
Pro Ile Ser Ser Leu His Ile Lys Thr Asn Asp Glu Ile Thr Leu Phe
515 520 525
Trp Asp Asp Ile Ser Ile Thr Asp Val Ala Ser Ile Lys Pro Glu Asn
530 535 540
Leu Thr Asp Ser Glu Ile Lys Gln Ile Tyr Ser Arg Tyr Gly Ile Lys
545 550 555 560
Leu Glu Asp Gly Ile Leu Ile Asp Lys Lys Gly Gly Ile His Tyr Gly
565 570 575
Glu Phe Ile Asn Glu Ala Ser Phe Asn Ile Glu Pro Leu Pro Asn Tyr
580 585 590
Val Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly Pro Asn Val
595 600 605
WO 96/10083 #P2 1 9 9 0 4 9 PC'r/EP95/03826
-130-
Ser Asp Thr Leu Glu Ser Asp Lys Ile Tyr Lys Asp Gly Thr Ile Lys
610 615 620
Phe Asp Phe Thr Lys Tyr Ser Lys Asn Glu Gln Gly Leu Phe Tyr Asp
625 630 635 640
Ser Gly Leu Asn Trp Asp Phe Lys Ile Asn Ala Ile Thr Tyr Asp Gly
645 650 655
Lys Glu Met Asn Val Phe His Arg Tyr Asn Lys
660 665
(2) INFORMATION FOR SEQ ID NO:8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 16 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(v) FRAGMENT TYPE: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus cereus
(B) STRAIN: AB78
(C) INDIVIDUAL ISOLATE: NRRL B-21058
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..16
(D) OTHER INFORMATION: /note= "N-terminal sequence of
protein purified from strain AB78"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:8:
Lys Arg Glu Ile Asp Glu Asp Thr Asp Thr Asx Gly Asp Ser Ile Pro
1 5 10 15
(2) INFORMATION FOR SEQ ID NO:9:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 21 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
WO 96/10083 2 1 9 9 4 4 9 PCT/E"5/03826
- 131 -
(iv) ANTI-SENSE: NO
(ix) FEATURE:
(A) NAME/KEY: misc_feature
(B) LOCATION: 1..21
(D) OTHER INFORMATION: /note= "Oligonucleotide probe based
on amino acids 3 to 9 of SEQ ID NO:8, using codon usage of
Bacillus thuringiensis"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:
GAAATTGATC AAGATACNGA T 21
(2) INFORMATION FOR SEQ ID NO:10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 14 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(v) FRAGMENT TYPE: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis
(B) STRAIN: AB88
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..14
(D) OTHER INFORMATION: /note= "N-terminal amino acid
sequence of protein known as anion exchange fraction 23
(smaller)"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:
Xaa Glu Pro Phe Val Ser Ala Xaa Xaa Xaa Gln Xaa Xaa Xaa
1 5 10
(2) INFORMATION FOR SEQ ID NO:11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 13 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: N-terminal
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-132-
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:
Xaa Glu Tyr Glu Asn Val Glu Pro Phe Val Ser Ala Xaa
1 5 10
(2) INFORMATION FOR SEQ ID NO:12:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 14 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thurigiensis
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:
Met Asn Lys Asn Asn Thr Lys Leu Pro Thr Arg Ala Leu Pro
1 5 10
(2) INFORMATION FOR SEQ ID NO:13:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 15 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(v) FRAGMENT TYPE: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis
(B) STRAIN: AB88
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..15
(D) OTHER INFORMATION: /note= "N-terminal amino acid
sequence of 35 kDa VIP active against Agrotis ipsilon"
WO 96/10083 PCT/EP95/03826
2199049
- 133-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:
Ala Leu Ser Glu Asn Thr Gly Lys Asp Gly Gly Tyr Ile Val Pro
1 5 10 15
(2) INFORMATION FOR SEQ ID NO:14:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 9 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:
Met Asp Asn Asn Pro Asn Ile Asn Glu
1 5
(2) INFORMATION FOR SEQ ID NO:15:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 9 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(v) FRAGMENT TYPE: N-terminal
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION : l..9
(D) OTHER INFORMATION: /note= "N-terminal sequence of 80
kDa delta-endotoxin"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:
Met Asp Asn Asn Pro Asn Ile Asn Glu
1 5
(2) INFORMATION FOR SEQ ID NO:16:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 11 amino acids
WO 96/10083 2 1 9 9 0 4 PGT/EP95/03826
r'- 9
-134-
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(v) FRAGMENT TYPE: N-terminal
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..11
(D) OTHER INFORMATION: /note= "N-terminal sequence from 60
kDa delta-endotoxin"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:
Met Asn Val Leu Asn Ser Gly Arg Thr Thr Ile
1 5 10
(2) INFORMATION FOR SEQ ID NO:17:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genocnic)
(iii) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 1..2_652
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence for 100 kd VIP1A(a) protein from AB78"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:
ATGAAGAACA TGAAGAAGAA GCTGGCCAGC GTGGTGACCT GCACCCTGCT GGCCCCCATG 60
TTCCTGAACG GCAACGTGAA CGCCGTGTAC GCCGACAGCA AGACCAACCA GATCAGCACC 120
ACCCAGAAGA ACCAGCAGAA GGAGATGGAC CGCAAGGGCC TGCTGGGCTA CTACTTCAAG 180
WO 96/10083 2 1 9 9 0 4 9 PGT/EP95/03826
-135-
GGCAAGGACT TCAGCAACCT GACCATGTTC GCCCCCACGC GTGACAGCAC CCTGATCTAC 240
GACCAGCAGA CCGCCAACAA GCTGCTGGAC AAGAAGCAGC AGGAGTACCA GAGCATCCGC 300
TGGATCGGCC TGATCCAGAG CAAGGAGACC GGCGACTTCA CCTTCAACCT GAGCGAGGAC 360
GAGCAGGCCA TCATCGAGAT CAACGGCAAG ATCATCAGCA ACAAGGGCAA GGAGAAGCAG 420
GTTGGGCACC TGGAGAAGGG CAAGCTGGTG CCCATCAAGA TCGAGTACCA GAGCGACACC 480
AAGTTCAACA TCGACAGCAA GACCTTCAAG GAGCTGAAGC TTTTCAAGAT CGACAGCCAG 540
AACCAGCCCC AGCAGGTGCA GCAGGACGAG CTGCGCAACC CCGAGTTCAA CAAGAAGGAG 600
AGCCAGGAGT TCCTGGCCAA GCCCAGCAAG ATCAACCTGT TCACCCAGCA GATGAAGCGC 660
GAGATCGACG AGGACACCGA CACCGACGGC GACAGCATCC CCGACCTGTG GGAGGAGGAC 720
GGCTACACCA TCCAGAACCG CATCGCCGTG AAGTGGGACG ACAGCCTGGC TAGCAAGGGC 780
TACACCAAGT TCGTGAGCAA CCCCCTGGAG AGCCACACCG TGGGCGACCC CTACACCGAC 840
TACGAGAAGG CCGCCCGCGA CCTGGACCTG AGCAACGCCA AGGAGACCTT CAACCCCCTG 900
GTGGCCGCCT TCCCCAGCGT GAGCGTGAGC ATGGAGAAGG TGATCCTGAG CCCCAACGAG 960
AACCTGAGCA ACAGCGTGGA GAGCCACTCG AGCACCAACT GGAGCTACAC CAACACCGAG 1020
GGCGCCAGCG TGGAGGCCGG CATCGGTCCC AAGGGCATCA GCTTCGGCGT GAGCGTGAAC 1080
TACCAGCACA GCGAGACCGT GGCCCAGGAG TGGGGCACCA GCACCGGCAA CACCAGCCAG 1140
TTCAACACCG CCAGCGCCGG CTACCTGAAC GCCAACGTGC GCTACAACAA CGTGGGCACC 1200
GGCGCCATCT ACGACGTGAA GCCCACCACC AGCTTCGTGC TGAACAACGA CACCATCGCC 1260
ACCATCACCG CCAAGTCGAA TTCCACCGCC CTGAACATCA GCCCCGGCGA GAGCTACCCC 1320
AAGAAGGGCC AGAACGGCAT CGCCATCACC AGCATGGACG ACTTCAACAG CCACCCCATC 1380
ACCCTGAACA AGAAGCAGGT GGACAACCTG CTGAACAACA AGCCCATGAT GCTGGAGACC 1440
AACCAGACCG ACGGCGTCTA CAAGATCAAG GACACCCACG GCAACATCGT GACCGGCGGC 1500
GAGTGGAACG GCGTGATCCA GCAGATCAAG GCCAAGACCG CCAGCATCAT CGTCGACGAC 1560
GGCGAGCGCG TGGCCGAGAA GCGCGTGGCC GCCAAGGACT ACGAGAACCC CGAGGACAAG 1620
ACCCCCAGCC TGACCCTGAA GGACGCCCTG AAGCTGAGCT ACCCCGACGA GATCAAGGAG 1680
ATCGAGGGCC TGCTGTACTA CAAGAACAAG CCCATCTACG AGAGCAGCGT GATGACCTAT 1740
CTAGACGAGA ACACCGCCAA GGAGGTGACC AAGCAGCTGA ACGACACCAC CGGCAAGTTC 1800
AAGGACGTGA GCCACCTGTA CGACGTGAAG CTGACCCCCA AGATGAACGT GACCATCAAG 1860
WO 96/10083 9 0 4 PCT/EP95/03826
2 1 9 9
!~ -136-
CTGAGCATCC TGTACGACAA CGCCGAGAGC AACGACAACA GCATCGGCAA GTGGACCAAC 1920
ACCAACATCG TGAGCGGCGG CAACAACGGC AAGAAGCAGT ACAGCAGCAA CAACCCCGAC 1980
GCCAACCTGA CCCTGAACAC CGACGCCCAG GAGAAGCTGA ACAAGAACCG CGACTACTAC 2040
ATCAGCCTGT ACATGAAGAG CGAGAAGAAC ACCCAGTGCG AGATCACCAT CGACGGCGAG 2100
ATATACCCCA TCACCACCAA GACCGTGAAC GTGAACAAGG ACAACTACAA GCGCCTGGAC 2160
ATCATCGCCC ACAACATCAA GAGCAACCCC ATCAGCAGCC TGCACATCAA GACCAACGAC 2220
GAGATCACCC TGTTCTGGGA CGACATATCG ATTACCGACG TCGCCAGCAT CAAGCCCGAG 2280
AACCTGACCG ACAGCGAGAT CAAGCAGATA TACAGTCGCT ACGGCATCAA GCTGGAGGAC 2340
GGCATCCTGA TCGACAAGAA GGGCGGCATC CACTACGGCG AGTTCATCAA CGAGGCCAGC 2400
TTCAACATCG AGCCCCTGCA GAACTACGTG ACCAAGTACG AGGTGACCTA CAGCAGCGAG 2460
CTGGGCCCCA ACGTGAGCGA CACCCTGGAG AGCGACAAGA TTTACAAGGA CGGCACCATC 2520
AAGTTCGACT TCACCAAGTA CAGCAAGAAC GAGCAGGGCC TGTTCTACGA CAGCGGCCTG 2580
AACTGGGACT TCAAGATCAA CGCCATCACC TACGACGGCA AGGAGATGAA CGTGTTCCAC 2640
CGCTACAACA AGTAG 2655
(2) INFORMATION FOR SEQ ID NO:18:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2004 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 1..2004
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence for VIP1A(a) 80 kd protein from AB78"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:
ATGAAGCGCG AGATCGACGA GGACACCGAC ACCGACGGCG ACAGCATCCC CGACCTGTGG 60
WO 96/10083 2 1 9 9 0 14 % PCT/EP95/03826
-137-
GAGGAGAACG GCTACACCAT CCAGAACCGC ATCGCCGTGA AGTGGGACGA CAGCCTGGCT 120
AGCAAGGGCT ACACCAAGTT CGTGAGCAAC CCCCTGGAGA GCCACACCGT GGGCGACCCC 180
TACACCGACT ACGAGAAGGC CGCCCGCGAC CTGGACCTGA GCAACGCCAA GGAGACCTTC 240
AACCCCCTGG TGGCCGCCTT CCCCAGCGTG AACGTGAGCA TGGAGAAGGT GATCCTGAGC 300
CCCAACGAGA ACCTGAGCAA CAGCGTGGAG AGCCACTCGA GCACCAACTG GAGCTACACC 360
AACACCGAGG GCGCCAGCGT GGAGGCCGGC ATCGGTCCCA AGGGCATCAG CTTCGGCGTG 420
AGCGTGAACT ACCAGCACAG CAAGACCGTG GCCCAGGAGT GGGGCACCAG CACCGGCAAC 480
ACCAGCCAGT TCAACACCGC CAGCGCCGGC TACCTGAACGCCAACGTGCG CTACAACAAC 540
GTGGGCACCG GCGCCATCTA CGACGTGAAG CCCACCACCA GCTTCGTGCT GAACAACGAC 600
ACCATCGCCA CCATCACCGC CAAGTCGAAT TCCACCGCCC TGAACATCAG CCCCGGCGAG 660
AGCTACCCCA AGAAGGGCCA GAACGGCATC GCCATCACCA GCATGGACGA CTTCAACAGC 720
CACCCCATCA CCCTGAACAA GAAGCAGGTG GACAACCTGC TGAACAACAA GCCCATGATG 780
CTGGAGACCA ACCAGACCGA CGGCGTCTAC AAGATCAAGG ACACCCACGG CAACATCGTG 840
ACCGGCGGCG AGTGGAACGG CGTGATCCAG CAGATCAAGG CCAAGACCGC CAGCATCATC 900
GTCGACGACG GCGAGCGCGT GGCCGAGAAG CGCGTGGCCG CCAAGGACTA CGAGAACCCC 960
GAGGACAAGA CCCCCAGCCT GACCCTGAAG GACGCCCAGA AGCTGAGCTA CCCCGACGAG 1020
ATCAAGGAGA TCGAGGGCCT GCTGTACTAC AAGAACAAGC CCATCTACGA GAGCAGCGTG 1080
ATGACCTATC TAGACGAGAA CACCGCCAAG GAGGTGACCA AGCAGCTGAA CGACACCACC 1140
GGCAAGT TCA AGGACGTGAG CCACCTGTAC GACGTGAAGC TGACCCCCAA GATGAACGTG 1200
ACCATCAAGC TGAGCATCCT GTACGACAAC GCCGAGAGCA ACGACAACAG CATCGGCAAG 1260
TGGACCAACA CCAACATCGT GAGCGGCGGC AACAACGGCA AGAAGCAGTA CAGCAGCAAC 1320
AACCCCGACG CCAACCTGAC CCTGAACACC GACGCCCAGG AGAAGCTGAA CAAGAACCGC 1380
GACTACTACA TCAGCCTGTA CATGAAGAGC GAGAAGAACA CCCAGTGCGA GATCACCATC 1440
GACGGCGAGA TATACCCCAT CACCACCAAG ACCGTGAACG TGAACAAGGA CAACTACAAG 1500
CGCCTGGACA TCATCGCCCA CAACATCAAG AGCAACCCCA TCAGCAGCCT GCACATCAAG 1560
ACCAACGACG AGATCACCCT GTTCTGGGAC GACATATCGA TTACCGACGT CGCCAGCATC 1620
AAGCCCGAGA ACCTGACCGA CAGCGAGATC AAGCAGATAT ACAGTCGCTA CGGCATCAAG 1680
CTGGAGGACG GCATCCTGAT CGACAAGAAG GGCGGCATCC ACTACGGCGA GTTCATCAAC 1740
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 138 -
GAGGCCAGCT TCAACATCGA GCCCCTGCAG AACTACGTGA CCAAGTACGA GGTGACCTAC 1800
AGCAGCGAGC TGGGCCCCAA CGTGAGCGAC ACCCTGGAGA GCGACAAGAT TTACAAGGAC 1860
GGCACCATCA AGTTCGACTT CACCAAGTAC AGCAAGAACG AGCAGGGCCT GTTCTACGAC 1920
AGCGGCCTGA ACTGGGACTT CAAGATCAAC GCCATCACCT ACGACGGCAA GGAGATGAAC 1980
GTGTTCCACC GCTACAACAA GTAG 2004
(2) INFORMATION FOR SEQ ID NO:19:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 4074 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1..1386
(D) OTHER INFORMATION: /product= "VIP2A(b) from Btt"
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1394..3895
(D) OTHER INFORMATION: /product= "VIPlA(b) from Btt"
(ix) FEATURE:
(A) NAME/KEY: misc_feature
(B) LOCATION : 1..4074
(D) OTHER INFORMATION: /note= "Cloned DNA sequence from
Btt which contains the genes for both VIP1A(b) and VIP2A(b)"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:
ATG CAA AGA ATG GAG GGA AAG TTG TTT GTG GTG TCA AAA ACA TTA CAA 48
Met Gln Arg Met Glu Gly Lys Leu Phe Val Val Ser Lys Thr Leu Gln
670 675 680
GTA GTT ACT AGA ACT GTA TTG CTT AGT ACA GTT TAC TCT ATA ACT TTA 96
Val Val Thr Arg Thr Val Leu Leu Ser Thr Val Tyr Ser Ile Thr Leu
685 690 695
TTA AAT AAT GTA GTG ATA AAA GCT GAC CAA TTA AAT ATA AAT TCT CAA 144
Leu Asn Asn Val Val Ile Lys Ala Asp Gln Leu Asn Ile Asn Ser Gln
700 705 710 715
AGT AAA TAT ACT AAC TTG CAA AAT CTA AAA ATC CCT GAT AAT GCA GAG 192
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Pro Asp Asn Ala Glu
WO 96/10083 1 9 9 04 9
PGT/EP95/03826
-139-
720 725 730
GAT TTT AAA GAA GAT AAG GGG AAA GCG AAA GAA TGG GGG AAA GAG AAA 240
Asp Phe Lys Glu Asp Lys Gly Lys Ala Lys Glu Trp Gly Lys Glu Lys
735 740 745
GGG GAA GAG TGG AGG CCT CCT GCT ACT GAG AAA GGA GAA ATG AAT AAT 288
Gly Glu Glu Trp Arg Pro Pro Ala Thr Glu Lys Giy Glu Met Asn Asn
750 755 760
TTT TTA GAT AAT AAA AAT GAT ATA AAG ACC AAT TAT AAA GAA ATT ACT 336
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
765 770 775
TTT TCT ATG GCA GGT TCA TGT GAA GAT GAA ATA'AAA GAT TTA GAA GAA 384
Phe Ser Met Ala Gly Ser Cys Glu Asp Glu Ile Lys Asp Leu Glu Glu
780 785 790 795
ATT GAT AAG ATC TTT GAT AAA GCC AAT CTC TCG AGT TCT ATT ATC ACC 432
Ile Asp Lys Ile Phe Asp Lys Ala Asn Leu Ser Ser Ser Ile Ile Thr
800 805 810
TAT AAA AAT GTG GAA CCA GCA ACA ATT GGA TTT AAT AAA TCT TTA ACA 480
Tyr Lys Asn Val Glu Pro Ala Thr Ile Gly Phe Asn Lys Ser Leu Thr
815 820 825
GAA GGT AAT ACG ATT AAT TCT GAT GCA ATG GCA CAG TTT AAA GAA CAA 528
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gin
830 835 840
TTT TTA GGT AAG GAT ATG AAG TTT GAT AGT TAT CTA GAT ACT CAT TTA 576
Phe Leu Gly Lys Asp Met Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
845 850 855
ACT GCT CAA CAA GTT TCC AGT AAA AAA AGA GTT ATT TTG AAG GTT ACG 624
Thr Ala Gln Gln Val Ser Ser Lys Lys Arg Val Ile Leu Lys Val Thr
860 865 870 875
GTT CCG AGT GGG AAA GGT TCT ACT ACT CCA ACA AAA GCA GGT GTC ATT 672
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
880 885 890
TTA AAC AAT AAT GAA TAC AAA ATG CTC ATT GAT AAT GGG TAT GTG CTC 720
Leu Asn Asn Asn Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Val Leu
895 900 905
CAT GTA GAT AAG GTA TCA AAA GTA GTA AAA AAA GGG ATG GAG TGC TTA 768
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Met Glu Cys Leu
910 915 920
CAA GTT GAA GGG ACT TTA AAA AAG AGT CTC GAC TTT AAA AAT GAT ATA 816
Gln Val Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
925 930 935
AAT GCT GAA GCG CAT AGC TGG GGG ATG AAA ATT TAT GAA GAC TGG GCT 864
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
-140-
Asn Ala Glu Ala His Ser Trp Gly Met Lys Ile Tyr Glu Asp Trp Ala
940 945 950 955
AAA AAT TTA ACC GCT TCG CAA AGG GAA GCT TTA GAT GGG TAT GCT AGG 912
Lys Asn Leu Thr Ala Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
960 965 970
CAA GAT TAT AAA GAA ATC AAT AAT TAT TTG CGC AAT CAA GGC GGG AGT 960
Gin Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
975 980 985
GGA AAT GAA AAG CTG GAT GCC CAA TTA AAA AAT ATT TCT GAT GCT TTA 1008
Gly Asn Glu Lys Leu Asp Ala Gln Leu Lys Asn Ile Ser Asp Ala Leu
990 995 1000
GGG AAG AAA CCC ATA CCA GAA AAT ATT ACC GTG TAT AGA TGG TGT GGC 1056
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
1005 1010 1015
ATG CCG GAA TTT GGT TAT CAA ATT AGT GAT CCG TTA CCT TCT TTA AAA 1104
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
1020 1025 1030 1035
GAT TTT GAA GAA CAA TTT TTA AAT ACA ATT AAA GAA GAC AAA GGG TAT 1152
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
1040 1045 1050
ATG AGT ACA AGC TTA TCG AGT GAA CGT CTT GCA GCT TTT GGA TCT AGA 1200
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
1055 1060 1065
AAA ATT ATA TTA CGC TTA CAA GTT CCG AAA GGA AGT ACG GGG GCG TAT 1248
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
1070 1075 1080
TTA AGT GCC ATT GGT GGA TTT GCA AGT GAA AAA GAG ATC CTA CTT GAT 1296
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
1085 1090 1095
AAA GAT AGT AAA TAT CAT ATT GAT AAA GCA ACA GAG GTA ATC ATT AAA 1344
Lys Asp Ser Lys Tyr His Ile Asp Lys Ala Thr Glu Val Ile Ile Lys
1100 1105 1110 1115
GGT GTT AAG CGA TAT GTA GTG GAT GCA ACA TTA TTA ACA AAT 1386
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
1120 1125
TAAGGAG ATG AAA AAT ATG AAG AAA AAG TTA GCA AGT GTT GTA ACC TGT 1435
Met Lys Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys
1 5 10
ATG TTA TTA GCT CCT ATG TTT TTG AAT GGA AAT GTG AAT GCT GTT AAC 1483
Met Leu Leu Ala Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Asn
15 20 25 30
WO 96/10083 2 1 9 9 0 4 9 PCT/E"5/03826
- 141 -
GCG GAT AGT AAA ATA AAT CAG ATT TCT ACA ACG CAG GAA AAC CAA CAG 1531
Ala Asp Ser Lys Ile Asn Gln Ile Ser Thr Thr Gln Glu Asn Gln Gln
35 40 45
AAA GAG ATG GAC CGA AAG GGA TTA TTG GGA TAT TAT TTC AAA GGA AAA 1579
Lys Glu Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys
50 55 60
GAT TTT AAT AAT CTT ACT ATG TTT GCA CCG ACA CGT GAT AAT ACC CTT 1627
Asp Phe Asn Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Asn Thr Leu
65 70 75
ATG TAT GAC CAA CAA ACA GCG AAT GCA TTA TTA GAT AAA AAA CAA CAA 1675
Met Tyr Asp Gin Gln Thr Ala Asn Ala Leu Leu Asp Lys Lys Gln Gln
80 85 90
GAA TAT CAG TCC ATT CGT TGG ATT GGT TTG ATT CAG CGT AAA GAA ACG 1723
Glu Tyr Gln Ser Ile Arg Trp Ile Gly Leu Ile Gin Arg Lys Glu Thr
95 100 105 110
GGC GAT TTC ACA TTT AAC TTA TCA AAG GAT GAA CAG GCA ATT ATA GAA 1771
Gly Asp Phe Thr Phe Asn Leu Ser Lys Asp Giu Gln Ala Ile Ile Glu
115 120 125
ATC GAT GGG AAA ATC ATT TCT AAT AAA GGG AAA GAA AAG CAA GTT GTC 1819
Ile Asp Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val
130 135 140
CAT TTA GAA AAA GAA AAA TTA GTT CCA ATC AAA ATA GAG TAT CAA TCA 1867
His Leu Glu Lys Glu Lys Leu Val Pro Ile Lys Ile Glu Tyr Gin Ser
145 150 155
GAT ACG AAA TTT AAT ATT GAT AGT AAA ACA TTT AAA GAA CTT AAA TTA 1915
Asp Thr Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu
160 165 170
TTT AAA ATA GAT AGT CAA AAC CAA TCT CAA CAA GTT CAA CTG AGA AAC 1963
Phe Lys Ile Asp Ser Gln Asn Gln Ser Gln Gln Val Gin Leu Arg Asn
175 18.0 185 190
CCT GAA TTT AAC AAA AAA GAA TCA CAG GAA TTT TTA GCA AAA GCA TCA 2011
Pro Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Ala Ser
195 200 205
AAA ACA AAC CTT TTT AAG CAA AAA ATG AAA AGA GAT ATT GAT GAA GAT 2059
Lys Thr Asn Leu Phe Lys Gln Lys Met Lys Arg Asp Ile Asp Glu Asp
210 215 220
ACG GAT ACA GAT GGA GAC TCC ATT CCT GAT CTT TGG GAA GAA AAT GGG 2107
Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly
225 230 235
TAC ACG ATT CAA AAT AAA GTT GCT GTC AAA TGG GAT GAT TCG CTA GCA 2155
Tyr Thr Ile Gln Asn Lys Val Ala Val Lys Trp Asp Asp Ser Leu Ala
240 245 250
WO 96/10083 U 4 .7
PCT/EP95/03826
-142-
AGT AAG GGA TAT ACA AAA TTT GTT TCG AAT CCA TTA GAC AGC CAC ACA 2203
Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Asp Ser His Thr
255 260 265 270
GTT GGC GAT CCC TAT ACT GAT TAT GAA AAG GCC GCA AGG GAT TTA GAT 2251
Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp
275 280 285
TTA TCA AAT GCA AAG GAA ACG TTC AAC CCA TTG GTA GCT GCT TTT CCA 2299
Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro
290 295 300
AGT GTG AAT GTT AGT ATG GAA AAG GTG ATA TTA TCA CCA AAT GAA AAT 2347
Ser Val Asn Val Ser Met Glu Lys Val Ile Leu-Ser Pro Asn Glu Asn
305 310 315
TTA TCC AAT AGT GTA GAG TCT CAT TCA TCC ACG AAT TGG TCT TAT ACG 2395
Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr
320 325 330
AAT ACA GAA GGA GCT TCC ATT GAA GCT GGT GGC GGT CCA TTA GGC CTT 2443
Asn Thr Glu Gly Ala Ser Ile Glu Ala Gly Gly Gly Pro Leu Gly Leu
335 340 345 350
TCT TTT GGC GTG AGT GTT ACT TAT CAA CAC TCT GAA ACA GTT GCA CAA 2491
Ser Phe Gly Val Ser Val Thr Tyr Gln His Ser Glu Thr Val Ala Gln
355 360 365
GAA TGG GGA ACA TCT ACA GGA AAT ACT TCA CAA TTC AAT ACG GCT TCA 2539
Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala Ser
370 375 380
GCG GGA TAT TTA AAT GCA AAT GTT CGG TAT AAC AAT GTA GGG ACT GGT 2587
Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly
385 390 395
GCC ATC TAT GAT GTA AAA CCT ACA ACA AGT TTT GTA TTA AAT AAC AAT 2635
Ala Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn Asn
400 405 410
ACC ATC GCA ACG ATT ACA GCA AAA TCA AAT TCA ACA GCT TTA CGT ATA 2683
Thr Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Arg Ile
415 420 425 430
TCT CCG GGG GAT AGT TAT CCA GAA ATA GGA GAA AAC GCT ATT GCG ATT 2731
Ser Pro Gly Asp Ser Tyr Pro Glu Ile Gly Glu Asn Ala Ile Ala Ile
435 440 445
ACA TCT ATG GAT GAT TTT AAT TCT CAT CCA ATT ACA TTA AAT AAA CAA 2779
Thr Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys Gln
450 455 460
CAG GTA AAT CAA TTG ATA AAT AAT AAG CCA ATT ATG CTA GAG ACA GAC 2827
Gln Val Asn Gln Leu Ile Asn Asn Lys Pro Ile Met Leu Glu Thr Asp
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-143-
465 470 475
CAA ACA GAT GGT GTT TAT AAA ATA AGA GAT ACA CAT GGA AAT ATT GTA 2875
Gln Thr Asp Gly Val Tyr Lys Ile Arg Asp Thr His Gly Asn Ile Val
480 485 490
ACT GGT GGA GAA TGG AAT GGT GTA ACA CAA CAA ATT AAA GCA AAA ACA 2923
Thr Gly Gly Glu Trp Asn Gly Val Thr Gln Gln Ile Lys Ala Lys Thr
495 500 505 510
GCG TCT ATT ATT GTG GAT GAC GGG AAA CAG GTA GCA GAA AAA CGT GTG 2971
Ala Ser Ile Ile Val Asp Asp Gly Lys Gln Val Ala Glu Lys Arg Val
515 520 525
GCG GCA AAA GAT TAT GGT CAT CCA GAA GAT AAA'ACA CCA CCT TTA ACT 3019
Ala Ala Lys Asp Tyr Gly His Pro Glu Asp Lys Thr Pro Pro Leu Thr
530 535 540
TTA AAA GAT ACC CTG AAG CTT TCA TAC CCA GAT GAA ATA AAA GAA ACT 3067
Leu Lys Asp Thr Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu Thr
545 550 555
AAT GGA TTG TTG TAC TAT GAT GAC AAA CCA ATC TAT GAA TCG AGT GTC 3115
Asn Gly Leu Leu Tyr Tyr Asp Asp Lys Pro Ile Tyr Glu Ser Ser Val
560 565 570
ATG ACT TAT CTG GAT GAA AAT ACG GCA AAA GAA GTC AAA AAA CAA ATA 3163
Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Lys Lys Gln Ile
575 580 585 590
AAT GAT ACA ACC GGA AAA TTT AAG GAT GTA AAT CAC TTA TAT GAT GTA 3211
Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Asn His Leu Tyr Asp Val
595 600 605
AAA CTG ACT CCA AAA ATG AAT TTT ACG ATT AAA ATG GCT TCC TTG TAT 3259
Lys Leu Thr Pro Lys Met Asn Phe Thr Ile Lys Met Ala Ser Leu Tyr
610 615 620
GAT GGG GCT GAA AAT AAT CAT AAC TCT TTA GGA ACC TGG TAT TTA ACA 3307
Asp Gly Ala Glu Asn Asn His Asn Ser Leu Gly Thr Trp Tyr Leu Thr
625 630 635
TAT AAT GTT GCT GGT GGA AAT ACT GGG AAG AGA CAA TAT CGT TCA GCT 3355
Tyr Asn Val Ala Gly Gly Asn Thr Gly Lys Arg Gln Tyr Arg Ser Ala
640 645 650
CAT TCT TGT GCA CAT GTA GCT CTA TCT TCA GAA GCG AAA AAG AAA CTA 3403
His Ser Cys Ala His Val Ala Leu Ser Ser Glu Ala Lys Lys Lys Leu
655 660 665 670
AAT CAA AAT GCG AAT TAC TAT CTT AGC ATG TAT ATG AAG GCT GAT TCT 3451
Asn Gln Asn Ala Asn Tyr Tyr Leu Ser Met Tyr Met Lys Ala Asp Ser
675 680 685
ACT ACG GAA CCT ACA ATA GAA GTA GCT GGG GAA AAA TCT GCA ATA ACA 3499
WO 96/10083 x 2 1 9 9 0 4 9 PCT/EP95/03826
-144-
Thr Thr Glu Pro Thr Ile Glu Val Ala Gly Glu Lys Ser Ala Ile Thr
690 695 700
AGT AAA AAA GTA AAA TTA AAT AAT CAA AAT TAT CAA AGA GTT GAT ATT 3547
Ser Lys Lys Val Lys Leu Asn Asn Gln Asn Tyr Gln Arg Val Asp Ile
705 710 715
TTA GTG AAA AAT TCT GAA AGA AAT CCA ATG GAT AAA ATA TAT ATA AGA 3595
Leu Val Lys Asn Ser Glu Arg Asn Pro Met Asp Lys Ile Tyr Ile Arg
720 725 730
GGA AAT GGC ACG ACA AAT GTT TAT GGG GAT GAT GTT ACT ATC CCA GAG 3643
Gly Asn Gly Thr Thr Asn Val Tyr Gly Asp Asp Val Thr Ile Pro Glu
735 740 745 750
GTA TCA GCT ATA AAT CCG GCT AGT CTA TCA GAT GAA GAA ATT CAA GAA 3691
Val Ser Ala Ile Asn Pro Ala Ser Leu Ser Asp Glu Glu Ile Gln Glu
755 760 765
ATA TTT AAA GAC TCA ACT ATT GAA TAT GGA AAT CCT AGT TTC GTT GCT 3739
Ile Phe Lys Asp Ser Thr Ile Glu Tyr Gly Asn Pro Ser Phe Val Ala
770 775 780
GAT GCC GTA ACA TTT AAA AAT ATA AAA CCT TTA CAA AAT TAT GTA AAG 3787
Asp Ala Val Thr Phe Lys Asn Ile Lys Pro Leu Gln Asn Tyr Val Lys
785 790 795
GAA TAT GAA ATA TAT CAT AAA TCT CAT CGA TAT GAA AAG AAA ACG GTC 3835
Glu Tyr Glu Ile Tyr His Lys Ser His Arg Tyr Glu Lys Lys Thr Val
800 805 810
TTT GAT ATC ATG GGT GTT CAT TAT GAG TAT AGT ATA GCT AGG GAA CAA 3883
Phe Asp Ile Met Gly Val His Tyr Glu Tyr Ser Ile Ala Arg Glu Gln
815 820 825 830
AAG AAA GCC GCA TAATTTTAAA AATAAAACTC GTTAGAGTTT ATTTAGCATG 3935
Lys Lys Ala Ala
GTATTTTTAA GAATAATCAA TATGTTGAAC CGTTTGTAGC TGTTTTGGAA GGGAATTTCA 3995
TTTTATTTGG TCTCTTAAGT TGATGGGCAT GGGATATGTT CAGCATCCAA GCGTTTNGGG 4055
GGTTANAAAA TCCAATTTT 4074
(2) INFORMATION FOR SEQ ID NO:20:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 462 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
WO 96/10083
1 9 9 n 4 PCT/EP95/03826
2 9
-145-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:
Met Gln Arg Met Glu Gly Lys Leu Phe Val Val Ser Lys Thr Leu Gin
1 5 10 15
Val Val Thr Arg Thr Val Leu Leu Ser Thr Val Tyr Ser Ile Thr Leu
20 25 30
Leu Asn Asn Val Val Ile Lys Ala Asp Gln Leu Asn Ile Asn Ser Gln
35 40 45
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Pro Asp Asn Ala Glu
50 55 60
Asp Phe Lys Glu Asp Lys Gly Lys Ala Lys Glu Trp Gly Lys Glu Lys
65 70 75 80
Gly Glu Glu Trp Arg Pro Pro Ala Thr Glu Lys Gly Giu Met Asn Asn
85 90 95
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
100 105 110
Phe Ser Met Ala Gly Ser Cys Glu Asp Glu Ile Lys Asp Leu Glu Glu
115 120 125
Ile Asp Lys Ile Phe Asp Lys Ala Asn Leu Ser Ser Ser Ile Ile Thr
130 135 140
Tyr Lys Asn Val Glu Pro Ala Thr Ile Gly Phe Asn Lys Ser Leu Thr
145 150 155 160
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gin
165 170 175
Phe Leu Gly Lys Asp Met Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
180 185 190
Thr Ala Gin Gin Val Ser Ser Lys Lys Arg Val Ile Leu Lys Val Thr
195 200 205
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
210 215 220
Leu Asn Asn Asn Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Val Leu
225 230 235 240
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Met Glu Cys Leu
245 250 255
Gin Val Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
260 265 270
Asn Ala Glu Ala His Ser Trp Gly Met Lys Ile Tyr Glu Asp Trp Ala
275 280 285
WO 96/10083 2 19 9 0 4 9 PCT/EP95/03826
-146-
Lys Asn Leu Thr Ala Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
290 295 300
Gin Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
305 310 315 320
Gly Asn Glu Lys Leu Asp Ala Gln Leu Lys Asn Ile Ser Asp Ala Leu
325 330 335
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
340 345 350
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
355 360 365
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
370 375 380
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
385 390 395 400
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
405 410 415
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
420 425 430
Lys Asp Ser Lys Tyr His Ile Asp Lys Ala Thr Glu Val Ile Ile Lys
435 440 445
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
450 455 460
(2) INFORMATION FOR SEQ ID NO:21:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 834 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:
Met Lys Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Met Leu
1 5 10 15
Leu Ala Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Asn Ala Asp
20 25 30
Ser Lys Ile Asn Gln Ile Ser Thr Thr Gln Glu Asn Gln Gln Lys Glu
35 40 45
WO 96/10083 9 n n PC /EP95/03826
-147-
Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe
50 55 60
Asn Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Asn Thr Leu Met Tyr
65 70 75 80
Asp Gln Gln Thr Ala Asn Ala Leu Leu Asp Lys Lys Gln Gln Glu Tyr
85 90 95
Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Arg Lys Glu Thr Gly Asp
100 105 110
Phe Thr Phe Asn Leu Ser Lys Asp Glu Gln Ala Ile Ile Glu Ile Asp
115 120 125
Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu
130 135 140
Glu Lys Glu Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr
145 150 155 160
Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys
165 170 175
Ile Asp Ser Gln Asn Gln Ser Gln Gln Val Gln Leu Arg Asn Pro Glu
180 185 190
Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Ala Ser Lys Thr
195 200 205
Asn Leu Phe Lys Gln Lys Met Lys Arg Asp Ile Asp Glu Asp Thr Asp
210 215 220
Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr
225 230 235 240
Ile Gln Asn Lys Val Ala Val Lys Trp Asp Asp Ser Leu Ala Ser Lys
245 250 255
Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Asp Ser His Thr Val Gly
260 265 270
Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser
275 280 285
Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser Val
290 295 300
Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu Asn Leu Ser
305 310 315 320
Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr
325 330 335
Glu Gly Ala Ser Ile Glu Ala Gly Gly Gly Pro Leu Gly Leu Ser Phe
WO 96/10083 1 2 1 9 9 0 4 9 PCTIEP95/03826
-148-
340 345 350
Gly Val Ser Val Thr Tyr Gin His Ser Glu Thr Val Ala Gin Glu Trp
355 360 365
Gly Thr Ser Thr Gly Asn Thr Ser Gin Phe Asn Thr Ala Ser Ala Gly
370 375 380
Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly Ala Ile
385 390 395 400
Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn Asn Thr Ile
405 410 415
Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala--Leu Arg Ile Ser Pro
420 425 430
Gly Asp Ser Tyr Pro Glu Ile Gly Glu Asn Ala Ile Ala Ile Thr Ser
435 440 445
Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys Gin Gin Val
450 455 460
Asn Gin Leu Ile Asn Asn Lys Pro Ile Met Leu Glu Thr Asp Gin Thr
465 470 475 480
Asp Gly Val-Tyr Lys Ile Arg Asp Thr His Gly Asn Ile Val Thr Gly
485 490 495
Gly Glu Tip Asn Gly Val Thr Gin Gin Ile Lys Ala Lys Thr Ala Ser
500 505 510
Ile Ile Val Asp Asp Gly Lys Gin Val Ala Glu Lys Arg Val Ala Ala
515 520 525
Lys Asp Tyr Gly His Pro Glu Asp Lys Thr Pro Pro Leu Thr Leu Lys
530 535 540
Asp Thr Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu Thr Asn Gly
545 550 555 560
Leu Leu Tyr Tyr Asp Asp Lys Pro Ile Tyr Glu Ser Ser Val Met Thr
565 570 575
Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Lys Lys Gin Ile Asn Asp
580 585 590
Thr Thr Gly Lys Phe Lys Asp Val Asn His Leu Tyr Asp Val Lys Leu
595 600 605
Thr Pro Lys Met Asn Phe Thr Ile Lys Met Ala Ser Leu Tyr Asp Gly
610 615 620
Ala Glu Asn Asn His Asn Ser Leu Gly Thr Trp Tyr Leu Thr Tyr Asn
625 630 635 640
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-149-
Val Ala Gly Gly Asn Thr Gly Lys Arg Gln Tyr Arg Ser Ala His Ser
645 650 655
Cys Ala His Val Ala Leu Ser Ser Glu Ala Lys Lys Lys Leu Asn Gln
660 665 670
Asn Ala Asn Tyr Tyr Leu Ser Met Tyr Met Lys Ala Asp Ser Thr Thr
675 680 685
Glu Pro Thr Ile Glu Val Ala Gly Glu Lys Ser Ala Ile Thr Ser Lys
690 695 700
Lys Val Lys Leu Asn Asn Gln Asn Tyr Gln Arg Val Asp Ile Leu Val
705 710 715' 720
Lys Asn Ser Glu Arg Asn Pro Met Asp Lys Ile Tyr Ile Arg Gly Asn
725 730 735
Gly Thr Thr Asn Val Tyr Gly Asp Asp Val Thr Ile Pro Glu Val Ser
740 745 750
Ala Ile Asn Pro Ala Ser Leu Ser Asp Glu Glu Ile Gin Glu Ile Phe
755 760 765
Lys Asp Ser Thr Ile Glu Tyr Gly Asn Pro Ser Phe Val Ala Asp Ala
770 775 780
Val Thr Phe Lys Asn Ile Lys Pro Leu Gln Asn Tyr Val Lys Glu Tyr
785 790 795 800
Glu Ile Tyr His Lys Ser His Arg Tyr Glu Lys Lys Thr Val Phe Asp
805 810 815
Ile Met Gly Val His Tyr Glu Tyr Ser Ile Ala Arg Glu Gln Lys Lys
820 825 830
Ala Ala
(2) INFORMATION FOR SEQ ID NO:22:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 4041 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 1..4038
(D) OTHER INFORMATION: /product= "VIP1A(a)/VIP2A(a) fusion
WO 96/10083 m2 19 9 0 4 9 PCT/EP95/03826
-150-
product"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:
ATG AAA AGA ATG GAG GGA AAG TTG TTT ATG GTG TCA AAA AAA TTA CAA 48
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys Leu Gln
835 840 845 850
GTA GTT ACT AAA ACT GTA TTG CTT AGT ACA GTT TTC TCT ATA TCT TTA 96
Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile Ser Leu
855 860 865
TTA AAT AAT GAA GTG ATA AAA GCT GAA CAA TTA AAT ATA AAT TCT CAA 144
Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu-Asn Ile Asn Ser Gln
870 875 880
AGT AAA TAT ACT AAC TTG CAA AAT CTA AAA ATC ACT GAC AAG GTA GAG 192
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu
885 890 895
GAT TTT AAA GAA GAT AAG GAA AAA GCG AAA GAA TGG GGG AAA GAA AAA 240
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys
900 905 910
GAA AAA GAG TGG AAA CTA ACT GCT ACT GAA AAA GGA AAA ATG AAT AAT 288
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn
915 920 925 930
TTT TTA GAT AAT AAA AAT GAT ATA AAG ACA AAT TAT AAA GAA ATT ACT 336
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
935 940 945
TTT TCT ATG GCA GGC TCA TTT GAA GAT GAA ATA AAA GAT TTA AAA GAA 384
Phe Ser Met Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu
950 955 960
ATT GAT AAG ATG TTT GAT AAA ACC AAT CTA TCA AAT TCT ATT ATC ACC 432
Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr
965 970 975
TAT AAA AAT GTG GAA CCG ACA ACA ATT GGA TTT AAT AAA TCT TTA ACA 480
Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr
980 985 990
GAA GGT AAT ACG ATT AAT TCT GAT GCA ATG GCA CAG TTT AAA GAA CAA 528
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln
995 1000 1005 1010
TTT TTA GAT AGG GAT ATT AAG TTT GAT AGT TAT CTA GAT ACG CAT TTA 576
Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
1015 1020 1025
ACT GCT CAA CAA GTT TCC AGT AAA GAA AGA GTT ATT TTG AAG GTT ACG 624
Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
151 -
1030 1035 1040
GTT CCG AGT GGG AAA GGT TCT ACT ACT CCA ACA AAA GCA GGT GTC ATT 672
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
1045 1050 1055
TTA AAT AAT AGT GAA TAC AAA ATG CTC ATT GAT AAT GGG TAT ATG GTC 720
Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val
1060 1065 1070
CAT GTA GAT AAG GTA TCA AAA GTG GTG AAA AAA GGG GTG GAG TGC TTA 768
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu
1075 1080 1085 1090
CAA ATT GAA GGG ACT TTA AAA AAG AGT CTT GAC TTT AAA AAT GAT ATA 816
Gin Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
1095 1100 1105
AAT GCT GAA GCG CAT AGC TGG GGT ATG AAG AAT TAT GAA GAG TGG GCT 864
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala
1110 1115 1120
AAA GAT TTA ACC GAT TCG CAA AGG GAA GCT TTA GAT GGG TAT GCT AGG 912
Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
1125 1130 1135
CAA GAT TAT AAA GAA ATC AAT AAT TAT TTA AGA AAT CAA GGC GGA AGT 960
Gin Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
1140 1145 1150
GGA AAT GAA AAA CTA GAT GCT CAA ATA AAA AAT ATT TCT GAT GCT TTA 1008
Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu
1155 1160 1165 1170
GGG AAG AAA CCA ATA CCG GAA AAT ATT ACT GTG TAT AGA TGG TGT GGC 1056
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
1175 1180 1185
ATG CCG GAA TTT GGT TAT CAA ATT AGT GAT CCG TTA CCT TCT TTA AAA 1104
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
1190 1195 1200
GAT TTT GAA GAA CAA TTT TTA AAT ACA ATC AAA GAA GAC AAA GGA TAT 1152
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
1205 1210 1215
ATG AGT ACA AGC TTA TCG AGT GAA CGT CTT GCA GCT TTT GGA TCT AGA 1200
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
1220 1225 1230
AAA ATT ATA TTA CGA TTA CAA GTT CCG AAA GGA AGT ACG GGT GCG TAT 1248
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
1235 1240 1245 1250
TTA AGT GCC ATT GGT GGA TTT GCA AGT GAA AAA GAG ATC CTA CTT GAT 1296
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-152-
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
1255 1260 1265
AAA GAT AGT AAA TAT CAT ATT GAT AAA GTA ACA GAG GTA ATT ATT AAA 1344
Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys
1270 1275 1280
GGT GTT AAG CGA TAT GTA GTG GAT GCA ACA TTA TTA ACA AAT ATG AAA 1392
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn Met Lys
1285 1290 1295
AAT ATG AAG AAA AAG TTA GCA AGT GTT GTA ACG TGT ACG TTA TTA GCT 1440
Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Thr Leu Leu Ala
1300 1305 1310
CCT ATG TTT TTG AAT GGA AAT GTG AAT GCT GTT TAC GCA GAC AGC AAA 1488
Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Tyr Ala Asp Ser Lys
1315 1320 1325 1330
ACA AAT CAA ATT TCT ACA ACA CAG AAA AAT CAA CAG AAA GAG ATG GAC 1536
Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu Met Asp
1335 1340 1345
CGA AAA GGA TTA CTT GGG TAT TAT TTC AAA GGA AAA GAT TTT AGT AAT 1584
Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Ser Asn
1350 1355 1360
CTT ACT ATG TTT GCA CCG ACA CGT GAT AGT ACT CTT ATT TAT GAT CAA 1632
Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr Asp Gln
1365 1370 1375
CAA ACA GCA AAT AAA CTA TTA GAT AAA AAA CAA CAA GAA TAT CAG TCT 1680
Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr Gln Ser
1380 1385 1390
ATT CGT TGG ATT GGT TTG ATT CAG AGT AAA GAA ACG GGA GAT TTC ACA 1728
Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr
1395 1400 1405 1410
TTT AAC TTA TCT GAG GAT GAA CAG GCA ATT ATA GAA ATC AAT GGG AAA 1776
Phe Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu Ile Asn Gly Lys
1415 1420 1425
ATT ATT TCT AAT AAA GGG AAA GAA AAG CAA GTT GTC CAT TTA GAA AAA 1824
Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu Glu Lys
1430 1435 1440
GGA AAA TTA GTT CCA ATC AAA ATA GAG TAT CAA TCA GAT ACA AAA TTT 1872
Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr Lys Phe
1445 1450 1455
AAT ATT GAC AGT AAA ACA TTT AAA GAA CTT AAA TTA TTT AAA ATA GAT 1920
Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys Ile Asp
1460 1465 1470
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-153-
AGT CAA AAC CAA CCC CAG CAA GTC CAG CAA GAT GAA CTG AGA AAT CCT 1968
Ser Gln Asn Gln Pro Gln Gln Val Gln Gln Asp Glu Leu Arg Asn Pro
1475 1480 1485 1490
GAA TTT AAC AAG AAA GAA TCA CAG GAA TTC TTA GCG AAA CCA TCG AAA 2016
Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro Ser Lys
1495 1500 1505
ATA AAT CTT TTC ACT CAA AAA ATG AAA AGG GAA ATT GAT GAA GAC ACG 2064
Ile Asn Leu Phe Thr Gln Lys Met Lys Arg Glu Ile Asp Glu Asp Thr
1510 1515 1520
GAT ACG GAT GGG GAC TCT ATT CCT GAC CTT TGG GAA GAA AAT GGG TAT 2112
Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr
1525 1530 1535
ACG ATT CAA AAT AGA ATC GCT GTA AAG TGG GAC GAT TCT CTA GCA AGT 2160
Thr Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp Ser Leu Ala Ser
1540 1545 1550
AAA GGG TAT ACG AAA TTT GTT TCA AAT CCA CTA GAA AGT CAC ACA GTT 2208
Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His Thr Val
1555 1560 1565 1570
GGT GAT CCT TAT ACA GAT TAT GAA AAG GCA GCA AGA GAT CTA GAT TTG 2256
Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu
1575 1580 1585
TCA AAT GCA AAG GAA ACG TTT AAC CCA TTG GTA GCT GCT TTT CCA AGT 2304
Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser
1590 1595 1600
GTG AAT GTT AGT ATG GAA AAG GTG ATA TTA TCA CCA AAT GAA AAT TTA 2352
Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu Asn Leu
1605 1610 1615
TCC AAT AGT GTA GAG TCT CAT TCA TCC ACG AAT TGG TCT TAT ACA AAT 2400
Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn
1620 1625 1630
ACA GAA GGT GCT TCT GTT GAA GCG GGG ATT GGA CCA AAA GGT ATT TCG 2448
Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly Ile Ser
1635 1640 1645 1650
TTC GGA GTT AGC GTA AAC TAT CAA CAC TCT GAA ACA GTT GCA CAA GAA 2496
Phe Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala Gln Glu
1655 1660 1665
TGG GGA ACA TCT ACA GGA AAT ACT TCG CAA TTC AAT ACG GCT TCA GCG 2544
Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala Ser Ala
1670 1675 1680
GGA TAT TTA AAT GCA AAT GTT CGA TAT AAC AAT GTA GGA ACT GGT GCC 2592
Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly Ala
1685 1690 1695
PCT/EP95/03826
WO 96/10083 2 '~ 9 n Q 4 9
-154-
ATC TAC GAT GTA AAA CCT ACA ACA AGT TTT GTA TTA AAT AAC GAT ACT 2640
Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn Asp Thr
1700 1705 1710
ATC GCA ACT ATT ACG GCG AAA TCT AAT TCT ACA GCC TTA AAT ATA TCT 2688
Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn Ile Ser
1715 1720 1725 1730
CCT GGA GAA AGT TAC CCG AAA AAA GGA CAA AAT GGA ATC GCA ATA ACA 2736
Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala Ile Thr
1735 1740 1745
TCA ATG GAT GAT TTT AAT TCC CAT CCG ATT ACA TTA AAT AAA AAA CAA 2784
Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys Lys Gin
1750 1755 1760
GTA GAT AAT CTG CTA AAT AAT AAA CCT ATG ATG TTG GAA ACA AAC CAA 2832
Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr Asn Gln
1765 1770 1775
ACA GAT GGT GTT TAT AAG ATA AAA GAT ACA CAT GGA AAT ATA GTA ACT 2880
Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile Val Thr
1780 1785 1790
GGC GGA GAA TGG AAT GGT GTC ATA CAA CAA ATC AAG GCT AAA ACA GCG 2928
Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys Thr Ala
1795 1800 1805 1810
TCT ATT ATT GTG GAT GAT GGG GAA CGT GTA GCA GAA AAA CGT GTA GCG 2976
Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg Val Ala
1815 1820 1825
GCA AAA GAT TAT GAA AAT CCA GAA GAT AAA ACA CCG TCT TTA ACT TTA 3024
Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu Thr Leu
1830 1835 1840
AAA GAT GCC CTG AAG CTT TCA TAT CCA GAT GAA ATA AAA GAA ATA GAG 3072
Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu Ile Glu
1845 1850 1855
GGA TTA TTA TAT TAT AAA AAC AAA CCG ATA TAC GAA TCG AGC GTT ATG 3120
Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser Val Met
1860 1865 1870
ACT TAC TTA GAT GAA AAT ACA GCA AAA GAA GTG ACC AAA CAA TTA AAT 3168
Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln Leu Asn
1875 1880 1885 1890
GAT ACC ACT GGG AAA TTT AAA GAT GTA AGT CAT TTA TAT GAT GTA AAA 3216
Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp Val Lys
1895 1900 1905
CTG ACT CCA AAA ATG AAT GTT ACA ATC AAA TTG TCT ATA CTT TAT GAT 3264
Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu Tyr Asp
WO 96/10083 9 Q 4 9 PCT/EP95/03826
-155-
1910 1915 1920
AAT GCT GAG TCT AAT GAT AAC TCA ATT GGT AAA TGG ACA AAC ACA AAT 3312
Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn Thr Asn
1925 1930 1935
ATT GTT TCA GGT GGA AAT AAC GGA AAA AAA CAA TAT TCT TCT AAT AAT 3360
Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gin Tyr Ser Ser Asn Asn
1940 1945 1950
CCG GAT GCT AAT TTG ACA TTA AAT ACA GAT GCT CAA GAA AAA TTA AAT 3408
Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gin Glu Lys Leu Asn
1955 1960 1965 1970
AAA AAT CGT GAC TAT TAT ATA AGT TTA TAT ATG AAG TCA GAA AAA AAC 3456
Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu Lys Asn
1975 1980 1985
ACA CAA TGT GAG ATT ACT ATA GAT GGG GAG ATT TAT CCG ATC ACT ACA 3504
Thr Gin Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile Thr Thr
1990 1995 2000
AAA ACA GTG AAT GTG AAT AAA GAC AAT TAC AAA AGA TTA GAT ATT ATA 3552
Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp Ile Ile
2005 2010 2015
GCT CAT AAT ATA AAA AGT AAT CCA ATT TCT TCA CTT CAT ATT AAA ACG 3600
Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu His Ile Lys Thr
2020 2025 2030
AAT GAT GAA ATA ACT TTA TTT TGG GAT GAT ATT TCT ATA ACA GAT GTA 3648
Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr Asp Val
2035 2040 2045 2050
GCA TCA ATA AAA CCG GAA AAT TTA ACA GAT TCA GAA ATT AAA CAG ATT 3696
Ala Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu Ile Lys Gin Ile
2055 2060 2065
TAT AGT AGG TAT GGT ATT AAG TTA GAA GAT GGA ATC CTT ATT GAT AAA 3744
Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile Asp Lys
2070 2075 2080
AAA GGT GGG ATT CAT TAT GGT GAA TTT ATT AAT GAA GCT AGT TTT AAT 3792
Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser Phe Asn
2085 2090 2095
ATT GAA CCA TTG CAA AAT TAT GTG ACC AAA TAT GAA GTT ACT TAT AGT 3840
Ile Glu Pro Leu Gin Asn Tyr Val Thr Lys Tyr Glu Val Thr Tyr Ser
2100 2105 2110
AGT GAG TTA GGA CCA AAC GTG AGT GAC ACA CTT GAA AGT GAT AAA ATT 3888
Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu Ser Asp Lys Ile
2115 2120 2125 2130
TAC AAG GAT GGG ACA ATT AAA TTT GAT TTT ACC AAA TAT AGT AAA AAT 3936
WO 96/10083 x 2 1 9 9 0 4 9 PCTIEP95/03826
-156-
Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser Lys Asn
2135 2140 2145
GAA CAA GGA TTA TTT TAT GAC AGT GGA TTA AAT TGG GAC TTT AAA ATT 3984
Glu Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe Lys Ile
2150 2155 2160
AAT GCT ATT ACT TAT GAT GGT AAA GAG ATG AAT GTT TTT CAT AGA TAT 4032
Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His Arg Tyr
2165 2170 2175
AAT AAA TAG 4041
Asn Lys
2180
(2) INFORMATION FOR SEQ ID NO:23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1346 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys Leu Gln
1 5 10 15
Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile Ser Leu
20 25 .30
Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu Asn Ile Asn Ser Gln
35 40 45
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu
50 55 60
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys
65 70 75 80
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn
85 90 95
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
100 105 110
Phe Ser Met Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu
115 120 125
Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr
130 135 140
Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr
WO 96/10083 x 2 1 9 9 0 4 9 PCTIEP95/03826
- 157 -
145 150 155 160
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln
165 170 175
Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
180 185 190
Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr
195 200 205
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
210 215 220
Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val
225 230 235 240
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu
245 250 255
Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
260 265 270
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala
275 280 285
Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
290 295 300
Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
305 310 315 320
Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu
325 330 335
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
340 345 350
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
355 360 365
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
370 375 380
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
385 390 395 400
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
405 410 415
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
420 425 430
Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys
435 440 445
WO 96/10083 = 2 1 9 9 0 4 9 PCT/EP95/03826
-158-
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn Met Lys
450 455 460
Asn Met Lys Lys Lys Leu Ala Ser Val Val Thr Cys Thr Leu Leu Ala
465 470 475 480
Pro Met Phe Leu Asn Gly Asn Val Asn Ala Val Tyr Ala Asp Ser Lys
485 490 495
Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu Met Asp
500 505 510
Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe Ser Asn
515 520 525
Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr Asp Gln
530 535 540
Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr Gln Ser
545 550 555 560
Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr
565 570 575
Phe Asn Leu Ser Glu Asp Giu Gln Ala Ile Ile Glu Ile Asn Gly Lys
580 585 590
Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val His Leu Glu Lys
595 600 605
Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr Lys Phe
610 615 620
Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys Ile Asp
625 630 635 640
Ser Gln Asn Gln Pro Gln Gln Val Gln Gln Asp Glu Leu Arg Asn Pro
645 650 655
Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro Ser Lys
660 665 670
Ile Asn Leu Phe Thr Gln Lys Met Lys Arg Glu Ile Asp Giu Asp Thr
675 680 685
Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr
690 695 700
Thr Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp Ser Leu Ala Ser
705 710 715 720
Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His Thr Val
725 730 735
WO 96/10083 ~. _ 2 1 9 9 0 4 PCT/EP95/03826
- 159 -
Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu
740 745 750
Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe Pro Ser
755 760 765
Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu Asn Leu
770 775 780
Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr Thr Asn
785 790 795 800
Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly Ile Ser
805 810 815
Phe Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala Gln Glu
820 825 830
Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala Ser Ala
835 840 845
Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr Gly Ala
850 855 860
Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn Asp Thr
865 870 875 880
Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn Ile Ser
885 890 895
Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala Ile Thr
900 905 910
Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys Lys Gln
915 920 925
Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr Asn Gln
930 935 940
Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile Val Thr
945 950 955 960
Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys Thr Ala
965 970 975
Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg Val Ala
980 985 990
Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu Thr Leu
995 1000 1005
Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu Ile Glu
1010 1015 1020
Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser Val Met
WO 96/10083 9 PCT/EP95/03826
-160-
1025 1030 1035 1040
Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln Leu Asn
1045 1050 1055
Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp Val Lys
1060 1065 1070
Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu Tyr Asp
1075 1080 1085
Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn Thr Asn
1090 1095 1100
Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr Ser Ser Asn Asn
1105 1110 1115 1120
Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gln Glu Lys Leu Asn
1125 1130 1135
Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu Lys Asn
1140 1145 1150
Thr Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile Thr Thr
1155 1160 1165
Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp Ile Ile
1170 1175 1180
Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu His Ile Lys Thr
1185 1190 1195 1200
Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr Asp Val
1205 1210 1215
Ala Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu Ile Lys Gln Ile
1220 1225 1230
Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile Asp Lys
1235 1240 1245
Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser Phe Asn
1250 1255 1260
Ile Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Glu Val Thr Tyr Ser
1265 1270 1275 1280
Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu Ser Asp Lys Ile
1285 1290 1295
Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser Lys Asn
1300 1305 1310
Glu Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe Lys Ile
1315 1320 1325
WO 96/10083 2 1 9 9 0 4 9 PCT/E"5/03826
- 161 -
Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His Arg Tyr
1330 1335 1340
Asn Lys
1345
(2) INFORMATION FOR SEQ ID NO:24:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1399 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(ix) FEATURE:
(A) NAME/KEY: raisc feature
(B) LOCATION: 1..1386
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence for VIP2A(a) protein from AB78"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:
ATGAAGCGCA TGGAGGGCAA GCTGTTCATG GTGAGCAAGA AGCTCCAGGT GGTGACCAAG 60
ACCGTGCTGC TGAGCACCGT GTTCAGCATC AGCCTGCTGA ACAACGAGGT GATCAAGGCC 120
GAGCAGCTGA ACATCAACAG CCAGAGCAAG TACACCAACC TCCAGAACCT GAAGATCACC 180
GACAAGGTGG AGGACTTCAA GGAGGACAAG GAGAAGGCCA AGGAGTGGGG CAAGGAGAAG 240
GAGAAGGAGT GGAAGCTTAC CGCCACCGAG AAGGGCAAGA TGAACAACTT CCTGGACAAC 300
AAGAACGACA TCAAGACCAA CTACAAGGAG ATCACCTTCA GCATGGCCGG CAGCTTCGAG 360
GACGAGATCA AGGACCTGAA GGAGATCGAC AAGATGTTCG ACAAGACCAA CCTGAGCAAC 420
AGCATCATCA CCTACAAGAA CGTGGAGCCC ACCACCATCG GCTTCAACAA GAGCCTGACC 480
GAGGGCAACA CCATCAACAG CGACGCCATG GCCCAGTTCA AGGAGCAGTT CCTGGACCGC 540
GACATCAAGT TCGACAGCTA CCTGGACACC CACCTGACCG CCCAGCAGGT GAGCAGCAAG 600
GAGCGCGTGA TCCTGAAGGT GACCGTCCCC AGCGGCAAGG GCAGCACCAC CCCCACCAAG 660
GCCGGCGTGA TCCTGAACAA CAGCGAGTAC AAGATGCTGA TCGACAACGG CTACATGGTG 720
CACGTGGACA AGGTGAGCAA GGTGGTGAAG AAGGGCGTGG AGTGCCTCCA GATCGAGGGC 780
ACCCTGAAGA AGAGTCTAGA CTTCAAGAAC GACATCAACG CCGAGGCCCA CAGCTGGGGC 840
WO 96/10083 9 9 O g PCT/EP95/03826
-162-
ATGAAGAACT ACGAGGAGTG GGCCAAGGAC CTGACCGACA GCCAGCGCGA GGCCCTGGAC 900
GGCTACGCCC GCCAGGACTA CAAGGAGATC AACAACTACC TGCGCAACCA GGGCGGCAGC 960
GGCAACGAGA AGCTGGACGC CCAGATCAAG AACATCAGCG ACGCCCTGGG CAAGAAGCCC 1020
ATCCCCGAGA ACATCACCGT GTACCGCTGG TGCGGCATGC CCGAGTTCGG CTACCAGATC 1080
AGCGACCCCC TGCCCAGCCT GAAGGACTTC GAGGAGCAGT TCCTGAACAC CATCAAGGAG 1140
GACAAGGGCT ACATGAGCAC CAGCCTGAGC AGCGAGCGCC TGGCCGCCTT CGGCAGCCGC 1200
AAGATCATCC TGCGCCTGCA GGTGCCCAAG GGCAGCACCG GCGCCTACCT GAGCGCCATC 1260
GGCGGCTTCG CCAGCGAGAA GGAGATCCTG CTGGACAAGG ACAGCAAGTA CCACATCGAC 1320
AAGGTGACCG AGGTGATCAT CAAGGGCGTG AAGCGCTACG TGGTGGACGC CACCCTGCTG 1380
ACCAACTAGA TCTGAGCTC 1399
(2) INFORMATION FOR SEQ ID NO:25:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 19 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..19
(D) OTHER INFORMATION: /note= "Secretion signal peptide to
secrete VIP2 out of a cell"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:
Gly Trp Ser Trp Ile Phe Leu Phe Leu Leu Ser Gly Ala Ala Gly Val
1 5 10 15
His Cys Leu
(2) INFORMATION FOR SEQ ID NO:26:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2655 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
WO 96/10083 2 1 9 9 /1 4 9 PCT/EP95/03826
-163-
(A) DESCRIPTION: /desc "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 1..2655
(D) OTHER INFORMATION: /note= "maize optimized DNA
sequence encoding VIP1A(a)"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:
ATGAAGAACA TGAAGAAGAA GCTGGCCAGC GTGGTGACCT`GCACCCTGCT GGCCCCCATG 60
TTCCTGAACG GCAACGTGAA CGCCGTGTAC GCCGACAGCA AGACCAACCA GATCAGCACC 120
ACCCAGAAGA ACCAGCAGAA GGAGATGGAC CGCAAGGGCC TGCTGGGCTA CTACTTCAAG 180
GGCAAGGACT TCAGCAACCT GACCATGTTC GCCCCCACGC GTGACAGCAC CCTGATCTAC 240
GACCAGCAGA CCGCCAACAA GCTGCTGGAC AAGAAGCAGC AGGAGTACCA GAGCATCCGC 300
TGGATCGGCC TGATCCAGAG CAAGGAGACC GGCGACTTCA CCTTCAACCT GAGCGAGGAC 360
GAGCAGGCCA TCATCGAGAT CAACGGCAAG ATCATCAGCA ACAAGGGCAA GGAGAAGCAG 420
GTGGTGCACC TGGAGAAGGG CAAGCTGGTG CCCATCAAGA TCGAGTACCA GAGCGACACC 480
AAGTTCAACA TCGACAGCAA GACCTTCAAG GAGCTGAAGC TTTTCAAGAT CGACAGCCAG 540
AACCAGCCCC AGCAGGTGCA GCAGGACGAG CTGCGCAACC CCGAGTTCAA CAAGAAGGAG 600
AGCCAGGAGT TCCTGGCCAA GCCCAGCAAG ATCAACCTGT TCACCCAGCA GATGAAGCGC 660
GAGATCGACG AGGACACCGA CACCGACGGC GACAGCATCC CCGACCTGTG GGAGGAGAAC 720
GGCTACACCA TCCAGAACCG CATCGCCGTG AAGTGGGACG ACAGCCTGGC TAGCAAGGGC 780
TACACCAAGT TCGTGAGCAA CCCCCTGGAG AGCCACACCG TGGGCGACCC CTACACCGAC 840
TACGAGAAGG CCGCCCGCGA CCTGGACCTG AGCAACGCCA AGGAGACCTT CAACCCCCTG 900
GTGGCCGCCT TCCCCAGCGT GAACGTGAGC ATCGAGAAGG TGATCCTGAG CCCCAACGAG 960
AACCTGAGCA ACAGCGTGGA GAGCCACTCG AGCACCAACT GGAGCTACAC CAACACCGAG 1020
GGCGCCAGCG TGGAGGCCGG CATCGGTCCC AAGGGCATCA GCTTCGGCGT GAGCGTGAAC 1080
TACCAGCACA GCGAGACCGT GGCCCAGGAG TGGGGCACCA GCACCGGCAA CACCAGCCAG 1140
TTCAACACCG CCAGCGCCGG CTACCTGAAC GCCAACGTGC GCTACAACAA CGTGGGCACC 1200
GGCGCCATCT ACGACGTGAA GCCCACCACC AGCTTCGTGC TGAACAACGA CACCATCGCC 1260
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-164-
ACCATCACCG CCAAGTCGAA TTCCACCGCC CTGAACATCA GCCCCGGCGA GAGCTACCCC 1320
AAGCAGGGCC AGAACGGCAT CGCCATCACC AGCATGGACG ACTTCAACAG CCACCCCATC 1380
ACCCTGAACA AGAAGCAGGT GGACAACCTG CTGAACAACA AGCCCATGAT GCTGGAGACC 1440
AACCAGACCG ACGGCGTCTA CAAGATCAAG GACACCCACG GCAACATCGT GACGGGCGGC 1500
GAGTGGAACG GCGTGATCCA GCAGATCAAG GCCAAGGCCG CCAGCATCAT CGTCGACGAC 1560
GGCGAGCGCG TGGCCGAGAA GCGCGTGGCC GCCAAGGACT ACGAGAACCC CGAGGACAAG 1620
ACCCCCAGCC TGACCCTGAA GGACGCCCTG AAGCTGAGCT ACCCCGACGA GATCAAGGAG 1680
ATCGAGGGCT TGCTGTACTA CAAGAACAAG CCCATCTACG AGAGCAGCGT GATGACCTAT 1740
CTAGACGAGA ACACCGCCAA GGAGGTGACC AAGCAGCTGA ACGACACCAC CGGCAAGTTC 1800
AAGGACGTGA GCCACCTGTA CGACGTGAAG CTGACCCCCA AGATGAACGT GACCATCAAG 1860
CTGAGCATCC TGTACGACAA CGCCGAGAGC AACGACAACA GCATCGGCAA GTGGACCAAC 1920
ACCAACATCG TGAGCGGCGG CAACAACGGC AAGAAGCAGT ACAGCAGCAA CAACCCCGAC 1980
GCCAACCTGA CCCTGAACAC CGACGCCCAG GAGAAGCTGA ACAAGAACCG CGACTACTAC 2040
ATCAGCCTGT ACATGAAGAG CGAGAAGAAC ACCCAGTGCG AGATCACCAT CGACGGCGAG 2100
ATATACCCCA TCACCACCAA GACCGTGAAC GTGAACAAGG ACAACTACAA GCGCCTGGAC 2160
ATCATCGCCC ACAACATCAA GAGCTACCCC ATCAGCAGCC TGCACATCAA GACCAACGAC 2220
GAGATCACCC TGTTCTGGGA CGACATATCG ATTACCGACG TCGCCAGCAT CAAGCCCGAG 2280
AACCTGACCG ACAGCGAGAT CAAGCAGATA TACAGTCGCT ACGGCATCAA GCTGGAGGAC 2340
GGCATCCTGA TCGACAAGAA AGGCGGCATC CACTACGGCG AGTTCATCAA CGAGGCCAGC 2400
TTCAACATCG AGCCCCTGCA GAACTACGTG ACCAAGTACG AGGTGACCTA CAGCAGCGAG 2460
CTGGGCCCCA ACGTGAGCGA CACCCTGGAG AGCGACAAGA TTTACAAGGA CGGCACCATC 2520
AAGTTCGACT TCACCAAGTA CAGCAAGAAC GAGCAGGGCC TGTTCTACGA CAGCGGCCTG 2580
AACTGGGACT TCAAGATCAA CGCCATCACC TACGACGGCA AGGAGATGAA CGTGTTCCAC 2640
CGCTACAACA AGTAG 2655
(2) INFORMATION FOR SEQ ID NO:27:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1389 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
WO 96/10083 2 1 9 g O 4 Or PCTIEP95/03826
-165-
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 1..1389
(D) OTHER INFORMATION: /note= "maize optimized DNA
sequence encoding VIP2A(a)"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:
ATGAAGCGCA TGGAGGGCAA GCTGTTCATG GTGAGCAAGA AGCTCCAGGT GGTGACCAAG 60
ACCGTGCTGC TGAGCACCGT GTTCAGCATC AGCCTGCTGA ACAACGAGGT GATCAAGGCC 120
GAGCAGCTGA ACATCAACAG CCAGAGCAAG TACACCAACC TCCAGAACCT GAAGATCACC 180
GACAAGGTGG AGGACTTCAA GGAGGACAAG GAGAAGGCCA AGGAGTGGGG CAAGGAGAAG 240
GAGAAGGAGT GGAAGCTTAC CGCCACCGAG AAGGGCAAGA TGAACAACTT CCTGGACAAC 300
AAGAACGACA TCAAGACCAA CTACAAGGAG ATCACCTTCA GCATAGCCGG CAGCTTCGAG 360
GACGAGATCA AGGACCTGAA GGAGATCGAC AAGATGTTCG ACAAGACCAA CCTGAGCAAC 420
AGCATCATCA CCTACAAGAA CGTGGAGCCC ACCACCATCG GCTTCAACAA GAGCCTGACC 480
GAGGGCAACA CCATCAACAG CGACGCCATG GCCCAGTTCA AGGAGCAGTT CCTGGACCGC 540
GACATCAAGT TCGACAGCTA CCTGGACACC CACCTGACCG CCCAGCAGGT GAGCAGCAAG 600
GAGCGCGTGA TCCTGAAGGT GACCGTCCCC AGCGGCAAGG GCAGCACCAC CCCCACCAAG 660
GCCGGCGTGA TCCTGAACAA CAGCGAGTAC AAGATGCTGA TCGACAACGG CTACATGGTG 720
CACGTGGACA AGGTGAGCAA GGTGGTGAAG AAGGGCGTGG AGTGCCTCCA GATCGAGGGC 780
ACCCTGAAGA AGAGTCTAGA CTTCAAGAAC GACATCAACG CCGAGGCCCA CAGCTGGGGC 840
ATGAAGAACT ACGAGGAGTG GGCCAAGGAC CTGACCGACA GCCAGCGCGA GGCCCTGGAC 900
GGCTACGCCC GCCAGGACTA CAAGGAGATC AACAACTACC TGCGCAACCA GGGCGGCAGC 960
GGCAACGAGA AGCTGGACGC CCAGATCAAG AACATCAGCG ACGCCCTGGG CAAGAAGCCC 1020
ATCCCCGAGA ACATCACCGT GTACCGCTGG TGCGGCATGC CCGAGTTCGG CTACCAGATC 1080
AGCGACCCCC TGCCCAGCCT GAAGGACTTC GAGGAGCAGT TCCTGAACAC CATCAAGGAG 1140
WO 96/10083 4 PCT/EP95/03826
1-2 1990 9
- 166 -
GACAAGGGCT ACATGAGCAC CAGCCTGAGC AGCGAGCGCC TGGCCGCCTT CGGCAGCCGC 1200
AAGATCATCC TGCGCCTGCA GGTGCCCAAG GGCAGCACTG GTGCCTACCT GAGCGCCATC 1260
GGCGGCTTCG CCAGCGAGAA GGAGATCCTG CTGGATAAGG ACAGCAAGTA CCACATCGAC 1320
AAGGTGACCG AGGTGATCAT CAAGGGCGTG AAGCGCTACG TGGTGGACGC CACCCTGCTG 1380
ACCAACTAG 1389
(2) INFORMATION FOR SEQ ID NO:28:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2378 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genccnic)
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 9..2375
(D) OTHER INFORMATION: /note= "Native DNA sequence
encoding VIP3A(a) protein frat AB88 as contained in pCIB7104"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:
AGATGAAC ATG AAC AAG AAT AAT ACT AAA TTA AGC ACA AGA GCC TTA CCA 50
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro
1 5 10
AGT TTT ATT GAT TAT TTT AAT GGC ATT TAT GGA TTT GCC ACT GGT ATC 98
Ser Phe Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile
15 20 25 30
AAA GAC ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA 146
Lys Asp Ile Net Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu
35 40 45
ACC CTA GAC GAA ATT TTA AAG AAT CAG CAG TTA CTA AAT GAT ATT TCT 194
Thr Leu Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Asp Ile Ser
50 55 60
GGT AAA TTG GAT GGG GTG AAT GGA AGC TTA AAT GAT CTT ATC GCA CAG 242
Gly Lys Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln
65 70 75
GGA AAC TTA AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT 290
Gly Asn Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn
80 85 90
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
- 167 -
GAA CAA AAT CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA 338
Glu Gln Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile
95 100 105 110
AAT ACG ATG CTT CGG GTA TAT CTA CCT AAA ATT ACC TCT ATG TTG AGT 386
Asn Thr Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser
115 120 125
GAT GTA ATG AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA 434
Asp Val Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Ile Glu Tyr Leu
130 135 140
AGT AAA CAA TTG CAA GAG ATT TCT GAT AAG TTG GAT ATT ATT AAT GTA 482
Ser Lys Gin Leu Gln Glu Ile Ser Asp Lys Let Asp Ile Ile Asn Val
145 150 155
AAT GTA CTT ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA 530
Asn Val Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gin
160 165 170
AGG ATT AAA TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA 578
Arg Ile Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr
175 180 185 190
GAA ACT AGT TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CTT 626
Glu Thr Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Leu
195 200 205
GAT GAG TTA ACT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA AAA AAT 674
Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn
210 215 220
GAT GTG GAT GGT TTT GAA TTT TAC CTT AAT ACA TTC CAC GAT GTA ATG 722
Asp Val Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met
225 230 235
GTA GGA AAT AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA 770
Val Gly Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu
240 245 250
TTA ATT ACT AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT 818
Leu Ile Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn
255 260 265 270
GTT TAT AAC TTC TTA ATT GTA TTA ACA GCT CTG CAA GCC CAA GCT TTT 866
Val Tyr Asn Phe Leu Ile Val Leu Thr Ala Leu Gin Ala Gin Ala Phe
275 280 285
CTT ACT TTA ACA ACA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT 914
Leu Thr Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp
290 295 300
TAT ACT TCT ATT ATG AAT GAA CAT TTA AAT AAG GAA AAA GAG GAA TTT 962
Tyr Thr Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe
WO 96/10083 1 9 9 0 4 9 PCT/EP95/03826
-168-
305 310 315
AGA GTA AAC ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT 1010
Arg Val Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn
320 325 330
TAT GCA AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA 1058
Tyr Ala Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu
335 340 345 350
GCT AAA CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA 1106
Ala Lys Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser
355 360 365
ATT ACA GTA TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA 1154
Ile Thr Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln
370 375 380
GTC GAT AAG GAT TCC TTA TCG GAA GTT ATT TAT GGT GAT ATG GAT AAA 1202
Val Asp Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys
385 390 395
TTA TTG TGC CCA GAT CAA TCT GAA CAA ATC TAT TAT ACA AAT AAC ATA 1250
Leu Len Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr Asn Asn Ile
400 405 410
GTA TTT CCA AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA 1298
Val Phe Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys
415 420 425 430
ATG AAA ACT TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT 1346
Met Lys Thr Len Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser
435 440 445
ACA GGA GAA ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG 1394
Thr Gly Gin Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala
450 455 460
GAG TAT AGA ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA 1442
Glu Tyr Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu
465 470 475
GGT GTC ATC AGT GAA ACA TTT TTG ACT CCG ATT AAT GGG TTT GGC CTC 1490
Gly Val Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu
480 485 490
CAA GCT GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT 1538
Gin Ala Asp Glu Asn Ser Arg Len Ile Thr Leu Thr Cys Lys Ser Tyr
495 500 505 510
TTA AGA GAA CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA 1586
Leu Arg Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys
515 520 525
TTG ATC GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG 1634
WO 96/10083 2 1 9 9 0 4 `s- PCT/EP95/03826
- 169 -
Leu Ile Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly
530 535 540
TCC ATA GAA GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT 1682
Ser Ile Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn
545 550 555
GCG TAT GTA GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT 1730
Ala Tyr Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr
560 565 570
GTT CAT AAG GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA 1778
Val His Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys
575 580 585 590
CCG AAA ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT 1826
Pro Lys Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly Lys Pro Ser
595 600 605
ATT CAT TTA AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA 1874
Ile His Len Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr
610 615 620
AAT AAT AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA 1922
Asn Asn Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr
625 630 635
GGA ACT GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA 1970
Gly Thr Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gln Asn Gly
640 645 650
GAT GAA GCT TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT 2018
Asp Glu Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser
655 660 665 670
GAA AAG TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT 2066
Glu Lys Leu Leu Ser Pro Glu Len Ile Asn Thr Asn Asn Trp Thr Ser
675 680 685
ACG GGA TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA 2114
Thr Gly Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly
690 695 700
GGA CGA GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT 2162
Gly Arg Gly Ile Len Lys Gin Asn Leu Gln Leu Asp Ser Phe Ser Thr
705 710 715
TAT AGA GTG TAT TTT TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA 2210
Tyr Arg Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg
720 725 730
AAT TCT AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC GGT GCT AAA 2258
Asn Ser Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys
735 740 745 750
WO 96/100831 W-2 1 9 9 0 4 9 PCT/EP95/03826
-170-
GAT GTT TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT AAC TTT TAT 2306
Asp Val Set Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr
755 760 765
ATA GAG CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT ATT GTA CAT 2354
Ile Glu Leu Ser Gln Gly Asn Asn Leu Tyr Giy Gly Pro Ile Val His
770 775 780
TTT TAC GAT GTC TCT ATT AAG TAA 2378
Phe Tyr Asp Val Ser Ile Lys
785
(2) INFORMATION FOR SEQ ID NO:29:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 789 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
1 5 10 15
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
20 25 30
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
35 40 45
Asp Glu Ile Leu Lys Asn Gln Gin Leu Leu Asn Asp Ile Ser Gly Lys
50 55 60
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gin Gly Asn
65 70 75 80
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gln
85 90 95
Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
100 105 110
Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
115 120 125
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gln Ile Glu Tyr Leu Ser Lys
130 135 140
Gln Leu Gln Glu Ile Ser Asp Lys Leu Asp Ile Ile Asn Val Asn Val
145 150 155 160
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
WO 96/10083 2 19904 9 PCT/EP95/03826
-171-
165 170 175
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
180 185 190
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Leu Asp Glu
195 200 205
Leu Thr Giu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
210 215 220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
225 230 235 240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr=Ala Ser Glu Leu Ile
245 250 255
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
260 265 270
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Gln Ala Phe Leu Thr
275 280 285
Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
290 295 300
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
305 310 315 320
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330 335
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Giu Ala Lys
340 345 350
Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser Ile Thr
355 360 365
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp
370 375 380
Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys Leu Leu
385 390 395 400
Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
405 410 415
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
420 425 430
Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly
435 440 445
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
450 455 460
WO 96/10083 k` 2 1 9 9 0 4 9 PCT/EP95/03826
-172-
Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Net Pro Leu Gly Val
465 470 475 480
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
485 490 495
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
500 505 510
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
515 520 525
Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly Ser Ile
530 535 -.540
Glu Glu Asp Asn Leu Glu Pro Tip Lys Ala Asn Asn Lys Asn Ala Tyr
545 550 555 560
Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His
565 570 575
Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys Pro Lys
580 585 590
Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly Lys Pro Ser Ile His
595 600 605
Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr Asn Asn
610 615 620
Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr Gly Thr
625 630 635 640
Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gin Asn Gly Asp Glu
645 650 655
Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser Glu Lys
660 665 670
Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn Trp Thr Ser Thr Gly
675 680 685
Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly Gly Arg
690 695 700
Gly Ile Leu Lys Gln Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg
705 710 715 720
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg Asn Ser
725 730 735
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
740 745 750
WO 96/10083 PCT/EP95/03826
2199049
- 173 -
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr Ile Glu
755 760 765
Leu Ser Gln Gly Asn Asn Leu Tyr Gly Gly Pro Ile Val His Phe Tyr
770 775 780
Asp Val Ser Ile Lys
785
(2) INFORMATION FOR SEQ ID NO:30:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2403 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: misc feature
(B) LOCATION: 11..2389
(D) OTHER INFORMATION: /note= "maize optimized DNA
sequence encoding VIP3A(a)"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:
GGATCCACCA ATGAACATGA ACAAGAACAA CACCAAGCTG AGCACCCGCG CCCTGCCGAG 60
CTTCATCGAC TACTTCAACG GCATCTACGG CTTCGCCACC GGCATCAAGG ACATCATGAA 120
CATGATCTTC AAGACCGACA CCGGCGGCGA CCTGACCCTG GACGAGATCC TGAAGAACCA 180
GCAGCTGCTG AACGACATCA GCGGCAAGCT GGACGGCGTG AACGGCAGCC TGAACGACCT 240
GATCGCCCAG GGCAACCTGA ACACCGAGCT GAGCAAGGAG ATCCTTAAGA TCGCCAACGA 300
GCAGAACCAG GTGCTGAACG ACGTGAACAA CAAGCTGGAC GCCATCAACA CCATGCTGCG 360
CGTGTACCTG CCGAAGATCA CCAGCATGCT GAGCGACGTG ATGAAGCAGA ACTACGCCCT 420
GAGCCTGCAG ATCGAGTACC TGAGCAAGCA GCTGCAGGAG ATCAGCGACA AGCTGGACAT 480
CATCAACGTG AACGTCCTGA TCAACAGCAC CCTGACCGAG ATCACCCCGG CCTACCAGCG 540
CATCAAGTAC GTGAACGAGA AGTTCGAAGA GCTGACCTTC GCCACCGAGA CCAGCAGCAA 600
GGTGAAGAAG GACGGCAGCC CGGCCGACAT CCTGGACGAG CTGACCGAGC TGACCGAGCT 660
GGCCAAGAGC GTGACCAAGA ACGACGTGGA CGGCTTCGAG TTCTACCTGA ACACCTTCCA 720
WO 96/10083 2 1 9 9 OA-9 PCT/EP95/03826
- 174 -
CGACGTGATG GTGGGCAACA ACCTGTTCGG CCGCAGCGCC CTGAAGACCG CCAGCGAGCT 780
GATCACCAAG GAGAACGTGA AGACCACCGG CAGCGAGGTG GGCAACGTGT ACAACATCGT 840
GATCGTGCTG ACCGCCCTGC AGGCCCAGGC CTTCCTGACC CTGACCACCT GTCGCAAGCT 900
GCTGGGCCTG GCCGACGTCG ACTACACCAG CATCATGAAC GAGCACTTGA ACAAGGAGAA 960
GGAGGAGTTC CGCGTGAACA TCCTGCCGAC CCTGAGCAAC ACCTTCAGCA ACCCGAACTA 1020
CGCCAAGGTG AAGGGCAGCG ACGAGGACGC CAAGATGATC GTGGAGGCTA AGCCGGGCCA 1080
CGCGTTGATC GGCTTCGAGA TCAGCAACGA CAGCATCACC GTGCTGAAGG TGTACGAGGC 1140
CAAGCTGAAG CAGAACTACC AGGTGGACAA GGACAGCTTG AGCGAGGTGA TCTACGGCGA 1200
CATGGACAAG CTGCTGTGTC CGGACCAGAG CGAGCAAATC TACTACACCA ACAACATCGT 1260
GTTCCCGAAC GAGTACGTGA TCACCAAGAT CGACTTCACC AAGAAGATGA AGACCCTGCG 1320
CTACGAGGTG ACCGCCAACT TCTACGACAG CAGCACCGGC GAGATCGACC TGAACAAGAA 1380
GAAGGTGGAG AGCAGCGAGG CCGAGTACCG CACCCTGAGC GCGAACGACG ACGGCGTCTA 1440
CATGCCACTG GGCGTGATCA GCGAGACCTT CCTGACCCCG ATCAACGGCT TTGGCCTGCA 1500
GGCCGACGAG AACAGCCGCC TGATCACCCT GACCTGAGAG AGCTACCTGC GCGAGCTGCT 1560
GCTAGCCACC GACCTGAGCA ACAAGGAGAC CAAGCTGATC GTGCCACCGA GCGGCTTCAT 1620
CAGCAACATC GTGGAGAACG GCAGCATCGA GGAGGACAAC CTGGAGCCGT GGAAGGCCAA 1680
CAACAAGAAC GCCTACGTGG ACCACACCGG CGGCGTGAAC GGCACCAAGG CCCTGTACGT 1740
GCACAAGGAC GGCGGCATCA GCCAGTTCAT CGGCGACAAG CTGAAGCCGA AGACCGAGTA 1800
CGTGATCCAG TACACCGTGA AGGGCAAGCC ATCGATTCAC CTGAAGGACG AGAACACCGG 1860
CTACATCCAC TACGAGGACA CCAACAACAA CCTGAGGGAC TACCAGACCA TCAACAAGCG 1920
CTTCACCACC GGCACCGACC TGAAGGGCGT GTACCTGATC CTGAAGAGCC AGAACGGCGA 1980
CGAGGCCTGG GGCGACAACT TGATCATCCT GGAGATCAGC CCGAGCGAGA AGCTGCTGAG 2040
CCCGGAGCTG ATCAACACCA ACAACTGGAC CAGCACCGGC AGCACCAACA TCAGCGGCAA 2100
CACCCTGACC CTGTACCAGG GCGGCCGCGG CATCCTGAAG CAGAACCTGC AGCTGGACAG 2160
CTTCAGCACC TACCGCGTGT ACTTCAGCGT GAGCGGCGAC GCCAACGTGC GCATCCGCAA 2220
CAGCCGCGAG GTGCTGTTCG AGAAGAGGTA CATGAGCGGC GCCAAGGACG TGAGCGAGAT 2280
GTTCACCACC AAGTTCGAGA AGGACAACTT CTACATCGAG CTGAGCCAGG GCAACAACCT 2340
WO 96/10083 2 19:9 Q 4 9 PCT/EP95/03826
- 175 -
GTACGGCGGC CCGATCGTGC ACTTCTACGA CGTGAGCATC AAGTTAACGT AGAGCTCAGA 2400
TCT 2403
(2) INFORMATION FOR SEQ ID NO: 31:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2612 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genanic)
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 118..2484
(D) OTHER INFORMATION: /note= "Native DNA sequence
encoding VIP3A(b) fran AB424"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:31:
ATTGAAATTG ATAAAAAGTT ATGAGTGTTT AATAATCAGT AATTACCAAT AAAGAATTAA 60
GAATACAAGT TTACAAGAAA TAAGTGTTAC AAAAAATAGC TGAAAAGGAA GATGAAC 117
ATG AAC AAG AAT AAT ACT AAA TTA AGC ACA AGA GCC TTA CCA AGT TTT 165
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
790 795 800 805
ATT GAT TAT TTC AAT GGC ATT TAT GGA TTT GCC ACT GGT ATC AAA GAC 213
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
810 815 820
ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA ACC CTA 261
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
825 830 835
GAC GAA ATT TTA AAG AAT CAG CAG CTA CTA AAT GAT ATT TCT GGT AAA 309
Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Asp Ile Ser Gly Lys
840 845 850
TTG GAT GGG GTG AAT GGA AGC TTA AAT GAT CTT ATC GCA CAG GGA AAC 357
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln Gly Asn
855 860 865
TTA AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT GAA CAA 405
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gln
870 875 880 885
AAT CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA AAT ACG 453
WO 96/10083 IN w PCT/EP95/03826
2199049
-176-
Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
890 895 900
ATG CTT CGG GTA TAT CTA CCT AAA ATT ACC TCT ATG TTG AGT GAT GTA 501
Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
905 910 915
ATG AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA AGT AAA 549
Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Ile Glu Tyr Leu Ser Lys
920 925 930
CAA TTG CAA GAG ATT TCT GAT AAG TTG GAT ATT ATT AAT GTA AAT GTA 597
Gln Leu Gln Glu Ile Ser Asp Lys Leu Asp Ile Ile Asn Val Asn Val
935 940 945
CTT ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA AGG ATT 645
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
950 955 960 965
AAA TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA GAA ACT 693
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
970 975 980
AGT TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CGT GAT GAG 741
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Arg Asp Glu
985 990 995
TTA ACT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA AAA AAT GAT GTG 789
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
1000 1005 1010
GAT GGT TTT GAA TTT TAC CTT AAT ACA TTC CAC GAT GTA ATG GTA GGA 837
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
1015 1020 1025
AAT AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA TTA ATT 885
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu Ile
1030 1035 1040 1045
ACT AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT GTT TAT 933
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
1050 1055 1060
AAC TTC CTA ATT GTA TTA ACA GCT CTG CAA GCA AAA GCT TTT CTT ACT 981
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Lys Ala Phe Leu Thr
1065 1070 1075
TTA ACA CCA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT TAT ACT 1029
Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
1080 1085 1090
TCT ATT ATG AAT GAA CAT TTA AAT AAG GAA AAA GAG GAA TTT AGA GTA 1077
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
1095 1100 1105
WO 96/10083 2 1 9 9 0 4 9 PCTIEP95/03826
- 177 -
AAC ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT TAT GCA 1125
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
1110 1115 1120 1125
AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA GCT AAA 1173
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu Ala Lys
1130 1135 1140
CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA ATT ACA 1221
Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser Ile Thr
1145 1150 1155
GTA TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA GTC GAT 1269
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln Val Asp
1160 1165 1170
AAG GAT TCC TTA TCG GAA GTT ATT TAT GGC GAT ATG GAT AAA TTA TTG 1317
Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys Leu Leu
1175 1180 1185
TGC CCA GAT CAA TCT GGA CAA ATC TAT TAT ACA AAT AAC ATA GTA TTT 1365
Cys Pro Asp Gln Ser Gly Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
1190 1195 1200 1205
CCA AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA ATG AAA 1413
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
1210 1215 1220
ACT TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT ACA GGA 1461
Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly
1225 1230 1235
GAA ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG GAG TAT 1509
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
1240 1245 1250
AGA ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA GGT GTC 1557
Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val
1255 1260 1265
ATC AGT GAA ACA TTT TTG ACT CCG ATT AAT GGG TTT GGC CTC CAA GCT 1605
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
1270 1275 1280 1285
GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT TTA AGA 1653
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
1290 1295 1300
GAA CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA TTG ATC 1701
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
1305 1310 1315
GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG TCC ATA 1749
Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly Ser Ile
1320 1325 1330
WO 96/10083 2 1 9 9 Q 4 A PCT/EP95/03826
-178-
GAA GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT GCG TAT 1797
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr
1335 1340 1345
GTA GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT GTT CAT 1845
Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His
1350 1355 1360 1365
AAG GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA CCG AAA 1893
Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys Pro Lys
1370 1375 1380
ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT ATT CAT 1941
Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly'Lys Pro Ser Ile His
1385 1390 1395
TTA AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA AAT AAT 1989
Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr Asn Asn
1400 1405 1410
AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA GGA ACT 2037
Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr Gly Thr
1415 1420 1425
GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA GAT GAA 2085
Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gln Asn Gly Asp Glu
1430 1435 1440 1445
GCT TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT GAA AAG 2133
Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser Glu Lys
1450 1455 1460
TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT ACG GGA 2181
Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn Trp Thr Ser Thr Gly
1465 1470 1475
TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA GGA CGA 2229
Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly Gly Arg
1480 1485 1490
GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT TAT AGA 2277
Gly Ile Leu Lys Gln Asn Leu Gln Leu Asp Ser Phe Ser Thr Tyr Arg
1495 1500 1505
GTG TAT TTC TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA AAT TCT 2325
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg Asn Ser
1510 1515 1520 1525
AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC GGT GCT AAA GAT GTT 2373
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
1530 1535 1540
TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT AAC TTC TAT ATA GAG 2421
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr Ile Glu
WO 96/10083 2 1 9 9 0 4PCT/E"5/03826
-179-
1545 1550 1555
CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT ATT GTA CAT TTT TAC 2469
Leu Ser Gln Gly Asn Asn Leu Tyr Gly Gly Pro Ile Val His Phe Tyr
1560 1565 1570
GAT GTC TCT ATT AAG TAAGATCGGG ATCTAATATT AACAGTPTTT AGAAGCTAAT 2524
Asp Val Ser Ile Lys
1575
TCTTGTATAA TGTCCTTGAT TATGGAAAAA CACAATTTTG TTTGCTAAGA TGTATATATA 2584
GCTCACTCAT TAAAAGGCAA TCAAGCTT 2612
(2) INFORMATION FOR SEQ ID N0:32:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 789 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
1 5 10 15
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
20 25 30
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
35 40 45
Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Asp Ile Ser Gly Lys
50 55 60
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln Gly Asn
65 70 75 80
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gln
85 90 95
Asn Gln Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
100 105 110
Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
115 120 125
Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Ile Glu Tyr Leu Ser Lys
130 135 140
Gln Leu Gln Glu Ile Ser Asp Lys Leu Asp Ile Ile Asn Val Asn Val
145 150 155 160
WO 96/10083 1:9 9 0 4 9 PCT/EP95/03826
-180-
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
165 170 175
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
180 185 190
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Arg Asp Glu
195 200 205
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
210 215 220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
225 230 235 240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu Ile
245 250 255
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
260 265 270
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Lys Ala Phe Leu Thr
275 280 285
Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
290 295 300
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
305 310 315 320
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330 335
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu Ala Lys
340 345 350
Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser Ile Thr
355 360 365
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln Val Asp
370 375 380
Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys Leu Leu
385 390 395 400
Cys Pro Asp Gln Ser Gly Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
405 410 415
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
420 425 430
Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly
435 440 445
WO 96/10083 2 1 9 9 0 4 9 PCT/E"5/03826
- 181 -
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
450 455 460
Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val
465 470 475 480
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
485 490 495
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
500 505 510
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
515 520 525
Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly Ser Ile
530 535 540
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr
545 550 555 560
Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His
565 570 575
Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys Pro Lys
580 585 590
Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly Lys Pro Ser Ile His
595 600 605
Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr Asn Asn
610 615 620
Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr Gly Thr
625 630 635 640
Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gln Asn Gly Asp Glu
645 650 655
Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser Glu Lys
660 665 670
Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn Trp Thr Ser Thr Gly
675 680 685
Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly Gly Arg
690 695 700
Gly Ile Leu Lys Gln Asn Leu Gln Leu Asp Ser Phe Ser Thr Tyr Arg
705 710 715 720
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg Asn Ser
725 730 735
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
WO 96/10083 M 2 1 9 9 0 4 9 PCTIEP95/03826
-182-
740 745 750
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr Ile Glu
755 760 765
Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro Ile Val His Phe Tyr
770 775 780
Asp Val Ser Ile Lys
785
(2) INFORMATION FOR SEQ ID NO:33:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "forward primer used to make
pCIB5526"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:
GGATCCACCA TGAAGACCAA CCAGATCAGC 30
(2) INFORMATION FOR SEQ ID NO:34:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 15 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "reverse primer used to make
pCIB5526"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:
AAGCTTCAGC TCCTT 15
(2) INFORMATION FOR SEQ ID NO:35:
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-183-
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2576 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 9..2564
(D) OTHER INFORMATION: /note= "Maize optimized sequence
encoding VIP1A(a) with the Bacillus secretion signal removed as
contained in pCIB5526"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:
GATCCACC ATG AAG ACC AAC CAG ATC AGC ACC ACC CAG AAG AAC CAG CAG 50
Met Lys Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln
825 830 835
AAG GAG ATG GAC CGC AAG GGC CTG CTG GGC TAC TAC TTC AAG GGC AAG 98
Lys Glu Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys
840 845 850
GAC TTC AGC AAC CTG ACC ATG TTC GCC CCC ACG CGT GAC AGC ACC CTG 146
Asp Phe Ser Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu
855 860 865
ATC TAC GAC CAG CAG ACC GCC AAC AAG CTG CTG GAC AAG AAG CAG CAG 194
Ile Tyr Asp Gln Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln
870 875 880
GAG TAC CAG AGC ATC CGC TGG ATC GGC CTG ATC CAG AGC AAG GAG ACC 242
Glu Tyr Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr
885 890 895
GGC GAC TTC ACC TTC AAC CTG AGC GAG GAC GAG CAG GCC ATC ATC GAG 290
Gly Asp Phe Thr Phe Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu
900 905 910 915
ATC AAC GGC AAG ATC ATC AGC AAC AAG GGC AAG GAG AAG CAG GTG GTG 338
Ile Asn Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gln Val Val
920 925 930
CAC CTG GAG AAG GGC AAG CTG GTG CCC ATC AAG ATC GAG TAC CAG AGC 386
His Leu Glu Lys Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser
935 940 945
GAC ACC AAG TTC AAC ATC GAC AGC AAG ACC TTC AAG GAG CTG AAG CTT 434
WO 96/10083 2 19 9 0 4 9 PCT/EP95/03826
-184-
Asp Thr Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu
950 955 960
TTC AAG ATC GAC AGC CAG AAC CAG CCC CAG CAG GTG CAG CAG GAC GAG 482
Phe Lys Ile Asp Ser Gin Asn Gin Pro Gin Gin Val Gin Gin Asp Glu
965 970 975
CTG CGC AAC CCC GAG TTC AAC AAG AAG GAG AGC CAG GAG TTC CTG GCC 530
Leu Arg Asn Pro Glu Phe Asn Lys Lys Glu Ser Gin Glu Phe Leu Ala
980 985 990 995
AAG CCC AGC AAG ATC AAC CTG TTC ACC CAG CAG ATG AAG CGC GAG ATC 578
Lys Pro Ser Lys Ile Asn Leu Phe Thr Gin Gin Met Lys Arg Glu Ile
1000 1005 1010
GAC GAG GAC ACC GAC ACC GAC GGC GAC AGC ATC CCC GAC CTG TGG GAG 626
Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu
1015 1020 1025
GAG AAC GGC TAC ACC ATC CAG AAC CGC ATC GCC GTG AAG TGG GAC GAC 674
Glu Asn Gly Tyr Thr Ile Gln Asn Arg Ile Ala Val Lys Trp Asp Asp
1030 1035 1040
AGC CTG GCT AGC AAG GGC TAC ACC AAG TTC GTG AGC AAC CCC CTG GAG 722
Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu
1045 1050 1055
AGC CAC ACC GTG GGC GAC CCC TAC ACC GAC TAC GAG AAG GCC GCC CGC 770
Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg
1060 1065 1070 1075
GAC CTG GAC CTG AGC AAC GCC AAG GAG ACC TTC AAC CCC CTG GTG GCC 818
Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala
1080 1085 1090
GCC TTC CCC AGC GTG AAC GTG AGC ATG GAG AAG GTG ATC CTG AGC CCC 866
Ala Phe Pro Ser Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro
1095 1100 1105
AAC GAG AAC CTG AGC AAC AGC GTG GAG AGC CAC TCG AGC ACC AAC TGG 914
Asn Glu Asn Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp
1110 1115 1120
AGC TAC ACC AAC ACC GAG GGC GCC AGC GTG GAG GCC GGC ATC GGT CCC 962
Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro
1125 1130 1135
AAG GGC ATC AGC TTC GGC GTG AGC GTG AAC TAC CAG CAC AGC GAG ACC 1010
Lys Gly Ile Ser Phe Gly Val Ser Val Asn Tyr Gin His Ser Glu Thr
1140 1145 1150 1155
GTG GCC CAG GAG TGG GGC ACC AGC ACC GGC AAC ACC AGC CAG TTC AAC 1058
Val Ala Gin Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gin Phe Asn
1160 1165 1170
WO 96/10083 ._ 2 1 9 9 0 .4 9 PCT/EP95/03826
9
-185-
ACC GCC AGC GCC GGC TAC CTG AAC GCC AAC GTG CGC TAC AAC AAC GTG 1106
Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val
1175 1180 1185
GGC ACC GGC GCC ATC TAC GAC GTG AAG CCC ACC ACC AGC TTC GTG CTG 1154
Gly Thr Gly Ala Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu
1190 1195 1200
AAC AAC GAC ACC ATC GCC ACC ATC ACC GCC AAG TCG AAT TCC ACC GCC 1202
Asn Asn Asp Thr Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala
1205 1210 1215
CTG AAC ATC AGC CCC GGC GAG AGC TAC CCC AAG AAG GGC CAG AAC GGC 1250
Leu Asn Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly
1220 1225 1230 1235
ATC GCC ATC ACC AGC ATG GAC GAC TTC AAC AGC CAC CCC ATC ACC CTG 1298
Ile Ala Ile Thr Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu
1240 1245 1250
AAC AAG AAG CAG GTG GAC AAC CTG CTG AAC AAC AAG CCC ATG ATG CTG 1346
Asn Lys Lys Gin Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu
1255 1260 1265
GAG ACC AAC CAG ACC GAC GGC GTC TAC AAG ATC AAG GAC ACC CAC GGC 1394
Glu Thr Asn Gln Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly
1270 1275 1280
AAC ATC GTG ACG GGC GGC GAG TGG AAC GGC GTG ATC CAG CAG ATC AAG 1442
Asn Ile Val Thr Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys
1285 1290 1295
GCC AAG ACC GCC AGC ATC ATC GTC GAC GAC GGC GAG CGC GTG GCC GAG 1490
Ala Lys Thr Ala Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu
1300 1305 1310 1315
AAG CGC GTG GCC GCC AAG GAC TAC GAG AAC CCC GAG GAC AAG ACC CCC 1538
Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro
1320 1325 1330
AGC CTG ACC CTG AAG GAC GCC CTG AAG CTG AGC TAC CCC GAC GAG ATC 1586
Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile
1335 1340 1345
AAG GAG ATC GAG GGC TTG CTG TAC TAC AAG AAC AAG CCC ATC TAC GAG 1634
Lys Glu Ile Glu Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu
1350 1355 1360
AGC AGC GTG ATG ACC TAT CTA GAC GAG AAC ACC GCC AAG GAG GTG ACC 1682
Ser Ser Val Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr
1365 1370 1375
AAG CAG CTG AAC GAC ACC ACC GGC AAG TTC AAG GAC GTG AGC CAC CTG 1730
Lys Gln Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu
1380 1385 1390 1395
WO 96/10083 iF 2 19 9 0 4 9 PCT/EP95/03826
- 186 -
TAC GAC GTG AAG CTG ACC CCC AAG ATG AAC GTG ACC ATC AAG CTG AGC 1778
Tyr Asp Val Lys Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser
1400 1405 1410
ATC CTG TAC GAC AAC GCC GAG AGC AAC GAC AAC AGC ATC GGC AAG TGG 1826
Ile Leu Tyr Asp Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp
1415 1420 1425
ACC AAC ACC AAC ATC GTG AGC GGC GGC AAC AAC GGC AAG AAG CAG TAC 1874
Thr Asn Thr Asn Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr
1430 1435 1440
AGC AGC AAC AAC CCC GAC GCC AAC CTG ACC CTG AAC ACC GAC GCC CAG 1922
Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr Led Asn Thr Asp Ala Gln
1445 1450 1455
GAG AAG CTG AAC AAG AAC CGC GAC TAC TAC ATC AGC CTG TAC ATG AAG 1970
Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys
1460 1465 1470 1475
AGC GAG AAG AAC ACC CAG TGC GAG ATC ACC ATC GAC GGC GAG ATA TAC 2018
Ser Glu Lys Asn Thr Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr
1480 1485 1490
CCC ATC ACC ACC AAG ACC GTG AAC GTG AAC AAG GAC AAC TAC AAG CGC 2066
Pro Ile Thr Thr Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg
1495 1500 1505
CTG GAC ATC ATC GCC CAC AAC ATC AAG AGC AAC CCC ATC AGC AGC CTG 2114
Leu Asp Ile Ile Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu
1510 1515 1520
CAC ATC AAG ACC AAC GAC GAG ATC ACC CTG TTC TGG GAC GAC ATA TCG 2162
His Ile Lys Thr Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser
1525 1530 1535
ATT ACC GAC GTC GCC AGC ATC AAG CCC GAG AAC CTG ACC GAC AGC GAG 2210
Ile Thr Asp Val Ala Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu
1540 1545 1550 1555
ATC AAG CAG ATA TAC AGT CGC TAC GGC ATC AAG CTG GAG GAC GGC ATC 2258
Ile Lys Gln Ile Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile
1560 1565 1570
CTG ATC GAC AAG AAA GGC GGC ATC CAC TAC GGC GAG TTC ATC AAC GAG 2306
Leu Ile Asp Lys Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu
1575 1580 1585
GCC AGC TTC AAC ATC GAG CCC CTG CAG AAC TAC GTG ACC AAG TAC GAG 2354
Ala Ser Phe Asn Ile Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Glu
1590 1595 1600
GTG ACC TAC AGC AGC GAG CTG GGC CCC AAC GTG AGC GAC ACC CTG GAG 2402
Val Thr Tyr Set Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu
WO 96/10083 ' 9 9 0 4 9 PGT/EP95/03826
- 187-
1605 1610 1615
AGC GAC AAG ATT TAC AAG GAC GGC ACC ATC AAG TTC GAC TTC ACC AAG 2450
Ser Asp Lys Ile Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys
1620 1625 1630 1635
TAC AGC AAG AAC GAG CAG GGC CTG TTC TAC GAC AGC GGC CTG AAC TGG 2498
Tyr Ser Lys Asn Glu Gln Gly Leu Phe Tyr Asp Ser Giy Leu Asn Trp
1640 1645 1650
GAC TTC AAG ATC AAC GCC ATC ACC TAC GAC GGC AAG GAG ATG AAC GTG 2546
Asp Phe Lys Ile Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val
1655 1660 1665
TTC CAC CGC TAC AAC AAG TAGATCTGAG CT 2576
Phe His Arg Tyr Asn Lys
1670
(2) INFORMATION FOR SEQ ID NO:36:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 852 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:
Met Lys Thr Asn Gln Ile Ser Thr Thr Gln Lys Asn Gln Gln Lys Glu
1 5 10 15
Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr Phe Lys Gly Lys Asp Phe
20 25 30
Ser Asn Leu Thr Met Phe Ala Pro Thr Arg Asp Ser Thr Leu Ile Tyr
35 40 45
Asp Gln Gln Thr Ala Asn Lys Leu Leu Asp Lys Lys Gln Gln Glu Tyr
50 55 60
Gln Ser Ile Arg Trp Ile Gly Leu Ile Gln Ser Lys Glu Thr Giy Asp
65 70 75 80
Phe Thr Phe Asn Leu Ser Glu Asp Glu Gln Ala Ile Ile Glu Ile Asn
85 90 95
Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu Lys Gin Val Val His Leu
100 105 110
Glu Lys Gly Lys Leu Val Pro Ile Lys Ile Glu Tyr Gln Ser Asp Thr
115 120 125
Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys Glu Leu Lys Leu Phe Lys
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
- 188 -
130 135 140
Ile Asp Ser Gin Asn Gln Pro Gln Gin Val Gln Gin Asp Glu Leu Arg
145 150 155 160
Asn Pro Glu Phe Asn Lys Lys Glu Ser Gln Glu Phe Leu Ala Lys Pro
165 170 175
Ser Lys Ile Asn Leu Phe Thr Gln Gln Met Lys Arg Glu Ile Asp Glu
180 185 190
Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro Asp Leu Trp Glu Glu Asn
195 200 205
Gly Tyr Thr Ile Gln Asn Arg Ile Ala Val Lys* Trp Asp Asp Ser Leu
210 215 220
Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser Asn Pro Leu Glu Ser His
225 230 235 240
Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu Lys Ala Ala Arg Asp Leu
245 250 255
Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn Pro Leu Val Ala Ala Phe
260 265 270
Pro Ser Val Asn Val Ser Met Glu Lys Val Ile Leu Ser Pro Asn Glu
275 280 285
Asn Leu Ser Asn Ser Val Glu Ser His Ser Ser Thr Asn Trp Ser Tyr
290 295 300
Thr Asn Thr Glu Gly Ala Ser Val Glu Ala Gly Ile Gly Pro Lys Gly
305 310 315 320
Ile Ser Phe Gly Val Ser Val Asn Tyr Gln His Ser Glu Thr Val Ala
325 330 335
Gln Glu Trp Gly Thr Ser Thr Gly Asn Thr Ser Gln Phe Asn Thr Ala
340 345 350
Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg Tyr Asn Asn Val Gly Thr
355 360 365
Gly Ala Ile Tyr Asp Val Lys Pro Thr Thr Ser Phe Val Leu Asn Asn
370 375 380
Asp Thr Ile Ala Thr Ile Thr Ala Lys Ser Asn Ser Thr Ala Leu Asn
385 390 395 400
Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys Gly Gln Asn Gly Ile Ala
405 410 415
Ile Thr Ser Met Asp Asp Phe Asn Ser His Pro Ile Thr Leu Asn Lys
420 425 430
WO 96/10083 2 19 9 0 4 PCf/EP95/03826
-189-
Lys Gln Val Asp Asn Leu Leu Asn Asn Lys Pro Met Met Leu Glu Thr
435 440 445
Asn Gln Thr Asp Gly Val Tyr Lys Ile Lys Asp Thr His Gly Asn Ile
450 455 460
Val Thr Gly Gly Glu Trp Asn Gly Val Ile Gln Gln Ile Lys Ala Lys
465 470 475 480
Thr Ala Ser Ile Ile Val Asp Asp Gly Glu Arg Val Ala Glu Lys Arg
485 490 495
Val Ala Ala Lys Asp Tyr Glu Asn Pro Glu Asp Lys Thr Pro Ser Leu
500 505 510
Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr Pro Asp Glu Ile Lys Glu
515 520 525
Ile Glu Gly Leu Leu Tyr Tyr Lys Asn Lys Pro Ile Tyr Glu Ser Ser
530 535 540
Val Met Thr Tyr Leu Asp Glu Asn Thr Ala Lys Glu Val Thr Lys Gln
545 550 555 560
Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp Val Ser His Leu Tyr Asp
565 570 575
Val Lys Leu Thr Pro Lys Met Asn Val Thr Ile Lys Leu Ser Ile Leu
580 585 590
Tyr Asp Asn Ala Glu Ser Asn Asp Asn Ser Ile Gly Lys Trp Thr Asn
595 600 605
Thr Asn Ile Val Ser Gly Gly Asn Asn Gly Lys Lys Gln Tyr Ser Ser
610 615 620
Asn Asn Pro Asp Ala Asn Leu Thr Leu Asn Thr Asp Ala Gln Glu Lys
625 630 635 640
Leu Asn Lys Asn Arg Asp Tyr Tyr Ile Ser Leu Tyr Met Lys Ser Glu
645 650 655
Lys Asn Thr Gln Cys Glu Ile Thr Ile Asp Gly Glu Ile Tyr Pro Ile
660 665 670
Thr Thr Lys Thr Val Asn Val Asn Lys Asp Asn Tyr Lys Arg Leu Asp
675 680 685
Ile Ile Ala His Asn Ile Lys Ser Asn Pro Ile Ser Ser Leu His Ile
690 695 700
Lys Thr Asn Asp Glu Ile Thr Leu Phe Trp Asp Asp Ile Ser Ile Thr
705 710 715 720
WO 96/10083 - 2 1 9 9 0 4 9 PCTIEP95/03826
-190-
Asp Val Ala Ser Ile Lys Pro Glu Asn Leu Thr Asp Ser Glu Ile Lys
725 730 735
Gln Ile Tyr Ser Arg Tyr Gly Ile Lys Leu Glu Asp Gly Ile Leu Ile
740 745 750
Asp Lys Lys Gly Gly Ile His Tyr Gly Glu Phe Ile Asn Glu Ala Ser
755 760 765
Phe Asn Ile Glu Pro Leu Gln Asn Tyr Val Thr Lys Tyr Glu Val Thr
770 775 780
Tyr Ser Ser Glu Leu Gly Pro Asn Val Ser Asp Thr Leu Glu Ser Asp
785 790 795 800
Lys Ile Tyr Lys Asp Gly Thr Ile Lys Phe Asp Phe Thr Lys Tyr Ser
805 810 815
Lys Asn Glu Gln Gly Leu Phe Tyr Asp Ser Gly Leu Asn Trp Asp Phe
820 825 830
Lys Ile Asn Ala Ile Thr Tyr Asp Gly Lys Glu Met Asn Val Phe His
835 840 845
Arg Tyr Asn Lys
850
(2) INFORMATION FOR SEQ ID NO:37:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "forward primer used to make
pCIB5527"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:
GGATCCACCA TGCTGCAGAA CCTGAAGATC AC 32
(2) INFORMATION FOR SEQ ID NO:38:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 18 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
WO 96/10083 2 1 9 9 0 4 9 PGT/EP95/03826
-191 -
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "reverse primer used to make
pCIB5527"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:
AAGCTTCCAC TCCTTCTC 18
(2) INFORMATION FOR SEQ ID NO:39:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1241 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 9..1238
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence encoding VIP2A(a) with the Bacillus secretion signal
removed as contained in pCIB5527"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:
GATCCACC ATG CTG CAG AAC CTG AAG ATC ACC GAC AAG GTG GAG GAC TTC 50
Met Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu Asp Phe
855 860 865
AAG GAG GAC AAG GAG AAG GCC AAG GAG TGG GGC AAG GAG AAG GAG AAG 98
Lys Glu Asp Lys Glu Lys Ala Lys Glu Tip Gly Lys Glu Lys Glu Lys
870 875 880
GAG TGG AAG CTT ACC GCC ACC GAG AAG GGC AAG ATG AAC AAC TTC CTG 146
Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu
885 890 895
GAC AAC AAG AAC GAC ATC AAG ACC AAC TAC AAG GAG ATC ACC TTC AGC 194
Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr Phe Ser
900 905 910
ATA GCC GGC AGC TTC GAG GAC GAG ATC AAG GAC CTG AAG GAG ATC GAC 242
WO 96/10083 2 1 9 9 0 4 9 PGT/EP95/03826
-192-
Ile Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu Ile Asp
915 920 925 930
AAG ATG TTC GAC AAG ACC AAC CTG AGC AAC AGC ATC ATC ACC TAC AAG 290
Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr Tyr Lys
935 940 945
AAC GTG GAG CCC ACC ACC ATC GGC TTC AAC AAG AGC CTG ACC GAG GGC 338
Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr Glu Gly
950 955 960
AAC ACC ATC AAC AGC GAC GCC ATG GCC CAG TTC AAG GAG CAG TTC CTG 386
Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln Phe Leu
965 970 975
GAC CGC GAC ATC AAG TTC GAC AGC TAC CTG GAC ACC CAC CTG ACC GCC 434
Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala
980 985 990
CAG CAG GTG AGC AGC AAG GAG CGC GTG ATC CTG AAG GTG ACC GTC CCC 482
Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr Val Pro
995 1000 1005 1010
AGC GGC AAG GGC AGC ACC ACC CCC ACC AAG GCC GGC GTG ATC CTG AAC 530
Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile Leu Asn
1015 1020 1025
AAC AGC GAG TAC AAG ATG CTG ATC GAC AAC GGC TAC ATG GTG CAC GTG 578
Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val His Val
1030 1035 1040
GAC AAG GTG AGC AAG GTG GTG AAG AAG GGC GTG GAG TGC CTC CAG ATC 626
Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu Gln Ile
1045 1050 1055
GAG GGC ACC CTG AAG AAG AGT CTA GAC TTC AAG AAC GAC ATC AAC GCC 674
Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile Asn Ala
1060 1065 1070
GAG GCC CAC AGC TGG GGC ATG AAG AAC TAC GAG GAG TGG GCC AAG GAC 722
Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala Lys Asp
1075 1080 1085 1090
CTG ACC GAC AGC CAG CGC GAG GCC CTG GAC GGC TAC GCC CGC CAG GAC 770
Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg Gln Asp
1095 1100 1105
TAC AAG GAG ATC AAC AAC TAC CTG CGC AAC CAG GGC GGC AGC GGC AAC 818
Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gin Gly Gly Ser Gly Asn
1110 1115 1120
GAG AAG CTG GAC GCC CAG ATC AAG AAC ATC AGC GAC GCC CTG GGC AAG 866
Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu Gly Lys
1125 1130 1135
WO 96/10083 n A 0 4 g PCT/EP95/03826
.PF
- 193 -
AAG CCC ATC CCC GAG AAC ATC ACC GTG TAC CGC TGG TGC GGC ATG CCC 914
Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly Met Pro
1140 1145 1150
GAG TTC GGC TAC CAG ATC AGC GAC CCC CTG CCC AGC CTG AAG GAC TTC 962
Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys Asp Phe
1155 1160 1165 1170
GAG GAG CAG TTC CTG AAC ACC ATC AAG GAG GAC AAG GGC TAC ATG AGC 1010
Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Giy Tyr Met Ser
1175 1180 1185
ACC AGC CTG AGC AGC GAG CGC CTG GCC GCC TTC GGC AGC CGC AAG ATC 1058
Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys Ile
1190 1195 1200
ATC CTG CGC CTG CAG GTG CCC AAG GGC AGC ACT GGT GCC TAC CTG AGC 1106
Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser
1205 1210 1215
GCC ATC GGC GGC TTC GCC AGC GAG AAG GAG ATC CTG CTG GAT AAG GAC 1154
Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp Lys Asp
1220 1225 1230
AGC AAG TAC CAC ATC GAC AAG GTG ACC GAG GTG ATC ATC AAG GGC GTG 1202
Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys Gly Val
1235 1240 1245 1250
AAG CGC TAC GTG GTG GAC GCC ACC CTG CTG ACC AAC TAG 1241
Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
1255 1260
(2) INFORMATION FOR SEQ ID NO:40:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 410 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:
Met Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu Asp Phe Lys Glu
1 5 10 15
Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys Glu Trp
20 25 30
Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu Asp Asn
35 40 45
Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr Phe Ser Ile Ala
50 55 60
WO 96/10083 2 19 9 0 4 9 PCT/EP95/03826
-194-
Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu Ile Asp Lys Met
65 70 75 80
Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr Tyr Lys Asn Val
85 90 95
Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr Glu Gly Asn Thr
100 105 110
Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln Phe Leu Asp Arg
115 120 125
Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala Gln Gln
130 135 -140
Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr Val Pro Ser Gly
145 150 155 160
Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile Leu Asn Asn Ser
165 170 175
Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val His Val Asp Lys
180 185 190
Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu Gln Ile Glu Gly
195 200 205
Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile Asn Ala Glu Ala
210 215 220
His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala Lys Asp Leu Thr
225 230 235 240
Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg Gln Asp Tyr Lys
245 250 255
Giu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser Gly Asn Glu Lys
260 265 270
Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu Gly Lys Lys Pro
275 280 285
Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly Met Pro Glu Phe
290 295 300
Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys Asp Phe Glu Glu
305 310 315 320
Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr Met Ser Thr Ser
325 330 335
Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys Ile Ile Leu
340 345 350
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-195-
Arg Leu Gin Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser Ala Ile
355 360 365
Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp Lys Asp Ser Lys
370 375 380
Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys Gly Val Lys Arg
385 390 395 400
Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
405 410
(2) INFORMATION FOR SEQ ID NO:41:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 72 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "oligonucleotide encoding
eukaryotic secretion signal used to construct pCIB5527"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:
GGATCCACCA TGGGCTGGAG CTGGATCTTC CTGTTCCTGC TGAGCGGCGC CGCGGGCGTG 60
CACTGCCTGC AG 72
(2) INFORMATION FOR SEQ ID NO:42:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1241 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 9..1238
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence encoding VIP2A(a) with the Bacillus secretion signal
removed and the eukaryotic secretion signal inserted as
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-196-
contained in pCIB5528"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:
GATCCACC ATG CTG CAG AAC CTG AAG ATC ACC GAC AAG GTG GAG GAC TTC 50
Met Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu Asp Phe
415 420
AAG GAG GAC AAG GAG AAG GCC AAG GAG TGG GGC AAG GAG AAG GAG AAG 98
Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys
425 430 435 440
GAG TGG AAG CTT ACC GCC ACC GAG AAG GGC AAG ATG AAC AAC TTC CTG 146
Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu
445 450 455
GAC AAC AAG AAC GAC ATC AAG ACC AAC TAC AAG GAG ATC ACC TTC AGC 194
Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr Phe Ser
460 465 470
ATA GCC GGC AGC TTC GAG GAC GAG ATC AAG GAC CTG AAG GAG ATC GAC 242
Ile Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu Ile Asp
475 480 485
AAG ATG TTC GAC AAG ACC AAC CTG AGC AAC AGC ATC ATC ACC TAC AAG 290
Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr Tyr Lys
490 495 500
AAC GTG GAG CCC ACC ACC ATC GGC TTC AAC AAG AGC CTG ACC GAG GGC 338
Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr Glu Gly
505 510 515 520
AAC ACC ATC AAC AGC GAC GCC ATG GCC CAG TTC AAG GAG CAG TTC CTG 386
Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln Phe Leu
525 530 535
GAC CGC GAC ATC AAG TTC GAC AGC TAC CTG GAC ACC CAC CTG ACC GCC 434
Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala
540 545 550
CAG CAG GTG AGC AGC AAG GAG CGC GTG ATC CTG AAG GTG ACC GTC CCC 482
Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr Val Pro
555 560 565
AGC GGC AAG GGC AGC ACC ACC CCC ACC AAG GCC GGC GTG ATC CTG AAC 530
Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile Leu Asn
570 575 580
AAC AGC GAG TAC AAG ATG CTG ATC GAC AAC GGC TAC ATG GTG CAC GIG 578
Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val His Val
585 590 595 600
GAC AAG GTG AGC AAG GTG GTG AAG AAG GGC GTG GAG TGC CTC CAG ATC 626
Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu Gln Ile
WO 96/10083 2 1 9 9 0 4 n PCT/EP95/03826
- 197-
605 610 615
GAG GGC ACC CTG AAG AAG AGT CTA GAC TTC AAG AAC GAC ATC AAC GCC 674
Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile Asn Ala
620 625 630
GAG GCC CAC AGC TGG GGC ATG AAG AAC TAC GAG GAG TGG GCC AAG GAC 722
Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala Lys Asp
635 640 645
CTG ACC GAC AGC CAG CGC GAG GCC CTG GAC GGC TAC GCC CGC CAG GAC 770
Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg Gin Asp
650 655 660
TAC AAG GAG ATC AAC AAC TAC CTG CGC AAC CAG GGC GGC AGC GGC AAC 818
Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser Gly Asn
665 670 675 680
GAG AAG CTG GAC GCC CAG ATC AAG AAC ATC AGC GAC GCC CTG GGC AAG 866
Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu Gly Lys
685 690 695
AAG CCC ATC CCC GAG AAC ATC ACC GTG TAC CGC TGG TGC GGC ATG CCC 914
Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly Met Pro
700 705 710
GAG TTC GGC TAC CAG ATC AGC GAC CCC CTG CCC AGC CTG AAG GAC TTC 962
Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys Asp Phe
715 720 725
GAG GAG CAG TTC CTG AAC ACC ATC AAG GAG GAC AAG GGC TAC ATG AGC 1010
Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr Met Ser
730 735 740
ACC AGC CTG AGC AGC GAG CGC CTG GCC GCC TTC GGC AGC CGC AAG ATC 1058
Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys Ile
745 750 755 760
ATC CTG CGC CTG CAG GTG CCC AAG GGC AGC ACT GGT GCC TAC CTG AGC 1106
Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser
765 770 775
GCC ATC GGC GGC TTC GCC AGC GAG AAG GAG ATC CTG CTG GAT AAG GAC 1154
Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp Lys Asp
780 785 790
AGC AAG TAC CAC ATC GAC AAG GTG ACC GAG GTG ATC ATC AAG GGC GTG 1202
Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys Gly Val
795 800 805
AAG CGC TAC GTG GTG GAC GCC ACC CTG CTG ACC AAC TAG 1241
Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
810 815 820
WO 96/10083 9 9 0 4 9 PCTJEP95/03826
-198-
(2) INFORMATION FOR SEQ ID NO:43:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 410 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:
Met Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu Asp Phe Lys Glu
1 5 10 15
Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys Glu Lys Glu Trp
20 25 30
Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn Phe Leu Asp Asn
35 40 45
Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr Phe Ser Ile Ala
50 55 60
Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu Ile Asp Lys Met
65 70 75 80
Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr Tyr Lys Asn Val
85 90 95
Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr Glu Gly Asn Thr
100 105 110
Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln Phe Leu Asp Arg
115 120 125
Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu Thr Ala Gln Gln
130 135 140
Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr Val Pro Ser Gly
145 150 155 160
Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile Leu Asn Asn Ser
165 170 175
Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val His Val Asp Lys
180 185 190
Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu Gln Ile Glu Gly
195 200 205
Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile Asn Ala Glu Ala
210 215 220
His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala Lys Asp Leu Thr
225 230 235 240
WO 96/10083 2 1 919 0 4 9 PCf/EP95/03826
-199-
Asp Ser Gin Arg Glu Ala Leu Asp Gly Tyr Ala Arg Gln Asp Tyr Lys
245 250 255
Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser Gly Asn Glu Lys
260 265 270
Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu Gly Lys Lys Pro
275 280 285
Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly Met Pro Glu Phe
290 295 300
Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys Asp Phe Glu Glu
305 310 315 320
Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr Met Ser Thr Ser
325 330 335
Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg Lys Ile Ile Leu
340 345 350
Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr Leu Ser Ala Ile
355 360 365
Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp Lys Asp Ser Lys
370 375 380
Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys Gly Val Lys Arg
385 390 395 400
Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
405 410
(2) INFORMATION FOR SEQ ID NO:44:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 86 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "oligonucleotide encoding
vacuolar targetting peptide used to construct pCIB5533"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:
CCGCGGGCGT GCACTGCCTC AGCAGCAGCA GCTTCGCCGA CAGCAACCCC ATCCGCGTGA 60
WO 96/10083 : 2 1 9 9 0 4 9 PCT/EP95/03826
- 200 -
CCGACCGCGC CGCCAGCACC CTGCAG 86
(2) INFORMATION FOR SEQ ID NO:45:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1358 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY : linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 9..1355
(D) OTHER INFORMATION: /note= "Maize optimized VIP2A(a)
with the Bacillus secretion signal removed and the vacuolar
targetting signal inserted as contained in pCIB5533"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:
GATCCACC ATG GGC TGG AGC TGG ATC TTC CTG TTC CTG CTG AGC GGC GCC 50
Met Gly Trp Ser Trp Ile Phe Leu Phe Leu Leu Ser Gly Ala
415 420
GCG GGC GTG CAC TGC CTC AGC AGC AGC AGC TTC GCC GAC AGC AAC CCC 98
Ala Gly Val His Cys Leu Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro
425 430 435 440
ATC CGC GTG ACC GAC CGC GCC GCC AGC ACC CTG CAG AAC CTG AAG ATC 146
Ile Arg Val Thr Asp Arg Ala Ala Ser Thr Leu Gln Asn Leu Lys Ile
445 450 455
ACC GAC AAG GTG GAG GAC TTC AAG GAG GAC AAG GAG AAG GCC AAG GAG 194
Thr Asp Lys Val Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu
460 465 470
TGG GGC AAG GAG AAG GAG AAG GAG TGG AAG CTT ACC GCC ACC GAG AAG 242
Trp Gly Lys Glu Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys
475 480 485
GGC AAG ATG AAC AAC TTC CTG GAC AAC AAG AAC GAC ATC AAG ACC AAC 290
Gly Lys Met Asn Asn Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn
490 495 500
TAC AAG GAG ATC ACC TTC AGC ATA GCC GGC AGC TTC GAG GAC GAG ATC 338
Tyr Lys Glu Ile Thr Phe Ser Ile Ala Gly Ser Phe Glu Asp Glu Ile
505 510 515 520
AAG GAC CTG AAG GAG ATC GAC AAG ATG TTC GAC AAG ACC AAC CTG AGC 386
WO 96/10083
9 0 PCT/EP95/03826
2 1949
-201 -
Lys Asp Leu Lys Glu Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser
525 530 535
AAC AGC ATC ATC ACC TAC AAG AAC GTG GAG CCC ACC ACC ATC GGC TTC 434
Asn Ser Ile Ile Thr Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe
540 545 550
AAC AAG AGC CTG ACC GAG GGC AAC ACC ATC AAC AGC GAC GCC ATG GCC 482
Asn Lys Ser Leu Thr Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala
555 560 565
CAG TTC AAG GAG CAG TTC CTG GAC CGC GAC ATC AAG TTC GAC AGC TAC 530
Gln Phe Lys Glu Gln Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr
570 575 580
CTG GAC ACC CAC CTG ACC GCC CAG CAG GTG AGC AGC AAG GAG CGC GTG 578
Leu Asp Thr His Leu Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val
585 590 595 600
ATC CTG AAG GTG ACC GTC CCC AGC GGC AAG GGC AGC ACC ACC CCC ACC 626
Ile Leu Lys Val Thr Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr
605 610 615
AAG GCC GGC GTG ATC CTG AAC AAC AGC GAG TAC AAG ATG CTG ATC GAC 674
Lys Ala Gly Val Ile Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp
620 625 630
AAC GGC TAC ATG GTG CAC GTG GAC AAG GTG AGC AAG GTG GTG AAG AAG 722
Asn Gly Tyr Met Val His Val Asp Lys Val Ser Lys Val Val Lys Lys
635 640 645
GGC GTG GAG TGC CTC CAG ATC GAG GGC ACC CTG AAG AAG AGT CTA GAC 770
Gly Val Glu Cys Leu Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp
650 655 660
TTC AAG AAC GAC ATC AAC GCC GAG GCC CAC AGC TGG GGC ATG AAG AAC 818
Phe Lys Asn Asp Ile Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn
665 670 675 680
TAC GAG GAG TGG GCC AAG GAC CTG ACC GAC AGC CAG CGC GAG GCC CTG 866
Tyr Glu Glu Trp Ala Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu
685 690 695
GAC GGC TAC GCC CGC CAG GAC TAC AAG GAG ATC AAC AAC TAC CTG CGC 914
Asp Gly Tyr Ala Arg Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg
700 705 710
AAC CAG GGC GGC AGC GGC AAC GAG AAG CTG GAC GCC CAG ATC AAG AAC 962
Asn Gln Gly Gly Ser Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn
715 720 725
ATC AGC GAC GCC CTG GGC AAG AAG CCC ATC CCC GAG AAC ATC ACC GTG 1010
Ile Ser Asp Ala Leu Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val
730 735 740
WO 96/10083 x 2 1 9 9 0 4 9 PCTIEP95/03826
- 202 -
TAC CGC TGG TGC GGC ATG CCC GAG TTC GGC TAC CAG ATC AGC GAC CCC 1058
Tyr Arg Trp Cys Gly Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro
745 750 755 760
CTG CCC AGC CTG AAG GAC TTC GAG GAG CAG TTC CTG AAC ACC ATC AAG 1106
Leu Pro Ser Leu Lys Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys
765 770 775
GAG GAC AAG GGC TAC ATG AGC ACC AGC CTG AGC AGC GAG CGC CTG GCC 1154
Glu Asp Lys Gly Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala
780 785 790
GCC TTC GGC AGC CGC AAG ATC ATC CTG CGC CTG CAG GTG CCC AAG GGC 1202
Ala Phe Gly Ser Arg Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly
795 800 805
AGC ACT GGT GCC TAC CTG AGC GCC ATC GGC GGC TTC GCC AGC GAG AAG 1250
Ser Thr Gly Ala Tyr Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys
810 815 820
GAG ATC CTG CTG GAT AAG GAC AGC AAG TAC CAC ATC GAC AAG GTG ACC 1298
Glu Ile Leu Leu Asp Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr
825 830 835 840
GAG GTG ATC ATC AAG GGC GTG AAG CGC TAC GTG GTG GAC GCC ACC CTG 1346
Glu Val Ile Ile Lys Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu
845 850 855
CTG ACC AAC TAG 1358
Leu Thr Asn
(2) INFORMATION FOR SEQ ID NO:46:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 449 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:
Met Gly Trp Ser Trp Ile Phe Leu Phe Leu Leu Ser Gly Ala Ala Gly
1 5 10 15
Val His Cys Leu Ser Ser Ser Ser Phe Ala Asp Ser Asn Pro Ile Arg
20 25 30
Val Thr Asp Arg Ala Ala Ser Thr Leu Gln Asn Leu Lys Ile Thr Asp
35 40 45
Lys Val Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly
50 55 60
WO 96/10083 1 9 9 0 4 9 PGT/EP95/03826
203-
Lys Glu Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys
65 70 75 80
Met Asn Asn Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys
85 90 95
Glu Ile Thr Phe Ser Ile Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp
100 105 110
Leu Lys Glu Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser
115 120 125
Ile Ile Thr Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys
130 135 140
Ser Leu Thr Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe
145 150 155 160
Lys Glu Gln Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp
165 170 175
Thr His Leu Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu
180 185 190
Lys Val Thr Val Pro Ser Gly Lys Giy Ser Thr Thr Pro Thr Lys Ala
195 200 205
Gly Val Ile Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly
210 215 220
Tyr Met Val His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val
225 230 235 240
Glu Cys Leu Gin Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys
245 250 255
Asn Asp Ile Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu
260 265 270
Glu Trp Ala Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly
275 280 285
Tyr Ala Arg Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln
290 295 300
Gly Gly Ser Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser
305 310 315 320
Asp Ala Leu Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg
325 330 335
Trp Cys Gly Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro
340 345 350
WO 96/10083 w 2 19 9 0 4 9 PCT/EP95/03826
-204-
Ser Leu Lys Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp
355 360 365
Lys Gly Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe
370 375 380
Gly Ser Arg Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr
385 390 395 400
Gly Ala Tyr Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile
405 410 415
Leu Leu Asp Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val
420 425 430
Ile Ile Lys Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr
435 440 445
Asn
(2) INFORMATION FOR SEQ ID N0:47:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 16 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: peptide
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: Peptide
(B) LOCATION: 1..16
(D) OTHER INFORMATION: /note= "linker peptide for fusion
of VIP1A(a) and VIP2A(a) used to construct pCIB5533"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:
Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Pro Thr Pro Ser
1 5 10 15
(2) INFORMATION FOR SEQ ID NO:48:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 66 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
WO 96/10083 2 1 9 9 0 4 9 1?CT/EP95/03826
-205-
(A) DESCRIPTION: /desc = "DNA encoding linker peptide
used to construct pCIB5533"
(iii) HYPOTHETICAL: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:
CCCGGGCCTT CTACTCCCCC AACTCCCTCT CCTAGCACGC CTCCGACACC TAGCGATATC 60
GGATCC 66
(2) INFORMATION FOR SEQ ID NO:49:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 4031 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "Synthetic DNA"
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 6..4019
(D) OTHER INFORMATION: /note= "Maize optimized DNA
sequence encoding a VIP2A(a) - VIP1A(a) fusion protein as
contained in pCIB5531"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:49:
GATCC ATG AAG CGC ATG GAG GGC AAG CTG TTC ATG GTG AGC AAG AAG 47
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys
450 455 460
CTC CAG GTG GTG ACC AAG ACC GTG CTG CTG AGC ACC GTG TTC AGC ATC 95
Leu Gln Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile
465 470 475
AGC CTG CTG AAC AAC GAG GTG ATC AAG GCC GAG CAG CTG AAC ATC AAC 143
Ser Leu Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu Asn Ile Asn
480 485 490 495
AGC CAG AGC AAG TAC ACC AAC CTC CAG AAC CTG AAG ATC ACC GAC AAG 191
Ser Gin Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys
500 505 510
GTG GAG GAC TTC AAG GAG GAC AAG GAG AAG GCC AAG GAG TGG GGC AAG 239
PGT/
PCT/]E"5/03826
WO 96/10083 i 2 199049
-206-
Val Glu Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys
515 520 525
GAG AAG GAG AAG GAG TGG AAG CTT ACC GCC ACC GAG AAG GGC AAG ATG 287
Glu Lys Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met
530 535 540
AAC AAC TTC CTG GAC AAC AAG AAC GAC ATC AAG ACC AAC TAC AAG GAG 335
Asn Asn Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu
545 550 555
ATC ACC TTC AGC ATA GCC GGC AGC TTC GAG GAC GAG ATC AAG GAC CTG 383
Ile Thr Phe Ser Ile Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu
560 565 570 575
AAG GAG ATC GAC AAG ATG TTC GAC AAG ACC AAC CTG AGC AAC AGC ATC 431
Lys Glu Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile
580 585 590
ATC ACC TAC AAG AAC GTG GAG CCC ACC ACC ATC GGC TTC AAC AAG AGC 479
Ile Thr Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser
595 600 605
CTG ACC GAG GGC AAC ACC ATC AAC AGC GAC GCC ATG GCC CAG TTC AAG 527
Leu Thr Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys
610 615 620
GAG CAG TTC CTG GAC CGC GAC ATC AAG TTC GAC AGC TAC CTG GAC ACC 575
Glu Gln Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr
625 630 635
CAC CTG ACC GCC CAG CAG GTG AGC AGC AAG GAG CGC GTG ATC CTG AAG 623
His Leu Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys
640 645 650 655
GTG ACC GTC CCC AGC GGC AAG GGC AGC ACC ACC CCC ACC AAG GCC GGC 671
Val Thr Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly
660 665 670
GTG ATC CTG AAC AAC AGC GAG TAC AAG ATG CTG ATC GAC AAC GGC TAC 719
Val Ile Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr
675 680 685
ATG GTG CAC GTG GAC AAG GTG AGC AAG GTG GTG AAG AAG GGC GTG GAG 767
Met Val His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Giu
690 695 700
TGC CTC CAG ATC GAG GGC ACC CTG AAG AAG AGT CTA GAC TTC AAG AAC 815
Cys Leu Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn
705 710 715
GAC ATC AAC GCC GAG GCC CAC AGC TGG GGC ATG AAG AAC TAC GAG GAG 863
Asp Ile Asn Ala Glu Ala His Ser Trp Giy Met Lys Asn Tyr Giu Glu
720 725 730 735
WO 96/10083 2 1 9 9 0 4 9 PGT/EP95/03826
-207-
TGG GCC AAG GAC CTG ACC GAC AGC CAG CGC GAG GCC CTG GAC GGC TAC 911
Trp Ala Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr
740 745 750
GCC CGC CAG GAC TAC AAG GAG ATC AAC AAC TAC CTG CGC AAC CAG GGC 959
Ala Arg Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly
755 760 765
GGC AGC GGC AAC GAG AAG CTG GAC GCC CAG ATC AAG AAC ATC AGC GAC 1007
Gly Ser Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp
770 775 780
GCC CTG GGC AAG AAG CCC ATC CCC GAG AAC ATC ACC GTG TAC CGC TGG 1055
Ala Leu Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp
785 790 795
TGC GGC ATG CCC GAG TTC GGC TAC CAG ATC AGC GAC CCC CTG CCC AGC 1103
Cys Gly Met Pro Glu Phe Gly Tyr Gin Ile Ser Asp Pro Leu Pro Ser
800 805 810 815
CTG AAG GAC TTC GAG GAG CAG TTC CTG AAC ACC ATC AAG GAG GAC AAG 1151
Leu Lys Asp Phe Glu Glu Gin Phe Leu Asn Thr Ile Lys Glu Asp Lys
820 825 830
GGC TAC ATG AGC ACC AGC CTG AGC AGC GAG CGC CTG GCC GCC TTC GGC 1199
Gly Tyr Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly
835 840 845
AGC CGC AAG ATC ATC CTG CGC CTG CAG GTG CCC AAG GGC AGC ACT GGT 1247
Ser Arg Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly
850 855 860
GCC TAC CTG AGC GCC ATC GGC GGC TTC GCC AGC GAG AAG GAG ATC CTG 1295
Ala Tyr Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu
865 870 875
CTG GAT AAG GAC AGC AAG TAC CAC ATC GAC AAG GTG ACC GAG GTG ATC 1343
Leu Asp Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile
880 885 890 895
ATC AAG GGC GTG AAG CGC TAC GTG GTG GAC GCC ACC CTG CTG ACC AAC 1391
Ile Lys Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn
900 905 910
TCC CGG GGG CCT TCT ACT CCC CCA ACT CCC TCT CCT AGC ACG CCT CCG 1439
Ser Arg Gly Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Pro
915 920 925
ACA CCT AGC GAT ATC GGA TCC ACC ATG AAG ACC AAC CAG ATC AGC ACC 1487
Thr Pro Ser Asp Ile Gly Ser Thr Met Lys Thr Asn Gln Ile Ser Thr
930 935 940
ACC CAG AAG AAC CAG CAG AAG GAG ATG GAC CGC AAG GGC CTG CTG GGC 1535
Thr Gln Lys Asn Gln Gln Lys Glu Met Asp Arg Lys Gly Leu Leu Gly
945 950 955
WO 96/10083 W 2 19 9 0 4 9 PCT/EP95/03826
- 208 -
TAC TAC TTC AAG GGC AAG GAC TTC AGC AAC CTG ACC ATG TTC GCC CCC 1583
Tyr Tyr Phe Lys Gly Lys Asp Phe Ser Asn Leu Thr Met Phe Ala Pro
960 965 970 975
ACG CGT GAC AGC ACC CTG ATC TAC GAC CAG CAG ACC GCC AAC AAG CTG 1631
Thr Arg Asp Ser Thr Leu Ile Tyr Asp Gln Gln Thr Ala Asn Lys Leu
980 985 990
CTG GAC AAG AAG CAG CAG GAG TAC CAG AGC ATC CGC TGG ATC GGC CTG 1679
Leu Asp Lys Lys Gln Gin Glu Tyr Gln Ser Ile Arg Trp Ile Gly Leu
995 1000 1005
ATC CAG AGC AAG GAG ACC GGC GAC TTC ACC TTC AAC CTG AGC GAG GAC 1727
Ile Gln Ser Lys Glu Thr Gly Asp Phe Thr Phe Asn Leu Ser Giu Asp
1010 1015 1020
GAG CAG GCC ATC ATC GAG ATC AAC GGC AAG ATC ATC AGC AAC AAG GGC 1775
Glu Gln Ala Ile Ile Glu Ile Asn Gly Lys Ile Ile Ser Asn Lys Gly
1025 1030 1035
AAG GAG AAG CAG GTG GTG CAC CTG GAG AAG GGC AAG CTG GTG CCC ATC 1823
Lys Glu Lys Gln Val Val His Leu Glu Lys Gly Lys Leu Val Pro Ile
1040 1045 1050 1055
AAG ATC GAG TAC CAG AGC GAC ACC AAG TTC AAC ATC GAC AGC AAG ACC 1871
Lys Ile Glu Tyr Gln Ser Asp Thr Lys Phe Asn Ile Asp Ser Lys Thr
1060 1065 1070
TTC AAG GAG CTG AAG CTT TTC AAG ATC GAC AGC CAG AAC CAG CCC CAG 1919
Phe Lys Glu Leu Lys Leu Phe Lys Ile Asp Ser Gln Asn Gin Pro Gln
1075 1080 1085
CAG GTG CAG CAG GAC GAG CTG CGC AAC CCC GAG TTC AAC AAG AAG GAG 1967
Gln Val Gln Gln Asp Glu Leu Arg Asn Pro Glu Phe Asn Lys Lys Glu
1090 1095 1100
AGC CAG GAG TTC CTG GCC AAG CCC AGC AAG ATC AAC CTG TTC ACC CAG 2015
Ser Gln Glu Phe Leu Ala Lys Pro Ser Lys Ile Asn Leu Phe Thr Gln
1105 1110 1115
CAG ATG AAG CGC GAG ATC GAC GAG GAC ACC GAC ACC GAC GGC GAC AGC 2063
Gln Met Lys Arg Glu Ile Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser
1120 1125 1130 1135
ATC CCC GAC CTG TGG GAG GAG AAC GGC TAC ACC ATC CAG AAC CGC ATC 2111
Ile Pro Asp Leu Trp Glu Glu Asn Gly Tyr Thr Ile Gln Asn Arg Ile
1140 1145 1150
GCC GTG AAG TGG GAC GAC AGC CTG GCT AGC AAG GGC TAC ACC AAG TTC 2159
Ala Val Lys Trp Asp Asp Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe
1155 1160 1165
GTG AGC AAC CCC CTG GAG AGC CAC ACC GTG GGC GAC CCC TAC ACC GAC 2207
Val Ser Asn Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp
WO 96/10083 2 1 9 9 A 4 9 PCT/EP95/03826
- 209 -
1170 1175 1180
TAC GAG AAG GCC GCC CGC GAC CTG GAC CTG AGC AAC GCC AAG GAG ACC 2255
Tyr Glu Lys Ala Ala Arg Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr
1185 1190 1195
TTC AAC CCC CTG GTG GCC GCC TTC CCC AGC GTG AAC GTG AGC ATG GAG 2303
Phe Asn Pro Leu Val Ala Ala Phe Pro Ser Val Asn Val Ser Met Giu
1200 1205 1210 1215
AAG GTG ATC CTG AGC CCC AAC GAG AAC CTG AGC AAC AGC GTG GAG AGC 2351
Lys Val Ile Leu Ser Pro Asn Glu Asn Leu Ser Asn Ser Val Glu Ser
1220 1225 1230
CAC TCG AGC ACC AAC TGG AGC TAC ACC AAC ACC GAG GGC GCC AGC GTG 2399
His Ser Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val
1235 1240 1245
GAG GCC GGC ATC GGT CCC AAG GGC ATC AGC TTC GGC GTG AGC GTG AAC 2447
Glu Ala Gly Ile Gly Pro Lys Gly Ile Ser Phe Gly Val Ser Val Asn
1250 1255 1260
TAC CAG CAC AGC GAG ACC GTG GCC CAG GAG TGG GGC ACC AGC ACC GGC 2495
Tyr Gln His Ser Glu Thr Val Ala Gin Glu Trp Gly Thr Ser Thr Gly
1265 1270 1275
AAC ACC AGC CAG TTC AAC ACC GCC AGC GCC GGC TAC CTG AAC GCC AAC 2543
Asn Thr Ser Gln Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn
1280 1285 1290 1295
GTG CGC TAC AAC AAC GTG GGC ACC GGC GCC ATC TAC GAC GTG AAG CCC 2591
Val Arg Tyr Asn Asn Val Gly Thr Gly Ala Ile Tyr Asp Val Lys Pro
1300 1305 1310
ACC ACC AGC TTC GTG CTG AAC AAC GAC ACC ATC GCC ACC ATC ACC GCC 2639
Thr Thr Ser Phe Val Leu Asn Asn Asp Thr Ile Ala Thr Ile Thr Ala
1315 1320 1325
AAG TCG AAT TCC ACC GCC CTG AAC ATC AGC CCC GGC GAG AGC TAC CCC 2687
Lys Ser Asn Ser Thr Ala Leu Asn Ile Ser Pro Gly Glu Ser Tyr Pro
1330 1335 1340
AAG AAG GGC CAG AAC GGC ATC GCC ATC ACC AGC ATG GAC GAC TTC AAC 2735
Lys Lys Gly Gln Asn Gly Ile Ala Ile Thr Ser Met Asp Asp Phe Asn
1345 1350 1355
AGC CAC CCC ATC ACC CTG AAC AAG AAG CAG GTG GAC AAC CTG CTG AAC 2783
Ser His Pro Ile Thr Leu Asn Lys Lys Gln Val Asp Asn Leu Leu Asn
1360 1365 1370 1375
AAC AAG CCC ATG ATG CTG GAG ACC AAC CAG ACC GAC GGC GTC TAC AAG 2831
Asn Lys Pro Met Met Leu Glu Thr Asn Gln Thr Asp Gly Val Tyr Lys
1380 1385 1390
ATC AAG GAC ACC CAC GGC AAC ATC GTG ACG GGC GGC GAG TGG AAC GGC 2879
WO 96/10083 " 2 1 9 9 0 4 9 PCT/EP95/03826
-210-
Ile Lys Asp Thr His Gly Asn Ile Val Thr Gly Gly Glu Trp Asn Gly
1395 1400 1405
GTG ATC CAG CAG ATC AAG GCC AAG ACC GCC AGC ATC ATC GTC GAC GAC 2927
Val Ile Gln Gln Ile Lys Ala Lys Thr Ala Ser Ile Ile Val Asp Asp
1410 1415 1420
GGC GAG CGC GTG GCC GAG AAG CGC GTG GCC GCC AAG GAC TAC GAG AAC 2975
Gly Glu Arg Val Ala Glu Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn
1425 1430 1435
CCC GAG GAC AAG ACC CCC AGC CTG ACC CTG AAG GAC GCC CTG AAG CTG 3023
Pro Glu Asp Lys Thr Pro Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu
1440 1445 1450 1455
AGC TAC CCC GAC GAG ATC AAG GAG ATC GAG GGC TTG CTG TAC TAC AAG 3071
Ser Tyr Pro Asp Glu Ile Lys Glu Ile Glu Gly Leu Leu Tyr Tyr Lys
1460 1465 1470
AAC AAG CCC ATC TAC GAG AGC AGC GTG ATG ACC TAT CTA GAC GAG AAC 3119
Asn Lys Pro Ile Tyr Glu Ser Ser Val Met Thr Tyr Leu Asp Glu Asn
1475 1480 1485
ACC GCC AAG GAG GTG ACC AAG CAG CTG AAC GAC ACC ACC GGC AAG TTC 3167
Thr Ala Lys Glu Val Thr Lys Gln Leu Asn Asp Thr Thr Gly Lys Phe
1490 1495 1500
AAG GAC GTG AGC CAC CTG TAC GAC GTG AAG CTG ACC CCC AAG ATG AAC 3215
Lys Asp Val Ser His Leu Tyr Asp Val Lys Leu Thr Pro Lys Met Asn
1505 1510 1515
GTG ACC ATC AAG CTG AGC ATC CTG TAC GAC AAC GCC GAG AGC AAC GAC 3263
Val Thr Ile Lys Leu Ser Ile Leu Tyr Asp Asn Ala Glu Ser Asn Asp
1520 1525 1530 1535
AAC AGC ATC GGC AAG TGG ACC AAC ACC AAC ATC GTG AGC GGC GGC AAC 3311
Asn Ser Ile Gly Lys Trp Thr Asn Thr Asn Ile Val Ser Gly Gly Asn
1540 1545 1550
AAC GGC AAG AAG CAG TAC AGC AGC AAC AAC CCC GAC GCC AAC CTG ACC 3359
Asn Gly Lys Lys Gln Tyr Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr
1555 1560 1565
CTG AAC ACC GAC GCC CAG GAG AAG CTG AAC AAG AAC CGC GAC TAC TAC 3407
Leu Asn Thr Asp Ala Gln Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr
1570 1575 1580
ATC AGC CTG TAC ATG AAG AGC GAG AAG AAC ACC CAG TGC GAG ATC ACC 3455
Ile Ser Leu Tyr Met Lys Ser Glu Lys Asn Thr Gln Cys Glu Ile Thr
1585 1590 1595
ATC GAC GGC GAG ATA TAC CCC ATC ACC ACC AAG ACC GTG AAC GTG AAC 3503
Ile Asp Gly Glu Ile Tyr Pro Ile Thr Thr Lys Thr Val Asn Val Asn
1600 1605 1610 1615
WO 96/10083 2 1 9 9 0 4 9 PCT/EP"/03826
-211 -
AAG GAC AAC TAC AAG CGC CTG GAC ATC ATC GCC CAC AAC ATC AAG AGC 3551
Lys Asp Asn Tyr Lys Arg Leu Asp Ile Ile Ala His Asn Ile Lys Ser
1620 1625 1630
AAC CCC ATC AGC AGC CTG CAC ATC AAG ACC AAC GAC GAG ATC ACC CTG 3599
Asn Pro Ile Ser Ser Leu His Ile Lys Thr Asn Asp Glu Ile Thr Leu
1635 1640 1645
TTC TGG GAC GAC ATA TCG ATT ACC GAC GTC GCC AGC ATC AAG CCC GAG 3647
Phe Trp Asp Asp Ile Ser Ile Thr Asp Val Ala Ser Ile Lys Pro Glu
1650 1655 1660
AAC CTG ACC GAC AGC GAG ATC AAG CAG ATA TAC AGT CGC TAC GGC ATC 3695
Asn Leu Thr Asp Ser Glu Ile Lys Gln Ile Tyr Ser Arg Tyr Gly Ile
1665 1670 = 1675
AAG CTG GAG GAC GGC ATC CTG ATC GAC AAG AAA GGC GGC ATC CAC TAC 3743
Lys Leu Glu Asp Gly Ile Leu Ile Asp Lys Lys Gly Giy Ile His Tyr
1680 1685 1690 1695
GGC GAG TTC ATC AAC GAG GCC AGC TTC AAC ATC GAG CCC CTG CAG AAC 3791
Gly Glu Phe Ile Asn Glu Ala Ser Phe Asn Ile Glu Pro Leu Gln Asn
1700 1705 1710
TAC GTG ACC AAG TAC GAG GTG ACC TAC AGC AGC GAG CTG GGC CCC AAC 3839
Tyr Val Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly Pro Asn
1715 1720 1725
GTG AGC GAC ACC CTG GAG AGC GAC AAG ATT TAC AAG GAC GGC ACC ATC 3887
Val Ser Asp Thr Leu Glu Ser Asp Lys Ile Tyr Lys Asp Gly Thr Ile
1730 1735 1740
AAG TTC GAC TTC ACC AAG TAC AGC AAG AAC GAG CAG GGC CTG TTC TAC 3935
Lys Phe Asp Phe Thr Lys Tyr Ser Lys Asn Glu Gln Gly Leu Phe Tyr
1745 1750 1755
GAC AGC GGC CTG AAC TGG GAC TTC AAG ATC AAC GCC ATC ACC TAC GAC 3983
Asp Ser Gly Leu Asn Trp Asp Phe Lys Ile Asn Ala Ile Thr Tyr Asp
1760 1765 1770 1775
GGC AAG GAG ATG AAC GTG TTC CAC CGC TAC AAC AAG TAGATCTGAG 4029
Gly Lys Glu Met Asn Val Phe His Arg Tyr Asn Lys
1780 1785
CT 4031
(2) INFORMATION FOR SEQ ID NO:50:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1338 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
WO 96/10083 Z19 9 0 4 9 PCT/EP95/03826
-212-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:
Met Lys Arg Met Glu Gly Lys Leu Phe Met Val Ser Lys Lys Leu Gln
1 5 10 15
Val Val Thr Lys Thr Val Leu Leu Ser Thr Val Phe Ser Ile Ser Leu
20 25 30
Leu Asn Asn Glu Val Ile Lys Ala Glu Gln Leu Asn Ile Asn Ser Gln
35 40 45
Ser Lys Tyr Thr Asn Leu Gln Asn Leu Lys Ile Thr Asp Lys Val Glu
50 55 60
Asp Phe Lys Glu Asp Lys Glu Lys Ala Lys Glu Trp Gly Lys Glu Lys
65 70 75 80
Glu Lys Glu Trp Lys Leu Thr Ala Thr Glu Lys Gly Lys Met Asn Asn
85 90 95
Phe Leu Asp Asn Lys Asn Asp Ile Lys Thr Asn Tyr Lys Glu Ile Thr
100 105 110
Phe Ser Ile Ala Gly Ser Phe Glu Asp Glu Ile Lys Asp Leu Lys Glu
115 120 125
Ile Asp Lys Met Phe Asp Lys Thr Asn Leu Ser Asn Ser Ile Ile Thr
130 135 140
Tyr Lys Asn Val Glu Pro Thr Thr Ile Gly Phe Asn Lys Ser Leu Thr
145 150 155 160
Glu Gly Asn Thr Ile Asn Ser Asp Ala Met Ala Gln Phe Lys Glu Gln
165 170 175
Phe Leu Asp Arg Asp Ile Lys Phe Asp Ser Tyr Leu Asp Thr His Leu
180 185 190
Thr Ala Gln Gln Val Ser Ser Lys Glu Arg Val Ile Leu Lys Val Thr
195 200 205
Val Pro Ser Gly Lys Gly Ser Thr Thr Pro Thr Lys Ala Gly Val Ile
210 215 220
Leu Asn Asn Ser Glu Tyr Lys Met Leu Ile Asp Asn Gly Tyr Met Val
225 230 235 240
His Val Asp Lys Val Ser Lys Val Val Lys Lys Gly Val Glu Cys Leu
245 250 255
Gln Ile Glu Gly Thr Leu Lys Lys Ser Leu Asp Phe Lys Asn Asp Ile
260 265 270
Asn Ala Glu Ala His Ser Trp Gly Met Lys Asn Tyr Glu Glu Trp Ala
WO 96/10083 '2 1 9 0. 4 9 PCTIEP95/03826
-213-
275 280 285
Lys Asp Leu Thr Asp Ser Gln Arg Glu Ala Leu Asp Gly Tyr Ala Arg
290 295 300
Gln Asp Tyr Lys Glu Ile Asn Asn Tyr Leu Arg Asn Gln Gly Gly Ser
305 310 315 320
Gly Asn Glu Lys Leu Asp Ala Gln Ile Lys Asn Ile Ser Asp Ala Leu
325 330 335
Gly Lys Lys Pro Ile Pro Glu Asn Ile Thr Val Tyr Arg Trp Cys Gly
340 345 350
Met Pro Glu Phe Gly Tyr Gln Ile Ser Asp Pro Leu Pro Ser Leu Lys
355 360 365
Asp Phe Glu Glu Gln Phe Leu Asn Thr Ile Lys Glu Asp Lys Gly Tyr
370 375 380
Met Ser Thr Ser Leu Ser Ser Glu Arg Leu Ala Ala Phe Gly Ser Arg
385 390 395 400
Lys Ile Ile Leu Arg Leu Gln Val Pro Lys Gly Ser Thr Gly Ala Tyr
405 410 415
Leu Ser Ala Ile Gly Gly Phe Ala Ser Glu Lys Glu Ile Leu Leu Asp
420 425 430
Lys Asp Ser Lys Tyr His Ile Asp Lys Val Thr Glu Val Ile Ile Lys
435 440 445
Gly Val Lys Arg Tyr Val Val Asp Ala Thr Leu Leu Thr Asn Ser Arg
450 455 460
Gly Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Pro Thr Pro
465 470 475 480
Ser Asp Ile Gly Ser Thr Met Lys Thr Asn Gln Ile Ser Thr Thr Gln
485 490 495
Lys Asn Gln Gln Lys Giu Met Asp Arg Lys Gly Leu Leu Gly Tyr Tyr
500 505 510
Phe Lys Gly Lys Asp Phe Ser Asn Leu Thr Met Phe Ala Pro Thr Arg
515 520 525
Asp Ser Thr Leu Ile Tyr Asp Gln Gln Thr Ala Asn Lys Leu Leu Asp
530 535 540
Lys Lys Gin Gln Glu Tyr Gin Ser Ile Arg Trp Ile Gly Leu Ile Gln
545 550 555 560
Ser Lys Glu Thr Gly Asp Phe Thr Phe Asn Leu Ser Glu Asp Glu Gln
565 570 575
WO 96/10083 w-v 2 1 9 9 0 4- 9"' PCT/EP95/03826
-214-
Ala Ile Ile Glu Ile Asn Gly Lys Ile Ile Ser Asn Lys Gly Lys Glu
580 585 590
Lys Gln Val Val His Leu Glu Lys Gly Lys Leu Val Pro Ile Lys Ile
595 600 605
Glu Tyr Gln Ser Asp Thr Lys Phe Asn Ile Asp Ser Lys Thr Phe Lys
610 615 620
Glu Leu Lys Leu Phe Lys Ile Asp Ser Gln Asn Gln Pro Gln Gln Val
625 630 635 640
Gln Gln Asp Glu Leu Arg Asn Pro Glu Phe Asn Lys Lys Glu Ser Gln
645 650 655
Glu Phe Leu Ala Lys Pro Ser Lys Ile Asn Leu Phe Thr Gln Gln Met
660 665 670
Lys Arg Glu Ile Asp Glu Asp Thr Asp Thr Asp Gly Asp Ser Ile Pro
675 680 685
Asp Leu Trp Glu Glu Asn Gly Tyr Thr Ile Gln Asn Arg Ile Ala Val
690 695 700
Lys Trp Asp Asp Ser Leu Ala Ser Lys Gly Tyr Thr Lys Phe Val Ser
705 710 715 720
Asn Pro Leu Glu Ser His Thr Val Gly Asp Pro Tyr Thr Asp Tyr Glu
725 730 735
Lys Ala Ala Arg Asp Leu Asp Leu Ser Asn Ala Lys Glu Thr Phe Asn
740 745 750
Pro Leu Val Ala Ala Phe Pro Ser Val Asn Val Ser Met Glu Lys Val
755 760 765
Ile Leu Ser Pro Asn Glu Asn Leu Ser Asn Ser Val Glu Ser His Ser
770 775 780
Ser Thr Asn Trp Ser Tyr Thr Asn Thr Glu Gly Ala Ser Val Glu Ala
785 790 795 800
Gly Ile Gly Pro Lys Gly Ile Ser Phe Gly Val Ser Val Asn Tyr Gln
805 810 815
His Ser Glu Thr Val Ala Gln Glu Trp Gly Thr Ser Thr Gly Asn Thr
820 825 830
Ser Gln Phe Asn Thr Ala Ser Ala Gly Tyr Leu Asn Ala Asn Val Arg
835 840 845
Tyr Asn Asn Val Gly Thr Gly Ala Ile Tyr Asp Val Lys Pro Thr Thr
850 855 860
WO 96/10083 2 19,9 0 4_ 9 PCT/EP95/03826
-215-
Set Phe Val Leu Asn Asn Asp Thr Ile Ala Thr Ile Thr Ala Lys Ser
865 870 875 880
Asn Ser Thr Ala Leu Asn Ile Ser Pro Gly Glu Ser Tyr Pro Lys Lys
885 890 895
Gly Gln Asn Gly Ile Ala Ile Thr Ser Met Asp Asp Phe Asn Ser His
900 905 910
Pro Ile Thr Leu Asn Lys Lys Gln Val Asp Asn Leu Leu Asn Asn Lys
915 920 925
Pro Met Met Leu Glu Thr Asn Gln Thr Asp Gly Val Tyr Lys Ile Lys
930 935 940
Asp Thr His Gly Asn Ile Val Thr Gly Gly Glu Trp Asn Gly Val Ile
945 950 955 960
Gln Gln Ile Lys Ala Lys Thr Ala Ser Ile Ile Val Asp Asp Gly Glu
965 970 975
Arg Val Ala Glu Lys Arg Val Ala Ala Lys Asp Tyr Glu Asn Pro Glu
980 985 990
Asp Lys Thr Pro Ser Leu Thr Leu Lys Asp Ala Leu Lys Leu Ser Tyr
995 1000 1005
Pro Asp Glu Ile Lys Glu Ile Glu Gly Leu Leu Tyr Tyr Lys Asn Lys
1010 1015 1020
Pro Ile Tyr Glu Ser Ser Val Met Thr Tyr Leu Asp Glu Asn Thr Ala
1025 1030 1035 1040
Lys Glu Val Thr Lys Gln Leu Asn Asp Thr Thr Gly Lys Phe Lys Asp
1045 1050 1055
Val Ser His Leu Tyr Asp Val Lys Leu Thr Pro Lys Met Asn Val Thr
1060 1065 1070
Ile Lys Leu Ser Ile Leu Tyr Asp Asn Ala Glu Ser Asn Asp Asn Ser
1075 1080 1085
Ile Gly Lys Trp Thr Asn Thr Asn Ile Val Ser Gly Gly Asn Asn Gly
1090 1095 1100
Lys Lys Gln Tyr Ser Ser Asn Asn Pro Asp Ala Asn Leu Thr Leu Asn
1105 1110 1115 1120
Thr Asp Ala Gln Glu Lys Leu Asn Lys Asn Arg Asp Tyr Tyr Ile Ser
1125 1130 1135
Leu Tyr Met Lys Ser Glu Lys Asn Thr Gln Cys Glu Ile Thr Ile Asp
1140 1145 1150
Gly Glu Ile Tyr Pro Ile Thr Thr Lys Thr Val Asn Val Asn Lys Asp
WO 96/10083 ~. 1 1 9 0 4 9 PCT/EP95/03826
-216-
1155 1160 1165
Asn Tyr Lys Arg Leu Asp Ile Ile Ala His Asn Ile Lys Ser Asn Pro
1170 1175 1180
Ile Ser Ser Leu His Ile Lys Thr Asn Asp Glu Ile Thr Leu Phe Tip
1185 1190 1195 1200
Asp Asp Ile Ser Ile Thr Asp Val Ala Ser Ile Lys Pro Glu Asn Leu
1205 1210 1215
Thr Asp Ser Glu Ile Lys Gln Ile Tyr Ser Arg Tyr Gly Ile Lys Leu
1220 1225 1230
Glu Asp Gly Ile Leu Ile Asp Lys Lys Gly Gly Ile His Tyr Gly Glu
1235 1240 1245
Phe Ile Asn Glu Ala Ser Phe Asn Ile Glu Pro Leu Gln Asn Tyr Val
1250 1255 1260
Thr Lys Tyr Glu Val Thr Tyr Ser Ser Glu Leu Gly Pro Asn Val Ser
1265 1270 1275 1280
Asp Thr Leu Glu Ser Asp Lys Ile Tyr Lys Asp Gly Thr Ile Lys Phe
1285 1290 1295
Asp Phe Thr Lys Tyr Ser Lys Asn Glu Gln Gly Leu Phe Tyr Asp Ser
1300 1305 1310
Gly Leu Asn Tip Asp Phe Lys Ile Asn Ala Ile Thr Tyr Asp Gly Lys
1315 1320 1325
Glu Met Asn Val Phe His Arg Tyr Asn Lys
1330 1335
(2) INFORMATION FOR SEQ ID NO:51:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2444 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION: 17..2444
(D) OTHER INFORMATION: /product= "3A(a) synthetic:native
fusion"
WO 96/10083 2 1 9 9 0 4 9 PCT/EP95/03826
-217-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:51:
GGATCCACCA ATGAAC ATG AAC AAG AAC AAC ACC AAG CTG AGC ACC CGC 49
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg
1 5 10
GCC CTG CCG AGC TTC ATC GAC TAC TTC AAC GGC ATC TAC GGC TTC GCC 97
Ala Leu Pro Ser Phe Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala
15 20 25
ACC GGC ATC AAG GAC ATC ATG AAC ATG ATC TTC AAG ACC GAC ACC GGC 145
Thr Gly Ile Lys Asp Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly
30 35 40
GGC GAC CTG ACC CTG GAC GAG ATC CTG AAG AAC CAG CAG CTG CTG AAC 193
Gly Asp Leu Thr Leu Asp Glu Ile Leu Lys Asn Gin Gln Leu Leu Asn
45 50 55
GAC ATC AGC GGC AAG CTG GAC GGC GTG AAC GGC AGC CTG AAC GAC CTG 241
Asp Ile Ser Gly Lys Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu
60 65 70. 75
ATC GCC CAG GGC AAC CTG AAC ACC GAG CTG AGC AAG GAG ATC CTT AAG 289
Ile Ala Gin Gly Asn Leu Asn Thr Glu Ieu Ser Lys Glu Ile Leu Lys
80 85 90
ATC GCC AAC GAG CAG AAC CAG GTG CTG AAC GAC GTG AAC AAC AAG CTG 337
Ile Ala Asn Glu Gln Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu
95 100 105
GAC GCC ATC AAC ACC ATG CTG CGC GTG TAC CTG CCG AAG ATC ACC AGC 385
Asp Ala Ile Asn Thr Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser
110 115 120
ATG CTG AGC GAC GTG ATG AAG CAG AAC TAC GCC CTG AGC CTG CAG ATC 433
Met Leu Ser Asp Val Met Lys Gln Asn Tyr Ala Leu Ser Leu Gln Ile
125 130 135
GAG TAC CTG AGC AAG CAG CTG CAG GAG ATC AGC GAC AAG CTG GAC ATC 481
Glu Tyr Leu Ser Lys Gin Leu Gin Glu Ile Ser Asp Lys Leu Asp Ile
140 145 150 155
ATC AAC GTG AAC GTC CTG ATC AAC AGC ACC CTG ACC GAG ATC ACC CCG 529
Ile Asn Val Asn Val Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro
160 165 170
GCC TAC CAG CGC ATC AAG TAC GTG AAC GAG AAG TTC GAA GAG CTG ACC 577
Ala Tyr Gln Arg Ile Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr
175 180 185
TTC GCC ACC GAG ACC AGC AGC AAG GTG AAG AAG GAC GGC AGC CCG GCC 625
Phe Ala Thr Glu Thr Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala
190 195 200
GAC ATC CTG GAC GAG CTG ACC GAG CTG ACC GAG CTG GCC AAG AGC GTG 673
WO 96/10083 ir- 2 1 9 9 0 4 9 PCr/EP95/03826
-218-
Asp Ile Leu Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val
205 210 215
ACC AAG AAC GAC GTG GAC GGC TTC GAG TTC TAC CTG AAC ACC TTC CAC 721
Thr Lys Asn Asp Val Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His
220 225 230 235
GAC GTG ATG GTG GGC AAC AAC CTG TTC GGC CGC AGC GCC CTG AAG ACC 769
Asp Val Met Val Gly Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr
240 245 250
GCC AGC GAG CTG ATC ACC AAG GAG AAC GTG AAG ACC AGC GGC AGC GAG 817
Ala Ser Glu Leu Ile Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu
255 260 265
GTG GGC AAC GIG TAC AAC TTC CTG ATC GIG CTG ACC GCC CTG CAG GCC 865
Val Gly Asn Val Tyr Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala
270 275 280
CAG GCC TTC CTG ACC CTG ACC ACC TGT CGC AAG CTG CTG GGC CTG GCC 913
Gln Ala Phe Leu Thr Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala
285 290 295
GAC ATC GAC TAC ACC AGC ATC ATG AAC GAG CAC TTG AAC AAG GAG AAG 961
Asp Ile Asp Tyr Thr Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys
300 305 310 315
GAG GAG TTC CGC GTG AAC ATC CTG CCG ACC CTG AGC AAC ACC TTC AGC 1009
Glu Glu Phe Arg Val Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser
320 325 330
AAC CCG AAC TAC GCC AAG GTG AAG GGC AGC GAC GAG GAC GCC AAG ATG 1057
Asn Pro Asn Tyr Ala Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met
335 340 345
ATC GTG GAG GCT AAG CCG GGC CAC GCG TTG ATC GGC TTC GAG ATC AGC 1105
Ile Val Glu Ala Lys Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser
350 355 360
AAC GAC AGC ATC ACC GTG CTG AAG GTG TAC GAG GCC AAG CTG AAG CAG 1153
Asn Asp Ser Ile Thr Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin
365 370 375
AAC TAC CAG GTG GAC AAG GAC AGC TTG AGC GAG GTG ATC TAC GGC GAC 1201
Asn Tyr Gln Val Asp Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp
380 385 390 395
ATG GAC AAG CTG CTG TGT CCG GAC CAG AGC GAG CAA ATC TAC TAC ACC 1249
Met Asp Lys Leu Leu Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr
400 405 410
AAC AAC ATC GTG TTC CCG AAC GAG TAC GTG ATC ACC AAG ATC GAC TTC 1297
Asn Asn Ile Val Phe Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe
415 420 425
WO 96/10083 2 1 9 9 0 4 9 PCT/E"5/03826
-219-
ACC AAG AAG ATG AAG ACC CTG CGC TAC GAG GTG ACC GCC AAC TTC TAC 1345
Thr Lys Lys Met Lys Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr
430 435 440
GAC AGC AGC ACC GGC GAG ATC CAC CTG AAC AAG AAG AAG GTG GAG AGC 1393
Asp Ser Ser Thr Gly Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser
445 450 455
AGC GAG GCC GAG TAC CGC ACC CTG AGC GCG AAC GAC GAC GGC GTC TAC 1441
Ser Glu Ala Glu Tyr Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr
460 465 470 475
ATG CCA CTG GGC GTG ATC AGC GAG ACC TTC CTG ACC CCG ATC AAC GGC 1489
Met Pro Leu Gly Val Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly
480 485 490
TIT GGC CTG CAG GCC GAC GAG AAC AGC CGC CTG ATC ACC CTG ACC TGT 1537
Phe Gly Leu Gln Ala Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys
495 500 505
AAG AGC TAC CTG CGC GAG CTG CTG CTA GCC ACC GAC CTG AGC AAC AAG 1585
Lys Ser Tyr Leu Arg Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys
510 515 520
GAG ACC AAG CTG ATC GTG CCA CCG AGC GGC TTC ATC AGC AAC ATC GTG 1633
Glu Thr Lys Leu Ile Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val
525 530 535
GAG AAC GGC AGC ATC GAG GAG GAC AAC CTG GAG CCG TGG AAG GCC AAC 1681
Glu Asn Gly Ser Ile Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn
540 545 550 555
AAC AAG AAC GCC TAC GTG GAC CAC ACC GGC GGC GTG AAC GGC ACC AAG 1729
Asn Lys Asn Ala Tyr Val Asp His Thr Gly Gly Val Asn Gly Thr Lys
560 565 570
GCC CTG TAC GTG CAC AAG GAC GGC GGC ATC AGC CAG TTC ATC GGC GAC 1777
Ala Leu Tyr Val His Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp
575 580 585
AAG CTG AAG CCG AAG ACC GAG TAC GTG ATC CAG TAC ACC GTG AAG GGC 1825
Lys Leu Lys Pro Lys Thr Glu Tyr Val Ile Gin Tyr Thr Val Lys Gly
590 595 600
AAG CCA TCG ATT CAC CTG AAG GAC GAG AAC ACC GGC TAC ATC CAC TAC 1873
Lys Pro Ser Ile His Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr
605 610 615
GAG GAC ACC AAC AAC AAC CTG GAG GAC TAC CAG ACC ATC AAC AAG CGC 1921
Glu Asp Thr Asn Asn Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg
620 625 630 635
TTC ACC ACC GGC ACC GAC CTG AAG GGC GTG TAC CTG ATC CTG AAG AGC 1969
Phe Thr Thr Gly Thr Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser
640 645 650
WO 96/1008sll- 1 9 9 049
PCT/EP95/03826
-220 -
CAG AAC GGC GAC GAG GCC TGG GGC GAC AAC TTC ATC ATC CTG GAG ATC 2017
Gln Asn Gly Asp Glu Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile
655 660 665
AGC CCG AGC GAG AAG CTG CTG AGC CCG GAG CTG ATC AAC ACC AAC AAC 2065
Ser Pro Ser Glu Lys Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn
670 675 680
TGG ACC AGC ACC GGC AGC ACC AAC ATC AGC GGC AAC ACC CTG ACC CTG 2113
Trp Thr Ser Thr Gly Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu
685 690 695
TAC CAG GGC GGC CGG GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT 2161
Tyr Gln Gly Gly Arg Gly Ile Leu Lys Gin Asn Leu Gln Leu Asp Ser
700 705 710 715
TTT TCA ACT TAT AGA GTG TAT TTT TCT GTG TCC GGA GAT GCT AAT GTA 2209
Phe Ser Thr Tyr Arg Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val
720 725 730
AGG ATT AGA AAT TCT AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC 2257
Arg Ile Arg Asn Ser Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser
735 740 745
GGT GCT AAA GAT GTT TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT 2305
Gly Ala Lys Asp Val Ser Glu Net Phe Thr Thr Lys Phe Glu Lys Asp
750 755 760
AAC TTT TAT ATA GAG CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT 2353
Asn Phe Tyr Ile Glu Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro
765 770 775
ATT GTA CAT TTT TAC GAT GTC TCT ATT AAG NAA GAT CGG GAT CTA ATA 2401
Ile Val His Phe Tyr Asp Val Ser Ile Lys Xaa Asp Arg Asp Leu Ile
780 785 790 795
TTA ACA GTT TTT AAA AGC NAA TTC TTG TAT AAT GTC CTT GAT T 2444
Leu Thr Val Phe Lys Ser Xaa Phe Leu Tyr Asn Val Leu Asp
800 805
(2) INFORMATION FOR SEQ ID NO:52:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 809 amino acids
(B) TYPE: amino acid
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:52:
Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe
1 5 10 15
WO 96/10083 9 9,0 4 9
PCT/EP95/03826
221-
Ile Asp Tyr Phe Asn Gly Ile Tyr Gly Phe Ala Thr Gly Ile Lys Asp
20 25 30
Ile Met Asn Met Ile Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu
35 40 45
Asp Glu Ile Leu Lys Asn Gln Gln Leu Leu Asn Asp Ile Ser Gly Lys
50 55 60
Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu Ile Ala Gln Gly Asn
65 70 75 80
Leu Asn Thr Glu Leu Ser Lys Glu Ile Leu Lys Ile Ala Asn Glu Gin
85 90 95
Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala Ile Asn Thr
100 105 110
Met Leu Arg Val Tyr Leu Pro Lys Ile Thr Ser Met Leu Ser Asp Val
115 120 125
Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin Ile Glu Tyr Leu Ser Lys
130 135 140
Gin Leu Gin Glu Ile Ser Asp Lys Leu Asp Ile Ile Asn Val Asn Val
145 150 155 160
Leu Ile Asn Ser Thr Leu Thr Glu Ile Thr Pro Ala Tyr Gln Arg Ile
165 170 175
Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr
180 185 190
Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp Ile Leu Asp Glu
195 200 205
Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val
210 215 220
Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly
225 230 235 240
Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu Ile
245 250 255
Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr
260 265 270
Asn Phe Leu Ile Val Leu Thr Ala Leu Gln Ala Gln Ala Phe Leu Thr
275 280 285
Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp Ile Asp Tyr Thr
290 295 300
WO 96/1QOt 9 PCT/EP95/03826
1 2 199 49
- 222 -
Ser Ile Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val
305 31C 315 320
Asn Ile Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala
325 330 335
Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met Ile Val Glu Ala Lys
340 345 350
Pro Gly His Ala Leu Ile Gly Phe Glu Ile Ser Asn Asp Ser Ile Thr
355 360 365
Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gln Asn Tyr Gln Val Asp
370 375 380
Lys Asp Ser Leu Ser Glu Val Ile Tyr Gly Asp Met Asp Lys Leu Leu
385 390 395 400
Cys Pro Asp Gln Ser Glu Gln Ile Tyr Tyr Thr Asn Asn Ile Val Phe
405 410 415
Pro Asn Glu Tyr Val Ile Thr Lys Ile Asp Phe Thr Lys Lys Met Lys
420 425 430
Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly
435 440 445
Glu Ile Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr
450 455 460
Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val
465 470 475 480
Ile Ser Glu Thr Phe Leu Thr Pro Ile Asn Gly Phe Gly Leu Gln Ala
485 490 495
Asp Glu Asn Ser Arg Leu Ile Thr Leu Thr Cys Lys Ser Tyr Leu Arg
500 505 510
Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu Ile
515 520 525
Val Pro Pro Ser Gly Phe Ile Ser Asn Ile Val Glu Asn Gly Ser Ile
530 535 540
Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr
545 550 555 560
Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His
565 570 575
Lys Asp Gly Gly Ile Ser Gln Phe Ile Gly Asp Lys Leu Lys Pro Lys
580 585 590
Thr Glu Tyr Val Ile Gln Tyr Thr Val Lys Gly Lys Pro Ser Ile His
w 21990449
WO 96/10083 PGT/EP95/03826
- 223 -
595 600 605
Leu Lys Asp Glu Asn Thr Gly Tyr Ile His Tyr Glu Asp Thr Asn Asn
610 615 620
Asn Leu Glu Asp Tyr Gln Thr Ile Asn Lys Arg Phe Thr Thr Gly Thr
625 630 635 640
Asp Leu Lys Gly Val Tyr Leu Ile Leu Lys Ser Gln Asn Gly Asp Glu
645 650 655
Ala Trp Gly Asp Asn Phe Ile Ile Leu Glu Ile Ser Pro Ser Glu Lys
660 665 670
Leu Leu Ser Pro Glu Leu Ile Asn Thr Asn Asn Trp Thr Ser Thr Gly
675 680 685
Ser Thr Asn Ile Ser Gly Asn Thr Leu Thr Leu Tyr Gln Gly Gly Arg
690 695 700
Gly Ile Leu Lys Gln Asn Leu Gln Leu Asp Ser Phe Ser Thr Tyr Arg
705 710 715 720
Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg Ile Arg Asn Ser
725 730 735
Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val
740 745 750
Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr Ile Glu
755 760 765
Leu Ser Gln Gly Asn Asn Leu Tyr Gly Gly Pro Ile Val His Phe Tyr
770 775 780
Asp Val Ser Ile Lys Xaa Asp Arg Asp Leu Ile Leu Thr Val Phe Lys
785 790 795 800
Ser Xaa Phe Leu Tyr Asn Val Leu Asp
805
